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General Introduction 
The loss or failure of an organ or tissue is one of the most important problems in human 
health care. Because of the shortage of organs and tissues available for donation, physicians and 
scientists are searching for alternatives.  
Tissue engineering applies the principles of biology and engineering to the development of 
functional substitutes for damaged tissue. Current tissue engineering approach consists in 
combining cells, engineering and biomaterials to improve the biological functions of damaged 
tissues or to replace them. Production of “artificial tissues” is still challenging and requires 
collaboration of scientists from different domains like cell biology, chemistry, materials and 
polymer science. 
Different types of tissues may be engineered by this approach, and among them skeletal 
muscle, which is one of the major tissues of the human body. Skeletal muscle tissue engineering 
holds promise for the replacement of muscle due to an injury following a surgery or due to a 
trauma, and for the treatment of muscle diseases, such as muscle dystrophies or paralysis. 
Engineered muscle tissues models are also required for pharmaceutical assays and fundamental 
studies of muscle regeneration.  
Satellite cells, muscle stem cells, are now considered as a powerful source for the 
regeneration of skeletal muscle, but also of several other tissues. A major limitation to the study 
and clinical applications of satellite cells consists in a rapid lost of their stem properties in vitro. 
The development of skeletal muscle is known to strongly depend on the interaction of muscle 
cells with their surrounding extracellular matrix (ECM), which provides them a variety of 
physical and biochemical signals. These are now recognized as being key parameters in 
numerous cellular processes, from adhesion to regulation of the cell fate. Moreover, mature 
skeletal muscle has a complex three-dimensional (3D) organization of aligned muscle fibers 
surrounded by ECM.  
Thus, engineering of a functional muscular tissue requires complex environments 
mimicking in vivo niche, to control cell adhesion, proliferation, differentiation and properly 
organize the cells. To this end, materials with tunable mechanical and chemical/biochemical 
properties for myoblast expansion and differentiation in vitro, as well as for the studies of 
myogenesis on controlled 2D microenvironments or in 3D scaffolds, are crucially needed.  
In this context, layer-by-layer (LbL) films offer numerous possibilities for the development 
of substrates with well-controlled mechanical and biochemical properties. The technique was 
introduced in the early 1990s and has attracted an increasing number of researchers in recent 
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years due to its high versatility and wide range of advantages they present for biomedical 
applications. Polyelectrolyte multilayer (PEM) films are currently emerging as a new kind of 
biomaterials coating that can be used to guide cell fate. They can be used either as 2D materials 
for investigation of cellular behavior on defined substrates, or for coating of 3D constructions 
such as implants or tissue engineering scaffolds. 
In this thesis work, we used layer-by-layer (LbL) assemblies for two goals. The first 
consisted in the development of multifunctional biomimetic thin films for the control of skeletal 
muscle cell fate on 2D substrates. We used LbL films made of polypeptides, which can be 
stiffened by chemical cross-linking and can be specifically functionalized by grafting of 
biomimetic peptides onto their surface. In addition, we combined the peptide-grafted films with 
substrate microtopography. Such approach is promising for the development or multifunctional 
materials that combine the different stimuli present in in vivo ECM. This part of the project was 
conducted in collaboration between two Grenoble laboratories, LMGP and CERMAV, one 
specialized in biomaterials and other in polymer chemistry. 
In the second part, we used LbL assemblies for the construction of 3D skeletal muscle 
microtissues by “cell-accumulation technique”. This part was conducted in collaboration with 
the laboratory of Pr Mitsuru Akashi from Osaka University, Japan. The method consists in 
coating myoblasts with fibronectin-gelatin nanofilms mimicking the ECM, before seeding them 
onto a substrate where the cells self-organize. Such approach makes it possible to rapidly build 
3D tissues and is promising for the in vitro construction of tissue models. 
During this project I had opportunity to work with people from different disciplines, trying 
to adapt their know-how to biological science. Being a cell biologist, according to my Master 
diploma, I could acquire new knowledge and competences in biomaterials, nanomaterials, 
chemical synthesis and discover methods for the analysis of synthesized products and different 
tools for the characterization of materials. This experience was very enriching both in human and 
in professional senses. 
My strong wish is to continue collaboration with people from different scientific fields in 
order to create “smart” materials for the control of cellular processes and develop new 
approaches for the construction of artificial tissues.  
 
  
10 
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This chapter serves to introduce important concepts of the biomaterials field and present 
the possibilities offered by different types of biomaterials for musculo-skeletal tissue 
engineering. It is divided in three parts. 
First, the importance of cell-surrounding environment will be demonstrated. An overview 
of the different types of stimuli presented by the surrounding matrix will be given.  
Second, an overview of currently existing biomaterials and their properties will be done 
and the concept of tissue engineering will be presented. The emphasis of this discussion will be 
on the currently existing methods for modification of biomaterials properties for better control of 
cellular behavior and tissue regeneration. LbL films as a type of highly versatile biomaterial 
offering numerous advantages for biomedical applications will be presented.  
Finally, the focus will be done on skeletal muscle tissue engineering, current approaches 
and challenges in this field. The applications of LbL films for the control skeletal muscle stem 
cell fate will be discussed. 
The objectives of this thesis will be presented at the end of the chapter. 
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I.A. THE CELL ENVIRONMENT 
I.A.1. General presentation of the extracellular matrix 
Our body is made of several types of tissues (skin, muscle, bone, cartilage…) whose 
properties and functions strongly depend on their composition. Tissues are composed of cells 
embedded within an extracellular matrix (ECM) made of proteins, polysaccharides and other 
bioactive molecules such as growth factors (Hynes 2009; Frantz et al. 2010). Tissues differ in 
cell types that compose them, but also in ECM composition and quantity (Halfter et al. 2013). 
For instance, tissues like cartilage are predominantly made of the ECM, while in brain it is only a 
minor constituent.  
ECM properties are extremely dynamic and are spatially- and temporally-controlled during 
development. From the earliest stages of embryogenesis and throughout the life, the ECM plays 
a role in development and morphogenesis, induces stem cells to differentiate into mature tissue 
cells, provides structural support to the cells and determines tissue architecture and function 
(Adams and Watt 1993; Gullberg and Ekblom 1995; Reilly and Engler 2010; Rozario and 
DeSimone 2010).  
The ECM molecules are synthesized intracellularly, secreted by exocytosis and remodeled 
by the cells. Abnormal ECM deposition is a characteristic feature of many diseases, and a 
number of pathologies involve changes in matrix properties (Jarvelainen et al. 2009; Frantz et al. 
2010). Deposition of amyloid fibers takes place in Alzheimer’s, Parkinson’s, Huntinghon’s 
diseases, atherosclerosis and rheumatoid arthritis, diabetes mellitus type 2 (Meredith 2005; 
Rambaran and Serpell 2008). In the liver, pancreas, kidney and lung fibrosis significantly affects 
organ functions (Zeisberg and Kalluri 2013). Fibrosis is characterized by changes in the 
composition and amount of many ECM proteins. Duchenne muscular dystrophy is also 
characterized by an increase in connective tissue (Klingler et al. 2012). Recently, evidence of 
important ECM remodelling in adipose tissue and, in particular, during the development of 
obesity was discovered (Divoux and Clement 2011).  
 I.A.2. Composition of the extracellular matrix
The ECM is composed of several types of macromolecules 
(GAGs), which are polysaccharide chains usually covalently linked to a protein core
proteins, including collagen, elastin, fibronectin,
growth factors (GF), are often bound to ECM components and presented to the cells in a matrix
bound manner (Fig. I-1) 
Figure I-1. Composition of the extracellular matrix.
highly hydrated substance in which the fibrous proteins are embedded.
components and are presented to the c
through cell surface receptors, especially cell adhesion and cell/cell receptors.
 
Extracellular matrix includes the interstitial matrix and the basement membrane. Interstitial 
matrix is ia highly hydrated network present in the intercellular spaces. The negatively
proteoglycan molecules form a highly hydrated substance in which the fibrous proteins are 
embedded. This gel allows rapid diffusion of nutrients and bioactive molecules, wh
proteins strengthen and organize the matrix. Basement membranes
ECM that surround muscle cells, Schwann cells, fat cells and underlies epithelial and endothelial 
cells (Yurchenco 2011; Halfter et al. 2013)
during the evolution of metazoan species, and they are the evolutionary oldest ECM proteins 
(Hynes 2012). BM contain collagen, proteoglycans and laminin, which is the major glycoprotein 
of the BM (Durbeej 2010). A core network of cross
laminin-binding glycoprotein nidogen and a very large and complex heparan sulfate 
proteoglycan perlecan (Yurchenco 2011; Hohenester and Yurchenco 2013)
encoding components of the skin basement membrane are associated with inherited skin 
disorders such as epidermolysis bullosa, which is characterized by skin fragility, mechanically 
induced blisters and erosions of the skin and mucous membranes 
2013).  
 
(Fig. I-1): 
 and laminin. Bioactive molecules, such as 
 The glycosaminoglycans and proteoglycans form a 
 Growth factors bind to ECM 
ells in a matrix-bound manner. The cell senses its environment 
 
 (BM) are the thin sheets of 
. BM proteins emerged about 500 million years ago 
-linked collagen is associated with laminin, 
(Bruckner
13 
glycosaminoglycans 
, and 
-
 
-charged 
ile fibrous 
. Mutations in genes 
-Tuderman and Has 
 Laminin, a major glycoprotein of the BM, consists of the three subunits: 
contains many distinct domains with different structure and functions 
1987; Beck et al. 1990) (Fig. I-
human, that form 16 laminin isoforms 
into a sheet through interactions between the ends of the laminin arms.
specifically recognizing laminins are ma
surface molecules (Miner and Yurchenco 2004)
 
Collagen, elastin and fibronectin are major components of the ECM fibrillar network. 
Collagens are a family of fibrous proteins found in all multicellular animals. They are 
major components of skin and bone and constitute about 25% of the total protein mass of the 
body. Collagen molecule has triple
chains. Collagen triple helices can be further cross
3A). Collagens play structural roles and contribute to mechanical properties, organization, and 
shape of tissues (Ricard-Blum 2011)
Fibronectin, a large glycoprotein found in all vertebrates, is a dimer composed of two very 
large subunits joined by disulfide bonds at one end. One of the FN isoforms, 
is soluble and circulates in the blood and other body fluids. In ot
cross-linked to one another by additional disulfide bonds and assemble on the cell surface and 
are deposited as highly insoluble 
(Engel and Furthmayr 
2). At present, 5 α, 3 β and 3 γ chains are known for mouse and 
(Miner and Yurchenco 2004). Laminins can self
inly integrins, α-dystroglycan, syndecans, and other cell 
.  
 
Figure I-2. Scheme of laminin heterotrimeric structure
Laminin α chain is depicted in green, 
blue. Laminin α chain consists of: the $ terminal globular 
domain (L$); tandem rod domains of epidermal growth 
factor (LEa, LEb, LEc), separating the L$, L4a and L4b 
globular domains; the laminin coiled
that tangles with the LCC domains of the 
and the C-terminal laminin globular (LG) domains. Sites 
of binding to different cell surface receptors are 
indicated.Adapted from ($guyen and Senior 2006)
 
 
 
-stranded helical structure made of three col
-linked and form sheet-like structures (Fig. I
.  
her forms, fibronectin dimers are 
fibers (Fig. I-3B) (Ruoslahti 1988a).  
14 
α, β and γ, and 
-assemble 
 Cellular receptors 
. 
β in violet and γ in 
-coil (LCC) domain 
β and γ chains; 
. 
 
lagen polypeptide 
-
plasma fibronectin, 
 Figure I-3. Extracellular matrix fibrillar compone
(image by Thomas Caceci, http://vetmd.vt.edu
C2C12 myoblasts in culture. 
 
Elastin is one of the major components of elastic fibers. Soluble tropoelastin is crosslinked 
into amorphous elastin by lysyl oxidase, making from it a highly stretchable molecule, which is a 
major provider of tissue elasticity. Elastin is the dominant ECM protei
50% of the dry weight of the largest artery 
Glycosaminoglycans (GAG) are a heterogeneous group of negatively charged 
polysaccharides that are covalently linked to protein to form proteoglyc
hyaluronan which is not linked to a protein core). They occupy a large volume and form 
hydrated gels in the extracellular space. Some proteoglycans, such as syndecans or glypicans, are 
also found anchored to the cell surface (Fig. 
Figure I-4. Scheme showing some proteoglycans and other GAGs of the extracellular space.
example of membrane-bound proteoglycan is syndecan which has several heparan sulfate chains 
attached to a core protein. Aggrecan is a com
hydrated gels in complexes with the free polysaccharide hyaluronan. 
 
nts. (A) Fibrillar and sheet-
). (B) Fibronectin matrix (labeled in green) secreted by 
n in arteries, comprising 
- the aorta (Debelle and Tamburro 1999)
an molecules (except for 
I-4) (Ruoslahti 1988b).  
 
mon proteoglycan of the interstitial space that form 
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like collagen network 
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I.A.3. Cell adhesion receptors 
Deciding which protein to express, when to divide, when to specialize, and when to 
commit or get into apoptosis are processes that permanently occur within the cells. These 
decisions are taken in response to the environmental stimuli such as extracellular signaling 
molecules (growth factors, cytokines…) and ECM. All the signals provided by the environment 
are transmitted from the outside by cell surface receptors and activate signaling pathways that 
regulate gene expression, protein synthesis and thus contribute to the control of cell fate (Fig. I-
5).  
The discovery of the integrins in the 1980s (Ruoslahti 1988a) allowed understanding of the 
physical linkages between intracellular and extracellular compartments that serve to mediate 
adhesion and bidirectional flow of the signals. Adhesion is of fundamental importance to a cell, 
as it provides anchorage, cues for migration, and signals for growth and differentiation. There are 
two principal types of cell adhesion: cell-matrix adhesion and cell-cell adhesion. Integrins appear 
to be the primary mediators of cell-matrix adhesion, and they also serve as one of the many 
families of molecules active in cell-cell adhesion (Ruoslahti 1988a; Hynes 1992; Hynes 2002). 
Later it became clear that a group of cell-surface associated proteoglycans named syndecans 
might act as co-receptors for the ECM and for certain growth factor receptors (Ruoslahti 1988b). 
Later, dystroglycan have emerged as another type of receptors that link the cytoskeleton to the 
ECM (Gullberg and Ekblom 1995; Matsumura et al. 1997). 
 
Figure I-5. Schematic presentation of signal transduction by cell surface receptors. Cell interaction 
with environmental cues (soluble ligands, extracellular matrix components) activate signaling pathways 
that regulate gene expression and protein synthesis. 
Gene expression
Protein 
synthesis
Control of cell fate
Soluble ligands
Receptor
Transcription 
factor (inactive)
Activated 
transcription 
factor
DNA
ECM components 
Signaling
pathway
Receptor
17 
 
The first integrin to be discovered bound to fibronectin (Ruoslahti and Pierschbacher 
1987; Ruoslahti 1988a) but it was soon found that several ECM components bind to similar 
types of receptors (Hynes 1992; Ruoslahti 1996b). Integrins are transmembrane heterodimeric 
molecules composed of α and β chains. So far, 24 distinct heterodimeric isoforms have been 
identified, composed of various combinations of the 18 α and 8 β chains (Hynes 1992). 
Generally the subunits possess a small intracellular domain, a single transmembrane spanning 
region, and a large extracellular domain, and link the intracellular compartment with the ECM 
(Fig. I-6). The name integrin was given to denote the importance of these receptors for the 
integrity of both the cytoskeleton and the ECM (Ruoslahti and Pierschbacher 1987; Ruoslahti 
1988a). 
From the large integrin repertoire that exists for each specific cell type, cells are known to 
sense the underlying substrates mainly via αvβ3 and α5β1, through focal complexes and focal 
adhesions. The αvβ3 and α5β1 integrins serve as receptors for a variety of extracellular matrix 
proteins with the exposed arginine-glycine-aspartic acid (RGD) sequence. The tripeptide 
sequence RGD is present in many ECM proteins, including fibronectin, vitronectin, fibrinogen, 
von Willebrand factor, thrombospondin, laminin, osteopontin, bone sialo protein, and some 
collagen isoforms (Ruoslahti 1996b), and binds to a wide range of integrin receptors.  
Focal adhesions are protein assemblies on the cytoplasmic side of the cell membrane 
where integrin receptors mechanically link the extracellular matrix to the actin cytoskeleton. 
Focal adhesions originate from the maturation of small focal complexes; they associate with 
actin stress fibres and are a place for cell traction (Fig. I-6). The transformation of focal 
adhesions into even bigger fibrillar adhesions is driven by integrin and cytoskeletal-generated 
tension (Zamir and Geiger 2001b; Zamir and Geiger 2001a; Hynes 2002; Bershadsky et al. 
2006). 
Syndecans are transmembrane heparan sulfate proteoglycans that bind a variety of ECM 
components, including fibronectin, laminin, tenascin, thrombospondin, vitronectin, and the 
fibrillar collagens. Their polysaccharide chains allow interaction with a variety of growth factors, 
so that syndecans act as “regulators” of growth factor receptor activation.  
The syndecan family includes 4 members named Syndecan-1 to -4, which are expressed in 
cell type-specific manner (Bernfield et al. 1999). Syndecan-1 (SDC-1), or cell surface antigen 
CD138, is the most studied of all the syndecans in cancer research. Altered expression of SDC-1 
has been detected in several different tumor types and (Beauvais and Rapraeger 2004). SDC-1 is 
also known to mediate fibroblast growth factor-2 binding and activity (Filla et al. 1998).  
 
 Figure I-6. Integrin-mediated bidirectional signaling between the intracellular and extracellular 
compartments and focal adhesion formation. 
a resting, inactive state in which they can be activated by inside
outside–in activation, when cells encounter a mechanically rigid matrix or are exposed to an
force integrins become activated, which favours integrin oligomerization or clustering, vinculin
association, and Src and focal adhesion kinase (FAK) stimulation of RhoGTPase
contractility and actin remodelling. Focal 
adhesion plaque proteins, including 
paxillin, which foster interactions between multiple signalling complexes to promote growth
and differentiation. From (Butcher et al. 2009)
 
For a long time, syndecans were considered as co
independent role in mediating cell adhesion and signaling has emerged 
synergistic control of cell adhesion by integrins and syndecans has been described 
2007), although the mechanisms and precise roles of this interplay remain unclear. 
shown to support integrin α2β1
suggesting a previously unknown link between integrin
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 Dystroglycan (DG) is a component of
cells, forms an important receptor system for ECM 
to be crucial for maintaining the integrity of sarcolemma and protecting muscle from damage. 
(Matsumura et al. 1997; Cohn et al. 2002; Han et al. 2009)
peripheral nerves (Masaki et al. 2003)
myelination and maintenance of myelin and nodal structures 
 
Cadherins are cell surface receptors t
calcium-dependent assembly of cell
the maintenance of normal tissue architecture and function. 
Originally considered  as cell adhesion molecules, cadherins were shown to be involved in cell 
signaling and communication, morphogenesis, angiogenesis and possibly neurotransmission 
(Angst et al. 2001). 
Figure I-9. Cadherin-mediated cell
the neighbouring cell. Intracellularly they bind to their cytoplasmic partners a
vinculin, and to the actin filament network. Adapted from 
C2C12 myoblast monolayer culture.
β-catenin
α-catenin
Actin filament networkA
Cadherins
 dystrophin-glycoprotein complex which, in muscle 
(Gullberg and Ekblom 1995)
. (Fig. I-8). DG is also expressed in 
, where it plays diverse roles in Schwann cells such as 
(Masaki and Matsumura 2010)
 
Figure I-8. Schematic representation of 
dystroglycan within the dystrophin
complex binding ECM.
composed of α and β subunits. It 
high affinity to the LG domains of laminin 
chain from the extracellular side, and dystrophin 
intracellularly. Adapted from 
Campbell 2006). 
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I.A.4. Signals provided by the extracellular matrix 
It is increasingly accepted that cell fate depend on the reciprocal and dynamic interactions 
of cells with their microenvironment that includes stimuli defined by neighboring cells, soluble 
bioactive molecules and ECM (Hynes 2009). Importantly, the ECM provides to the cells a 
variety of physical and biochemical signals that are now recognized as being key parameters in 
regulating numerous cellular processes (adhesion, differentiation etc.). In Figure I-10, different 
types of stimuli provided by the ECM are described.  
Biochemical stimuli are provided to the cells by the surrounding biological molecules that 
compose the matrix (fibrillar proteins, glycoproteins, proteoglycans/glycosaminoglycans) and by 
soluble molecules that are often presented in a matrix-bound form (GF, cytokines, 
chemokines…) (Fig. I-10). For this type of interactions, composition and conformation of the 
ECM molecules is of the utmost importance (Garcia et al. 1999). Growth factors can bind to the 
ECM via the glycosaminoglycan side chains or the protein cores of matrix molecules. ECM 
binding of growth factors can have a number of biological consequences. By limiting diffusion, 
the ECM provides a local store of growth factor that persists after growth factor production has 
ceased; for example, matrix bound FGF is degraded more slowly than free FGF, prolonging its 
activity (Klagsbrun 1990). 
 
Figure I-10. Different types of stimuli provided by the extracellular matrix (ECM). Biochemical stimuli 
are provided to the cells by the surrounding biological molecules: polysaccharides and proteins. ECM 
composition and cross-linking of the ECM proteins determines the stiffness of the matrix, thus providing 
mechanical stimuli. Bioactive molecules such as growth factors can form gradients and promote cell 
directional migration. 
 
Young’s modulus (E), or elastic modulus, is defined as a ratio between a shear stress over a 
relative deformation for a homogeneous and isotropic sample. It serves a measure of the stiffness 
of an elastic material and is used to characterize materials, but also the live tissues. Stiffness of 
Adhesion to ECM 
components
Matrix stiffness
Growth factor 
gradients
Soluble signals
Signaling
Basement
membrane
 the tissues can vary from around 1 kPa (liver) to several tens of GPa for bone 
2010) (Fig. I-11). The difference between the values is due to the properties of tissue
ECM. The stiffest tissues, ligaments and bone, contain a big quantity of collagen fibers that can 
be cross-linked together and significantly stiffen the matrix. As for bone, the high stiffness of its 
matrix is explained by the presence of inorganic hydrox
Figure I-11. Range of stiffness found in selected human tissues.
around 1 kPa (liver) to several tens of GPa for bone. Adapted from
 
Cells are mechano-sensors known to transduce a mechanical signal into a biochemical 
signal, or vice versa, via integrins, that exhibit conformational changes in response to mechanical 
stimuli (Hynes 2002). Many cell types are sensitive to the mechanical pr
underlying substrate and respond by increasing their adhesion, spreading and proliferation 
(Mammoto and Ingber 2009; Schaller 2010)
Another important characteristic of the ECM is its 
porous structure that determines the diffusion of nutritive elements and cell migration. The 
matrix is constantly remodeled by the cells. Matrix proteases are secreted to degrade the matrix 
proteins when the matrix is too dense, and new matrix proteins are secreted when the
too sparse. Matrix remodeling process is involved in inflammation, 
cancer invasion (Wolf and Friedl 2011)
many tissues. For instance, muscle fibers must be 
niche is a microenvironment where stem cells are found, and which regulates their fate 
(Schofield 1978; Scadden 2006)
The native ECM is also a highly anisotropic environment. 
(growth factors, cytokines, etc.) and physical signals (matrix porosity, stiffness, etc.) are often 
implicated in cellular processes such as adhesion, proliferation, migration, and differentiation 
(Kucia et al. 2005; Lortat-Jacob 2009)
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I.A.5. Transition 
Until recently, cell biologists commonly used glass substrates or tissue culture polystyrene 
substrates to investigate cellular behavior in vitro. However, such substrate is very different from 
the natural cell environment and may significantly affect cell behavior in vitro compared to in 
vivo conditions (Fig. I-12). 
 
 
Figure I-12. Differences in cell microenvironment in vivo and in vitro. In vivo, cells are surrounded by 
the extracellular matrix that provides a variety of physical and biochemical signals. In vitro, cells are 
usually cultured on substrates which are much stiffer than the majority of tissues. Bioactive molecules 
such as growth factors are delivered in solution, while in vivo, they are usually presented in a matrix-
bound form.  
 
Nowadays, classical approaches of cell biology and biochemistry are being completed by 
interdisciplinary approaches aiming to reproduce natural cell environment, in order to study the 
cells in more physiological conditions. The development of micro- and nanotechnologies makes 
it possible to create substrates and matrices that precisely mimic the natural cell environment. 
Engineered artificial matrices find numerous applications in the field of implantable materials, 
but also in tissue engineering and drug delivery.  
In the next part, we will present biomaterials and how their properties can be modulated to 
render them more physiologically relevant, but also to intentionally control cellular processes, 
for applications in tissue engineering field. We will particularly focus on layer-by-layer (LbL) 
films and on the possibilities that such films offer for the development of substrates with well-
controlled mechanical and biochemical properties. 
 
Mechanical signals
Adhesion molecules
Growth factor receptors
Growth factors
In vivo In vitro
Increasing stiffness
Soft tissues Glass/plastic substrates
Elastic modulus
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 I.B. BIOMATERIALS AND TISSUE ENGINEERING  
I.B.1. Definitions and historical overview 
Below are two definitions of biomaterials from 1986 and 1992 Biomaterials Consensus 
Conferences:  
 “A nonviable material used in a medical device, intended to interact with biological 
systems.”(1
st
 Biomaterials Consensus Conference, 1986, Chester, UK)  
“A material intended to interface with biological systems to evaluate, treat, augment, or 
replace any tissue, organ, or function of the body.” (2
nd
 Biomaterials Consensus Conference, 
1992, Chester, UK) 
As we can notice, the definitions remain partially similar, but the second describes a much 
larger field of application. Indeed, biomaterials first appeared mostly to replace a part of the 
human body (prosthesis). The main requirements for this type of materials were its mechanical 
properties and ability to partially replace the function of the missing body part. 
The first surgical acts making use of biomaterials took place in the end of 19
th
 century. In 
1891, Pr Glück produced an ivory ball and socket joint that he fixed to bone with nickel-plated 
screws. Metal-on-metal total hip replacements were first implanted in the 1930s. In 1938, Smith-
Petersen introduced a vitallium mould arthroplasty using a cup made from cobalt-chrome alloy 
(Smith-Petersen 1948). Integration of the material into human body now required it to be 
biocompatible, i.e. nontoxic and not promoting the immune response.  
Today, this type of biomaterials is largely used for many medical applications (Fig. I-13). 
For example, hollow polymeric tubes replace the blood vessels; metals are used to fix fractures 
and cements to fill the bone defects. Artificial skin saves the lives of burned people. Many of us 
have contact lens or dental implants. However, for certain applications, integration of 
biomaterials with surrounding native tissue may be limited or tissue repair is not satisfying yet 
(Castner and Ratner 2002).  
 
Figure I-13. Overview of the 
different applications of 
biomaterials. Implants and 
prosthesis can be made of 
metals, ceramics, and 
polymers (synthetic or 
natural). 
 
Ocular prosthesis & Contact lenses
Ear replacement
Mammary implants
Knee prosthesis
Hip prosthesis
Synthetic skin
Cardiac valve
Tendon prosthesis
Mesh for hernia repair
Vascular prosthesis
Dental implants
 But as the progress goes on, biomaterials evolve too. Development 
particular polymer science, opened new possibilities for biomaterials design. Numerous aspects 
of biomaterials properties are known to affect cell behavior, so all o
carefully adjusted, as they have an influence on subsequent cellular and tissue events.
them, materials surface chemistry and morphology, bulk and mechanical properties, 
degradability and biochemical functionality. Changing
bone implant improves osteointegration 
Contact lenses with good wettability are generally better tolerated by the eye 
Postnikoff 2013; Tighe 2013). Mol
the design of biomaterials, as many cells need to adhere for their survival 
Humphries 1996). More recently, other parameters like mechanical properties of biomaterials 
(Pelham and Wang 1997; Engler et al. 2006) 
have also been taken into account.
Such modification of biomaterial’s surface properties allows not only to improve the 
biocompatibility and integration, but also to induce a specific response of the host tissue. These 
materials are biomimetic and/or 
possible to create materials with precise control over their multiple properties, making them 
multifunctional.  
The scheme of biomaterials evolution, from just biocompatible to those presenting 
additional functionalities, is shown in Figu
Figure I-14. Evolution in the development of biomaterials. 
requires it to be biocompatible. Modification of biomaterial’s surface properties allows to improve its 
biocompatibility and integration, but 
biomimetic materials. “Smart” bioactive and multifunctional materials participating in tissue 
regeneration by stimulating specific cell response or responding to changes of physiological co
are currently being designed. 
 
Such materials find numerous applications in the field of implantable 
injectable (Li et al. 2012a) materials, for targeted and controlled drug delivery 
Akashi 2009), but also for tissue engineering
cell-material interaction (Lutolf and Hubbell 2005; Stevens and George 2005)
focus on the design of biomaterials for tissue engineering applications. 
of materials
f these parameters must be 
 the surface roughness and porosity of the 
(Hertz and Bruce 2007; Le Guehennec et al. 2007)
ecules promoting cell adhesion have already been included in 
and delivery of growth factors 
 
bioactive. By combining different techno
re I-14. 
 
Integration of the material into human body 
also to induce a specific response of the host tissue 
, and as model materials for fundamental studies of 
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Tissue engineering applies the principles of biology and engineering to the development 
of functional substitutes for damaged tissue, and was pioneered about 20 years ago by Langer 
and colleagues from MIT (Langer and Vacanti 1993). Current tissue engineering approach 
consists in combining cells, engineering and biomaterials to improve the biological functions of 
damaged tissues (bone, cartilage, blood vessels, skin…) or replace them.  
The cells can be taken from the patient or from a compatible person, and biomaterials will 
support cell attachment and provide them with the appropriate cues to organize the cells into a 
tissue- or organ-like structure. Here, biomaterials must be “smart” enough to stimulate the 
regeneration of tissues by controlling and guiding the cells (Lutolf and Hubbell 2005; Stevens 
and George 2005). Such tissues and organs, grown from a patient’s own cells, should avoid the 
problems of immune rejection. In addition to having a therapeutic application, tissue engineering 
can have diagnostic applications: the tissue is made in vitro and used for testing drug metabolism 
and toxicity. Besides in vitro tissue engineering, the tissue formation and repair may take place 
in vivo due to achievements in the field of injectable hydrogels, which allow in vivo delivery in a 
minimally invasive way (Li et al. 2012a). 
 
I.B.2. Current challenges in tissue engineering  
The progress in the field of artificial scaffolds for tissue engineering has been impressive. 
For instance, cartilage (DeNovo® NT Natural Tissue Grafts) and skin (Apligraf
TM
) are already 
on the market, and engineered bladders are in clinical trials (Atala et al. 2006). 
These tissues all consist of a small number of cell types, and/or are either flat planes or 
hollow constructs, that are relatively simple to produce. However, organs such as the lungs, 
heart, liver, and kidneys are bigger, they contain dozens of cell types, and they have a complex 
architecture with a network of blood vessels.  
Production of such constructs is still challenging and requires collaboration of scientists 
from different domains like cell biology, chemistry, materials and polymer science. The main 
challenges are represented in Figure I-15 and include stem cell amplification, biomaterial’s 
design and tissue maturation/organization.  
I.B.2.a) Cell amplification 
Stem cells can be defined as unspecialized cells that can renew their own population while 
also supplying cells that differentiate into the specialized tissue-specific cell types (Janzen and 
Scadden 2006). (Fig I-16). This presents important issues for tissue engineering, as stem cells 
can be amplified in vitro and differentiated into a specific cell type. 
 Figure I-15. Current challenges in tissue engineering.
scaffolds in which cells can adhere, proliferate, differentiate and synthesize their own matrix to 
regenerate tissues. Adult tissues contain very few stem cells, so they have to be amplified in vitro in or
to get enough cells to fill the scaffold.
of the materials are very important to properly organize the tissue.
 
 
In vivo, stem cells are localized in “niches” 
their involvement in tissue regeneration and repair 
cells generally have limited function and, when cultured 
stem properties. For this reason s
order to identify the important factors regulating stem cells 
Reproducing such factors in vitro
control of stem cell fate.  
In vitro studies, drug 
evaluation (pharmacology)
Implantation
Cells from 
 A goal of biomaterials scientists is to design the 
 As most of the tissues are 3D structures, spatio
 
— specific tissue compar
(Schofield 1978). Without this niche, stem 
in vitro, they may rapidly lose their 
cientists are studying the various components of the niche, in 
in vivo (Lutolf et al. 2009b)
 by the mean of biomimetic materials will allow the precise 
Figure I-16. Possible fates of stem 
cells. Stem cells are unspecialized 
cells that can renew their own 
population and/or supply cells that 
differentiate into the specialized 
tissue-specific cell types.
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I.B.2.b) Scaffold design and tissue maturation  
Probably the most important step is to design biocompatible scaffolds in which cells can 
adhere, proliferate, differentiate and synthesize their own matrix to regenerate tissue (Lutolf and 
Hubbell 2005; Stevens and George 2005). Stiff polymeric materials can be employed as 
scaffolds when mechanical strength is needed, and soft hydrogels can be used for soft tissues 
(Drury and Mooney 2003).  
As described in the part I.A. The cell environment, cells respond to a variety of stimuli, 
including biochemical, topographical and mechanical signals originating from their in vivo 
micro-environment. All of these parameters must be carefully adjusted by appropriate 
biomaterial’s design, to provide it with new functionalities and induce a specific cell response.  
As most of the tissues are 3D structures, spatio-temporal properties of the materials are 
very important to properly organize the tissue. Last but not least, developing tissues may require 
supply of different bioactive molecules or presentation of different adhesive ligands at different 
times of tissue maturation. This will require controlled molecule delivery by the biomaterial.  
Different approaches for the biomaterials design are described below. 
 
I.B.3. Design of synthetic and natural polymeric materials for tissue 
engineering (Review article 1) 
In a first part of my PhD thesis, we made a literature review of synthetic and natural 
polymeric materials with well-characterized and tunable mechanical and biochemical properties. 
We also highlighted how biochemical signals can be presented to the cells by combining them 
with these biomaterials (Gribova et al. 2011).  
Here, we will give a short overview of the different types of polymeric materials, including 
synthetic and natural ones. For more details, the reader is referred to the review article that can 
be found in Annexe I. We will also present important aspects that have to be taken into account 
when designing biomimetic materials.  
Polymeric 2D substrates and 3D scaffolds made of either synthetic or natural polymers are 
the most widely used in the development of biomimetic and bioactive materials due to their high 
versatility: they can be tuned in terms of composition, rate of degradation, mechanical and 
chemical properties, and thus offer a wide range of possibilities to control cellular processes and 
tissue regeneration. If surface properties of the materials are taken into consideration, they are 
viewed as 2D materials and cells will interact with them from their basal side. In the case of 
hydrogels, that are usually uses as 3D materials, their bulk (volumic) properties are important, as 
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the cells embedded in the hydrogel are fully surrounded by it. Accumulating evidence has shown 
that there is a significant difference in cell behavior in 2D and 3D microenvironments (Lee et al. 
2008). However, it is important to underline that both 2D and 3D studies of cell/material 
interactions are required, as these studies provide complementary information. For instance, 2D 
materials may serve for cell amplification or for coating of other materials, while 3D materials 
are required for fabrication of thick tissue constructs.  
Both synthetic and natural polymers present some advantages and drawbacks in terms of 
their applications as biomimetic substrates. The main properties of natural and synthetic 
materials, from 2D to 3D materials are summarized in Table I-1. 
Synthetic polymers can be tuned in terms of composition, rate of degradation, mechanical 
and chemical properties. Among the mostly employed synthetic polymers, polyacrylamide (PA) 
gels, polydimethylsiloxane (PDMS) and polyelectrolyte multilayer films made of synthetic 
polyelectrolytes, which are used as 2D culture substrates; crosslinked networks of poly(ethylene 
glycol) (PEG) are often used as a 3D hydrogels with cells embedded inside. The coupling 
strategy is often required for synthetic materials, which do not have any natural interaction with 
biomolecules (Table I-1). 
 
Table I-1. Summary of the main properties of natural and synthetic materials, from 2D to 3D 
materials, which are used in mechano-sensitivity studies. This includes their physical/mechanical and 
biochemical properties. Their main disadvantages and advantages are also given. (Gribova et al. 2011). 
PROPERTIES NATURAL                            SYNTHETIC
2D
3D
PEM-films
Fibrin
Collagen
Hyaluronan
Alginate
PA gels
PDMS
PEG
Physical/mechanical
properties
- Viscoelasticity
- Physical architecture
- Porosity (nm to µm scale)
- Degradability (proteases)
- Pure elasticity
- No physical architecture
- Small porosity
- Non biodegradabile (unless
grafted with MMP peptides)
Biochemical
properties
- Non specific interactions
(electrostatic, H-bonds)
- Specific (natural ligands)
- Inertness
- Need grafting with ligands
Main disadvantage - Difficulty to decouple
mechanics and chemistry
- High swellability (for PEG)
- Stability over time
Main advantage -Biomimetism
(natural presence in tissues)
-Versatility of the control
IPN
Composites
 2atural polymers can be derived from animals (collagen, fibrin, chitosan) or from 
plants/algae (cellulose, alginate, agarose). They can be used as 2D or 3D hydrogels or as thin 
multilayer films. Multilayer films made by self
are emerging as a new class of materials with well
Natural polymers have the advantage of being components of native ECM matrices, i.e. 
they provide compositional uniqueness such as stimulating a specific cellular response and serve 
both as mechanical as well as biochemical signals (Table I
particularly interesting due to their unique structural properties. Their nano
are similar to that of native tissues in terms of functional groups and
Interestingly, natural materials exhibit low and high affinity interactions with ECM proteins and 
growth factors, and can be favorably exploited to present these stimuli. Conversely, natural 
materials have also some drawbacks. The
In addition, their natural bioactivity makes it difficult to fully decouple the effect of mechanics 
from chemistry.  
The modifications of synthetic and natural polymeric materials are summarized in Fig
17 and include modifications of mechanical and biochemical properties, as well as control of 
material’s topography and degradability. 
Figure I-17. Scheme presenting the three major ways of control of  the cell microenvironment using 
engineered materials : mechanical properties with typical variation in elastic moduli from few Pa to tens 
of MPa; biochemical properties obtained by adsorbing or grafting entire proteins, protein fragments as 
well as peptides; spatio-temporal properties, e.g. hydroly
presentation of ligands by nano and micropatterning. Adapted from 
-assembly of polypeptides and polysaccharides 
-defined properties.  
-1). Natural materials are also 
 structural organization. 
y are more fragile, polydisperse, and not always pure. 
 
tically degradable materials or controlled 
(Gribova et al. 2011)
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I.B.3.a) Control of mechanical properties 
Cells are mechanosensors known to transduce a mechanical signal into a biochemical 
signal, or vice versa, via specific proteins that are known to play a key role in this process. 
Among those are integrins, transmembrane receptors that exhibit conformational changes in 
response to mechanical stimuli (Ingber 1991). Many cell types are sensitive to the mechanical 
properties of the underlying substrate and respond by increasing their adherence, spreading and 
proliferation. How the cells exert forces on to a substrate and how these forces are transmitted at 
the molecular level inside the cells are key questions, which have been and are still being 
investigated. This has also led to the development of new materials that would, ideally, make 
possible independent variation in mechanical and biochemical properties. 
In a pioneer study by Discher’s group, decoupling (or independent adjusting) of the 
mechanical and chemical properties has been achieved, using model synthetic gels such as 
polyacrylamide gels grafted with COL at increasing densities.(Engler et al. 2004a). The same 
group showed that altering polyacrylamide gel stiffness made possible MSC differentiation into 
neurons on soft PA gels, bone cells on stiff gels that mimicked collagenous bone (Engler et al. 
2006) and myoblasts for gels of intermediate stiffness (Fig. I-18).  
 
Figure I-18. Effect of substrate stiffness on cell differentiation. Human MSCs (hMSCs) exhibit 
neurogenic, myogenic and osteogenic phenotypes when cultured on collagen-coated polyacrylamide 
(PAAm) hydrogels with stiffness similar to brain (0.1–1 kPa), muscle (8–17 kPa) and nascent bone (>34 
kPa), respectively. From (Engler et al. 2006).  
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Other types of synthetic and natural polymeric materials with controlled mechanical 
properties have been developed, such as PEG hydrogels (Lutolf et al. 2003b; Gilbert et al. 2010; 
Moon et al. 2010), PDMS (Trappmann et al. 2012), alginate gels of varying stiffness (Genes et 
al. 2004; Boontheekul et al. 2007), hyaluronan (Young and Engler 2011), and polyelectrolyte 
multilayer films made of biopolymers (Ren et al. 2008). Recently, Post and coworkers (Boonen 
et al. 2009) showed, using PA gels of varying rigidity and protein coating that proliferation was 
influenced only by rigidity, whereas differentiation was influenced both by rigidity and by 
protein coating. 
For more detailed presentation of materials used for mechanosensitivity studies, the reader 
is referred to the review article in Annexe I (Gribova et al. 2011). An overview of the main 
strategies used to modulate mechanical properties of synthetic and natural materials is given in 
Figure I-19. Although a full decoupling of mechanical and chemical properties is the ideal goal, 
this is in fact very difficult to achieve, because many of the cross-linking strategies are based on 
a chemical modification of the material. In addition, in case of synthetic materials that usually 
provide poor adhesive properties, biochemical ligands have to be added by grafting it or by 
adsorbing it. This also involves modification of materials surface.   
 
Figure I-19. Overview of the main strategies used to modulate mechanical properties of synthetic and 
natural materials. The methods are essentially based on chemical cross-linking, as physical cross-linking 
is so far barely employed for biomaterials. We have classified cross-linking by divalent cations at the 
border between chemical and physical cross-linking, as addition of cations changes the film chemistry 
but, at the same time, induces a physical gelation (no need for covalent crosslinks). From (Gribova et al. 
2011). 
Type of cross-linking Properties
CHEMICAL
PHYSICAL
Amide bond (EDC/sulfoNHS)
COO- and NH3
+     →
Irreversible
UV Photo-induced
Ex: HA-Methacrylate
Ex: PEG-Diacrylate
Irreversible
Possible variation in 
spacer arm 
Thiol groups; disulfide bond
S-H  +   H-S  → S-S
Reversible
Enzyme mediated
Transglutaminase: amine and glutamine  
Irreversible
Divalent cations
Ca2+ , Sr2+, or Ba2+ (Ex: alginate)
Gel formation, 
reversible by 
chelating agents
Incorporation of nano-objects
Nanoparticles
Nanotubes
Irreversible
10 nm
10 nm
32 
 
I.B.3.b) Biochemical functionalization 
Synthetic polymers such as PA, PDMS and PEG hydrogels are poorly adhesive due to their 
inertness and lack of specific adhesive motifs. In the case of natural materials, although cells 
may possess specific receptors recognizing the material, their naturally high hydration and 
softness often render them poorly adhesive, too. Such low cell attachment has been observed for 
hydrated polysaccharides such as HA and ALG. Researchers have thus designed strategies for 
giving additional biochemical functionality to different types of synthetic and natural materials.  
Biochemical functionalization has up to now mostly focused on improving cell adhesion 
by presenting cell adhesive ligands:  adsorbing cell adhesion proteins (collagen, fibronectin, 
etc.) or grafting adhesion peptides. Recent developments have begun, however, to present not 
only adhesive signals, but also signals triggered by growth factors (FGF, BMP, VEGF, NGF), 
which modulate cell proliferation and differentiation. Notably, presentation of a biochemical 
signal from a biomaterial in a “matrix-bound” manner is important for mimicking physiological 
conditions, as many bioactive molecules are bound to the ECM matrix in vivo.  
Two main strategies of functionalization are usually employed: covalent coupling or 
physical adsorption of the bioactive molecules (entire proteins, fragments or peptides) (Fig. I-
20). The coupling strategy is often required for synthetic materials, which do not have any 
natural interaction with biomolecules. Conversely, natural materials, that exhibit low and high 
affinity interactions with ECM proteins and growth factors can be favorably exploited to present 
these stimuli. Summary of the main functionalization strategies for 2D and 3D materials are 
shown in Figure I-20. Examples of molecules usually immobilized are also indicated. 
 
Figure I-20. Main strategies for immobilization of bioactive molecules on 2D substrates or in 3D 
hydrogels. The molecules can be either grafted or attached by adsorbtion due to specific or non-specific 
interactions. Covalent links are represented as black dots or black dashes. 
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The advantage of grafting is that it provides good control of surface composition, a stable 
link and limits release of the functional group into the culture medium. Covalent grafting of short 
bioactive peptides or protein fragments is more frequently performed than that of full length 
ECM proteins, which is more difficult to handle. A key issue is to preserve the bioactivity of the 
grafted molecules, especially entire proteins, because their activity depends on their 3D 
conformation. Grafting of proteins/peptides can be performed in solution on hydrogel 
components, prior to formation of the 2D or 3D biomaterial, or directly at the surface of a 
biomaterial.  
Proteins can be coupled to polymers via their amino-groups using sulfo-SANPAH 
(sulfosuccinimidyl 6-(4'-azido-2'-nitrophenylamino)hexanoate) cross-linker (Kandow et al. 
2007) or carbodiimide coupling chemistry (Grabarek and Gergely 1990).  Thiol groups of 
proteins or peptides are another target for coupling reactions. They can be grafted to polymers 
via maleimide linker molecules or reacted with acrylates under defined experimental conditions 
(Hern and Hubbell 1998; Mann et al. 2001; Peyton et al. 2006).  
For more detailed presentation of the grafting strategies, as well as for more details on 
adsorption and grafting of full-length molecules including ECM proteins and GF, the reader is 
referred to the review article in Annex I (Gribova et al. 2011). Here, we will focus on the recent 
developments that use bioactive peptides and are aimed to achieve a better selectivity, i.e. target 
a particular cell surface receptor and thus create substrates/scaffolds with well-defined 
properties.  
In entire proteins (ECM proteins or GF), many different active sequences can be 
recognized by cell surface receptors. Using a bioactive fragment makes it possible to enhance the 
specificity of the interaction and to target one particular partner to better control cellular 
processes. Such short sequences are, however, often less bioactive than entire molecules, 
because of the loss of active site spatial architecture, which is defined by protein’s specific 
conformation (Ruoslahti 1996a).  
The most common grafted peptides are derived from ECM proteins, mainly fibronectin 
(Petrie et al. 2008), collagen (Lutolf et al. 2003c; Trappmann et al. 2012), laminin (Hozumi et al. 
2009; Urushibata et al. 2010), and vitronectin (Doran et al. 2010) (Table I-2). More recently, 
peptides that exhibit protease sensitive sequences have been grafted to the biomaterials, to add 
biodegradability in response to cellular activity (Raeber et al. 2007).  
The tripeptide sequence RGD is very popular, as it is present in many ECM proteins, 
including fibronectin, vitronectin, fibrinogen, von Willebrand factor, thrombospondin, laminin, 
osteopontin, bone sialoprotein, and some collagen isoforms (Ruoslahti 1996a). It binds to a wide 
range of integrin receptors in a non-selective manner, i.e. is not specific to a given integrin 
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receptor. The literature about the various forms of RGD-containing peptides is rich and the 
reader is referred to more specialized reviews (Ruoslahti 1996b; Hersel et al. 2003).  
The recent developments are aimed to achieve a better selectivity, i.e. target a particular 
cell surface receptor, integrin or non-integrin. To this end, several strategies have been 
investigated: i) synthesis of cyclic RGD peptides (Hsiong et al. 2009), or RGD peptide 
multimerization to enhance avidity with particular cell adhesion receptors (Suzuki et al. 2003b), 
ii) using a more selective peptide sequence that is not based on RGD but contains other key 
sequences or iii) associating two different bioactive peptides derived from the same ECM protein 
(Benoit and Anseth 2005) or from different ones (Rezania and Healy 1999) (Table I-2). Thus, 
collagen-mimetic peptides (Picart et al. 2005; Reyes et al. 2007; Weber et al. 2007), laminin-
derived peptides (Hozumi et al. 2009; Werner et al. 2009; Urushibata et al. 2010) and 
fibronectin-derived peptides or fragments (Benoit and Anseth 2005; Petrie et al. 2008) are 
increasingly used for their higher selectivity. 
 
Table I-2. Peptide sequences used for targeting adhesion receptors of four main ECM proteins. The 
targeted receptor (or receptor family) as well as cell type used in the study are indicated. From (Gribova 
et al. 2011). 
ECM protein
PEPTIDE SEQUENCE TARGETED RECEPTOR CELL  TYPE REFERENCE
GFOGER lntegrin α2β1
Primary bone marrow stromal 
cells
 Reyes et al., Biomaterials  2007 
[94]
CGPKGDRGDAGPKGA
Integrins α1β1 , α2β1 Primary human osteoblasts
Picart et al.  Adv. Funct. Mater . 
2005 [76]
DGEA lntegrin α2β1 MIN6 b-cells Weber Biomaterials 2007 [95]
Osteoblasts
Petrie et al., Biomaterials  2008 
[83]
hESC, hMSC
Doran et al., Biomaterials  2010 
[75]
RGD-PHSRN Inegrin α5β1 Osteoblasts
Benoit and Anseth, Biomaterials 
2005 [90]
RKRLQVQLSIRT (α1 chain 
LAM-1, LG4 module)
Syndecans
ATLQLQEGRLHFXFDLGKGR, 
X: Nle (α1 chain, LG4 module)
lntegrin α2β1
PPFLMLLKGSTRFC (LG3 of 
the lam-5  α3 chain)
Integrins α6β4, α3β1
Oral keratinocyte cell line, TERT-
2 OKF-6
Werner et al., Biomaterials  2009 
[96]
IKLLI (LAM α1 chain) lntegrin α3β1
IKVAV (LAM α1 chain)
110 kDa laminin receptor 
protein
YIGSR (LAM β1 chain)
67 kDa laminin receptor 
protein
VITRONECTIN rhVN, N-terminal Somatomedin 
B and RGD domain
Plasminogen activator inhibitor-
1 (PAI-1), integrin receptors
hESC
 Doran et al., Biomaterials  2010 
[75]
MC3T3-E1 preostoblasts
Zouani et al., Biomaterials  2010 
[100]
Human foreskin fibroblasts 
Lutolf et al., Nature Biotech . 2003 
[84]
G4RGDSP Integrins
Cyclic RGD: G4CRGDSPC
Integrin receptors, higher 
specifity for αVβ3
MMP-sensitive peptide: Ac-
GCRD-GPQGIWGQ-DRCG-
NH2
Matrix metalloproteinases 
(MMP)
Human foreskin fibroblasts
Lutolf et al. Nature Biotech  2003 
[84]
 Hsiong et al. Tissue Eng . 2009 
[92]
Hozumi et al, Biomaterials  2009 
[83]
LAMININ 
(LAM)
COLLAGEN 
(Type I)
FIBRONECTIN 
(FN)
RGDSPC
Multiple ECM 
proteins 
Primary human bone marrow 
stromal cells, MC3T3-E1 
preosteoblasts, mouse bone 
marrow stromal D1 cell line
Human dermal fibroblasts, neural 
PC12
MIN6 b-cells
rhFN fragment FNIII7-10  (with 
RGD and PHSRN)
Interin α5β1
Integrins
 Weber, Biomaterials  2007 [95]
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We are now progressively entering a new era, where peptides with higher specificity, high 
biological activity as well as targeting other receptors than integrins are being designed (Table I-
2). Indeed, it is now acknowledged that besides integrin receptors, other families of receptors 
including syndecans (Bellin et al. 2009) and growth factor receptors play key roles in early 
cellular events. Recent developments also include grafting the peptide sequence of growth 
factors, mostly bone morphogenetic protein 2 (BMP-2) derived peptides (Saito et al. 2003; Saito 
et al. 2005; He et al. 2008b; Zouani et al. 2010; Moore et al. 2011; Zouani et al. 2013), but also 
BMP-9 (Marquis et al. 2008; Bergeron et al. 2009).  
 
I.B.3.c) Micro- and nanotopography  
Material’s topographical cues are recognized to be a powerful tool for regulating cell 
functions. Scaffold architecture and substrate topography affect cell adhesion, migration, growth 
and differentiation (Curtis and Wilkinson 1997; Rapier et al. 2010; Nikkhah et al. 2012).  
Surfaces of biomaterials are rarely flat at a molecular level: such surfaces only occur after 
cleavage of single crystal materials in particular planes. Thus, most of the materials possess 
“natural” or “accidental” topography. Otherwise, nano- and micropatterned surfaces and scaffold 
can be intentionally fabricated, in order to investigate the effects of spatial parameters on the 
cellular processes and/or to control these processes. Many micro- and nanofabrication processes 
have been employed to control substrate characteristics in both 2D and 3D environments. 
Among them, optical and electron beam lithography, soft lithography, and printing technologies 
(Falconnet et al. 2006; Khademhosseini et al. 2006). Patterning on biomaterial surfaces and 
scaffold topography are important for fundamental studies of cell–cell and cell–substrate 
interactions, and in biomedical applications such as tissue engineering, cell-based biosensors and 
diagnostic devices. For instance, in the field of tissue engineering, one of the main issues is to 
engineer scaffold with controlled architecture, to obtain a properly organized tissue in vitro. 
The basic principle of materials patterning is to create controlled spatial arrangement of 
surface chemical and physical properties. Gradients are also being developed and used to 
understand how cells respond to these cues (Burdick et al. 2004; Kutejova et al. 2009). 
 “Physical” topography includes surface roughness (Lampin et al. 1997; Fan et al. 2002; 
Chung et al. 2003; Yamakawa et al. 2003; Ranella et al. 2010), stiffness patterns (Chien et al. 
2009), grooved substrates (Teixeira et al. 2003; Monge et al. 2012), and micropillars (Ghibaudo 
et al., Biophys J, 2009). Several examples of physical topography are shown in Figure I-21.   
 
 Figure I-21. 7anotopographically defined in vitro cell culture tools.
nanotopography geometries commonly used as cell culture substrates. Anisotropic topographies are 
directionally dependent, in this case, providing cues along a single axis. Isotropic topographies are 
uniform in all directions, providing cues along multiple axes. Topography gradients provide cues through 
gradual changes in physical features (e.g., groove spacing) along a particular direction (Kim JBC 2012)
 
Chemical/biochemical topography includes micro
molecules (Gallant et al. 2002; Wu et al. 2010)
adhesive molecular organization regulates different cell functions depending on its scale.
Micropatterned surfaces can be used to orient th
geometry of the cell adhesive microenvironment was shown to direct cell surface polarization, 
internal organization and division 
2010). Moreover, cell adhesive surface geometry may also regulate cell differentiation 
(Guvendiren and Burdick 2010)
density (Ranucci and Moghe 2001; Berg et al. 2004)
proliferation, and differentiation.
The porosity of the material must be considered when designing 3D scaffolds, as it is an 
important parameter for cell migration within the scaffolds. Also, porosity can greatly influence 
cell adhesion and interaction with the matrix components. Depending on the porosity of the 
scaffold, the cells can sometimes behave as on 2D surfaces, i.e. interact with their environment 
only from the basal side even in 3D materials (Figure I
 Schematics of three representative 
- or nano- patterned 
. Chemical patterning achieved using spatial cell
e cells or to control their geometry. The 
(Thery and Bornens 2006; Thery et al. 2006; Pitaval et al. 
. Nanopatterned topographical features such as matrix ligand 
 are important for cell adhesion, 
 
-22).  
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domains of adhesive 
-
 
 Another important parameter of 3D materials is degradability. It was shown that the 
degradation rate of hydrogel can influence differentiation of mesenchymal stem cells 
al. 2013). In this study, MSCs within HA hydrogels of equivalent elastic moduli with 
cell-mediated degradation exhibited variable degrees of 
osteogenesis or adipogenesis. 
In case of dense polymeric hydrogels, specific peptide crosslinkers may be introduced into 
the polymer network. Such peptides
progression through the gels (Lutolf et al. 2003a)
engineered synthetic ECM may be controlled selectively by the choice of protease specific 
peptide crosslinker (Bracher et al. 2013)
Figure I-22. Scaffold architecture affects cell binding and spreading.
scaffolds with microscale architectures flatten and spread as if cultured on flat surfaces.
with nanoscale architectures have larger surface areas to adsorb proteins, presenting many more binding 
sites to cell membrane receptors. Adapted from 
 
 
I.B.3.d) Multifunctional materials and high
Control over biochemical and mechanical properties of materials in a spatially
manner has to be achieved to investigate the respective role of each parameter
produce innovative multifunctional biomaterials 
methodological developments emerging from soft lithography and microfluidics can be 
combined to further develop these 2D and 3D biomaterials 
these technologies can be applied to a wide range of polymeric biomaterials currently in use. 
cell spreading and favoured either 
 are cleavable by secreted metalloproteases and allow cell 
. Invasion and growth of different cell types in 
. 
 (A and B) Cells binding to 
(Stevens and George 2005). 
-throughput screeni
(Huebsch and Mooney 2
(Lutolf et al. 2009
37 
(Khetan et 
different 
 
 (C) Scaffolds 
ng 
-controlled 
, as well as to 
009). New 
). Importantly, 
 This will make it possible to incorporate spatial control which is crucial for developing complex 
microenvironments (Marklein and Burdick 2010)
Current technologies also allow creation of 
screening (Ranga and Lutolf 2012)
I-23. Recently, PEG microgels with modular dimension, stiffness and surface
biomolecule composition were created by combining hydrogel engineering with droplet 
microfluidic technology (Allazetta et al. 2013)
components and additives, providing opportunity to generate a huge divers
cell manipulation and screening applications.
Figure I-23. Example of a state-of
and biophysical niche effectors. 
solutions on micropillars of a microfabricated silicon stamp. The printed stamps can be pressed against a 
thin (partially crosslinked) hydrogel layer. Finally, the stamp can be demolded t
niche microarray suitable for both adherent or nonadherent stem cells. Adapted from 
2012). 
  
. 
in vitro platforms for high
. Example of the creation of such platform is shown in Figure 
. Such approach allows to combine multiple gel 
 
 
-the-art combinatorial biomaterial microarray to probe biochemical 
A D$A spotter with solid pins can be used to spot different protein 
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 I.B.4. Polyelectrolyte multilayer (PEM) films as thin polymeric 
substrates (Review article 2)
Layer-by-layer (LbL) films o
with well-controlled mechanical and biochemical properties, and have become a highly studied 
class of biomaterials over the past decade. The technique was introduced in the early 1990s by 
Decher, Möhwald, and Lvov 
attracted an increasing number of researchers in recent years due to its high versatility and wide 
range of advantages they present for biomedical applications. Polyelectrolyte
films are currently emerging as a new kind of biomaterials coating that can be used to guide cell 
fate (Boudou et al. 2010; Leguen et al. 2007; Detzel et al. 2011)
materials for investigation of cellular beh
constructs such as implants or tissue engineering scaffolds.
The reader is referred to our recent review article 
Annexe II) for detailed presentation of different possibilities of controlling cell behavior by 
means of PEM film composition, presentation of bioactive molecules and modulation of 
mechanical properties. Here, we will present a principle o
short description of the main techniques used for the control of PEM film properties. 
 
The LbL deposition method consists in the alternate adsorption of polyelectrolytes that 
self-organize on the material’s surface, lead
(PEM) films (Fig. I-24) (Decher et al. 1992; Lvov et al. 1994; Decher 1997)
Figure I-24. Schematic of layer-by
adsorption steps, depicting film deposition starting with a positively charged substrate. Adapted from 
(Decher 1997). 
 
 
ffer numerous possibilities for the development of substrates 
(Decher et al. 1992; Lvov et al. 1994; Decher 1997)
. They can be used either as 2D 
avior on defined substrates, or for coating of 3D 
 
(Gribova et al. 201
f LbL deposition method and give a 
ing to the formation of polyelectrolyte multilayer 
.
-layer deposition method. Simplified molecular picture of the first two 
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 multilayer (PEM) 
2) (please find in 
 
 
 
 The method was originally developed by dipping the substrate (e.g. glass slides or silicon 
wafer) in the different polyelectrolyte
solutions on the substrate by spin
deposited onto small particles, which can be further dissolved to give hollow microcapsules, that 
can be used for drug delivery and many other applications 
Becker et al. 2010), or onto viable cells 
cell viability and function upon 
assembly are being developed, such as film deposition by spraying (Fig. I
faster and easier to adapt at an industrial level 
Figure I-25. Construction of layer
dipping method. (b) by spin coating a solution onto the substrate . (c) by spraying. From  
2012b).  
 
The procedure of LbL deposition is relatively simple and versatile, as it is possib
modulate film growth and internal structure by choosing the nature of polyelectrolytes and 
assembly parameters such as pH and ionic strength 
fabrication can be performed under mild conditions in an aqueous enviro
advantage when using biopolymers and bioactive molecules
molecules and can easily lose their properties if using harsh chemistry. Also, films can be either 
stratified or can exhibit some interdiffusio
barriers (Garza et al. 2005) or as compartments for the loading of bioactive molecules 
 solutions. The analogous method consists in
-coating (Fig. I-25a and b). Polyelectrolytes can also be 
(Antipov and Sukhorukov 2004; 
(Wilson et al. 2011). Such coating helped to maintain 
in vivo transplantation. Nowadays, other meth
-25c), which is  much 
(Izquierdo et al. 2005; Schaaf et al. 2012)
-by-layer assemblies using different deposition techniques.
(Shiratori and Rubner 2000)
nment, which is a great 
, which are often very sensitive 
n, which makes it possible to use them either as 
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(Li et al. 
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. PEM film 
(Crouzier 
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et al. 2009). Importantly, as will be shown below, PEM films appear highly suitable for 
immobilization of biomolecules with preserved bioactivity.  
Besides polyelectrolytes, other types of components can be assembled using LbL method, 
among them proteins (Johansson et al. 2005; Zhang et al. 2005), nanoparticles, nanowires and 
carbon nanotubes (Jan and Kotov 2007; Srivastava and Kotov 2008; Zhang et al. 2012), and even 
living cells (Matsusaki et al. 2007; Chetprayoon et al. 2013).  
 
Advantageously, multiple parameters of the films can be controlled. The films can be 
functionalized by bioactive molecules such as adhesive peptides (Berg et al. 2004; Picart et al. 
2005; Tsai et al. 2009) and charged with growth factors for local delivery (Crouzier et al. 2009; 
Crouzier et al. 2011b; Macdonald et al. 2011; Shah et al. 2011; Guillot et al. 2013). The different 
strategies of incorporing bioactive molecules inside or on top of PEM films are summarized in 
Figure I-26. Biochemical stimuli may also be delivered in response to external stimuli. Cyto-
mechanoresponsive surface that becomes cell-adhesive through exhibition of arginine-glycine-
aspartic acid (RGD) adhesion peptides under stretching has been described (Davila et al. 2012). 
The controlled presentation of bioactive molecules to cells by means of the engineered PEM 
films offers a new tool for biophysicists who are interested in unraveling the subtle interplay 
between cell adhesion receptors, growth factor receptors and mechano-transduction pathways. 
 
Figure I-26. Scheme representing different possibilities of incorporing bioactive molecules inside or on 
top of PEM films. (A) Adsorption of the bioactive molecule can be achieved after film buildup or at a 
certain step during build up. In case of diffusion, the bioactive molecule can be loaded in the “bulk” of 
the film; (B) Very small molecules such as bioactive peptides can be grafted to one of the 
polyelectrolytes; (C) if one of the components is hydrolysable, then the bioactive molecule can be 
delivered in solution. From (Gribova et al. 2012) 
 
Adsorption of biomolecules
diffusion inside no diffusion embedding
A
RGDRGDRGDRGDRGD
Grafted peptidesB Hydrolysable polyelectrolyteC
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The mechanical properties of the films can be modulated by several techniques, including 
chemical cross-linking by carbodiimide (Richert et al. 2004) and photo-crosslinking using 
photosensitive derivatives of the polyelectrolytes (Olugebefola et al. 2006; Pozos Vazquez et al. 
2009). The main techniques are shown in Figure I-27.  
 
FIGURE I-27. Overview of the main strategies used to modulate mechanical properties of 
polyelectrolyte multilayer films. The methods are essentially based on ionic cross-linking, chemical 
cross-linking and physical cross-linking. From (Gribova et al. 2012) 
 
The films can also be micropatterned to have (X-Y) architecture by combining with 
microfabrication techniques such as photolithography, microcontact printing or microfluidics 
(Berg et al. 2004; Chien et al. 2009; Monge et al. 2012; Almodovar et al. 2013). Furthermore, 
they can be deposited on various types of supporting materials, including metals, polymers and 
ceramics, which are already approved as implantable materials (Boudou et al. 2010).  
Interestingly, PEM films can also be fabricated as free-standing membranes (Ono and Decher 
2006; Larkin et al. 2010; Pennakalathil and Hong 2011).  
The versatility of PEM films makes of them a valuable tool for the studies of the effects of 
different stimuli, physical and biochemical, on cellular processes, and for the control of cell fate.  
Moulation of film mechanical properties Properties
IONIC
CROSSLINKING
Variations in pH or ionic strength
(role of H bonds, ionization of the 
charged groups COO-/COOH)
Reversible
CHEMICAL
PHYSICAL
Carbodiimide
Amide bond (EDC/sulfoNHS)
COO- and NH3
+            →
Irreversible
UV Photo-induced
Ex: vinyl benzyl →
Irreversible
Possible variation in 
spacer arm 
Thiol groups; disulfide bond
S-H  +   H-S  → S-S Reversible
Natural cross-linkers
Ex : Genipin:  reaction with amine 
groups
Irreversible
Incorporation of nano-objects
Nanoparticles
Nanotubes
Irreversible
10 nm
10 nm
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I.B.5. Transition 
 
Skeletal muscle tissue engineering holds promise for the replacement of muscle due to an 
injury and for the treatment of muscle diseases, such as muscle dystrophies or paralysis, but is 
also required for pharmaceutical assays. To this end, complex environments with tunable 
mechanical and chemical/biochemical properties mimicking in vivo muscle ECM are needed.  
In the next part, we will focus on skeletal muscle tissue engineering using skeletal muscle 
multipotent stem cells, and give an overview of the current approaches that exist for the in vitro 
2D and 3D engineering of skeletal muscle.  
The emphasis of this discussion will be on the applications of polyelectrolyte multilayer 
films for the control of the cell fate of skeletal myoblasts.  
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I.C. SKELETAL MUSCLE TISSUE ENGINEERING  
Skeletal muscle is one of the major tissues of the human body. An average adult male is 
made up of 42% of skeletal muscle and an average adult female is made up of 36% (as a 
percentage of body mass). Skeletal muscle is anchored by tendons to bone and is used for 
locomotion.  
Skeletal muscle tissue engineering holds promise for the replacement of muscle due to an 
injury following a surgery or due to a trauma and for the treatment of muscle diseases, such as 
muscle dystrophies or paralysis.  
Engineered muscle tissues models are also required for pharmaceutical assays, in particular 
for the development and evaluation of drugs against diabetes, because skeletal muscle plays a 
crucial role in insulin-mediated uptake and disposal of blood glucose (Jensen et al. 2011). In 
vitro engineered models of diseased muscle may find use for the examination of the functional 
effects of patient-specific mutations.  
Besides clinical and pharmacological applications, in vitro engineered muscle tissue 
models are also needed for fundamental studies. Structural, biochemical, cellular, and functional 
changes in skeletal muscle ECM contribute to the deterioration in muscle mechanical properties 
with aging (Kragstrup et al. 2011). Muscle atrophy is of particular interest to the spaceflight 
community, since the weightlessness results is a loss of as much as 30% of mass in some 
muscles (Narici and de Boer 2011)  
Different fields that require engineered skeletal muscle tissues are schematically 
represented in Figure I-28. 
 
Figure I-28. Schematic representation of different fields that require engineered skeletal muscle 
tissues. Skeletal muscle tissue engineering holds promise for the replacement of muscle due to an injury. 
They are also required as models for pharmaceutical assays and for fundamental studies. 
Aging/Atrophy
Pharmacological 
assays
Injury
Surgery
Dystrophies
Muscle tissue 
replacement
In vitro models
Problem
Solution
Approach Skeletal muscle tissue 
engineering
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I.C.1. Skeletal muscle organization and extracellular matrix 
The development of skeletal muscle is known to strongly depend on the interaction of 
muscle cells with their surrounding extracellular matrix. Mature skeletal muscle has a complex 
three-dimensional (3D) organization of aligned muscle fibers surrounded by ECM (Fig. I-29). 
The ECM of skeletal muscle consists of two distinct structures: the basement membrane 
delineating individual myofibres and interstitial connective tissue layers including endomysium, 
perimysium and epimysium which connect muscle fibers, fascicles, and bundles (Trotter and 
Purslow 1992; Gillies and Lieber 2011). The interstitial connective tissue consists mostly of 
collagens type I, III and V, and fibronectin (Light and Champion 1984). 
 
Figure I-29. Muscle organization and extracellular matrix. (A) Schematic diagram of the gross 
organization of muscle tissue. Muscle ECM can be categorized as epimysium (surrounding the muscle), 
perimysium (surrounding muscle fascicles), and endomysium (surrounding muscle fibers). (B) Scanning 
electron microscopy of the collagenous endomysial network around muscle fibers Low power overview of 
the endomysium reveals an array of “tubes” into which muscle fibers insert (arrows) as well as a 
thickened area surrounding the fibers that is presumably perimysium (arrowhead). Adapted from (Trotter 
and Purslow 1992) and (Gillies and Lieber 2011). 
 
Skeletal muscle basement membrane (BM) contains collagen type IV, laminin and heparan 
sulfate proteoglycans and is composed of two layers: an internal, felt-like basal lamina (BL) 
directly linked to the plasma membrane, and an external, fibrillar reticular lamina (Sanes 2003) 
(Fig. I-30).  
Basal lamina plays an important role in maintaining sarcolemma integrity, which is 
required for muscle function (Gillies and Lieber 2011; Hinds et al. 2011; Thorsteinsdottir et al. 
2011). The laminin-α2 chain, which is a component of laminin-211, -221 and -213, is the 
predominant laminin alpha chain expressed in adult skeletal muscle (Miner and Yurchenco 
2004). The laminin-α2 chain is involved in anchoring myofibers to the basal lamina, promoting 
muscle cell integrity and survival (Miyagoe et al. 1997). 
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Figure I-30. Schematic presentation od skeletal muscle basement membrane. Skeletal muscle basement 
membrane (BM) surround myofibers and is composed of two layers: basal lamina and reticular lamina. 
Basal lamina is linked to sarcolemma via dystroglycan and integrin interaction with laminin globular 
domains. Adapted from (Bezakova and Ruegg 2003). 
 
It was shown that, in vivo, local irradiation enhances the laminin content in the host muscle 
microenvironment and provides a better engraftment of human myoblasts (Silva-Barbosa et al. 
2008). In another study, injection of laminin-111 restored the regeneration in mdx mice and 
protected muscle from exercise-induced damage (Rooney et al. 2009a; Rooney et al. 2009b). 
Laminin-111 (α1, β1, γ1), which is the most widely studied laminin isoform, is expressed during 
embryonic development, but is absent in postnatal normal or dystrophic skeletal muscle. 
Goudenege et al. showed that intramuscular injection of laminin-111 increased muscle strength 
and resistance in mdx mice and improved proliferation and drastically increased migration in 
vitro (Goudenege et al. 2010). These data provide combined in vivo and in vitro evidence that 
laminins may serve as a novel therapeutic agent for patients with congenital myopathies. 
Among various cell surface receptors, integrins are the most characterized and have been 
shown to be crucial for skeletal muscle development and function (Mayer 2003; Perkins et al. 
2010). For instance, β3 integrin was found to be crucial for myogenic differentiation of C2C12 
myoblasts, and to mediate satellite cell differentiation (Liu et al. 2011), while β1-integrin, which 
is constitutively expressed in skeletal muscle, has earlier been shown to be dispensable to 
myogenesis (Hirsch et al. 1998). 
Dystroglycan is a component of dystrophin-glycoprotein complex which, in muscle cells, 
forms an important receptor system for ECM (Gullberg and Ekblom 1995; Durbeej et al. 1998b). 
Dystroglycan
Laminin-α2
Integrin
Dystrophin
Actin fibers
Collagen
fibers
Basal 
lamina
Myofiber
Reticular
lamina
Basement
membrane
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Dystroglycan interaction with laminin-α2 chain was shown to be crucial for maintaining the 
integrity of sarcolemma and protecting muscle from damage (Matsumura et al. 1997; Durbeej et 
al. 1998b; Cohn et al. 2002; Han et al. 2009; Munoz et al. 2010). Mutations that lead to loss of 
dystroglycan result in the loss of other members of the dystrophin-glycoprotein complex along 
the sarcolemmal membrane, and deficits in most of these proteins cause muscular dystrophies 
(Durbeej et al. 1998a). Defects in the glycosylation of a-dystroglycan cause muscular 
dystrophies called dystroglycanopathies (Hewitt 2009; Muntoni et al. 2011). 
In parallel, syndecans, transmembrane heparan sulfate proteoglycans, were shown to play 
an important role in myogenesis. Syndecan-3 and syndecan-4 specifically mark skeletal muscle 
satellite cells and are implicated in satellite cell maintenance and muscle regeneration 
(Cornelison et al. 2001). Syndecan-1 expression was found downregulated during myoblast 
differentiation (Larrain et al. 1997), and its overexpression inhibited the differentiation (Larrain 
et al. 1998; Velleman et al. 2004) and promoted proliferation (Velleman et al. 2007).  
Besides biochemical properties, mechanical properties of the muscle ECM are important. 
Muscle is a soft tissue with Young’s modulus around 10 kPa. In dystrophic muscle, a more 
fibrotic tissue and an increased rigidity of the diaphragm have been observed as compared to 
normal diaphragm (Stedman et al. 1991). This leads to an abnormal muscle function. 
 
I.C.2. Skeletal muscle stem cells 
Although several cell types may contribute to muscle repair in vivo or used for skeletal 
muscle generation in vitro, and among them ES cells, MSC or mesoangioblasts (for review, see 
Rossi et al. 2010), the canonical myogenic progenitor is the muscle satellite cell, characterized 
by its specific location on muscle fibers under the basal lamina (Fig. I-31) (Mauro 1961). These 
cells are multipotent and are now considered as a powerful source for the generation of several 
tissues. Besides skeletal muscle (Bischoff 1975), they are able to give smooth muscle (Le 
Ricousse-Roussanne et al. 2007), bone (Katagiri et al. 1994; Schindeler et al. 2009) or fat tissue 
(Teboul et al. 1995; Wada et al. 2002). This makes of them interesting candidates for 
engineering of muscle and other tissues.  
 
I.C.2.a) Muscle regeneration 
The process of muscle formation requires that satellite cells become activated, proliferate, 
differentiate, and fuse together to form multinucleated myotubes (Fig. I-32). For skeletal 
myoblasts, cell cycle arrest is necessary to undergo differentiation.  
 Figure I-31. Skeletal muscle microenvironment surrounding satellite cell
extracellular matrix, as well as cell surface receptors, are indicated. The elements are not drawn to scale.
 
During myogenic differentiation, a highly ordered process of temporally separable events 
that begins with the expression of myogenic transcription factors such as myogenin, and is 
followed by cell cycle arrest takes place 
A major limitation to the study and clinical application of muscle progenitors is a rapid 
loss of their muscle stem cell properties once they are removed from their 
(Cosgrove et al. 2009). For this reason, myoblast cell lines are often used for
of myogenic differentiation. Several myoblast cell lines are available, such as C2C12 or MM14 
mouse myoblasts. These cells are able to reproduce processes that take place during 
differentiation of skeletal muscle progenitors 
subclone of C2 myoblasts (Yaffe and Saxel 1977)
removal (Blau et al. 1983). 
Using cell lines presents, however, several disadvantages. Some studies show that the 
expression of surface markers, as well as response to environmental stimuli, is different for 
primary myoblasts and cell lines 
that one must be cautious in generalizing results obtained with cell lines 
relevant processes (e.g., tissue regeneration), as significantly different or even opposing results 
may be obtained for primary cells. 
 
 
. Different components of the 
(Andres and Walsh 1996).  
(Bach et al. 2004). C2C12 myoblasts are a 
 which differentiate in culture after serum 
(Boontheekul et al. 2007; Grabowska et al. 2010)
to more physiologically 
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in vivo environment 
 the in vitro studies 
in vivo 
. This indicate 
 Figure I-32. Muscle regeneration. 
become activated, proliferate, differentiate, and fuse together to form multinucleated myotubes. Different 
markers (adapted from Zammit et al. 2006) expressed during this process are indicated.
 
I.C.2.b) Osteogenic differentiation of muscle
Besides regeneration of skeletal muscle, muscle stem cells 
bone repair (Schindeler et al. 2009
differentiation when treated with BMP
Bone morphogenetic protein
al. 2007). BMP-2 through 7 and BMP
mesenchymal stem cells into osteoblasts 
1995; Mayer et al. 1996). Recently, it was shown that BMP
skeletal muscle stem cell fate: i
differentiation, thus permitting population expansion (Ono et al. 2011).
BMP-2 has two epitopes referred to as the ‘‘wrist epitope’’ and the ‘‘knuckle epitope’’, 
forms dimers and bind to BMP recep
activities (Fig. I-33A). The cytoplasmic domain of the BMP
phosphorylates the BMP receptor type I 
BMP receptor type I then phosphorylates Smad1, which is a cytoplasmic signaling molecule 
specifically mediating the action of BMP
promotes osteoblastic differentiation by controlling the expression of several genes (Fig. 
Differentiating osteoblasts have elevated alkaline phosphatase (ALP) activity and form bone 
tissue by promoting the secretion of bone matrix.
The process of muscle formation requires that muscle 
 progenitors 
in vivo can also contribute to 
). In vitro, C2C12 myoblasts can undergo osteogenic 
-2 growth factor (Katagiri et al. 1994)
-2 (BMP-2) is a member of a large BMP family 
-9 have the unique ability to induce differentiation of 
(Chen et al. 1991; Yamaguchi et al. 1991; Hughes et al. 
-4 plays a role in the control of 
t stimulated satellite cell division and inhibited myogenic 
 
tors type I and type II on the cell surface to init
-bound BMP receptor type II 
(Wrana et al. 1994) (Fig. I-33B). The phosphorylated 
-2. Phosphorylated Smad1 moves into the nucleus and 
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precursor cells 
 
.  
(Gautschi et 
iate their 
I-33B). 
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Figure I-33. Representation of BMP-2 with its epitopes and BMP signaling pathway. (A) The butterfly-
shaped architecture of the dimeric ligand resembles two hands assembled palm-to-palm. The convex side 
of the fingers termed knuckle epitope is the binding interface for type II receptors. Type I receptor 
binding occurs in the so-called wrist epitope formed by the concave side of the fingers and the palm of the 
ligand. Adapted from (Mueller and $ickel 2012).(B) BMP dimer binds to BMP receptor type II which 
recruits type I receptors, so that a hetero-tetramer is formed with two receptors of each type. The 
proximity of the receptors allows the type II receptor to phosphorylate the type I receptor. Activated type 
I receptors phosphorylate R-smads or receptor regulated Smads (Smad1/5/8) which form complex with 
Smad4. Activated Smad complexes regulate gene expression of several target genes.  
 
I.C.3. Current approaches for skeletal muscle tissue engineering 
Therapeutic treatments for skeletal myopathies and loss of functional muscle require either 
the implantation of differentiated muscle tissue constructs (in vitro tissue engineering) or the 
injection of muscle-precursor cells into sites of disfunction for subsequent formation of new 
muscle tissue (in vivo tissue engineering). Both of these approaches require artificial matrices, 
either for cell amplification in vitro before injection, or for their differentiation and organization 
into functional muscle tissue. Current approaches in muscle tissue engineering include the 
development of 2D substrates with controlled stiffness and/or ligand presentation, as well as 
creation of 3D muscle tissue models.  The main approaches are summarized in Figure I-34 and 
will be further described in more details. 
 
Figure I-34. Current approaches for skeletal muscle tissue engineering. 2D substrates with controlled 
stiffness, ligand presentation and topography are used for studies of cellular processes and for the 
control of cell organization. 3D muscle tissue models are being developed using biomimetic scaffolds or 
hierarchical cell manipulation. 
A B
• Biochemically/mechanically defined substrates for the 
control of cell fate
•Microstructured substrates for cell alignment 
• Hydrogel scaffolds for the buildup of 3D 
constructs
• Cell sheet-based techniques 
2D
3D
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I.C.3.a) 2D models 
Modulation of substrate biochemical properties  
Flat substrates are widely used to study the effects of different signals on skeletal muscle 
cell fate. Many studies of muscle cell differentiation in vitro are conducted using full-length 
ECM proteins such as fibronectin (Grossi et al. 2007; Bajaj et al. 2011), laminin (Grossi et al. 
2007; Munoz et al. 2010; Serena et al. 2010), or collagen (Engler et al. 2004b; Boonen et al. 
2009).  
These full-length molecules contain, however, many active domains able to interact with 
different cell surface receptors and thus may influence very different cell processes. To precisely 
control myogenic differentiation, more defined substrates are needed. Currently, coupling of 
RGD peptide is the most widely used strategy to control myoblast adhesion in a more specific 
manner. It was shown that RGD peptide was necessary to promote myoblast attachment to 
alginate hydrogels, and that myoblast differentiated only on alginate gels with specific 
combination of monomeric ratio and RGD grafting density (Rowley and Mooney 2002). RGD 
was used to study myoblast adhesion and differentiation in 2D versus 3D alginate gels 
(Boontheekul et al. 2007) or in PEG hydrogels (Hume Acta Biomat 2012). In another study, 
RGD-peptides were found to significantly improve myoblast cell adhesion onto grooved 
polystyrene substrates (Wang et al. 2012). 
There are only very few works where specific cell receptors are targeted. Munoz et al. used 
short laminin globular (LG4-5) modules of the laminin-α2 chain that binds α-dystroglycan. 
When incorporated into poly(2-hydroxyethyl methacrylate), this fragment promoted myotube 
attachment and prevented anoikis  (Munoz et al. 2010). In another study, syndecan-1 antibody 
was used to study the effect of syndecan-mediated signaling on C2C12 myoblast adhesion and 
migration (Chakravarti et al. 2005).  
Modulation of substrate mechanical properties  
Besides biochemical properties, mechanical properties of the substrate can affect muscle 
cell adhesion, spreading, proliferation and differentiation. Different types of synthetic and 
natural materials are being used to study and control the cell fate of muscle cells in vitro: model 
synthetic PA gels coated with collagen (Engler et al. 2004b), PEG hydrogels (Gilbert et al. 
2010), alginate gels of varying stiffness (Boontheekul et al. 2007) and polyelectrolyte multilayer 
films made of biopolymers (Ren et al. 2008). Recently, Post and coworkers (Boonen et al. 2009) 
showed, using PA gels of varying rigidity and protein coating, that proliferation was influenced 
only by rigidity, whereas differentiation was influenced both by rigidity and by protein coating.  
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Topographical cues 
One of the main issues of in vitro skeletal muscle tissue engineering is to obtain a properly 
organized tissue. On flat tissue culture polystyrene, myotubes are randomly organized, while 
natural muscle cells are perfectly aligned. This disorganization severely interferes with 
differentiation studies. Notably, synchronous contraction is very important, as the primary 
function of skeletal muscle is the generation of a longitudinal force (Stern-Straeter et al. 2007). 
Thus, the controlled alignment of myotubes in vitro could have significant applications 
clinically.  
It has been shown that myoblast adhesion and the subsequent formation of myotubes in 
vitro are sensitive to microstructured topography. To guide muscle cell alignment in vitro, 
different types of microstructured substrates such as silicon microgrooves or wavy patterns, as 
well as aligned nanofibers prepared by electrospinning, have been used (Huang et al. 2006; Lam 
et al. 2006; Charest et al. 2007; Gingras et al. 2009; Aviss et al. 2010; Huang et al. 2010; Bajaj et 
al. 2011; Monge et al. 2012).  
 
I.C.3.b) 3D models 
One of the current challenges in muscle tissue engineering is to construct 3D well-
organized muscle tissues. Another important challenge consists in vascularizing such engineered 
tissues, since blood supply is necessary to bring nutritive elements and oxygen to the cells in 
thick constructs (Koning et al. 2009). The most commonly used method for 3D muscle tissue 
construction consists in myoblast association to polymeric scaffolds.  
 
Scaffolds made of synthetic materials 
Different scaffolds made of synthetic materials have been developed (Levenberg et al. 
2005; Shah et al. 2005; Williamson et al. 2006). Levenberg et al. have used a polymer scaffold 
composed of 50% poly- (L-lactic acid) (PLLA) and 50% poly(lactic-glycolic) acid (PLGA) to 
construct a prevascularized skeletal muscle 3D constructs by co-culturing myoblasts, endothelial 
cells and fibroblasts (Levenberg et al. 2005). This scaffold was also used to evaluate the effect of 
the stiffness on myoblasts. The results indicated that compliant scaffolds were insufficient to 
withstand cell forces, while excessively firm scaffolds could not lead to parallel oriented 
myotube organization (Levy-Mishali et al. 2009). In another study, a UV-photopatterned thiol-
ene mold was employed to produce long channels within a PEG–RGD hydrogel, where skeletal 
myoblasts formed multiple cell layers within the channels (Hume Acta Biomat 2012). 
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Scaffolds made of natural materials 
However, natural matrices such as collagen gels (Bian and Bursac 2009), matrigel 
(Vandenburgh et al. 2008; Bian et al. 2012) or fibrin gels (Chiron et al. 2012) present advantages 
compared to synthetic scaffolds, because they possess cell adhesion ligands that can interact with 
integrins and thus naturally allow cell anchorage.  In addition, some of the scaffolds, e.g. fibrin 
gels, have the capacity to bind specifically many growth factors (Janmey et al. 2009). 
Interestingly, application of a continuous strain to a fibrin gel induced myotube alignment in the 
direction of the applied strain (Matsumoto et al. 2007). In another study, human myoblasts were 
embedded in a fibrin matrix cast between two posts, and myoblasts also aligned along the 
longitudinal axis of the gel (Chiron et al. 2012). Cell-interactive alginate gels with tunable 
degradation rate and stiffness were used to study the effects of mechanical stiffness and 
degradability on proliferation and differentiation of primary myoblast versus C2C12 myoblast 
cell line (Boontheekul et al. 2007).  
 
Cell sheets 
Another widely used method to create 3D muscle constructs is cell sheet-based tissue 
engineering. A thermoresponsive polymer poly(N-isopropylacrylamide) (PNIPAAm), grafted on 
a cell culture substrate, allows confluent cells to be detached as a single cell sheet and to create 
scaffold-free 3D tissues by layering multiple cell sheets (Yamada et al. 1990; Akiyama et al. 
2004). Sasagawa et al. developed prevascularized 3D tissues using human umbilical vein 
endothelial cells (HUVECs) sandwiched between two myoblast sheets (Sasagawa et al. 2010). 
Recently, myoblast sheets with well-aligned orientation were fabricated to create 3D oriented 
myoblast and myotube constructs (Takahashi et al. 2013).  
 
I.C.4. PEM films for the control of cell fate of skeletal myoblasts 
Due to their versatility, PEM films can be used as model biomaterial surfaces for guiding 
the cell fate of skeletal muscle progenitors. Stiffness, biochemical properties and topography of 
PEM films can be controlled independently or simultaneously, thus providing a wide platform 
for investigation of the effects of different stimuli on skeletal muscle regeneration.  
Here, we will present recent achievements in controlling adhesion and differentiation of 
skeletal myoblasts using PEM films as biomimetic substrate with controlled properties.   
 
 
 I.C.5.a) Differentiation towards myogenic pathway
PEM films made of hyaluronan (HA) and PLL are a model substrate for cell adhesion and 
differentiation studies due to their mechani
constituent of the ECM, and PLL
(PLL/HA) films can be cross-
while other parameters such as film roughness, wettability
significantly modified (Schneider et al. 2005)
(PLL/HA) films of controlled stiffness were used to investigate the effects of the stiffness 
on C2C12 myoblast adhesion, proliferation and differentiation
(E(0)>320 kPa) promoted the formation of focal adhesions and organization of the cytoskeleton, 
as well as an enhanced proliferation, whereas softer films 
favorable for cell anchoring, spreading, or proliferation. Cell differenti
also greatly dependent on film stiffness. 
320 kPa) were favorable for the differentiation of C2C12 myoblasts, whereas softer films were 
not favorable for differentiation (Fig. 
Figure I-35. Effect of (PLL/HA) film stiffness on C2C12 myoblast differentiation. 
films (here, EDC 50 and EDC 100, corresponding to higher cross
for the myogenic differentiation of C2C12 myoblasts, as compared to softer films (here, EDC10). 
Troponin T is labeled in green and nuclei i
  
C2C12 myoblast adhesion and proliferation was also studied on three types of multilayer 
films made from poly(L-lysine)/hyaluronan, chitosan/hyaluronan, and poly(allylamine 
hydrochloride)/poly(L-glutamic acid). The results 
proliferation was controlled by film cross
cell spreading areas correlated with the film stiffness 
C2C12 myoblast adhesion on (PLL/HA) films, including 
cytoskeleton connection, and focal adhesion formation, were also studied 
More recently, (PLL/HA) films were also used to orient and confine myoblasts. When 
combined with molded PDMS, they were used to reproduce 
myotubes in a regular and parallel network (Monge 
 
cal and biochemical properties.
 appears to be biocompatible (Tryoen
linked in a tunable manner, which leads to increased stiffness, 
 and serum protein adsorption a
. 
 (Ren et al. 2008)
(E(0) from 3 to 320 kPa) 
ation into myotubes was 
This study revealed that stiffer (PLL/HA) films (E(0) > 
I-35).  
-linking degrees) were more favorable 
n blue. From (Ren et al. 2008). 
showed that, for all films, adhesion and 
-linking, independently of their internal chemistry. The 
(Boudou et al. 2011). The mechanisms of 
integrin clustering, integrin 
(Ren et al. 2010)
in vitro the natural organization of 
et al. 2013). Multilayer films made of PLL 
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 HA is a major 
-Toth et al. 2002). 
re not 
. Stiff films 
were not 
Stiffer (PLL/HA) 
and actin 
.  
 and a photoreactive hyaluronan derivative, which can be photo
to create stiffness patterns, were used to create spatial patterns of rigidity 
These films allowed cell confinement on the stiffer areas in case of circular micropatterns, and 
myoblast alignment on linear patterns. 
Interestingly, an approach for the controlled detachment of C2C12 
from (PLL/HA) films with a topmost layer of fibronectin was proposed 
Adding a low concentration of nontoxic ferrocyanide to the cell culture medium 
erosion of the polyelectrolyte multilayer and rapid detachment of viable cell sheets (Fig. I
This technique is promising to cell sheet engineering and could potentially be used for skeletal 
muscle regenerative medicine (Zahn et al. 2012)
Figure I-36. Schematic representation of ferrocyanide
culture dishes (gray) are coated with an (HA/PLL) film; the first block (dark blue) is crosslinked and the 
second block is native (light blue). Confluent cell sheets (orange) are grown on a fibronectin adhesion 
layer (green). (B) Upon addition of ferrocyanide (black) the native (HA/PLL) multilayer dissolves 
resulting in the detachment of the cell sheet and the fibronectin layer. From 
 
Besides HA-based PEM films, C2C12 myoblast cell adhesion was also studied on 
multilayer films made of synthetic polymers. The effect of terminal layer and of different film 
composition (e.g. varying PSS molecular weight) of poly(sodium
poly(allylamine hydrochloride) (PAH) films on C2C12 cell behaviour was investigated 
et al. 2011). A ”double-sheet” PDMS with stiffness microdomains coated with 
Salts/Protamine (DXS/PRM) multilayers promoted C2C12 myoblasts alignment and 
differentiation. In another study, (PAH/PSS)
muscle regeneration without switching to their optimal differentiative culture medium 
al. 2013).  
 
I.C.5.b) Differentiation towards osteogenic pathway
Besides using PEM films for myogenic differentiation of skeletal myoblasts, (PLL/HA) 
films were used to guide myoblasts towards the osteogenic pathway 
Crouzier et al. 2010). As already mentioned, C2C12 myoblasts can undergo osteogeni
differentiation when treated with BMP
-crosslinked thro
(Monge et al. 2013)
 
myoblasts
. 
-induced cell sheet detachment.
(Zahn et al. 2012)
-4-sulfonate) (PSS) and 
₅-coated microgrooves allowed C2C
 
(Crouzier et al. 2009; 
-2 growth factor (Katagiri et al. 1994)
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ugh a photomask 
. 
 cell sheets 
(Zahn et al. 2012). 
resulted in 
-36). 
 
 (A) Polystyrene 
. 
(Ricotti 
Dextran Sulphate 
12 skeletal 
(Palamà et 
c 
. 
 In vivo, soluble bioactive molecules (GF, cytokines, chemokines…) have natural affinity to 
ECM components and are often presented in a matrix
incorporation and targeted in vivo
approved by the US Food and Drug Administration (FDA) for delivery in absorbable 
sponges (Bessa et al. 2008). Currently, multiple studies have convinci
2 to be a safe, effective treatment option to enhance bone healing in many animal models and in 
humans (For review, see (Ghodadra and Singh 2008)
It was shown that crosslinked (PLL/HA) layer
for delivery of BMP-2 (Fig. I-37A)
(recombinant human BMP-2) 
dependent manner. Low doses of surface
myotubes, while higher doses allowed the development of an osteogenic phenotype
by ALP production (Fig. I-37B)
culture sequences while remaining bioactive, t
of rhBMP-2 immobilization. 
Figure I-37. Effect of BMP-2 loaded into (PLL/HA) films on C2C12 myogenic and osteogenic 
differentiation. (A) BMP-2 loading into PLL/HA films. (B) Immunochemical and histoche
of troponin T (green) and ALP (alkaline phosphatase, violet) of C2C12 on BMP
increasing BMP-2 initial concentrations. Adapted from 
 
These results show that PEM films constitute an innovative tool allowing to control 
myoblast adhesion, proliferation and differentiation by modulating chemical/biochemical 
composition and mechanical properties of the film.  The films can also be used for t
spatial cell organization.  
-bound form. This property can be u
 drug delivery. For instance, BMP-2 and BMP
ngly demonstrated rhBMP
). 
-by-layer films can also serve a
. C2C12 culture on (PLL/HA) films charged with rhBMP
induced myoblasts differentiation into osteoblasts in a dose
-adsorbed rhBMP-2 blocked C2C12 differentiation into 
. The rhBMP-2-containing films could sustain three successive 
hus confirming the important and protective effect 
(Crouzier et al. 2009). 
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I.D. THESIS SCOPE  
In this work, we used layer-by-layer (LbL) assemblies for two goals. The first consisted in 
the development of multifunctional biomimetic thin films for the control of skeletal muscle cell 
fate on 2D substrates. We used LbL films made of polypeptides, which can be stiffened by 
chemical cross-linking (Schneider et al. 2006a) and can be specifically functionalized by grafting 
of biomimetic peptides onto their surface (Picart et al. 2005). 
Our second goal was to explore the potentiality of LbL-coated skeletal muscle cells to form 
3D muscle tissues. Here, we used LbL assemblies for the construction of 3D skeletal muscle 
microtissues by “cell-accumulation technique” (Nishiguchi et al. 2011).  
The PhD project is divided in four major parts corresponding to the targeting of different 
cellular receptors in a 2D environment and to the engineering of 3D muscle tissue (Figure I-38).  
 
 
 
Figure I-38. PEM films as a model biomimetic substrate for the stimulation of skeletal muscle 
progenitors via various cell surface receptors and for the construction of 3D muscle tissue models. In 
2D: the films with tunable stiffness and grafted with different types of peptides were designed to 
investigate the effects of peptides on cellular processes, including cell fate. In 3D: construction of thick 
3D tissues using LbL protein deposition on the cell surface. 
The manuscript chapters corresponding to each type of film are indicated. 
 
 
Integrins
C2C12 skeletal
myoblast
1.RGD peptide
Syndecan-1 Dystroglycan BMP-2 receptor
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1) Firstly, we wanted to investigate the combined and independent effects of biochemical 
functionality and mechanical properties of PEM film on cellular processes of skeletal myoblasts. 
In chapter III, we investigate the influence of the substrate stiffness and nanoscale presentation 
of an integrin-targeting RGD peptide (alone or in combination) on C2C12 myoblast adhesion, 
proliferation and differentiation (Fig. I-38 (1)). 
2) Besides RGD peptide, peptides containing other key sequences are being developed. 
Among them, laminin-α2 derived peptides targeting syndecans and dystroglycans (Nomizu et al. 
1996; Hoffman et al. 1998; Suzuki et al. 2010; Urushibata et al. 2010). In chapter IV, we focus 
on the development of laminin peptide-grafted PEM films for specific targeting of syndecan-1 
and dystroglycan (Fig. I-38 (2)). 
3) C2C12 myoblasts can differentiate not only into myotubes, but also go towards 
osteogenic pathway when treated with osteoinductive growth factor BMP-2 (Katagiri et al. 
1994). In chapter V, we investigate if BMP-2 mimetic peptide presented by PEM films could 
orient skeletal muscle progenitors towards an osteogenic pathway (Fig. I-38 (3)).   
4) Recently, a new technology allowing fast construction of thick 3D tissues using LbL 
deposition method has been developed (Nishiguchi et al. 2011). In chapter VI, we apply the 
“cell-accumulation technique” to construct 3D muscle tissue models made of C2C12 myoblasts 
(Fig. I-38 (4)). This work has been conducted in collaboration with Pr Mitsuru Akashi and Dr 
Michiya Matsusaki from Osaka University. 
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CHAPTER II – Materials and Methods  
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This chapter introduces materials and techniques used during the thesis. The principles and 
details of different experimental methods will be described to allow the reproduction and 
facilitate the future research.  
First, the construction, modification and characterization of bioactive PEM films will be 
presented. Second, we will focus on fluorescent microscopy, which was widely used in this 
work. Next, cell culture conditions and the approach for construction of 3D micro-tissues will be 
described. The last part concerns the different techniques used for the evaluation of the cell 
behavior on the 2D films and inside 3D constructs. 
 
II.A. CONSTRUCTION OF PEM FILMS 
II.A.1. Polyelectrolyte solutions and film buildup  
The polyelectrolytes used in this work are polypeptides poly(L-lysine) (PLL, P2636, 
Sigma) and poly(L-glutamic) acid (PGA, P-4886, Sigma). Their chemical structure is shown in 
Figure II-1. 
 
Figure II-1. Chemical structures of poly(L-lysine) 
(PLL) and poly(L-glutamic) acid (PGA). 
 
 
 
Here, we will focus on the construction of (PLL/PGA) multilayer films. Both 
polyelectrolytes were dissolved at 0.5 mg/mL in a “HEPES-NaCl” buffer (20 mM HEPES, 150 
mM NaCl, at pH 7.4). The rinsing solution was composed of 150 mM NaCl (pH 6.5). 
For most of the experiments, films were manually constructed in 96-well plates. Such 
approach allows construction of many films at the same time, to increase the number of 
conditions and replicates. In addition, the small area of the wells requires smaller amounts of the 
products. We used the ultrathin bottom plates (Greiner Bio-One), allowing high magnification 
microscopy observations. The solutions were deposited in the wells with the help of 
multichannel pipettes. To empty the wells, the plates were turned upside down and shortly 
shaked to remove the liquid.   
A first layer of a positively-charged poly(ethyleneimine) (PEI) dissolved at 5 mg/mL in 
HEPES-NaCl buffer was deposited to improve the film anchorage. For this, 50 µL of PEI 
Poly(L-lysine) 
(PLL)
Poly(L-glutamic acid) 
(PGA)
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solution was deposited in the wells and incubated for 20 min at RT. Then, the wells were 
rigorously rinsed 4 times for 15 min to remove the unbound PEI molecules. 
To deposit the subsequent polyelectrolyte layers, 50 µL of the polyelectrolyte solution was 
deposited in each well and let for 8 min before being rinsed twice for 30 sec and 5 min, 
respectively, with 100 µL of 150 mM NaCl (pH 6.5). This sequence was repeated until the 
buildup of a (PGA/PLL)6  film was achieved.  
 
II.A.2. Modification of PEM films 
The modifications included modulation of films stiffness by chemical cross-linking and/or 
functionalization by bioactive peptides.  
 
II.A.2.a) Stiffness modulation  
Chemical cross-linking of (PLL/PGA) films is a way to increase their stiffness (Schneider 
et al. 2006b). The approach is based on carbodiimide chemistry. EDC, or 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide (Sigma Aldrich E7750), is used as a crosslinker and N-
hydroxysulfosuccinimide (Chemrio) as a catalyser. During the reaction, amide bonds between 
amine groups of PLL and carboxylic groups of PGA are formed (Fig. II-2). 
 
Figure II-2. Schematic presentation of PLL and PGA cross-linking using carbodiimide chemistry. 
 
For the cross-linking, 100 µL of EDC/sulfo-NHS solution in 150 mM NaCl pH 5.5 (mixed 
v/v with final EDC concentrations of 15 mg/mL and 5.5 mg.mL) were deposited in the wells and 
incubated at 4° C overnight. Finally, the films were thoroughly washed with the HEPES-NaCl 
buffer. 
 
II.A.2.b) Functionalization by bioactive peptides 
The sequences (Table II-1) were selected according to the existing literature and purchased 
from GeneCust (Dudelange, Luxembourg). The choice of the sequences will be described in the 
Amide bond
Poly(L-lysine) 
(PLL)
Poly(L-glutamic
acid) (PGA)
 next chapters. Cys-Gly (CG) sequence was added at the N
“linker” and allow peptide covalent attachment via a cystein residue. 
A scrambled L2synd peptide was designed using
http://www.mimotopes.com/peptideLibraryScreening.asp?id=97
 
Table II-1. Peptide sequences, targeted receptors and positions in the original protein.
 
The peptides were grafted to PGA using maleimide chemistry. Peptide grafting to PGA 
was performed in 2 steps, as described previously 
were grafted to PGA; then, cystein
Figure II-3. Two-step protocol for peptide grafting to PGA. Adapted from 
 
Name Peptide sequence
RGD CGPKGDRGDAGPKGA
pBMP-2 (1) CGKIPKASSVPTELSAISTLYL
pBMP-2 (2) CGKIPKACCVPTELSAISMLYL
L2synd CGKNRLTIELEVRT
L2synd 
scrambled
CGERRTETLVKNIL
L2dystro CGVQLRNGFPYFSY
-terminus of each peptide to creat
 
 a tool available at the following link: 
.  
(Picart et al. 2005). First, maleimide groups 
-ending peptides could bind to the maleimide
 (Picart et al. 2005)
Targeted receptor
Protein of origin 
and position
Integrins
Type I collagen, 
728-741
BMP-2 receptors
rhBMP-2, 73-92 
(C78,79S, M89T)
BMP-2 receptors rhBMP-2, 73-92 
Syndecan-1 
Laminin-α2,    
2780-2791
 α-Dystroglycan
Laminin-α2,    
2812-2823
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 (Fig. II-3). 
 
. 
References
(Picart et al., 2005)
(Saito et al., 2003)
(Nomizu et al., 1996) 
(Hoffman et al., 1998)
(Suzuki et al., 2010)
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Step 1. Synthesis of PGA-maleimide  
Briefly, to graft maleimide groups onto PGA side chains, PGA is reacted with EDC, sulfo-
NHS and maleimide trifluoroacetate in HEPES 10 mM pH 6.5 buffer in an inert atmosphere 
(nitrogen gas) under magnetic stirring for 24 h. After removal of the byproducts via dialysis 
against water, the PGA–maleimide is freeze-dried and analyzed by 
1
H NMR (Fig. II-4). The 
detailed protocol of the grafting can be found in Annexe III. The average number of maleimide 
groups bound to PGA was equal to 16% (i.e. in average 16 maleimide groups every one hundred 
repeating PGA units), as determined via 
1
H NMR analysis (Annexe IV).  
 
Figure II-4. Procedure of maleimide grafting to PGA. 
 
Step 2: Grafting of the peptides 
The further protocol depended on the type of peptides. Briefly, for RGD and BMP-2 
peptides, a previously described protocol of peptide grafting to PGA and subsequent PGA-
peptide deposition on the films surface was applied (Picart et al. 2005). For laminin-derived 
peptides, this protocol had to be modified, because L2synd and L2dystro grafting to PGA-
maleimide and subsequent freeze-drying led to totally insoluble products. The respective 
approaches are described below. 
RGD- and pBMP-2 functionalized films 
For RGD peptides, in the second step, the PGA-maleimide was reacted with the peptide to 
form the PGA-RGD in HEPES 10 mM pH 7.4 buffer. After 24 h, an excess of 
mercaptopropionic acid (MPA) was used to neutralize the unreacted maleimide groups. The 
solution was dialyzed against water, freeze-dried and the final product analysed by 
1
H NMR 
(Fig. 5). The detailed protocol of the grafting can be found in Annexe III. The quantitative 
grafting ratio of the peptide was determined by 
1
H NMR analysis, and the effective degree of 
substitution (DS) was found to be 10% (Annexe IV). To obtain PGA-RGD with lower DS, RGD 
peptide quantities added to the reaction were proportionally decreased. 
 Figure II-5.Procedure of RGD peptide grafting to PGA
 
After the grafting of RGD was accomplished, the PGA
buffer) was deposited on the final layer of (PGA/PLL
Figure II-6. Design of biomimetic thin film combining physical and biochemical cues.
polyelectrolyte multilayer film (PEM) is built onto a substrate by alternating deposits of PLL and of PGA. 
2- The PEM film can be covalently cross
stiffness. 3- Biochemical functionality is provided by adding a final lay
containing peptide. 
 
For films functionalization with pBMP
peptide was grafted to PGA as described above, the 
determined by 
1
H NMR analysis (Annexe IV),
layer of the films.  
 
Laminin peptide-grafted films
For the grafting of laminin
protocol was slightly modified. The first step consist
groups onto PGA chains. Then, the obtained PGA
buffer) was deposited on the top of 
Next, 100µL of MilliQ water
peptide or 1:1 (v/v) mix of both were added to the wells (Fig. II
overnight at RT under agitation, then the films were rinsed twice with MilliQ water to remove 
the unbound peptide.  
-maleimide. 
-RGD (0.5 mg/mL in HEPES
) films (Fig. 6).  
-linked using a water-soluble carbodiimide to modulate its 
er of PGA grafted with a RGD
-2, the same grafting procedure was applied. The 
quantitative grafting ratio of the peptide was 
 and PGA-pBMP-2 was deposited on the final 
 
-derived peptides and their co-grafting with RGD, previous 
ed, as previously, in grafting 
-maleimide (0.5 mg/mL in 
(PGA/PLL) films constructed in 96-well plates. 
-dissolved 60 µg/mL laminin peptides, 50 µg/mL of RGD 
-7). The grafting was carried out 
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Figure II-7. Construction of laminin peptide-grafted films. 1- Polyelectrolyte multilayer film is built 
onto a substrate by alternating deposits of PLL and of PGA. 2- PGA-maleimide is added on the last layer 
of the film. 3- Biochemical functionality is provided by adding peptides that covalently bind to maleimide 
group. 
 
II.A.3. Qualitative assessment of film quality 
To check the surface of the constructed films, we used fluorescent PLL (PLL
FITC
). PLL 
diffuses into the films and allows to observe the films under fluorescent microscope (Fig. II-8). 
To this end, 0.5 mg/mL of
  
PLL
FITC
 dissolved in HEPES-NaCl buffer were added to the wells 
containing constructed films, incubated for 8 min, then rinsed with 150 mM NaCl (pH 6.5). The 
principle of the fluorescence and fluorescent microscopy are described below (Part IIB). 
   
Figure II-8. Scratch on PLL
FITC  
labeled films for a quality control . (A) The film appears homogeneous 
and well formed. (B) The film presents aggregates at the surface. (C) The film is not propertly formed. 
 
II.A.4. Film growth monitoring by quartz crystal microbalance  
Film buildup was followed by in situ quartz crystal microbalance (QCM D300, QSense, 
Sweden) using a previously published procedure (Crouzier and Picart 2009). PLL, PGA, PGA-
maleimide or PGA-RGD, which were prepared at 0.5 mg/mL in the HEPES-NaCl buffer, were 
successively injected in the cell. They were let to adsorb for 8 min and rinsed for 5 min with the 
HEPES-NaCl buffer. For L2synd-functionalized films, after adding PGA-maleimide, the films 
were equilibrated in MilliQ water, and the MilliQ water-dissolved 60 µg/mL L2synd peptide was 
injected overnight. The unbound peptide was rinced with MilliQ water. 
1. Construction of 
(PGA/PLL) film
2. Addition of PGA-maleimide
on the last layer
3. Grafting of peptides to 
maleimide groups
A B C
100 µm
 This technique allows to measure film thickness using the
1999) and to calculate the adsorbed mass
measurements are conducted in air, the resulting decrease 
equation: 
where C is the mass sensitivity 
number. 
 
 
II.B. FLUORESCENT AND CONFO
In many experiments, visualization of the films (Fig. II
required. Fluorescent labeling
miscroscope is a common laboratory technique that is used for this goal.
 
II.B.1. Fluorescence 
Fluorescence is a property of a molecule to adsorb a photon and then to re
higher wavelength (Fig. II-9). When it is submitted to light excitation at a given wavelength, the 
fluorescent molecule is brought to an excited electronic state (S
internal conversion induces a partial loss of energy and the molecule fal
state of lower energy (S1). When the molecule comes back to its stable state (S
release of energy takes the form of light. The loss of energy corresponds to the emission of light 
at a higher wavelength than the initi
Stocke’s shift.  
 
 
 Voigt model 
. When a mass ∆m is adsorbed at the crystal and the 
∆f typically obeys the Sauerbrey 
 
constant (17.7 ng/cm
2
/Hz at 5 MHz), and 
CAL MICROSCOPY  
-8), cells or their components was 
 followed by observations using epifluorescent or confocal 
 
1’). At ambient temperature, the 
ls down to an excited 
al adsorption wavelength. This phenomenon is known as 
Figure II-9. Jablonski diagram
electron from the fluorophore adsorbs 
light (1) and becomes excited (stage S
When it is desexcited, there is first a loss 
of energy by internal 
(vibration, chock…). The molecule is then 
a the excitation state (S
to its stable state S
corresponds to a release of energy (light) 
at a higher wavelength (as the energy is 
lower). 
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n is the overtone 
-emit it at a 
o), the associated 
. An 
1’). 
conversion 
1) and comes back 
0. This transition 
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II.B.2. Epifluorescent microscopy 
In epifluorescence microscopy (Fig. II-10A), the light is first filtered through an excitation 
filter and passes through a dichroic mirror to be sent to the objective. The objective serves as a 
condenser of the excitation light. The objective is then used to collect the fluorescence light that 
is emitted by the sample. The emitted light passes through an emission filter before being 
detected by the camera (or observed by eye using the ocular ports). In this work, we used Zeiss 
Axiovert 200 inverted epifluorescence microscope equipped with a camera (Fig. II-10B). 
 
Figure II-10. Epifluorescence microscopy. (A) Schematic presentation: the light is sent to a dichroic 
mirror which directs it to the sample. The emitted light from the sample passes through the dichroic 
mirror before being collected. (B) Zeiss Axiovert 200 inverted epifluorescence microscope equipped with 
a camera. 
 
 
II.B.3. Confocal microscopy 
However, the fluorescence coming from the non-focal points is also acquired and a 
volumetric analysis is not possible. This is the reason why confocal microscopy has been 
developed by Minsky in 1957. The light source has been replaced by a laser, which allows the 
light at a precise wavelength to be sent to the sample. However, similarly to epifluorescence 
microscopy, the sample generates fluorescence out of the focal plane. To avoid this unwanted 
fluorescence, a pinhole is placed before the detector, which only allows light from the focal 
plane to be detected (Fig. II-11A). The image obtained in these conditions has a good signal to 
noise ratio. The scanning of the sample in X,Y direction by the laser allows an image of the focal 
plane to be taken. This scanning is obtained via motorized mirrors that are disposed on the 
optical path of the laser. For the scanning in the Z direction, the objective is mounted on a piezo-
electric mirror. It is thus possible to obtain images of different focal planes and to reconstitute a 
3D structure.  
A B
 The confocal microscope used is a Zeiss LSM 700
four different laser diodes, allowing the simultaneous observation of various fluorophores
II-11B). Thus, by the appropriate choice of the antibodies and stains, it is possible to visualize 
different subcellular structures at the sa
allows to maintain the cells at 37°C and 5% CO
Figure II-11. Confocal microscopy
point being reflected by the dichroic mirror and after passing through the objective. The fluorescent light 
is sent collected by a detector. To avoid out of plane fluorescence, a pinhole is placed in the emitted path. 
(B) Zeiss LSM 700 confocal microscope
cells at 37°C and 5% CO2 during long lasting experiments.
 
II.C. CELL CULTURE  
Cells are maintained at an appropriate temperature, humidity and gas mixture (typically, 
37°C, 5% CO2 for mammalian cells) in a cell incubator (Fig. II
 Figure II-12. Cells grown in an incubator. 
A
 (his name is Hanniba
me time. He is also equipped with an incubator that 
2 (Fig. II-11B).  
. (A) Schematic presentation: the laser source is condensed to a focal 
 equipped with an incubator. The system allows to maintain the 
 
-12).  
 
B
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Cell culture procedures are performed in sterile conditions. Sterile technique prevents from 
introducing contaminating microorganisms that can destroy the cells. All cell culture material 
(dishes, media, pipette tips etc.) are sterile, and all procedures are done in a laminar flow hood 
(or cell culture hood) that provides an aseptic work area (Fig. II-13). 
 
Figure II-13. Cell culture hood for the work in sterile conditions. 
 
 
II.C.1. C2C12 myoblasts 
Mouse myoblasts (C2C12 cells) were used as a cellular model in most of the studies. These 
cells are able to reproduce processes that take place during in vivo differentiation of skeletal 
muscle progenitors. C2C12 myoblasts are a subclone of C2 myoblasts (Yaffe and Saxel 1977) 
which differentiate in culture after serum removal (Blau et al. 1983).  
C2C12 cells (purchased from ATCC, used at passages 5-15) were maintained in 
polystyrene dishes in an incubator at 37° C and 5% CO2. They were cultured in growth medium 
(GM) composed of Dulbecco’s modified Eagle’s medium (DMEM)/F12 medium (1:1; Gibco, 
Invitrogen, Cergy-Pontoise, France) supplemented with 10% fetal bovine serum (PAA 
Laboratories, Les Mureaux, France) containing 10 U/mL of penicillin G and 10 µg/mL of 
streptomycin (Gibco, Invitrogen, Cergy-Pontoise, France). Cells were subcultured prior to 
reaching 60–70% confluence (approximately every 2 days) in GM (Fig. II-14). Myogenic 
differentiation was induced by putting the cells at ~80% of confluence into the medium 
containing 2% of horse serum (HS) (called hereafter DM). 
 Figure II-14. Phase contrast microscopy observations of C2C12 in culture.
 
II.C.2. MC3T3 preosteoblasts
MC3T3 murine preosteoblastic cell line is a good model for 
differentiation as they present a similar behavior to primary calvarial osteoblasts. They
high levels of osteoblast-specific markers and are a
acid-containing medium for several days 
MC3T3-E1 cells, subclone 4 (
composed of αMEM (A1049001, Invitrogen) supplemented with
(N4637-500ML Sigma) and 1%
Confluent culture of MC3T3 is shown in 
Figure II-15. Culture of MC3T3-E1 pre
 
II.C.3. Cell culture on biomimetic PEM films
For all adhesion experiments on the films, C2C12 cells were seeded at 15 000 cells/cm
96-well plates. Such seeding density allows to have a sufficient cell number for analysis, 
although maintaining the cells individual. 
The cells were allowed to adhere in a serum
1:1 and supplemented with antibiotics
 
 
in vitro studying of osteogenic 
ble to mineralize after growth in ascorbic 
(Wang et al. 1999). 
CRL-2593, ATCC), were maintained in growth medium 
 10% Newborn Calf Serum 
 antibiotics (penicillin-streptomycin mix, 15140122 Invitrogen). 
(Fig. II-15) 
 
-osteoblasts after 6 days in osteogenic differenti
 
 
-free medium (SFM) composed of DMEM/F12 
, to eliminate any effect of serum on early adhesion.
71 
 
 express 
ation medium. 
2
 in 
 After 
72 
 
1 h of adhesion, the cells were either fixed, or the SFM was replaced by the GM, depending on 
the type of experiment (Fig. II-16). For the work on L2synd peptide-grafted films, where a very 
high degree of specificity was required, the cells were maintained in SFM until 4 h, and only 
then put in GM, if the experiment (such as migration) required a further culture (Fig. II-16). 
For differentiation assays, cells were seeded at 30 000 cells/cm
2
 and allowed to adhere for 
1 h (or 4 h in the case of L2synd peptide-grafted films) in SFM. Cells were then grown for 1 day 
in GM to reach about 80% confluence, and then switched to DM (Fig. II-16). The medium was 
changed twice a week.  
 
Figure II-16. Chronology of C2C12 culture on PEM films. The different  experiments are indicated by 
colored arrows. SFM: serum-free medium; GM: growth medium, DM: differentiation medium. 
 
 
II.C.4. Construction of C2C12 multilayered tissues 
The technique consists in coating the cell surface with fibronectin (FN)/gelatin (G) 
nanofilms, (FN/G)4FN (Fig. II-17A), and then seeding the appropriate cell number in 24-well 
inserts to get the desired number of layers (Fig. II-17B). The inserts with porous bottom allow 
medium supply to thick multilayered tissues both from the top and from the bottom (Fig. II-
17C).  
Materials: 
• Tris-HCl buffer (50 mM pH 7.4) 
• Fibronectin (FN): Sigma, F4759, fibronectin from bovine plasma, 5 mg, MW = 450 kDa 
• Gelatin (G): Wako 077-3155, 500g 
• 24-well insert: Corning 3470, polyester, pore size 0.4 µm, growth area 0.33 cm2 
Cell coating: 
FN and G working solutions are prepared at 0.04 mg/mL in Tris-HCl and stored at 4°C. 
The cells are detached from culture dishes and washed twice with the GM. After resuspending 
the cells in Tris-HCl buffer, the cells are subsequently incubated for 1 min using a microtube 
rotater with 0.04 mg/mL FN or G solutions, then centrifuged at 200 g for 1 min, and the 
supernatant is gently removed by pipetting. After each FN or G deposition step the cells are 
rinsed in Tris-HCl buffer for 1 min using a microtube rotater, followed by centrifugation.  
1h 4h 24h
Day 0 Day 1
D D D DDD48h 72h DDD
Differentiation
Day 2
D
Adhesion
SFM +GM +GM 
(L2synd-
grafted films)
+DM
Migration
 Figure II-17. Schematic presentation of C2C12 multilayered tissues construction by 
technique.  (A) Cell coating by (F$/G)
inserts. (C) The medium is supplied by both sides.
 
Cell seeding: 
When (FN/G)4FN nanofilms are formed, the cells are resuspended in 
cell suspension containing desired cell number (10
well inserts with a semipermeable membrane coated with FN
One milliliter of GM is added in 24
cells are incubated for 1-2 hours at 37°C, then another 1 mL of GM is added to 24
make a liquid connection between the inside and the outside of the insert (Fig. II
For inserts coating, 100 µL of 0.04 mg/mL FN solution is deposited into the inserts and 
incubated at 37°C for 30 min, then rinsed once with Tris
For the differentiation, the constructs are maintained in GM for 24 h, then switched to DM.
Suspension of 
coated cells
B
FN-coated insert
Cell culture 
medium
Porous membrane
C
4F$ nanofilms. (B) Construction of multilayered tissues in 24
 
5
, 5 x 10
5
 or 10
6
 cells) are deposited into 
, and placed into 24
-well plate, respectively, outside the inserts (Fig. II
-HCl buffer.  
Figure II
presentation of cell 
seeding into 24
inserts and culture in 
24-
Culture 
medium
FN-coated insert
Culture 
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Cell multilayers
24 h
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 II.D. EVALUATION OF CELLULA
The major goal of this work was to study the effects of biomimetic PEM films on different 
cellular processes: adhesion, migration, 
study the internal organization of 3D myoblast structures and to investigate cell behavior in such 
thick constructs. In this part, we will present different techniques used to evaluate cellular 
response on 2D biomimetic substrates and in 3D constructs.
 
II.D.1. Fluorescent cell labeling 
II.D.1.a) Principle of immunolabeling 
In many assays, visualization of the cells or its components was required. 
Immunofluorescence (IF) is a common technique that is used to fluorescently label specific 
components of the cell by antibodies that target specific antigens of cellular proteins (Fig. II
Figure II-16. Examples of fluorescent labeling of specific components of 
for actin (red), tubulin (green) and nuclei (blue).
 
The antibody can be coupled to a fluorochrome and can thus be detected by fluorescent 
microscopy (direct IF, Fig. II
fluorochrome and recognizing the primary antibody is used (indirect IF, Fig. II
possibility is to use a primary antibody coupled to a biotin molecule. In this case, detection is 
made by a fluorochrome-conjugated streptavidin (Fig. II
There are also other types of direct fluorescent labeling of cellular components. 
instance, phalloidin, a toxin from 
and, if coupled to a fluorochrome, can be detected by fluorescent 
stained by DAPI or Hoechst fluorescent dyes that bind DNA.
R RESPONSE 
proliferation and differentiation. Another goal was to 
 
 
 
    
a cell. 
 
-17A). However, usually a secondary antibody coupled to 
-17C). 
Amanita phalloides, a deadly poisonous fungus, binds F
microscopy. The nuclei can be 
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Figure II-17. Different strategies for antigen detection by immunofluorescence. (A) Direct immuno-
fluorescence: a primary antibody coupled to a fluorochrome is used. (B) and (C) Indirect immuno-
fluorescence.(B) A secondary antibody coupled to a fluorochrome and recognizing the primary antibody 
is used.(C) Fluorochrome-conjugated streptavidin binds to a primary antibody coupled to biotin 
molecule. 
 
 
II.D.1.b) Classic immunostaining protocol 
Cells were first rinsed in PBS and fixed in 3.7% formaldehyde for 30 min at RT before 
being permeabilized in 0.5% Triton X-100 for 4 min. After rinsing with PBS, samples were 
incubated for 1h in 0.1 % BSA in TRIS-buffered saline (TBS, 50 mM TRIS, 150 mM NaCl, 
0.1% NaN3, pH 7.4). Actin was labeled with phalloidin-TRITC (1:800, Sigma) for 30 min. After 
the incubations with the primary antibodies (diluted in 0.2% TBS-gelatin) for 30 min at RT, cells 
were washed 3 times in TBS and incubated for 30 min with the secondary antibodies. Cell nuclei 
were stained with Hoechst 33342 (Invitrogen) at 5 µg/mL for 10 min. A list of used antibodies 
and their dilutions is provided (Table II-2). 
  II.D.1.c) Immunostaining protocol to observe adhesion receptors 
For Syndecan-1 immunostaining, a protocol adapted from Garcia and coworker was 
applied (Keselowsky and Garcia 2005). In this protocol, the membrane proteins are cross-linked 
with the substrate, and intracellular components are removed. Such approach allows better 
visualization of membrane proteins situated at the basal side of the adherent cell. It has already 
been applied to cells plated on polyelectrolyte multilayer films, as the film is adding some noise 
in the fluorescence signal (Ren et al. 2010). Briefly, cells were rinsed in PBS and incubated in 
ice-cold 1 mM DTSSP (3,3-dithiobis-(sulfosuccinimidyl)propionate, Calbiochem-Merck, Merck 
Chemicals, Nottingham, UK) in PBS for 30 min. Unreacted cross-linker was quenched with 50 
mM Tris in PBS for 15 min, and bulk cellular components were extracted in 0.1% SDS in PBS. 
The slides were then blocked in BSA (0.1% in TBS). After this, Syndecan-1 was immunostained 
with 281-2 mouse anti Syndecan-1 (CD138) antibody conjugated to biotin (1:100, BD 
Antigen Antigen
Primary 
antibody
Primary 
antibody
Secondary 
antibody
Fluorochrome Fluorochrome
Antigen
Primary 
antibody-
biotin
Fluorochrome-
streptavidin
A B C
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Pharmingen, BD Biosciences), and FITC-Streptavidin (1:500, BD Pharmingen, BD Biosciences) 
was used for visualization (Table II-2).  
Primary antibodies 
Antibody Reference Provider Animal Clone Final dilution 
Anti-β-Tubulin T4026 Sigma-Aldrich Mouse TUB 2.1 1:200 
Anti-CD138 (Syndecan-1)  553713 BD Biosciences Mouse 281-2 1:100 
Anti-FAK pY397  44624G Invitrogen Rabbit   1:200 
Anti-Fibronectin F3648 Sigma-Aldrich Rabbit   1:100 
Anti-Myogenin (M225) sc576 Santa Cruz Rabbit M-225 1:60 
Anti-N-cadherin 610921 BD Biosciences Mouse 32/N-Cadherin 1:200 
Anti-Skeletal Myosin (Fast) M4276 Sigma-Aldrich Mouse MY-32 1:500 
Anti-Troponin T T6277 Sigma-Aldrich Mouse JLT12 1:100 
 
Secondary antibodies 
Antibody Reference Provider Animal Final dilution 
Anti-mouse Alexa Fluor 488 A-11008 Invitrogen Goat 1:1000 
Anti-mouse Alexa Fluor 568 A-11004 Invitrogen Goat 1:1000 
Anti-mouse Alexa Fluor 647 A-21235 Invitrogen Goat 1:1000 
Anti-rabbit Alexa Fluor 488 A-11008 Invitrogen Goat 1:1000 
Anti-rabbit Alexa Fluor 568 A-11011 Invitrogen Goat 1:1000 
Anti-rabbit Alexa Fluor 647 A-21244 Invitrogen Goat 1:1000 
 
Product Reference Provider Final dilution 
Phalloidin P1951 Sigma-Aldrich 1:1000 
Hoechst 33342 A3570 Invitrogen 5 µg/mL 
Streptavidin-FITC 554060 BD Biosciences 1:500 
 
Table II-2. List of primary antibodies, secondary antibodies, and other products, used for fluorescent 
cell labeling. 
 
II.D.2. Quantification of cell adhesion 
Adhesion is the very first and important step of cell-substrate interactions, which is 
especially important for anchorage-dependent cells. To evaluate the effects of film stiffness, of 
peptide functionalization or of specific treatments on cell adhesion, cells were cultured on 
different types of films in specified conditions for 1 or 4 h. Different parameters such as number 
of adherent cells, spreading area, morphological parameters and cytoskeletal organization were 
evaluated.  
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The data on morphological parameters were manually obtained using a Wacom graphic 
tablet (named Ginette) which allows to precisely draw the cell contour on microscopy images 
(Fig. II-18). The data are collected and analysed by ImageJ software (v 1.44p, NIH, Bethesda), 
which calculates the cell area, circularity and aspect ratio. Cell circularity is a parameter defined 
by the formula: Circularity = 4π(A/P
2
), (A being the cell area and P its perimeter) that allows to 
characterize cell morphology: a circularity value of 1.0 indicates a perfect circle and a decrease 
toward 0 indicates an increasingly elongated polygon. The aspect ratio is a parameter [Major 
Axis]/[Minor Axis] of the particle’s fitted ellipse. 
 
Figure II-18. Wacom graphic tablet used for the analysis of cell morphological parameters. 
 
II.D.3. Analysis of cell-film interaction  
To evaluate the specificity of cell interaction with L2synd-grafted films, i.e. if the cells 
specifically recognize the peptide sequence and bind to it via syndecan-1, we performed two 
competition assays. In the first assay, we pre-incubated the cells with 10 µg/mL of peptide in 
SFM or with SFM alone for 30 min at 37°C and allowed to adhere on the films grafted with the 
same peptide for 2 h.  In the second assay, we compared cell adhesion on L2synd-grafted films 
and on the films grafted with a scrambled peptide: a peptide that has the same amino acid 
composition as L2synd, but not in the same order. For this, the films were grafted with either 
original or scrambled L2synd peptide, and the cells were allowed to adhere on L2synd-grafted 
films for 4 h in SFM.  
Involvement of proteoglycan adhesion receptors was tested by a competition assay in 
presence of 1 mg/mL HA MW 360 kDa (Lifecore Biomedical, Chaska, MN, USA) and 200 kDa 
(gift from Pr Auzély-Velty, CERMAV, Grenoble) and 100 µg/mL heparin (H4784, Sigma). The 
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cells were pre-incubated for 30 min in SFM alone or containing respective molecules, and 
allowed to adhere on L2synd-grafted films for 4 h.  
Involvement of integrin receptors on different types of PEM films was tested by cell 
adhesion assay in presence of 2 mM EDTA (Sigma) and 2 mM EGTA (Roth). The cell adhesion 
via integrin receptors requires divalent ions such as Ca
2+ 
and Mg
2+
. EDTA and EGTA are 
chelating agents that can inhibit integrin-mediated adhesion by sequestering the divalent cations.  
The cells were pre-incubated for 30 min in SFM alone or containing respective molecules and 
allowed to adhere on L2synd-grafted films for 4 h.  
For adhesion assays in presence of Rac1 and Cdc42 inhibitors, the cells were allowed to 
adhere for 4h in absence or in presence of 50 µg/ml of NSC23766 (Rac1 inhibitor) or 10 µM of 
ML141 (Cdc42 inhibitor) in SFM. DMSO was used as a control for ML141 which is dissolved in 
DMSO.  
 
II.D.4. Knock-down of integrin receptors using siRNA 
The major integrin beta chains in C2C12 myoblasts are β1-integrin, which is constitutively 
expressed in skeletal muscle (Hirsch et al. 1998) and β3 integrin, which was found to be crucial 
for myogenic differentiation of C2C12 myoblasts (Liu et al., FASEB J., 2011). In order to 
investigate their possible role in cell adhesion on peptide-grafted films, we performed β1 or β3 
integrin (or both) knockdown using siRNA approach.  
Small interfering RNA (siRNA) are double-stranded RNA molecules, 20-25 base pairs in 
length. They interfere with the expression of specific genes with complementary nucleotide 
sequence by inducing their degradation via RNase-containing RISC (RNA-induced silencing 
complex) (Hamilton and Baulcombe 1999; Elbashir et al. 2001) (Fig. II-19). 
Briefly, the cells were transfected with siRNA against β1 and β3 integrins (ON-TARGET 
plus SMARTpool, respectively Mouse ITGB1 and Mouse ITGB3, Thermo Scientific 
Dharmacon) individually or at the same time, a scrambled siRNA (All Stars negative Control 
siRNA, Qiagen) being taken as control. For this, the cells were seeded at 30 000 cells/cm
2
 in a 6-
well plate and cultured in GM (2 mL per well) for 15 h. 
 Figure II-19. Mechanism of siR7A interference.
 
The transfection mix was prepared as following (volumes given for one well): 
i) 6 µL of lipofectamine RNAiMAX Reagent (Invitrogen) were added to 305 µL of Opti
MEM medium (Gibco) (= Mix 1);
ii) 0.72 µL of 1 mM siRNA were added to another 305 µL of Opti
iii) Mix 1 was gently added to Mix 2 and incubated for 20 min at room temperature. 
Previously to transfection, the GM of the wells was replaced by the GM without 
antibiotics. Then, 610 µL of the final mix were added to each well. After
37°C, the cells were transfected for the second time following the protocol described above and 
incubated for another 24 h. Then the cells were detached by trypsin
000 cells/cm
2
 on the films built in 96
were fixed and their area was quantified.
 
II.D.5. Cell migration assay
To follow cell migration on different types of PEM films, C2C12 cells were seeded at 15 
000 cells/cm
2
 in 96-well plates, allowed to
using Zeiss LSM 700 microscope equipped with an incubator. Images were taken every 10 min 
during 10 h. For the analysis, at least 20 cells were tracked using ImageJ (v1.45d, NIH, 
Bethesda) Chemotaxis and Migration To
directionality. Directionality is defined as
cell, and expresses the trajectory of the cell movement. When directionality value is close to 1, 
this indicates almost straight trajectory; the directionality close to 0 means random movement 
(Fig. II-20).  
 
 
-MEM medium (= Mix 2);
 24 h of incubation at 
-EDTA, seeded in GM at 20 
-well plate and allowed to adhere for 4 h. Then, the cells 
 
 
 adhere for 4 h and followed by time
ol. This tool allows to quantify cell velocity and 
 beginning to end distance / total displacement of the 
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Figure II-20. Cell trajectory characterized by 
directionality parameter. Directionality is 
defined as beginning to end distance / total 
displacement of the cell.  
 
 
II.D.6. BrdU and EdU cell proliferation assays 
During myogenic differentiation, a highly ordered process of temporally separable events 
that begins with the expression of myogenic transcription factors and is followed by cell cycle 
arrest takes place (Andres and Walsh, J. Cell Biol., 1996). Thus, study of cell proliferation is 
important for the follow-up of myogenic differentiation, but also for the general evaluation of the 
proliferative activity.  
Cell proliferation was quantified by a BrdU (5-bromo-2'-deoxyuridine) assay (Cell 
Proliferation Kit, RPN20, GE Healthcare) or by EdU (5-ethynyl-2'-deoxyuridine) assay (Click-iT 
EdU Imaging Kit, Invitrogen). The principle of BrdU assay is presented in Figure II-21. Briefly, 
BrdU incorporated into DNA during replication is detected by a primary anti-BrdU antibody, 
which is detected by a secondary peroxydase-conjugated antibody. Peroxydase substrate giving a 
colored product is then added. 
 
 
Figure II-21. Mechanism of BrdU proliferation assay. 
 
EdU assay is a novel alternative to the BrdU assay. The detection is based on a click 
reaction between the alkyne of EdU and azide of Alexa Fluor. In addition, this technique does 
not require DNA denaturation. 
BrdU (5-bromo-2’-deoxyuridine):
thymidine (T) analogue
Incubation with BrdU
=> Incorporation of BrdU into 
replicating DNA
1. Anti-BrdU antibody
2. Secondary antibody coupled to a peroxydase
3. Peroxydase substrate => colored product
Detection
Random movement Straight movement
Directionality ~ 0 Directionality ~ 1
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At the chosen time point the cells grown in GM or in DM, on the PEM films or as 3D 
structures, were incubated with BrdU or EdU diluted at 1/1000 in cell culture medium for 1 h.  
The detection was carried out following the manufacturer instructions. At the end, nuclei 
were counter-stained with Hoechst 33432 (Invitrogen). The images of BrdU-positive nuclei 
taken by phase contrast microscopy and the images of Hoechst-labeled nuclei taken using an 
inverted fluorescence microscopy were merged to determine the ratio of BrdU positive nuclei 
(Fig. II-22A). The images of EdU and Hoechst-labeled nuclei were taken using inverted 
fluorescence microscopy (Fig. II-22B).  
 
Figure II-22. Exemples of images obtained after BrdU and EdU proliferation assays. (A) BrdU assay, 
nuclei of proliferating cells are in black. (B) EdU assay, nuclei of proliferating cells are in yellow. 
 
II.D.7. Myogenic and osteogenic differentiation assays 
II.D.7.a) Myogenic differentiation 
Myogenic differentiation was induced by putting the cells at ~80% of confluence into the 
medium containing 2% of horse serum (HS). This induces the secretion by the cells of different 
growth factors and promotes cell alignment and fusion into multinucleated myotubes. 
To follow the differentiation process, expression of myogenic markers by the cells was 
analysed at different stages of the differentiation (Fig. II-23). Myogenin was used as an early 
marker (Day 1 to 3), Troponin T for the early formation of myotubes, and myosin heavy chain 
was labeled to follow the maturation which as accompanied by the formation of contractile units 
(“striations”).  
A B
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Figure II-23. Markers of different stages of myogenic differentiation. Adapted from from (Zammit et al. 
2006). 
The efficiency of differentiation was characterized by the fusion index, which is a ratio of 
the nuclei contained in myotubes reported to the total number of nuclei (Charrasse et al. 2007) 
Fig II-24A). The percentage of striated myotubes was used to evaluate the maturation (Fig II-
24B). 
 
Figure II-24. Methods for characterization of the myogenic differentiation. (A) Fusion index is a ratio 
of the nuclei (blue) contained in myotubes (Troponin T, green) reported to the total number of nuclei. (B) 
Labelling of myosin heavy chain (green) to visualize striations in myotubes, indicating their maturation. 
 
II.D.7.b) Osteogenic differentiation 
C2C12 myoblasts can also undergo osteogenic differentiation when treated with BMP-2 
growth factor (Katagiri et al. 1994). In this study, we used the cells seeded on plastic at 30 000 
cells/cm
2
 in GM supplemented with 500 ng/mL of rhBMP-2 as a positive control of osteogenic 
differentiation. In this condition, after 2-3 days of culture, the myoblasts start to express ALP 
that can be dosed by ALP assay or by histochemical staining (Fig.II-25). 
 
Myogenin Troponin T Myosin (fast)
A B
 Figure II-25. Differentiation potenti
osteogenic markers. 
 
For the induction of osteogenic differentiation of MC3T3 preosteoblasts, the cells were 
seeded in 24 well-plates at 50 000 cell
Ascorbic acid (A4403, Sigma) and 10
rhBMP-2. ALP activity can be measured after 7 days of culture.
The gradual process of osteogenesis can be followed by different proteins being expressed 
at various time points, comprising early and late genes. In the present study, we used two 
methods for the evaluation of early osteogenic differentiation of C2C12 myoblasts and MC3T3 
pre-osteoblasts in response to BMP
The first method consisted in the measurement of a
ALP is a membrane bound hydrolase enzyme responsible for removing phosphate groups, is 
expressed during osteogenic differentiation (Fig. II
The second method consists in following the activation of the SMAD pathway (Figure II
26). To this end, we used C2C12
reporter gene placed under Id1 gene promoter 
expressed in response to Smad pathway activation (Fig. II
ALP test 
The ALP colorimetric assay is based on monitoring the colour change, as para
phosphate (pNPP), which is colourless, is cleaved by ALP to phosphate and paranit
which is yellow.  
For C2C12 myoblasts, the test was made after 3 days of culture (Fig. II
grafted PEM films or in presence of soluble pBMP
plastic and treated with 500 ng/mL rhBMP
on plastic (2,5.10
4
 cellules/cm², 24 well
al of C2C12 myoblasts and some of the usual myogenic and 
s per well. The medium is supplemented with 50 
-7
 M Dexamethasone (D4902, Sigma) and 
 
-2 derived peptide or rhBMP-2.  
lkaline phosphatase (
-26) and is often used as an early marker.
-A5 myoblasts transfected with a construct containing luciferase 
(Logeart-Avramoglou et al. 2006)
-26).  
-2. As a positive control, cells seeded on 
-2 were used. For MC3T3 cells, the cells were seeded 
-plates) in growth medium supplemented or not with 250 
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ALP) activity. 
  
-
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rophenol, 
-27) on peptide-
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ng/mL of rhBMP-2 or with 200 ng/mL and 500 ng/mL of pBMP-2, and cultured for 7 days (Fig. 
II-27).
 
 
Figure II-26. Early osteogenic markers ALP and Id1 induced via Smad and non-Smad pathways. 
Adapted from (Shore and Kaplan 2010). 
 
Briefly, the cells are lysed in 0.5 mL of 0.1% Triton X100 (Sigma) in PBS for 10 minutes 
at 4°C. For the test in a 96 well plate (flat, transparent), 20 µL of sample are mixed with 180 µL 
of working solution prepared as following: 0.1 M 2-amino-2-methyl-l-propanol, 1 mM MgCI2 
and 3.34 mg/ml (9 mM) pNPP (1026, Euromedex) in MilliQ water and adjusted to pH 10. 
The reaction kinetics are followed by the multiwell plate reader (TECAN infinite M1000) 
using a program that follows the 405 nm absorbance at 405 nm (for p-nitrophenol) every 30 sec 
for 10 minutes. The cell number is normalized by measuring protein amount by using a BCA 
protein assay kit (Interchim, France) following manufacturer’s instructions. The enzyme activity 
is expressed as micromoles of p-nitrophenol produced per min per mg of protein (using the slope 
obtained from the kinetics):  
ALP (µmol pNPP / min / mg of protein) = (reaction volume (L)) x (slope) x (10
-3
 * E(p-nitrophenol) * l) 
Reaction volume = 200 µL 
E(p-nitrophenol) = 18.75 mM
-1
.cm
-1
.L 
L = 0.2 cm 
Molecular Weight: 371.1 g.mol
-1 
 
 
 
BMP-2 receptors
ALP Id1
Non-
SMAD 
pathway
SMAD 
pathway
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Luciferase assay 
The activation of Smad pathway was measured using the C2C12 A5 cells with the Bright-
Glo™ Luciferase Assay System (E2610, Promega) after 24h of culture (Fig. II-27) on peptide-
grafted PEM films or in presence of soluble pBMP-2, in 96-well plates As a positive control, 
cells seeded on plastic and treated with 500 ng/mL rhBMP-2 were used. 
To measure the luminescence, the culture medium is first replaced by 25µl of fresh GM, 
then 25µl of Luciferase Assay Reagent are added per well, and the measurement is done after 15 
min of incubation at room temperature. Cell number is normalized by DNA content 
measurement using CyQuant NF Proliferation assay kit (Molecular Probes, Invitrogen) following 
manufacturer’s instructions. The method is based on measurement of cellular DNA content via 
fluorescent dye binding.  
Figure II-27 summarizes the different tests used and their time scale.  
 
Figure II-27. Time scales of the ALP and luciferase assays used to study early osteogenic 
differentiation 
 
II.D.8. Statistical analysis 
The results represent at least two independent experiments. Data are reported as means ± 
standard deviation, or as box plots built using SigmaPlot Version 11.0 software.  
Statistical comparisons were performed using SigmaPlot Version 11.0 software. Student's 
t-test was used for comparison of two groups of samples. Analysis for more groups was based on 
an analysis of variance (ANOVA) followed by an appropriate pairwise comparison or 
comparison versus control group procedure (P < 0.05 was considered significant). Statistically 
different values are reported on the figures.  
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CHAPTER III – RGD-functionalized PEM films 
with tunable stiffness for muscle cell adhesion 
and differentiation 
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In this chapter, we studied the effect of a collagen-derived peptide containing RGD 
adhesive motif on myogenesis using C2C12 skeletal myoblasts as cellular model. We also 
combined RGD to stiffness modulation of the PEM films, as both biochemical cues and stiffness 
are known to regulate cell behavior. We explored how the cells respond to peptide-grafted films 
of different stiffnesses, in order to identify the specific effects of each type of stimuli, 
biochemical and mechanical, or their synergy. We also studied the effect of RGD grafting ratio 
variations on cell adhesion and differentiation, and performed cell alignment trials on RGD-
functionalized film coated PDMS microgrooved substrates.  
 
 
III.A. EFFECT OF RGD-FUNCTIONALIZATION AND STIFFNESS 
MODULATION OF PEM FILMS ON MUSCLE CELL DIFFERENTIATION 
III.A.1. Article summary 
Satellite cells are now considered as a powerful source for the regeneration of several types 
of tissues. A major limitation to the study and clinical applications of satellite cells consists in a 
rapid loss of their stem properties in vitro. Moreover, engineering of a functional muscular tissue 
requires complex environments mimicking in vivo niche. Both biochemical cues and matrix 
stiffness are known to affect muscle cell adhesion, spreading, proliferation and differentiation.  
Although RGD substrates have been widely explored in tissue engineering, to date, there is no 
study investigating the combined effects of RGD nanoscale presentation and matrix stiffness on 
myogenesis. In this work, we studied the influence of substrate stiffness and RGD nanoscale 
presentation (alone or in combination) on C2C12 myoblast adhesion, migration, proliferation and 
differentiation. To this end, we cultured the myoblasts on PEM films made of poly(L-lysine) 
(PLL) and poly(L-glutamic) acid (PGA) whose rigidity can be tuned by chemical cross-linking 
(Schneider et al. 2006a). Presentation of a RGD-containing peptide was achieved by chemically 
grafting the peptide to PGA (Picart et al. 2005) and adsorbing it as final layer of the film. Four 
different types of films, with or without cross-linking and with or without the RGD-peptide, 
were constructed and used for cell studies.  Architecture and nomenclature of the films is given 
in the Figure III-1. 
 Figure III-1. Four types of films used for investigation of the effects 
stiffness modulation of polyelectrolyte multilayer films on muscle cell differentiation.
 
Cell adhesion assays showed that either cross
sufficient to promote cell adhesion, while non cross
The cells spread more on the RGD
on stiff films. Our results also suggested that soft films with RGD and stiff films recruit different 
combinations of integrin receptors: while 
spreading on NCL-RGD films, the knockdown of both 
spreading on CL and CL-RGD films.
Differentiation to myotubes was only possible on soft films with RGD peptide, whereas 
stiff films induced enhanced proliferation and decreased myogenin expression. Moreover, the 
cells detached from stiff films after few days in differentiation medium, probably because of 
excessive cell confluence due to absence of cell cycle withdrawal. 
Interestingly, myoblast differentiation could be partially rescued on CL films by treatment 
with ROCK inhibitor, which decreased proliferation level and increased myogenin expression. 
However, on CL-RGD films, even if the myoblast treated with ROCK inhibitor showed a 
decreased proliferation level, they were still unable to express myogenin and to diff
Based on our experimental data, we proposed a model for the interplay between 
mechanical and biochemical stimuli during induction of C2C12 myogenic differentiation. This 
work suggest that thin films with tunable mechanical and biochemical prope
tool for biophysical studies of muscle progenitors on controlled 2D microenvironments as well 
as for their expansion and differentiation 
of RGD-
-linking or RGD-functionalization were 
-linked film without RGD was non
-functionalized films, but cell migration spe
β3 knockdown alone had an effect on myoblast 
β1 and β3 is required
 
 
in vitro.  
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Abstract  
Skeletal muscle tissue engineering holds 
promise for the replacement of muscle due to 
an injury and for the treatment of muscle 
diseases. Although RGD substrates have been 
widely explored in tissue engineering, there is 
no study aimed at investigating the combined 
effects of RGD nanoscale presentation and 
matrix stiffness on myogenesis. In the present 
work, we use polyelectrolyte multilayer films 
made of poly(L-lysine) (PLL) and poly(L-
glutamic) acid (PGA) as substrates of tunable 
stiffness that can be functionalized by a RGD 
adhesive peptide to investigate important 
events in myogenesis, including adhesion, 
migration, proliferation and differentiation. 
C2C12 myoblasts were used as cellular models. 
RGD presentation on soft films and increased 
film stiffness could both induce cell adhesion, 
but integrins involved in adhesion were 
different in case of soft and stiff films. 
Moreover, soft films with RGD peptide 
appeared to be the most appropriate substrate 
for myogenic differentiation while the stiff 
PLL/PGA films significantly induced cell 
migration, proliferation and inhibited myogenic 
differentiation. The ROCK kinase was found to 
be involved in myoblast response to the 
different films. Indeed, its inhibition was 
sufficient to rescue the differentiation on stiff 
films, but no significant changes were observed 
on stiff films with the RGD peptide. These 
results suggest that different signaling 
pathways may be activated depending on 
mechanical and biochemical properties of the 
multilayer films. This study emphasizes the 
superior advantage of the soft PLL/PGA films 
presenting the RGD peptide in terms of 
myogenic differentiation. This soft RGD-
presenting film may be further used as coating 
of various polymeric scaffolds for muscle 
tissue engineering.  
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1. Introduction 
Regenerative medicine and tissue engineering 
make use of injected cells or of biomaterials to 
support cell attachment and to provide them 
with the appropriate cues to guide their 
differentiation. Skeletal muscle tissue 
engineering holds promise for the replacement 
of muscle due to an injury following a surgery 
or due to a trauma and for the treatment of 
muscle diseases, such as muscle dystrophies or 
paralysis. Adult skeletal muscle progenitor 
cells are considered as a powerful source for 
the generation of several tissues, especially 
skeletal muscles 
1
 but also smooth muscle 
2
, 
bone 
3; 4
 or fat tissue 
5; 6
. The process of muscle 
formation requires that muscle precursor cells 
become activated, proliferate, differentiate, and 
fuse together to form multinucleated myotubes. 
Proliferation and differentiation of skeletal 
myoblasts are mutually exclusive events, which 
are governed by the upregulation of 
transcriptional activators 
7
. A major limitation 
to the clinical application of muscle progenitors 
is a rapid loss of their muscle stem cell 
properties once they are removed from their in 
vivo environment 
8
.  
The development of skeletal muscles is known 
to depend on the interaction of muscle cells 
with their surrounding extra-cellular matrix 
(ECM) 
9
. Transmembrane receptors like the 
dystrophin-glycoprotein complex are known to 
be important 
10; 11
. However, other 
transmembrane receptors of the integrin family 
12
 have been shown to be crucial for skeletal 
muscle development and function 
13; 14
.  
Tissue engineering requires a combination of 
engineering methods, cell biology and 
materials. In this context, a goal of biomaterials 
scientists is to design biocompatible scaffolds 
in which cells can adhere, proliferate, 
differentiate and synthesize their own matrix to 
regenerate tissues. Adhesive properties can be 
provided either by grafting or by physically 
adsorbing cell adhesion molecules.  
The tripeptide sequence RGD is present in 
many ECM proteins, including fibronectin, 
vitronectin, fibrinogen, von Willebrand factor, 
thrombospondin, laminin, osteopontin, bone 
sialo protein, and some collagen isoforms 
15
. It 
binds to a wide range of integrin receptors in a 
non selective manner, i.e. not specifically to a 
given integrin receptor. To achieve better 
selectivity and/or target only one type of 
integrin receptor, several strategies can be 
applied (for review, see 
16
). In vitro, ligands 
containing the RGD peptide have already been 
used in the field of biomaterials to increase 
early adhesion of anchorage-dependent cells 
17
. 
This was especially targeted to osteoblasts on 
peptide-grafted poly(ethylene glycol) hydrogels 
18
, to fibroblasts on ethylene-acrylic copolymer 
film with immobilized peptides 
19
 and to 
endothelial cells on polyurethane 
20
.  
However, so far, studies of muscle cell 
differentiation in vitro rather used full-length 
ECM proteins such as fibronectin 
21
, laminin 
22
, 
or collagen 
23
, which are difficult to couple to 
synthetic or natural biomaterials. In addition, 
the functionality of these ECM proteins may be 
altered by adsorption or chemical coupling onto 
materials. Mooney and coworkers 
24
 showed 
that RGD coupling improved the initial 
adhesion and enabled the differentiation of 
myoblast cultured on 2D alginate gels or inside 
3D alginate gels.  
Besides biochemical cues, matrix stiffness has 
also been shown to be an important parameter 
in regulating function of various tissue and cell 
types, in vivo and in vitro 
25
. Indeed, a number 
of pathologies, including muscle pathologies, 
involve changes in matrix properties. In 
dystrophic muscles, a more fibrotic tissue and 
an increased rigidity of the diaphragm have 
been observed as compared to normal 
diaphragm 
26
.  
In vitro, it is now acknowledged that 
mechanical properties of the substrate can 
affect muscle cell adhesion, spreading, 
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proliferation and differentiation. This has been 
shown using different types of synthetic and 
natural materials, such as model synthetic 
polyacrylamide (PA) gels coated with collagen 
23
, poly(ethylene glycol) (PEG) hydrogels 
27
, 
alginate gels of varying stiffness 
24
 and 
polyelectrolyte multilayer films made of 
biopolymers 
28
. Recently, Post and coworkers 
29
 showed, using PA gels of varying rigidity 
and protein coating that proliferation was 
influenced only by rigidity, whereas 
differentiation was influenced both by rigidity 
and b
30; 31
y protein coating. 
However, to date, there is no study aimed to 
investigate the combined effects of RGD 
nanoscale presentation and matrix stiffness in 
myoblast adhesion, proliferation and 
differentiation. Polyelectrolyte multilayer films 
32
 are currently emerging as a new kind of 
biomaterials coating that can be used to guide 
cell fate 
33; 34
. Advantageously, the architecture 
of the films, their biodegradability and 
bioactivity can be controlled 
35
. The films can 
also be micropatterned to have (X-Y) 
architecture by combining with 
microfabrication techniques such as 
photolithography, microcontact printing or 
microfluidics (Berg_Rubner, Langmuir 2004; 
Chien, Biomaterials 2009; Monge, Tissue Eng 
2012). Furthermore, they can be deposited on 
various types of supporting materials, including 
metals, polymers and ceramics, which are 
already approved as implantable materials 
35
.  
In this study, we investigated the influence of 
substrate rigidity and RGD nanoscale 
presentation alone or in combination on C2C12 
myoblast adhesion, proliferation and 
differentiation. To this end, we cultured the 
myoblasts on polyelectrolyte multilayer films 
made of poly(L-lysine) (PLL) and poly(L-
glutamic) acid (PGA) whose rigidity can be 
tuned by chemical cross-linking 
36
. Moreover, 
such films are of particular interest since they 
are made of biodegradable polymers and 
appear to be biocompatible. 
 In addition, presentation of a RGD-containing 
peptide was achieved by chemically grafting 
the peptide to PGA 
37
 and adsorbing it as final 
layer of the film. Such covalent grafting 
provides a good control of surface composition, 
a stable link and limits release of the functional 
group into the culture medium.  
We studied the combined effects of RGD 
nanoscale presentation and matrix stiffness on 
early adhesion of the myoblasts to their late 
differentiation in myotubes after 9 days in 
culture, until the formation of sarcomeres.  
 
2. Materials and methods  
2.1. Covalent grafting of RGD adhesion 
peptide to PGA (poly(L-glutamic) acid) 
The type I collagen-derived peptide was chosen 
according to a published sequence that was 
shown to induce adhesion of human primary 
osteoblasts in vitro 
37
. The 15-amino-acid 
peptide containing a central RGD (Arg-Gly-
Asp) sequence (Cys-Gly-Pro-Lys-Gly-Asp-
Arg-Gly-Asp-Ala-Gly-Pro-Lys-Gly-Ala, 
CGPKGDRGDAGPKGA) was purchased from 
GeneCust (Dudelange, Luxembourg). The 
peptide was grafted as described previously 
37
. 
Briefly, the first step consisted in grafting 
maleimide groups onto PGA (P-4886, Sigma) 
chains. To accomplish this grafting, 60 mg of 
PGA were dissolved in 3 mL of a solution 
containing 10 mM HEPES buffer (pH 6.5), 20 
mg of EDC, and 3 mg of sulfo-NHS in an inert 
atmosphere (nitrogen gas) under magnetic 
stirring. Then, 24 mg of N-(2-aminoethyl) 
maleimide trifluoroacetate was added. The 
reaction was allowed to proceed at room 
temperature (RT) for 24 h. After removal of the 
byproducts via dialysis against water, the 
PGA–maleimide was freeze-dried. The average 
number of maleimide groups bound to PGA 
was equal to 16% ((i.e. in average 16 
maleimide groups every one hundred repeating 
PGA units), as determined via 
1
H NMR 
 analysis. In the second step, the PGA
maleimide was reacted with the peptide to form 
the PGA-RGD: 5 mg of PGA–maleimide were 
mixed with 5 mg of peptide in 1.5 mL of 10 
mM HEPES buffer (pH 7.4) and maintained for 
24 h under magnetic stirring at RT. An excess 
of mercaptopropionic acid was used to 
neutralize the unreacted maleimide groups. The 
solution was dialyzed against water and freeze
dried. The quantitative grafting ratio of the 
peptide was determined by 
1
H NMR, and the 
effective degree of grafting was found to be 
10% analysis. 
2.2. Polyelectrolyte solutions and PEM film 
buildup  
Poly(L-lysine) (PLL, P2636, Sigma) and 
poly(L-glutamic) acid (PGA, P
were dissolved at 0.5 mg/mL in a HEPES
buffer (20 mM HEPES, 150 mM NaCl, at pH 
7.4). For all experiments, films were manually 
constructed in 96-well plates starting with
first layer of poly(ethyleneimine) (PEI) at 5 
mg/ml. To deposit the subsequent 
polyelectrolyte layers, 50 µL of the 
polyelectrolyte solution was deposited in each 
well and let for 8 min before being rinsed twice 
for 30 sec and 5 min, respectively, with 
of 150 mM NaCl (pH 6.5). This sequence was 
repeated until the buildup of a (PGA/PLL)
was achieved. Then, the last layer of PGA (0.5 
mg/mL) or of the PGA-RGD (0.5 mg/mL) was 
added, giving (PGA/PLL)
(PGA/PLL)6-PGA-RGD films.  
In order to increase the stiffness, (PGA/PLL)
PGA films were chemically cross
give [(PGA/PLL)6-PGA]CL films. To obtain the 
cross-linked films functionalized with PGA
RGD, cross-linking was done after 
(PGA/PLL)6, and PGA-RGD was added after 
the cross-linking, giving [(PGA/PLL)
PGA-RGD films. For the cross-linking, 100 µL 
of EDC/sulfo-NHS solution in 150 mM NaCl 
pH 5.5 (mixed v/v with final EDC 
concentrations of 15 mg/mL and 5.5 mg.mL) 
-
-
-4886, Sigma) 
-NaCl 
 a 
100 µL 
6 film 
6-PGA and 
6-
-linked to 
-
6]CL-
were deposited in the wells and incubated at 4° 
C overnight. Finally, the films were thoroughly 
washed with the HEPES
nomenclature of the film is given in Table 1. 
2.3. Quartz Crystal Microbalance with 
dissipation monitoring (QCM
Film buildup was followed by 
crystal microbalance (QCM D300, QSense, 
Sweden) using a previously published 
procedure 
38
. PLL, PGA and PGA with grafted 
RGD peptide prepared at 0.5 mg/mL in the 
HEPES-NaCl buffer were successively injected 
in the cell. They were let to adsorb for 
and rinsed for 5 min with the HEPES
buffer.  
When a mass ∆m is adsorbed at the crystal and 
the measurements are conducted in air, the 
resulting decrease ∆f 
Sauerbrey equation: 
where C is the mass sensitivity constant (17.7 
ng ·cm-2 Hz-1 at 5 MHz), and 
number. 
2.4. C2C12 culture 
C2C12 cells (from ATCC, used at passages 5
15) were maintained in polystyrene dishes in an 
incubator at 37° C and 5% CO
growth medium (GM) composed of Dulbecco’s 
modified Eagle’s medium (DMEM)/F12 
medium (1:1; Gibco, Invitrogen, Cergy
Pontoise, France) supplemented with 10% fetal 
bovine serum (PAA Laboratories, Les 
Mureaux, France) containing 10 U/mL of 
penicillin G and 10 µg/mL of streptomycin 
(Gibco, Invitrogen, Cergy
Cells were subcultured prior to reaching 60
70% confluence (approximately every 2 days). 
For all experiments, C2C12 cells were first 
allowed to adhere in a serum
(SFM) composed of DMEM/F12 1:1 and 
supplemented with antibiotics.
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Film design  
Film architecture Film nomenclature 
PGA  Cross-linking PGA- RGD 
×   (PGA/PLL)6-PGA NCL 
  × (PGA/PLL)6-PGA-RGD NCL-RGD 
× ×  [(PGA/PLL)6-PGA]CL CL 
 × × [(PGA/PLL)6]CL-PGA-RGD CL-RGD 
TABLE 1. Summary of the conditions used for the buildup of the films.  
 
 
After 1 h of adhesion, the cells were fixed or 
the SMF was replaced by the GM, depending 
on the type of experiment (see below). Cell 
were differentiated in a differentiation medium 
(DM) composed of DMEM/F12 (1:1) 
supplemented with 2% horse serum (PAA 
Laboratories, Les Mureaux, France) and 
antibiotics. 
2.5. Cell adhesion, proliferation, migration and 
differentiation assays 
For cell adhesion tests, C2C12 cells were 
seeded at 15 000 cells/cm
2
 in 96-well plates 
and allowed to adhere in SFM for 1 h. For the 
short-term adhesion tests (1 h), cells were then 
fixed in 3.7% formaldehyde. For adhesion tests 
at 4 h, the medium was changed to GM after 1 
h and the cells were fixed at 4 h.  
Cell proliferation was quantified by a BrdU (5-
bromo-2'-deoxyuridine) assay (Cell 
Proliferation Kit, RPN20, GE Healthcare) 
following the manufacturer instructions. Three 
time points were chosen: 4, 24, and 48 h. The 
cells were incubated for 1 h at 37°C. Nuclei 
were counter-stained with Hoechst 3342 
(Invitrogen). The images of BrdU-positive 
nuclei taken by phase contrast microscopy and 
the images of Hoechst-labeled nuclei taken 
using an inverted fluorescence microscope 
were merged to determine the ratio of BrdU 
positive nuclei. 
To follow cell migration, C2C12 cells were 
mixed 1:1 with C2C12 HB1 GFP cells (kindly 
provided by E.Gomes, Institut de Myology, 
Paris) and seeded at 15 000 cells/cm
2
 in 96-
well plates. Images of the fluorescent nuclei 
were taken every 30 min during 5 h. For 
analysis, at least 20 cells were tracked using 
ImageJ (v1.45d, NIH, Bethesda). 
For differentiation assays, cells were seeded at 
30 000 cells/cm
2
 and allowed to adhere for 1 h 
in SFM. Cells were then grown for 1 day in 
GM and then switched to DM. The medium 
was changed twice a week. For the 
proliferation and differentiation tests in the 
presence of the ROCK kinase inhibitor (Y-
27632, Calbiochem), 5 µM of inhibitor was 
added at day 1 in DM. Fresh drug was then 
added every 24 h.  
For the quantitative analysis of adhesion and 
differentiation, at least 50 cells of at least ten 
different fields (430 µm x 320 µm) were 
analyzed per condition. To characterize cell 
adhesion, cell number per field, cell area and 
circularity were quantified. Cell circularity is a 
parameter defined by the formula: Circularity = 
4π(A/P
2
), (A being the cell area and P its 
perimeter) that allows to characterize cell 
morphology: a circularity value of 1.0 indicates 
a perfect circle and a decrease toward 0 
indicates an increasingly elongated polygon. 
The differentiation was characterized by the 
fusion index, which is a ratio of the nuclei 
contained in myotubes reported to the total 
number of nuclei 
39
, and by the percentage of 
striated myotubes. 
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 2.6. Transfection by siR$A 
Cells were transfected with siRNA against β1 
and β3 integrins (ON-TARGET plus 
SMARTpool, respectively Mouse ITGB1 and 
Mouse ITGB3, Thermo Scientific Dharmacon) 
individually or at the same time, a scrambled 
siRNA (All Stars negative Control siRNA, 
Qiagen) being taken as control. For this, the 
cells were seeded at 30 000 cells/cm
2
 in a 6-
well plate and cultured in GM (2 mL per well) 
for 15 h. The transfection mix was prepared as 
following: for one well, 6 µL of lipofectamine 
RNAiMAX Reagent (Invitrogen) were added to 
305 µL of Opti-MEM medium (Gibco) and 
0.72 µL of 1 mM siRNA were added to another 
305 µL of Opti-MEM medium. Lipofectamine-
containing mix was added to siRNA-containing 
mix and incubated for 20 min at room 
temperature. Previously to transfection, the GM 
of the wells was replaced by the GM without 
antibiotics. Then, 610 µL of the final mix were 
added to each well. After 24 h of incubation at 
37°C, the cells were transfected for the second 
time following the protocol described above 
and incubated for another 24h. Then the cells 
were detached by trypsin-EDTA, seeded in GM 
at 20 000 cells/cm
2
 on the films built in 96-well 
plate and allowed to adhere for 4 h. Then, the 
cells were fixed and their area was quantified. 
2.7. Immuno-staining 
Cells were first rinsed in PBS and fixed in 
3.7% formaldehyde for 30 min at RT before 
being permeabilized in 0.5% Triton X-100 for 
4 min. After rinsing with PBS, samples were 
incubated for 1 h in 0.1 % BSA in TRIS-
buffered saline (TBS, 50 mM TRIS, 150 mM 
NaCl, 0.1% NaN3, pH 7.4). Actin was labeled 
with phalloidin-TRITC (1:800, Sigma) for 30 
min. Cell nuclei were stained with Hoechst 
33342 (Invitrogen) at 5 µg/ml for 10 min. After 
the incubations with the primary antibodies 
(diluted in 0.2% TBS-gelatin) for 30 min at RT, 
cells were washed 3 times in TBS and 
incubated for 30 min with the secondary 
antibodies : rabbit anti-FAK pY397 antibody, 
(1:200, Invitrogen), myogenin (rabbit anti-
myogenin antibody (1:30, Tebu-Bio) and 
myosin heavy chain (mouse anti-myosin heavy 
chain (1:500, Sigma) . Alexa-Fluor 388 or 558 
conjugated antibodies (Invitrogen) were used at 
1:1000. Images were taken by means of Zeiss 
Axiovert 200 inverted or Zeiss LSM 700 
confocal microscope.  
2.8. Statistics 
The results represent three independent 
experiments. Data are reported as means ± 
standard deviation. Student’s t-test was 
performed to compare the different conditions 
(p < 0.05 was considered significant). 
Statistically different values are reported on the 
figures. 
 
3. Results  
3.1. Density of RGD peptide on the film surface 
The principle of film buildup with or without 
subsequent cross-linking (CL) and/or 
functionalization with the RGD peptide is 
depicted in Figure 1A. The four different film 
architecture studied are given in Table 1: NCL, 
NCL-RGD, CL and CL-RGD. The film buildup 
was followed in situ by Quartz Crystal 
Microbalance with dissipation monitoring 
(QCM-D) (Fig. 1B), which allowed us to 
measure film thickness using the Voigt model 
40
. Film thickness was 120 nm for a film made 
of 6 layer pairs.  
Knowing the grafting density of the RGD 
peptide to PGA (10%) the amount of RGD 
peptide present at the film surface was 
quantified. The adsorbed mass of PGA-RGD 
was 400 ng/cm
2
, which corresponded to a RGD 
surface density of 0.78 molecules of peptide 
per nm
2
 (or 300 pmol/cm
2
). This is a relatively 
high surface coverage. The Young’s modulus 
of these films deposited on a thick 
polyelectrolyte cushion has previously been 
measured to be 51 ± 17 kPa for NCL films and 
230 ± 70 kPa for CL ones 
36
. 
 3.2. Effect of RGD-functionalization and film 
cross-linking on C2C12 myoblast adhesion, 
spreading and morphology 
Adhesion is the very first and important step of 
cell-substrate interactions, which is especially 
important for anchorage-dependent cells. To 
evaluate the effect of film stiffness and RGD
functionalization on C2C12 myoblast adhesion, 
cells were cultured on the four different types 
of films NCL, NCL-RGD, CL and CL
The cells were allowed to adhere for 1 h in 
serum free medium (SFM) to eliminate any
effect of serum on early adhesion. The number 
of adherent cells as well as their spreading area 
and morphology (circularity) were evaluated. 
Actin and nuclei staining of C2C12 cells (Fig. 
2A) revealed the presence of adherent cells on 
NCL-RGD, CL and CL-RGD films but of very 
FIGURE 1. Design of biomimetic thin film combining physical and biochemical cues.
polyelectrolyte multilayer film (PEM) is built onto a substrate by alternating deposits of PLL and of PGA. 
The PEM film can be covalently cross
Biochemical functionality is provided 
peptide. (B) Exponential growth of the film followed by QCM
 
1- PLL/PGA multilayer film
Layer-by-Layer 
deposition
A
-
-RGD. 
 
few cells on NCL ones. In addition, these cells 
were poorly spread. Quantitative measurements 
of the number of adherent cells confirmed the 
microscopy observations with no statistical 
differences between NCL
RGD (Fig. 2B). However, after 1 h, cell area 
was significantly higher on films presenting 
PGA-RGD (Fig. 2C) as compared to those 
ending with PGA only. Cells spread also about 
two times more on CL films as compared to 
NCL ones. Thus, both substrate stiffness and 
RGD-functionalization had an effect on cell 
spreading. The circularity index was 
significantly lower for films containing the 
RGD peptide as compared to films without 
peptide (NCL and CL) (Fig. 2D). This 
indicated that the presence of RGD but not film 
stiffness influenced the cell circularity. 
 
 
-linked using a water-soluble carbodiimide to modulate its stiffness. 
by adding a final layer of PGA grafted with a RGD
-D. 
 
Cross-links
2- Stiffness modulation 
+PGA-RGD
95 
-RGD, CL and CL-
 
 
 (A) 1- a 
2- 
3- 
-containing 
RGD peptide
3- Biofunctionalization
96 
 
3.3. Characterization of adhesion via integrin 
receptors and cell migration 
The cells are mechano-sensors that actively 
sense their environment via specific cell 
surface receptors, especially integrins 
41
. 
Several integrins can interact with RGD ligand, 
especially α5β1 and αVβ3. Cell sensing and 
integrin activation lead to the formation of 
focal adhesions (FA), sites where the cells 
contact with the matrix. FA are enriched in 
integrins and many other proteins, are linked to 
actin stress fibers and are a place for cell 
traction 
42; 43
.  
 
 
 
FIGURE 2. Adhesion and spreading of C2C12 myoblasts at early time. Initial C2C12 cell adhesion and 
spreading were observed 1 h after plating the cells on $CL, CL, $CL-RGD and CL-RGD films. (A) Actin 
(red) and nuclei (blue) staining of C2C12 cells to visualize adhesion and spreading on the four types of films 
(B) $umber of adherent cells. (C) Spreading area. (D) Cell circularity quantification. Error bars correspond 
to SD, * : p < 0.05. 
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To characterize cell interaction with the 
substrate via integrin receptors, the formation 
of stress fibers and the presence of focal 
adhesions by labeling phosphorylated focal 
adhesion kinase (pFAK, an important 
component of mature FA), were first analyzed 
in C2C12 cells cultured on the different films 
after 4 h (Fig. 3A and B). After 4 h, stress 
fibers were observed on all types of films (Fig. 
3A). Robust focal adhesions or even fibrillar 
adhesions (small dashes at the cell periphery) 
were formed only on NCL-RGD films, while 
only small and thin focal adhesions or focal 
complexes (small dots) were visible on CL 
and CL-RGD films (Fig. 3B). These results 
showed that both film stiffness and RGD-
functionalization played a role in the 
organization of the actin cytoskeleton and in 
the formation of focal adhesions as well. The 
presence of the adhesive ligand on soft films 
led to the formation of numerous focal and 
fibrillar adhesions, while only focal complexes 
formed on the stiffest films, even in the 
presence of RGD. 
 
FIGURE 3. Effect of film stiffness and RGD fonctionalization on cytoskeletal organization, focal 
adhesions and migration. (A) Staining of actin cytoskeleton (red) after 4 h of culture. (B) Staining of 
phosphorylated focal adhesion kinase (pFAK Y397, green) after 4 h of culture. (C) Myoblast migration 
measured over 5 h after seeding. (D) Effect of blocking β1 and/or β3 integrins using siR$A: quantification of 
the cell area after 4 h of adhesion (* p < 0.05 compared to scrambled siR$A). Focal adhesions/complexes 
are indicated by white arrowheads.  
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As stress fibers and focal complexes/adhesions 
play a key role in cell migration, we 
investigated whether cell migration is 
influenced by the substrates. To this end, cell 
migration on the different films over 5 h after 
cell seeding was followed by tracking 
individual cells. The results for the migration 
speed on the different films are shown in Fig. 
3C. Cell migrated at ∼20 µm/h on stiff films 
(CL and CL-RGD), which was about two times 
faster than cells on NCL-RGD films (10 µm/h). 
Thus, the decrease of focal adhesions on stiff 
films (CL and CL-RGD) correlated with an 
enhanced migration on these films. 
In order to investigate the possible role of beta 
chain integrins in cell adhesion, the knockdown 
of β1 or β3 integrin or both using siRNA 
approach was studied. These integrins are 
known to be involved in cell mechano-sensing 
and β1 and β3 integrins are present in C2C12 
myoblasts 
44
 
45
. The cell area of the transfected 
cells was quantified after 4 h of adhesion (Fig. 
3D). On NCL-RGD films, only β3 blocking but 
not of β1 lead to a slight decrease in cell 
spreading. Double tranfection of β1 and β3 
siRNA gave similar results. These data 
suggested that myoblast interaction with the 
RGD-containing peptide involved partly β3 
integrins. On CL and CL-RGD films, siRNA 
against β1 or β3 alone did not decrease cell 
spreading, and even significantly increased it in 
the case of siRNA β3 treatment on CL film. 
However, when the cells were transfected with 
both β1 and β3 siRNA, cell area decreased 
significantly on CL and CL-RGD films, 
suggesting that both β1 and β3 integrins can be 
used by the cells in a commutable way to 
interact with these films. Thus, it appeared that 
integrins involved in cell spreading on the 
different films are different. 
3.4. Effect of film cross-linking and RGD-
functionalization on myogenic differentiation  
C2C12 myoblasts are a well-known model for 
the in vitro study of myogenic differentiation 
due to their ability to reproduce processes that 
take place during in vivo differentiation of 
skeletal muscle progenitors 
46
. The effect of 
film stiffness and presentation of the RGD 
ligand on myoblast differentiation in myotubes 
were studied over 9 days. Phase contrast 
microscopy images of myogenic differentiation 
are shown in Fig. 4A. The formation of 
myotubes was observed on NCL-RGD films, 
while cell aggregation followed by detachment 
occurred on both CL and CL-RGD films, after 
1-2 days on CL-RGD films and after 2-3 on CL 
ones. Some detached cells were able to form 
aggregates that remained adherent until day 9 
of differentiation.  
Staining of myosin heavy chain (MHC), a late 
marker of myogenic differentiation 
7
 was used 
to characterize myogenic differentiation and the 
formation of myotubes. MHC was well-
expressed only in myoblast cultured on NCL-
RGD films, while its expression on CL and 
CL-RGD films was very weak (Fig. 4B). The 
fusion index was of 25% of NCL-RGD films 
and only of 8% for CL and 3% for CL-RGD 
films (Fig. 4C). Thus, only a small fraction of 
the remaining cell adhered on CL and CL-RGD 
films was able to fuse. Moreover, the 
multinucleated cells on these films neither had 
the typical elongated morphology of myotubes 
nor were striated. It was solely for cells grown 
on NCL-RGD films that striation reached 67% 
of the myotubes, indicating that their 
maturation was very good (Fig. 4B, upper 
image of right column).  
These results showed that the soft RGD-
functionalized film used in our study was the 
only film architecture enabling myoblast 
differentiation and fusion in an efficient 
manner. Conversely, CL and CL-RGD films 
were not appropriate for long term 
differentiation in myotubes. 
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FIGURE 4. Myogenic differentiation of C2C12 myoblasts is effective on 7CL-RGD films. (A) Phase 
contrast microscopy observations of C2C12 cell differentiation on the $CL-RGD, CL, and CL-RGD films. 
After 24 h of proliferation in GM (ie Day -1), the cells were put in DM (ie Day 0) and were let to 
differentiate until Day 9. Cell detachment was observed on CL and CL-RGD films after few days in DM. (B) 
Myosin heavy chain (green) and nuclei (blue) labeling (20 x and 63 x magnification). (C) Quantification of 
the fusion index. Error bars correspond to SD, * : p < 0.05. 
 
 
3.5. C2C12 myoblasts poor differentiation on 
stiff films is associated with a decreased 
myogenin expression and enhanced 
proliferation  
For skeletal myoblasts, cell cycle arrest is 
necessary to undergo differentiation. During 
myogenic differentiation, a highly ordered 
process of temporally separable events that 
begins with the expression of myogenic 
transcription factors and is followed by cell 
cycle arrest takes place 
7
. In order to further 
understand the origin of the inappropriate 
differentiation on stiff films, we quantified the 
expression of the transcription factor 
myogenin at early times of the differentiation 
process (Day 1 to 3) (Fig. 5). On NCL-RGD 
films, myogenin was already expressed at day 
1 (4% of nuclei) and steadily increased until 
day 3 (13% of nuclei). On CL films, only 1% 
of nuclei were myogenin-positive at Day 1 and 
5% at Day 3. On CL-RGD films, no positive 
nuclei was detected at Day 1 or 3, but about 
2.5% of myogenin-positive cells were 
observed at Day 2. These results showed that 
myogenin expression is decreased on stiff 
films, especially on CL-RGD one where no 
positive nuclei were found at Day 3. 
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  FIGURE 5. Myogenin expression is decreased on 
stiff films. After 24 h of proliferation in GM, the 
medium was changed to DM and cells were let to 
differentiate for 2 days. (A) Myogenin labeling at 
day 1, 2 and 3 of differentiation. (B) 
of the percentage of myogenin expressing cells. 
Error bars correspond to SD, * : p < 0.05.
 
As down-regulation of proliferation is needed 
for myogenesis to occur 
7
, we also quantified 
cell proliferation on the different types of films 
before and after addition of the DM (Day 
1) by a BrdU incorporation assay (Fig. 6). Day 
-1 and Day 0 represent the initial growth phase 
in GM at 4 h and 24 h after cell seeding, 
respectively, before switching to DM. No 
difference in the percentage of proliferating 
cells between the three types of films was 
observed in GM (Fig. 6B). However, 
significant differences were observed after 24 h 
of culture in DM, noted here Day 1. As 
anticipated, the rate of proliferating cells 
decreased drastically on NCL-RGD films from 
50 % to 10 %, which corresponded to the cell 
Day 1 Day 2
A
CL
CL-
RGD
NCL-
RGD
 
 
Quantification 
 
-1 to 
cycle arrest. Conversely, on CL and CL
films, these rates not only failed to decrease but 
still increased to reach 
consequence, at Day -1 and Day 0, the total cell 
number on the three types of films was similar 
(Fig. 6C) but at Day 1, the number of cells on 
stiff films was higher than on NCL
highest cell number was found on CL
film.  
These results showed that two key events in 
myogenic differentiation, i.e. myogenin 
expression and cell cycle arrest, were altered on 
stiff films. Cells on stiff films bypass the 
cycle exit induced by growth factor 
deprivation. Cell detachment observe
films may thus be due to enhanced proliferation 
leading to excessive cell confluence, and/or to 
enhanced cell migration.  
3.6. Effect of inhibition of ROCK kinase on 
myogenin expression, proliferation and 
differentiation on stiff films
Previous studies have shown that myoblast 
differentiation is regulated through Rho/ROCK 
pathways that must be downregulated to allow 
myogenesis 
47
. These authors have shown that 
constitutive activation of ROCK resulted in 
decreased myogenin expression and inhibitio
of myogenic differentiation in C2C12, while 
inhibition of ROCK led to an accelerated exit 
from the cell cycle and induced myogenin 
expression. These data suggested that ROCK is 
involved in keeping the myoblasts cycling and 
prevents commitment to differen
thus hypothesized that decreased myogenin 
expression and excessive proliferation on CL 
films, resulting in poor differentiation, may be 
due to an enhanced ROCK activity. To 
investigate if ROCK pathway was involved in 
inappropriate cell differentiation on stiff films, 
the ROCK inhibitor Y27632 was added at Day 
0 of differentiation. Its effect
expression was evaluated at Days 1, 2 and 3, 
and on proliferation at Day 1. In addition, 
MHC was labeled at Day 6. 
Day 3
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 FIGURE 6. Proliferation is enhanced on CL films resulting in an increased cell number. 
proliferation in GM (Day -1), the medium was changed to DM (Day 0) and cells were let to differentiate for 
one day. (A) Staining of BrdU in the nuclei
(blue). (B) Percentage of BrdU-positive cells. 
bars correspond to SD, * : p < 0.05.
 
First, we studied the effect of ROCK inhibitor 
on myogenin expression (Fig. 7A
RGD films, Y27632 treatment did not alter 
myogenin expression at any time (Fig. 7A). On 
CL films, a 2-fold increase in myogenin
positive nuclei was observed after 3 days of 
treatment, reaching 10% (Fig. 7B). On CL
RGD films, myogenin expression remained 
very weak at less than 3% in any conditions. 
However, it was still present at Day 3 when 
treated with ROCK inhibitor, while it was 
absent in a control (non-treated) condition (Fig. 
7C).  
The effect of Y27632 on C2C12 myoblast 
proliferation at Day 1 was also tested (Fig 7D). 
There was no difference for NCL
but we observed a 3-fold decrease in BrdU
A
NCL-
RGD
CL 
CL-
RGD
 (in black) associated to a fluorescent labeling of total nuclei 
(C) Quantification of the total number of adherent cells. Error 
 
-C). On NCL-
-
-
-RGD films, 
-
incorporating cells on CL and CL
This indicated that ROCK was involved
excessive C2C12 proliferation on these films. 
MHC expression on NCL
modified by Y27632 treatment (Fig. 7E). In 
contrast, on CL films, Y27632 treatment was 
sufficient to prevent cell detachment and to 
allow myogenic differentiation. O
myotubes formed were not as elongated as on 
NCL-RGD films and nuclei were more 
clustered. Finally, no differentiation was 
observed on CL-RGD films upon Y27632 
treatment, suggesting that ROCK inhibition 
alone was insufficient to restore the 
differentiation program, and that a more 
complex molecular mechanism was involved in 
the cell response to these films. 
Day 1Day -1 Day 0
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 FIGURE 7. ROCK kinase inhibition decreases myoblast proliferation and rescues differentiation on CL 
films. After 24 h of proliferation in GM, cells were transferred to DM and let to differentiate for 6 days. 
B, C) Myogenin labeling at day 1, 2 and 3 in DM. 
differentiation. (E) Myosin heavy chain labeling at Day 
p <0.05. 
 
4. Discussion 
It is becoming increasingly clear that 
mechanical and biochemical properties of the 
substrate both play an important role not only 
in cell adhesion, but in many other processes 
such as proliferation and differentiation 
However, the contribution of each type of 
signal, i.e substrate stiffness and adhesive 
ligand, is not always easy to decouple. 
Mechano-sensitivity studies often use synthetic 
hydrogels such as PA with ECM proteins or 
PEG grafted with ECM fragments 
already acknowledged that mechanical 
properties of the substrate can affect muscle 
cell adhesion and differentiation. This has been 
observed on PA surfaces 
23
, PEG hydrogels 
and on PEM films made of PLL and 
(D) Percentage of BrdU-positive cells at Day 1 of 
6 of differentiation. Error bars correspond to SD, * : 
25
. 
49
. It is 
27
 
hyaluronan 
28; 50
. However, little work has been 
done on the role of RGD-
myogenic differentiation. Rowley and Mooney 
51
 showed that RGD-peptide was necessary to 
promote myoblast attachment to alginate 
hydrogels and that myoblast differentiated only 
on alginate gels with specific combination of 
monomeric ratio and RGD grafting density 
In addition, RGD-peptides were found to 
significantly improve myoblast cell adhesion 
onto grooved polystyrene substrates 
Here, we used layer-by
polypeptides as modular substrates, which can 
be stiffened by chemical cross
be specifically functionalized by grafting a 
RGD-containing peptide onto PGA 
previous study, the 15
102 
 
(A, 
containing peptides in 
51
. 
52
. 
-layer films made of 
-linking and can 
37
. In a 
-amino-acid collagen 
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type I-derived peptide containing an RGD 
adhesive sequence has been tested for both 
short-term adhesion properties and long-term 
proliferation of primary osteoblasts 
37
. In the 
present work, four different types of films with 
or without cross-linking and with or without 
the RGD-peptide allowed investigation of the 
effect of mechanical and biochemical signals 
and their combinations as well, on important 
events of myogenesis. We especially focused 
on the sequence of events involved in C2C12 
cell differentiation including early adhesion, 
migration, proliferation, differentiation and 
fusion of myoblast into myotubes.  
The results obtained by QCM-D regarding 
(PLL/PGA) film growth (Fig. 1) are consistent 
with those obtained previously by optical 
waveguide lightmode spectroscopy on the same 
films 
37
, with however a higher thickness 
measured by QCM-D due to the water 
incorporated in the films.  
While the cells spread more on the RGD-
functionalized films, a more detailed analysis 
of cell interaction with the substrates showed 
that the stiffness was also very important: only 
cells on NCL-RGD film exhibited formation of 
robust focal adhesions and migrated at low 
speed. The presence of only small focal 
complexes on stiff films (CL and CL-RGD) 
(Fig. 3) correlated with an enhanced migration 
on these films (Fig. 6). Our results also 
suggested that soft films with RGD and stiff 
films recruit different combinations of integrin 
receptors: while β3 knockdown alone had an 
effect on myoblast spreading on NCL-RGD 
films, the knockdown of both β1 and β3 is 
required to affect myoblast spreading on CL 
and CL-RGD films (Fig 3D). However, the 
inhibition of cell spreading on the different 
films was never complete by blocking β1, β3 or 
both integrins at the same time (Fig 3D), 
suggesting that other integrin or non-integrin 
receptors may be involved. It has been shown 
using epithelial cells that β1 and β3 integrins 
promote different migration modes: adhesion 
by β3 resulted in static cell-matrix adhesions 
and persistent migration, while adhesion by β1 
promoted highly dynamic cell-matrix 
interactions and random migration 
53
. These 
results make a link between cell-surface 
interactions via specific integrin receptors, 
focal adhesion dynamics and cell migration. 
Our results on myoblasts show that there is a 
correlation between integrins that are recruited, 
size of focal adhesions/complexes and cell 
migration speed: involvement of β3 correlates 
with robust adhesion and low migration speed, 
while recruitement of both β1 and β3 are related 
to smaller adhesion complexes and enhanced 
cell migration (Fig. 3). Our results thus 
suggests that control of motile strategy by 
integrins may be a common feature of different 
cell types. 
Interestingly, β3 integrin was found to be 
crucial for myogenic differentiation of C2C12 
myoblasts, and to mediate satellite cell 
differentiation 
45
, while β1-integrin, which is 
constitutively expressed in skeletal muscle, has 
earlier been shown to be dispensable to 
myogenesis 
54
. This is in agreement with our 
data showing that on the PEM films, the 
differentiation was only possible on soft films 
with RGD peptide whereas stiff films offer 
unfavorable conditions for the differentiation; 
proliferation was enhanced (Fig. 6) and 
myogenin expression was decreased on stiff 
films (Fig. 7). Moreover, the cells detached 
from stiff films after few days in DM. We 
hypothesize that cell detachment could be due 
to enhanced proliferation leading to excessive 
cell confluence, and/or to enhanced cell 
migration. The ROCK kinase, which is known 
to be involved in myogenic differentiation but 
also in cell blebbing may be responsible for cell 
detachment (for review, see 
55
).  
Interestingly, myoblast differentiation could be 
partially rescued on CL films by treatment with 
ROCK inhibitor, which decreased proliferation 
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level and increased myogenin expression (Fig 
7B). However, on CL-RGD films, even if the 
myoblast treated with ROCK inhibitor showed 
a decreased proliferation level, they were still 
unable to express myogenin and to differentiate 
(Fig. 7C). Enhanced ROCK activity on stiff 
films may be the consequence of the 
engagement of β1 integrin on these films since 
it was reported that β1 induces a higher RhoA 
activity than β3 
53
. Both RhoA and its effector 
ROCK play a crucial role in myogenic 
differentiation as both activities must be 
downregulated to allow myogenesis to occur  
47; 48; 56; 57
. 
In our previous work 
28
 we evaluated the 
adhesion and differentiation of C2C12 
myoblasts using poly(L-lysine) and hyaluronan 
(PLL/HA) multilayer films of varying 
stiffnesses. On these films, formation of focal 
adhesions was increased on stiff films as 
compared to soft ones. Evaluation of the 
adhesive behaviour during the initial steps of 
spreading showed that blocking β3, but not β1 
integrins inhibited cell adhesion on stiff 
(PLL/HA) films 
50
. This is different from cross-
linked (PLL/PGA) films, which are stiffer than 
(PLL/HA) films) and for which blocking of 
both β1 and β3 integrins was necessary to 
inhibit cell spreading. Thus, molecular 
mechanisms of cell/film interactions involved 
different integrins depending on film type, film 
stiffness and presence of a specific ligand 
(RGD peptide).  
Cell adhesion to ECM influences cell 
proliferation by transducing signals through 
cell surface integrin receptors, and proliferation 
is generally low in soft matrix and high in stiff 
matrix 
58; 59
. Proliferation of C2C12 myoblasts 
was also increased on stiff substrates as 
compared to soft ones 
24; 28
. Here, we showed 
that the proliferation of C2C12 was 
significantly increased on stiff films via the 
activation of ROCK (Fig. 7). Rho/ROCK 
pathway is also known to be implicated in the 
remodeling of focal adhesions and migration of 
tumor cells 
60
. Similarly, tumor malignancy and 
invasion is associated to matrix stiffening 
61
. In 
this context, C2C12 cells on stiff films seemed 
to acquire some features of cancer cells: they 
bypassed the cell cycle exit induced by growth 
factor deprivation, showed an absence of 
mature focal adhesions and enhanced 
migration. Thus, CL and/or CL-RGD films 
may be used as a model basement membrane 
for studies of cancer cell behavior in response 
to matrix stiffening. Decreased myogenin 
expression and absence of exit from the cell 
cycle observed on cross-linked films could also 
be a potential tool for in vitro amplification of 
satellite cell while preserving their multiple 
differentiation potential. Indeed, these primary 
cells rapidly lose their stem properties and 
switch to differentiation upon removal from 
their niche and cultured in vitro 
8
. 
Based on our experimental data, we propose a 
model for the interplay between mechanical 
and biochemical stimuli during induction of 
C2C12 myogenic differentiation (Fig. 8). 
Adhesion on NCL-RGD films involved β3 
integrins and provided favorable conditions for 
myogenic differentiation of C2C12 cells. 
Adhesion on stiff films (CL and CL-RGD) 
involved β1 integrins in addition to β3 integrins 
and promoted ROCK activation. This leads to a 
high proliferative state without myogenic 
differentiation. On CL films, ROCK inhibition 
allowed myogenic differentiation. However, on 
CL films ending by RGD peptide, ROCK 
inhibition was not sufficient to induce 
myogenin expression and to allow cells 
differentiation. We suggest that mechanical 
signals (stiffness) on CL-RGD films may affect 
cell interaction with biochemical signals (RGD 
peptide), resulting in the inhibition of β3 
integrins by RGD peptide or by β1 integrins.  
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FIGURE 8. Model of the interplay between mechanical and biochemical stimuli during induction of 
C2C12 myogenic differentiation on soft/stiff films functionalized or not with the RGD peptide. Adhesion 
involving β3 integrins on $CL-RGD films (soft films with covalently attached RGD peptide) provides 
favorable conditions for myogenic differentiation of C2C12 cells: when the medium is changed to DM, the 
rate of proliferating cells decreases and that of myogenin increases. Adhesion on CL and CL-RGD films 
(stiff films) involving β1 and β3 integrins promotes ROCK activation leading to a high proliferative state even 
in DM and to low myogenin expression. When the cells on stiff films are treated with ROCK inhibitor during 
differentiation, the rate of proliferating cells decreases significantly on both CL and CL-RGD films. 
Additionally, on CL films, myogenin expression increases, allowing the cells to undergo myogenic 
differentiation. However, on CL-RGD films, ROCK inhibition was not sufficient to induce myogenin 
expression and to allow cell to differentiate. We suggest that mechanical signals (stiffness) on CL-RGD films 
may affect cell interaction with biochemical signals (RGD peptide), resulting in the inhibition of β3 integrins 
by RGD peptide or by β1 integrins.  
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Thus, our findings underline the importance of 
engineering substrates with well-controlled 
properties, as mechanical signals provided by 
the substrate can modify cell responses to 
biochemical cues. In this context, NCL-RGD 
represents a tool for the study of cell responses 
to RGD independently of the pathways 
activated by mechanical signal. Besides, in 
view of their excellent capacity to support 
myogenic differentiation, the soft films ending 
by RGD may be used as coating of various 
types of scaffolds used in muscle tissue 
engineering.  
 
5. Conclusions 
In the present work, four different types of 
PEM films, with or without cross-linking and 
with or without the RGD-peptide, allowed 
investigation of the effect of mechanical and 
biochemical signals and their combinations on 
important events of myogenesis. Soft films 
with RGD peptide appeared as the most 
appropriate for myogenic differentiation of 
C2C12 myoblasts, while stiff films (CL and 
CL-RGD) induced enhanced migration and 
proliferation and inhibited myogenic 
differentiation. ROCK inhibition was 
sufficient to rescue C2C12 differentiation on 
CL films but no significant changes were 
observed on CL-RGD films, showing that 
different signaling pathways were activated on 
each type of film depending on their 
mechanical and biochemical properties. Our 
model allowed highlighting how important 
events in myogenesis such as adhesion, 
migration proliferation, myogenin expression 
and fusion are regulated by substrate elasticity 
and presence of an adhesive ligand.  
These results suggest that thin films with 
tunable mechanical and biochemical properties 
may be a useful tool for biophysical studies of 
muscle progenitors on controlled 2D 
microenvironments as well as for their 
expansion and differentiation in vitro.  In 
addition, these films could be very easily be 
used to coat a wide range of 2D structured 
materials and 3D scaffolds.  
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III.B. COMPLEMENTARY EXPERIMENTS 
III.B.1.Effect of RGD density on cell adhesion and differentiation 
As shown in previous part, the mass of PGA-RGD adsorbed onto the films surface was 400 
ng/cm
2
, which corresponded to a RGD surface density of 0.78 molecules of peptide per nm
2
 (or 300 
pmol/cm
2
). This is a relatively high surface coverage.  
An integrin molecule being about 8-12 nm in size (Xiong et al. 2002), theoretically, RGD 
spacing of less than 10 nm is not necessary. The effects of RGD nanospacing was studied using 
micro- and nanopatterns on non-fouling substrates such as PEG hydrogels with gold nanoparticles 
positioned at a certain distance. In this case, the RGD peptides are grafted onto gold nanoparticles 
(Sun et al. 2008). The critical nanospacing for integrin clustering and activation was found to be 
around 70 nm (Arnold et al. 2004; Sun et al. 2008). Additionally, it is known that the RGD 
nanospacing within a local cluster is more important than RGD density (Arnold et al. 2004; Huang 
et al. 2009; Deeg et al. 2011; Schvartzman et al. 2011).  RGD spacing and density are known to 
induce cytoskeleton remodelling (Cavalcanti-Adam et al. 2007; Huang et al. 2009), but also to 
influence the cell fate (Arnold et al. 2008; Peng et al. 2011; Wang et al. 2013).  
In this work, we investigated if a lower RGD density on (PLL/PGA) films could be sufficient 
for myoblast adhesion and differentiation. Our approach consisted in grafting RDG onto PGA with 
a lower DS. This was achieved by controlling the RDG quantity allowed to react with PGA, and 
verified by 
1
H NMR. The obtained products with a lower DS were deposited onto (PLL/PGA)-PLL 
films as previously described (Chapter IIIA). Thus, RGD density on the films surface could be 
varied (Fig. III-2). 
 
Figure III-2. Control of RGD density on PEM films. Variation of RGD density by functionalization of the 
film with PGA-RGD where RDG is grafted onto PGA with different degrees of substitution (DS).  
 
First, we investigated C2C12 cell adhesion and spreading on the films functionalized with 
PGA-RGD with DS 10% or 1%. The cells adhered and spread on both RGD densities (Fig. III-3A). 
The quantifications showed that RGD density had no statistically significant effect on cell number 
and cell spreading area (Fig. III-3B). 
Lower DSHigher DS
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Figure III-3. Cell adhesion on the films with variable RGD density. Variation of RGD density was 
achieved by functionalization of the film with PGA-RGD where RDG is grafted onto PGA with different 
degrees of substitution (DS).The cells were seeded and allowed to adhere for 4h. (A) Staining of actin (red) 
and nuclei (blue). (B) Quantification of the number of adherent cells and of the cell area. 
 
It was already shown that cell surface attachment was not sensitive to pattern density, whereas 
the formation of stable focal adhesions was (Cavalcanti-Adam et al. 2007). We thus visualized focal 
adhesions on both substrates, DS 10% and DS 1%, by immunolabelling of pFAK (Fig. III-4A). The 
quantification of the number of focal adhesion per cell showed a statistically significant difference: 
the cells seeded on the films with higher RGD density (DS 10%) had more focal adhesions per cell 
(Fig. III-4B). 
 
Figure III-4. Formation of focal adhesions on the films with variable RGD density. The cells were seeded 
and allowed to adhere for 4h. (A) Staining of pFAK. (B) Quantification of the number of focal adhesions per 
cell. * p<0,05. 
 
Next, we evaluated the capacity of the films with different RGD densities to support 
myogenic differentiation. Here, a film functionalized with PGA-RGD DS 7%, that is only slightly 
lower than the control DS 10%, was added to the study. The C2C12 myoblasts were seeded on 
different films and allowed to differentiate in DM for 5 days. As described previously (Chapter 
IIIA), myotube formation was observed on the films with PGA-RGD DS 10% (Fig.III-5).  On the 
films with RGD DS 1%, total cell sheet detachment occurred at Day 3. On DS 7% films, partial cell 
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sheet detachment and cell agregation could be observed, although some myotubes were also 
present.  
 
Figure III-5. Effect of RGD density on myogenic differentiation. Phase contrast microscopy 
observations of C2C12 cell differentiation on different films. After 24 h of proliferation in GM, the cells were 
put in DM (i.e. Day 0) and were let to differentiate until Day 5. 
 
These data show that PGA-RGD DS 10% films are the most efficient for C2C12 myogenic 
differentiation, although only slight differences were observed for cell adhesion. Although RGD 
surface density of 0.78 molecules of peptide per nm
2
 is a very high surface coverage, a part of RGD 
peptide molecules is probably inaccessible due to the diffusion of PGA-RGD into the film. Another 
possibility is that a fraction of the RGD peptides may not have the appropriate conformation to 
interact with integrins. Indeed, secondary structure of the grafted molecules, and RGD peptides 
among them, is important for their interactions with the cells. There are currently developments in 
the modification and grafting of RGD based peptides, in order to improve their affinity, but also to 
enhance their specificity to a given receptor (Ruoslahti 1996; Hersel et al. 2003). 
  
DS 10%
DS 7%
1h Day 1 Day 3 Day 5
DS 1% N/A
 III.B.2. Adhesion and differentiation on PDMS microgrooved 
substrates 
One of the main challenges in muscle tissue engineering consists to properly organize 
spatially the tissue. This can be achieved using microfabricated polydimethylsiloxane (PDMS) 
substrates. PDMS is a biocompatible material that can be easily molded and st
ideal candidate for both biomedical applications and musculo
(Dennis and Kosnik 2000). However, due to its hydrophobicity, PDMS is poorly adhesive and 
requires surface modification. This can be achieved by the adsorption of ECM proteins, such as 
gelatin (Yim et al. 2010), fibronectin 
by covalent grafting (Wipff et al. 2009; Mikhail et al. 2010)
coating (Kidambi et al. 2007). 
In this work, we investigated if NCL
promote C2C12 cell adhesion and m
The topographically patterned surface was fabricated by molding PDMS against a silicon 
mold as described previously (Monge et al. 2012)
were oxidized by oxygen plasma in a microwave
10 s. Next, the microgrooved PDMS was coated by (PLL/PGA)
The coating was verified by adding PLL
homogeneous film deposition onto
Figure III-6. PEM film-coated PDMS microgrooved substrate. 
films were built on PDMS surface. PLL
 
Next, we studied C2C12 cell adhesion on PEM
µm and 30 µm (Fig. III-7). On 10 µm grooved substrates, the cells were significantly elongated as 
compared to flat PDMS substrates (Fig. III
on 10 µm grooves, but were still elongated in the direction of the grooves (Fig. III
These results indicated that 30 µm grooves were able to orient the cells without significantly 
affecting their morphology, as observed on 10 µm grooves. For this reason, we selected 30 
substrate for C2C12 myogenic differentiation.
-skeletal tissue engineering 
(Peterson and Papautsky 2006) or laminin 
 or polyelectrolyte multilayer (PEM) 
-RGD films were a suitable coating for PDMS and could 
yogenic differentiation. 
. Before the buildup of films, the PDMS substrates 
 downstream etcher (Plassys) at 1500W power for 
-PLL-PGA-RGD multilayer films. 
FITC
. Observations by fluorescent microscopy show 
 the PDMS surface (Fig. III-6). 
(PLL/PGA)-PLL--PGA
FITC 
was added to visualize the films 
-coated PDMS with groove thicknesses of 10 
-7A). On 30 µm grooves, the cells were more spread than 
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ructured, making it an 
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(Lam et al. 2006), 
 
-RGD multilayer 
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Figure III-7. C2C12 myoblast adhesion on PDMS microgrooved substrates coated with (PLL/PGA)-PLL--
PGA-RGD multilayer films. (A) Cell adhesion on flat PDMS and on PDMS with 10 µm or 30 µm grooves. 
(B) Cell adhesion on 30 µm grooved PDMS.Red: actin, blue: nuclei. 
 
To study the effect of PEM-coated PDMS on C2C12 myoblasts differentiation, the cells were 
seeded on flat PDMS or with 30 µm grooves, and allowed to differentiate for 5 days in DM. 
Myoblast fusion and Troponin T staining was observed on both substrates (Fig. III-8). However, on 
flat PDMS, the myotubes were randomly oriented, while on 30 µm grooves PDMS, they were 
aligned in the direction of the grooves.  
These results show that NCL-RGD films can be used as efficient coating for microstructured 
PDMS, for the alignment of myotubes. 
 
Figure III-8. C2C12 myoblast differentiation on PDMS microgrooved substrates coated with (PLL/PGA)-
PLL--PGA-RGD multilayer films. The cells were seeded on, flat or with 30 µm grooves, and allowed to 
differentiate for 5 days in myogenic differentiation medium.Green: troponin T, red: actin, blue: nuclei. 
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CHAPTER IV – Laminin-derived peptides for 
targeting of non-integrin cell surface receptors of 
skeletal myoblasts 
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In this chapter, we focused on the development peptide-grafted PEM films for specific 
targeting of non-integrin skeletal muscle receptors such as syndecans and dystroglycans. Besides 
well-studied integrin receptors, these receptors also play important roles in skeletal muscle 
development and maintenance. However, their precise roles and functions are not fully understood. 
We used previously described maleimide chemistry to couple the peptides to PLL/PGA multilayer 
films and studied their effects on cellular processes of skeletal myoblasts. 
 
IV.A. GENERAL INTRODUCTION  
IV.A.1. Physiological importance 
The laminin-α2 chain is the predominant laminin alpha chain expressed in adult skeletal 
muscle and a major component of muscle basement membranes (Miner and Yurchenco 2004). The 
laminin-α2 chain is involved in anchoring myofibers to the basal lamina, promoting muscle cell 
integrity and survival (Miyagoe et al. 1997). Mutations in the laminin-α2 gene result in congenital 
muscular dystrophy type 1A (MDC1A) (Collins and Bonnemann 2010).  
Laminin-α2 chains interacts with various cell receptors via globular domains located in their 
N- and C-terminus (Suzuki et al. 2005). Among them, syndecan-1 (SDC-1) and α-dystroglycan 
(αDG) (Hoffman et al. 1998; Barresi and Campbell 2006; Urushibata et al. 2010).  
Syndecan-1 (SDC-1) was identified as one of laminin receptors interacting with laminin-α2 
G-domain (Hoffman et al. 1998). It was found downregulated during myoblast differentiation 
(Larrain et al. 1997) and its overexpression inhibited myogenic differentiation (Larrain et al. 1998; 
Velleman et al. 2004) while promoting proliferation (Velleman et al. 2007). Adams et al. showed 
that syndecan-1 was involved in C2C12 adhesion to laminin and directional migration (Chakravarti 
et al. 2005). However, the precise mechanism of SDC-1/laminin-α2 interaction and its role in 
myogenesis remain unclear. 
Dystroglycan in muscle cells interacts with laminin-α2 chain and was shown to be crucial for 
maintaining the integrity of sarcolemma and protecting muscle from damage (Gullberg and Ekblom 
1995; Matsumura et al. 1997; Durbeej et al. 1998b; Cohn et al. 2002; Han et al. 2009; Munoz et al. 
2010). Mutations that lead to loss of α-dystroglycan (αDG) cause muscular dystrophies (Durbeej et 
al. 1998a), and defects in the glycosylation of αDG cause muscular dystrophies called 
dystroglycanopathies (Hewitt 2009; Muntoni et al. 2011). 
Non-differentiated cultures of C2C12 myoblasts express low amounts of dystroglycan 
mRNA, which then progressively appears during myoblast differentiation into myotubes 
(Kostrominova and Tanzer 1995). However, it was found that satellite cells expressing dystroglycan 
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supported continued efficient regeneration of skeletal muscle. Besides, maintenance of the 
regenerative capacity by satellite cells expressing dystroglycan could be responsible for mild 
progression of muscular dystrophy caused by disruption of posttranslational dystroglycan 
processing (Cohn et al. 2002).  
These data underline the importance of αDG for muscle regeneration. However, its precise 
role in satellite cell function and myogenic differentiation remains unclear.   
 
IV.A.2. Selection of the peptides 
The study of laminin interaction with its partners, SDC-1 and αDG, is rather challenging due 
to the difficulty of the specific targeting of these receptors by laminin. For instance, cell culture on 
total laminin-coated substrates does not allow specific targeting of a particular receptor, while 
overexpression of the receptors in the cells does not exclude the possibility of signaling via other 
receptors. 
To study the specific interactions of laminin-α2 with SDC-1 or αDG, we selected two peptide 
sequences derived from laminin-α2 chain that were shown to specifically interact with either SDC-1 
or αDG (Nomizu et al. 1996; Hoffman et al. 1998; Suzuki et al. 2010; Urushibata et al. 2010). We 
used these sequences to functionalize PLL/PGA films via covalent grafting by maleimide chemistry 
to create a either αDG or SDC-1-targeting surfaces. The peptides are named hereafter L2synd and 
L2dystro for SDC-1 and α-dystroglycan targeting sequences, respectively.  
 
 
Figure IV-2. Laminin-derived peptide presentation by PLL/PGA multilayer films for SDC-1 and αDG 
targeting. 
 
In addition, we co-grafted laminin-derived peptides with RGD peptide used in the previous 
study to investigate the combined effects of signaling via integrin and non-integrin receptors.  
 
 IV.A.2. “On-film” grafting method
IV.A.2.a) Effect of grafting method on film quality
The peptide grafting protocol used for RGD had to be slightly modified because L2synd and 
L2dystro grafting to PGA-maleimide and subsequent freeze
This is probably due to the amino acid composition of the peptide and possible formation of 
hydrogen/hydrophobic bonds in dry state. Thus, a protocol of direct peptide grafting on the films 
pre-functionnalized with PGA-maleimide was developed. T
described in Chapter II - Materials and methods
on the final layer of (PGA/PLL)6 
Initially, PGA-RGD was deposited on the fi
grafting of laminin peptides in HEPES or HEPES/NaCl buffer led to the formation of big 
aggregates or to film’s deterioration, while grafting in water did not affect film’s homogeneity, 
although some small aggregates could be detected (Fig. IV
Figure IV-3. Qualitative observation of film formation : Films grafted with L2synd and L2dystro were 
observed by fluorescence microscopy  using PLL
HEPES/$aCl buffers and added onto (PGA/PLL)
 
Thus, the grafting of laminin peptide and of the RGD peptide was further performed in milliQ 
water. Before studying the effects of laminin
some preliminary tests were performed in order to verify that such protocol did not affect films 
homogeneity or peptide bioactivity. 
To verify the quality of the films, control films used in previous study (NCL and NCL
last layer deposition in HEPES/NaC
grafted with RGD peptide, laminin peptide or their combinations deposited in water were labeled 
 
 
-drying led to totally insoluble
he detailed grafting procedure is 
. Briefly, it consists in PGA
films and addition of the peptides in solution. 
lm surface in HEPES/NaCl buffer. However,  
-3).  
-FITC. The peptides were dissolved in water, HEPES or 
6 films pre-functionnalized with PGA
-derived peptides on cell adhesion and diffe
 
l buffer), films functionalized with PGA
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 products. 
-maleimide deposition 
 
 
-maleimide. 
rentiation, 
-RGD, 
-maleimide and films 
 with PLL-FITC (Fig. IV-4). All the films showed homogeneous surfaces which were comp
NCL and NCL-RGD films with the last layer deposited  in HEPES/Nacl buffer.
Figure IV-4. Fluorescent labeling of different films using PLL
films, last layer was deposited in HEPES/7aCl buffer. 
water and added onto (PGA/PLL)6 films pre
12% or 16%. 
 
IV.A.2.b) Validation of the “on
Next, we verified the biological functionality
film grafting”. For this, we compared C2C12 cell adhesion and differentiation on RGD
functionalized films prepared by the “pre
distinguish between the films, we preserved the previously used nomenclature (NCL
film prepared by deposition of pre
(deposition of PGA-maleimide, then addition of peptide solution) were called RGD12 and RGD16 
for RGD peptide solution deposited on the films functionalized with PGA
PGA-maleimide DS 16%, respectively. 
On all types of films, the cells adhered and spread by forming thick actin stress fibers and 
focal adhesions (Fig. IV-5A and B). Interestingly, number of focal adhesion per cell was even two
times higher on the films prepared by the new method (Fig. IV
-FITC. For 7CL, 7CL
For the other films, the peptides were dissolved in 
-functionnalized with PGA-maleimide with substitution degrees 
-film” grafting protocol 
 of the films prepared by the new method of “on
-grafting” and the “on-film grafting” methods. To 
-grafted PGA. Films prepared by the “on-
-maleimide 
 
-5C).  
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-RGD and PGA-Mal 
-
-
-RGD) for the 
film grafting” method 
DS 12% and 
-
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Figure IV-5. C2C12 cell adhesion after 4h on RGD-grafted films prepared by the the “pre-grafting” and 
the “on-film grafting” methods. (A) Fluorescent labeling of actin (red) and nuclei (blue). (B) Fluorescent 
labeling of phosphorylated focal adhesion kinase (pFAK). (C) Quantification of the number of focal 
adhesions per cell.  $CL-RGD: film prepared by PGA-RGD deposition (“pre-grafting” method). RGD12 
and RGD16: films prepared by RGD peptide solution deposited on the films functionalized with PGA-
maleimide 12% and PGA-maleimide 16%, respectively (“on-film grafting” method).  
 
The cells were also able to differentiate on all the film types: after 5 days in DM, myotubes 
were observed on all the film types (Fig. IV-6A). Striations were also observed (Fig. IV-6B). The 
fusion index was not affected by the RGD grafting method (Fig. IV-6C). However, on RGD16 
films, myotubes were slightly longer and wider (Fig. IV-6D and E).  
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Figure IV-6. C2C12 cell differentiation after 5 days on RGD-grafted films prepared by the “old” and the 
“new” methods. (A) and (B) Fluorescent labeling of myosin heavy chain (green) and nuclei (blue). (C) 
Quantification of the fusion index. (D) Quantification of myotube length. (E) Quantification of myotube 
width. $CL-RGD: film prepared by PGA-RGD deposition (“old” method). RGD12 and RGD16: films 
prepared by RGD peptide solution deposited on the films functionalized with PGA-maleimide 12% and PGA-
maleimide 16%, respectively (“new” method).  
 
Based on these data, we concluded that RGD “pre-grafting” and the “on-film grafting” 
methods were globally equal in terms of C2C12 adhesion and differentiation, and selected RGD16 
films as a control myogenic substrate for the further experiments. Similarly, laminin peptides were 
grafted onto PGA-maleimide 16% pre-functionalized films.  
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IV.B. PEM FILMS FOR SDC-1 TARGETING IN SKELETAL MYOBLASTS 
IV.B.1. Article summary 
In this work, we use a 12-amino acid laminin-α2 chain derived peptide (named L2synd) that 
was shown to specifically interact with SDC-1 (Hoffman et al. 1998). The peptide was grafted to 
PEM films using maleimide chemistry to create a SDC-1-targeting surface. 
Cell adhesion assays showed that RGD peptide induced better cell spreading, while L2synd 
peptide was responsible for elongated morphology. Interestingly, the cells seeded on mixed 
RGD/L2synd film presented both of these features: they were as spread as the cells on RGD films 
and as elongated as on L2synd films. Thus, the peptides can act simultaneously and induce a 
combination of the effects that each of them induces alone. 
We also revealed that, on L2synd films, the cells presented a polarized phenotype with 
lamellipodia at the leading edge, and increased directional migration. Polarization and directional 
migration are usually induced by environmental cues such as growth factor or chemokine gradients; 
here, polarization was induced by a ligand presented from the basal side, and the cells adapted 
directional migration mode even in absence of classic directionality-inducing factors.  
Our data also suggest a crosstalk between SDC-1 and β1-integrin on L2synd-grafted 
substrate, since cell polarity was inhibited by beta1 integrin blocking, although the substrate did not 
present any ligands for β1-integrin. Also, polarized cell morphology on L2synd films correlated 
with the presence of non-centrosomal microtubules and was linked to Rac1 and Cdc42 activity. 
Interestingly, cell response to Rac1 and Cdc42 inhibition on L2synd-containing films “mimicked” 
the effect of β1 blocking, suggesting that these are the elements of the same pathway and that β1-
integrin – SDC-1 crosstalk results in Rac1 and Cdc42 signaling. Understanding of this cooperation 
is very important, because both modifications of SDC-1 expression and altered Rac1 activity are 
observed in many cancer types, leading to increased cell proliferation, loss of polarity and increased 
motility. Besides, the cells on L2synd films exhibited increased proliferation and absence of cell 
cycle exit in differentiation medium, decreased myogenin expression and absence of myotube 
formation. 
Finally, we proposed a model of L2synd effect on cytoskeleton organization and cell polarity. 
We also propose a model according to which some of previously observed effects of laminin 
presentation or SDC-1 stimulation on skeletal myoblasts can be due to laminin-a2/SDC-1 
interaction. This study demonstrates that by combining materials science/chemistry and cell biology 
approaches it is possible to target specific cell surface receptors and study their roles without 
changing their normal expression level by transfection or knock-down.  
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1. Introduction 
Tissue engineering is an approach that consists 
in combining stem cells and biomaterials to 
create tissues and organs in vitro. The goal of 
biomaterials scientists is to design 
biocompatible scaffolds in which cells can 
adhere, proliferate, differentiate and synthesize 
their own matrix to regenerate tissues 
1
. For 
this, a good understanding of each type of 
stimulus provided by the matrix, physical or 
biochemical, as well as interplay and synergy 
of these signals, is needed. 
Skeletal muscle tissue engineering holds 
promise for the replacement of muscle after an 
injury, for the treatment of muscle diseases, 
drug screening or fundamental studies. The 
process of muscle formation requires that 
muscle precursor cells become activated, 
proliferate, differentiate, and fuse together to 
form multinucleated myotubes 
2; 3
. Besides 
ability to generate the skeletal muscle, adult 
skeletal muscle progenitor cells can give 
smooth muscle 
4
, bone 
5; 6
 or fat tissue 
7; 8
. This 
makes of them good candidates for 
engineering of several types of tissues. A 
major limitation to the clinical application of 
muscle progenitors is a rapid loss of their stem 
cell properties once they are removed from 
their in vivo environment 
9
.  
The development of skeletal muscle is known 
to strongly depend on the interaction of muscle 
cells with their surrounding extracellular 
matrix (ECM) 
10
. Thus, engineering of a 
functional muscle tissue in vitro requires 
complex environments mimicking muscle 
natural extracellular matrix. To this end, 
substrates with tunable mechanical and 
chemical/biochemical properties for myoblast 
expansion and differentiation in vitro, as well 
as for the studies of myogenesis on controlled 
2D microenvironments, are crucially needed.  
Skeletal muscle ECM consists of the basement 
membrane that surrounds individual myofibers 
and of interstitial connective tissue 
10; 11; 12; 13
. 
In adult muscle, satellite cells are situated in a 
compartment between the myotube membrane 
(sarcolemma) and the basal lamina 
14
. 
Laminin, which is the major glycoprotein of 
the basement membranes,
15
 consists of 
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subunits α, β and γ, and contains many distinct 
domains with different structure and functions 
16; 17
. It is known that laminins have effect on 
myoblasts cell shape, migration, proliferation 
and differentiation, both in vitro and in vivo 
18; 
19
 
20; 21
.  
The laminin-α2 chain, a component of 
laminin-211, -221 and -213, is the 
predominant laminin alpha chain expressed in 
adult skeletal muscle 
22
. The laminin-α2 chain 
is involved in anchoring myofibers to the basal 
lamina, promoting muscle cell integrity and 
survival 
22
. Mutations in the laminin-α2 gene 
result in congenital muscular dystrophy type 
1A (MDC1A) 
23
. Among various laminin 
receptors, integrins 
24; 25
 are the most 
characterized and have been shown to be 
crucial for skeletal muscle development and 
function 
26; 27
. However, other cellular 
receptors are now recognized to play a role in 
skeletal muscle regeneration. 
Among them, syndecans, transmembrane 
heparan sulfate proteoglycans (HSPG) that 
bind a variety of ECM ligands, including 
fibronectin, laminin, vitronectin, collagen and 
others 
28
. For a long time, syndecans were 
considered as co-receptors. Recently, their 
independent role in mediating cell adhesion 
and signaling has emerged 
29
. Besides their 
numerous roles in different tissues 
28; 30
, 
syndecans were shown to play an important 
role in myogenesis. Syndecan-3 and syndecan-
4 specifically mark skeletal muscle satellite 
cells and are implicated in satellite cell 
maintenance and muscle regeneration 
31
. 
Syndecan-1 (SDC-1), which was shown to 
interact with laminin-α2 G-domain 
32
 was 
found downregulated during myoblast 
differentiation 
33
. Its overexpression inhibited 
the differentiation 
34; 35
 while promoting 
proliferation 
36
. Adams et al. showed that 
syndecan-1 was involved in C2C12 adhesion 
to laminin and directional migration 
37
. 
These data demonstrate a crucial role for 
laminin-α2 and one of its receptor syndecan-1 
in muscle regeneration. However, laminins are 
complex proteins containing many active 
domains that interact with a variety of cell 
receptors 
38
. A good understanding of various 
laminin domain functions is thus necessary for 
targeting precise cell surface receptors, to 
induce a specific cell response and thus control 
the cell fate. 
The recent developments in the field of 
biomimetic materials are often aimed to 
achieve a better selectivity, and make use of 
biomimetic peptides. Short sequences make it 
possible to enhance the specificity of the 
interaction by targeting a particular receptor. 
Thus, collagen-mimetic peptides 
39; 40; 41
, 
laminin-derived peptides 
42; 43; 44
 and 
fibronectin-derived peptides or fragments 
45; 46
 
are increasingly used for their high selectivity. 
In this work, we use laminin-α2 chain derived 
peptide that was shown to specifically interact 
with SDC-1. This peptide was first described 
by Nomizu et al. as MG-73, a sequence 
derived from LG4 globular domain of laminin-
α2 
47
. Hoffman and al. showed that the peptide 
bound to syndecan-1 
32
.  
We grafted to PEM films using maleimide 
chemistry to create a SDC-1-targeting surface. 
PEM films 
48; 49
 
50
 are a type of highly versatile 
biomaterials offering numerous advantages for 
biomedical applications: ease of preparation, 
capability of incorporating bioactive 
molecules, functionalization by extracellular 
matrix components and biopolymers, tunable 
mechanical properties, and spatio-temporal 
control over film organization
51
. The 
advantage of grafting approach is that it 
provides good control of surface composition, 
a stable link and limits release of the 
functional group into the culture medium. 
Thus, covalent grafting of bioactive peptides 
allows creation of stable biomimetic and 
highly-specific surfaces. 
We thus propose a model surface for the study 
of SDC-1 mediated adhesion to laminin and its 
specific effect on skeletal myoblast cellular 
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processes. In addition, we combine SDC-1 
targeting peptide with a collagen-derived 
peptide that contains RGD motif, to study the . 
Its effect on myogenic differentiation of 
C2C12 myoblasts has been described in our 
previous work 
52
.  
 
2. Materials and methods  
2.1. PEM film buildup and  
Poly(L-lysine) (PLL, P2636, Sigma) and 
poly(L-glutamic) acid (PGA, P-4886, Sigma) 
were dissolved at 0.5 mg/mL in a HEPES-
NaCl buffer (20 mM HEPES, 150 mM NaCl, 
at pH 7.4). For all experiments, films were 
manually constructed in 96-well plates starting 
with a first layer of poly(ethyleneimine) (PEI) 
at 5 mg/ml. To deposit the subsequent 
polyelectrolyte layers, 50 µL of the 
polyelectrolyte solution was deposited in each 
well and let for 8 min before being rinsed 
twice for 30 sec and 5 min, respectively, with 
100 µL of 150 mM NaCl (pH 6.5). This 
sequence was repeated until the buildup of a 
(PGA/PLL)6 film was achieved.  
2.2. PEM films functionalization by adhesion 
peptides 
The laminin alpha2 chain derived peptide 
L2synd was chosen according to a published 
sequence that was shown to interact with 
Syndecan-1 transmembrane proteoglycan 
32; 47; 
53
. RGD peptide that was previously shown to 
promote C2C12 adhesion and differentiation 
52
 
was used as a control myogenic peptide. A 
scrambled L2synd peptide was designed using 
a tool available at the following website: 
http://www.mimotopes.com/ 
The peptides RGD 
(CGPKGDRGDAGPKGA), L2synd 
(CGKNRLTIELEVRT) and scrambled L2synd 
(CGERRTETLVKNIL) were purchased from 
GeneCust (Dudelange, Luxembourg). 
Previously published protocol of peptide 
grafting 
41
 was slightly modified. Briefly, the 
first step consisted in grafting maleimide 
groups onto PGA (P-4886, Sigma) chains. To 
accomplish this grafting, 60 mg of PGA were 
dissolved in 3 mL of a solution containing 10 
mM HEPES buffer (pH 6.5), 20 mg of EDC, 
and 3 mg of sulfo-NHS in an inert atmosphere 
(nitrogen gas) under magnetic stirring. Then, 
24 mg of N-(2-aminoethyl) maleimide 
trifluoroacetate was added. The reaction was 
allowed to proceed at room temperature (RT) 
for 24 h. After removal of the byproducts via 
dialysis against water, the PGA–maleimide 
was freeze-dried. The average number of 
maleimide groups bound to PGA was equal to 
16% (i.e. in average 16 maleimide groups 
every one hundred repeating PGA units), as 
determined via 
1
H NMR analysis. In the 
second step, the PGA-maleimide was 
deposited on the top of PLL-ending films and 
reacted with 100µl of MilliQ water-dissolved 
60µg/mL L2synd peptide, 50µg/mL of RGD 
peptide or 1:1 (v/v) mix of both. The grafting 
was carried out overnight at RT under 
agitation, then the films were rinced twice with 
MilliQ water to remove the unbound peptide. 
2.3. C2C12 culture 
C2C12 cells (from ATCC, used at passages 5-
15) were maintained in polystyrene dishes in 
an incubator at 37° C and 5% CO2 and 
cultured in growth medium (GM) composed of 
Dulbecco’s modified Eagle’s medium 
(DMEM)/F12 medium (1:1; Gibco, Invitrogen, 
Cergy-Pontoise, France) supplemented with 
10% fetal bovine serum (PAA Laboratories, 
Les Mureaux, France) containing 10 U/mL of 
penicillin G and 10 µg/mL of streptomycin 
(Gibco, Invitrogen, Cergy-Pontoise, France). 
Cells were subcultured prior to reaching 60–
70% confluence (approximately every 2 days). 
For all experiments, C2C12 cells were first 
allowed to adhere in a serum-free medium 
(SFM) composed of DMEM/F12 1:1 and 
supplemented with antibiotics. After 4 h of 
adhesion, the cells were fixed or the SMF was 
replaced by the GM, depending on the type of 
experiment (see below). Cell were 
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differentiated in a differentiation medium 
(DM) composed of DMEM/F12 (1:1) 
supplemented with 2% horse serum (PAA 
Laboratories, Les Mureaux, France) and 
antibiotics.  
2.4. Cell adhesion assays 
For cell adhesion tests, C2C12 cells were 
seeded at 15 000 cells/cm
2
 in 96-well plates 
and allowed to adhere in SFM for 4 h, then 
fixed in 3.7% formaldehyde. For adhesion 
specificity test using L2synd peptide in 
solution (sL2synd) the cells were preincubated 
with 10 µg/mL of peptide in SFM or with 
SFM alone for 30 min at 37°C and allowed to 
adhere on L2synd-grafted films for 2h. For 
adhesion specificity test using scrambled 
peptide the films were grafted with either 
original or scrambled L2synd peptide, and the 
cells were allowed to adhere on L2synd-
grafted films for 4h in SFM. Involvement of 
integrin and proteoglycan adhesion receptors 
was tested by cell adhesion assay in presence 
of 2 mM EDTA (Sigma), 2 mM EGTA (Roth), 
1 mg/mL HA (MW 360 kDa (Lifecore 
Biomedical, Chaska, MN, USA)) and 200 kDa 
(gift from Prof. Auzély-Velty, CERMAV, 
Grenoble) and 100 µg/mL heparin (H4784, 
Sigma). The cells were pre-incubated for 30 
min in SFM alone or containing respective 
molecules and allowed to adhere on L2synd-
grafted films for 4h. 
For adhesion assays in presence of Rac1 and 
Cdc42 inhibitors, the cells were allowed to 
adhere for 4h in absence or in presence of 50 
µg/ml of NSC23766 (Rac1 inhibitor) or 10µM 
of ML141 (Cdc42 inhibitor) in SFM. DMSO 
was used as a control for ML141 which is 
dissolved in DMSO.  
To quantify cell morphology, fluorescence 
images were analysed with ImageJ software (v 
1.44p,NIH, Bethesda) to determine cell area 
and aspect ratio. Confocal images in Z were 
analysed to measure the cell height. The aspect 
ratio is a parameter [Major Axis]/[Minor Axis] of 
the particle’s fitted ellipse. 
Microtubule orientation was quantified after 
4h of adhesion in SFV with ImageJ software. 
Angle θ is defined as the angle between the 
vector parallel to the microtubule and the 
vector from the centrosome to the 
microtubule’s closest segment. 
 
2.5. Transfection by siR$A 
Cells were transfected with siRNA against β1 
and β3 integrins (ON-TARGET plus 
SMARTpool, respectively Mouse ITGB1 and 
Mouse ITGB3, Thermo Scientific Dharmacon) 
individually or at the same time, a scrambled 
siRNA (All Stars negative Control siRNA, 
Qiagen) being taken as control. For this, the 
cells were seeded at 30 000 cells/cm
2
 in a 6-
well plate and cultured in GM (2 mL per well) 
for 15 h. The transfection mix was prepared as 
following: for one well, 6 µL of lipofectamine 
RNAiMAX Reagent (Invitrogen) were added 
to 305 µL of Opti-MEM medium (Gibco) and 
0.72 µL of 1 mM siRNA were added to 
another 305 µL of Opti-MEM medium. 
Lipofectamine-containing mix was added to 
siRNA-containing mix and incubated for 20 
min at room temperature. Previously to 
transfection, the GM of the wells was replaced 
by the GM without antibiotics. Then, 610 µL 
of the final mix were added to each well. After 
24 h of incubation at 37°C, the cells were 
transfected for the second time following the 
protocol described above and incubated for 
another 24h. Then the cells were detached by 
trypsin-EDTA, seeded in GM at 10 000 
cells/cm
2
 on the films built in 96-well plate 
and allowed to adhere for 4 h in SFM.  
2.6. Immuno-staining 
Cells were first rinsed in PBS and fixed in 
3.7% formaldehyde for 30 min at RT before 
being permeabilized in 0.5% Triton X-100 for 
4 min. After rinsing with PBS, samples were 
incubated for 1 h in 0.1 % BSA in TRIS-
buffered saline (TBS, 50 mM TRIS, 150 mM 
NaCl, 0.1% NaN3, pH 7.4). Actin was labeled 
with phalloidin-TRITC (1:800, Sigma) for 30 
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min. Cell nuclei were stained with Hoechst 
33342 (Invitrogen) at 5 µg/ml for 10 min. 
After the incubations with the primary 
antibodies (diluted in 0.2% TBS-gelatin) for 
30 min at RT, cells were washed 3 times in 
TBS and incubated for 30 min with the 
secondary antibodies. Primary antibodies: 
mouse anti-β-tubulin antibody (1:200), rabbit 
anti-FAK pY397 antibody, (1:200, 
Invitrogen), myogenin (rabbit anti-myogenin 
antibody (1:30, Tebu-Bio). Secondary 
antibodies: Alexa-Fluor 488, 594 and 647-
conjugated antibodies (Invitrogen) were used 
at 1:1000. Images were taken by means of 
Zeiss LSM 700 confocal microscope.  
For Syndecan-1 immunostaining, a protocol 
adapted from Garcia and coworker was 
applied 
55
. Briefly, cells were rinsed in PBS 
and incubated in ice-cold 1 mM DTSSP (3,3-
dithiobis-(sulfosuccinimidyl)propionate, 
Calbiochem-Merck, Merck Chemicals, 
Nottingham, UK) in PBS for 30 min. 
Unreacted cross-linker was quenched with 50 
mM Tris in PBS for 15 min and bulk cellular 
components were extracted in 0.1% SDS in 
PBS. The slides were then blocked in BSA 
(0,1% in TBS). After this, Syndecan-1 was 
immunostained with 281-2 mouse anti 
Syndecan-1 (CD138) antibody conjugated to 
biotin (1:100, BD Pharmingen, BD 
Biosciences) and FITC-Streptavidin (1:500, 
BD Pharmingen, BD Biosciences) was used 
for visualization.  
2.7. Scanning Electron Microscopy (SEM) 
To image the cells on the films by SEM, the 
films were constructed on 1 x 1 cm silicium 
wafers. The cells were seeded at 15 000 
cells/cm
2 
and allowed to adhere for 4 h before 
fixing them in 2,5% glutaraldehyde in 0,1 M 
cocadylate buffer pH 7.2 for 30 min. After 
rinsing with 0,1 M cocadylate buffer pH 7.2, 
the samples were dehydrated as following: 10 
min in 70% ethanol, 10 min in 95% ethanol 
and 10 min in 100% ethanol. After drying, the 
samples were imaged by scanning electron 
microscopy (SEM) using a FEI-Quanta 250 
SEM-FEG. 
2.8. Cell migration 
To follow cell migration, C2C12 cells were 
seeded at 15 000 cells/cm
2
 in 96-well plates. 
Images were taken every 10 min during 10 h. 
For analysis, at least 20 cells were tracked 
using ImageJ (v1.45d, NIH, Bethesda). 
2.9. Cell proliferation and differentiation 
Cell proliferation was quantified by a EdU (5-
ethynyl-2'-deoxyuridine) assay (Click-iT EdU 
Imaging Kit, Invitrogen). For the evaluation of 
cell proliferation in GM, the cells were seeded 
at 15 000 cells/cm
2
 and allowed to adhere for 1 
h in SFM, then cultured in GM for 24h, 48h or 
72h. For proliferation in DM, the cells were 
seeded at 30 000 cells/cm
2
 and allowed to 
adhere for 1 h in SFM. Cells were then grown 
for 1 day in GM and then for 1 day in DM. At 
the chosen time point the cells were incubated 
with EdU diluted at 1/1000 in cell culture 
medium for 1h at 37°C. The detection was 
carried out following the manufacturer 
instructions. At the end, nuclei were counter-
stained with Hoechst 33432 (Invitrogen). The 
images of EdU and Hoechst-labeled nuclei 
were taken using a Zeiss LSM 700 confocal 
microscope For differentiation assays, cells 
were seeded at 30 000 cells/cm
2
 and allowed 
to adhere for 1 h in SFM. Cells were then 
grown for 1 day in GM and then switched to 
DM. The medium was changed every 3 days.  
2.10. Statistics 
The results represent three independent 
experiments. For cell morphological 
measurements, at least 50 cells were analysed. 
For the ratio of proliferating cells, at least 20 
images taken at 20x magnification were 
analysed. Data are reported as means ± 
standard deviation. Statistical comparisons 
were performed using SigmaPlot Version 11.0 
software and based on an analysis of variance 
(ANOVA) followed by an appropriate 
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pairwise comparison or comparison versus 
control group procedure (P < 0.05 was 
considered significant). Statistically different 
values are reported on the figures. 
 
3. Results  
3.1. Density of L2synd peptide on the film 
surface 
The principle of film buildup and 
functionalization with the peptide is depicted 
in Figure 1A. The film buildup was followed 
in situ by Quartz Crystal Microbalance with 
dissipation monitoring (QCM-D) (Fig. S1), 
which allowed us to measure film thickness 
using the Voigt model 
56
 and to calculate the 
adsorbed mass of L2synd peptide. Film 
thickness was about 70 nm for a film made of 
6 layer pairs, and the quantity of bound 
peptide was about 500 ng/cm
2
. The Young’s 
modulus of the (PLL/PGA) films deposited on 
a thick polyelectrolyte cushion has previously 
been measured and were found 51 ± 17 kPa 
57
.  
3.2. Effect of L2synd functionalization on 
C2C12 myoblast adhesion  and morphology 
Adhesion is the very first and important step of 
cell-substrate interactions, which is especially 
important for anchorage-dependent cells. To 
evaluate the effect of L2synd peptide on 
C2C12 myoblast adhesion, cells were cultured 
on L2synd-grafted films. RGD-grafted films 
were used as a positive control for myoblast 
adhesion 
52
 and PGA-maleimide 
functionalized peptide-free films were used as 
a negative control. In addition, mixed 
RGD/L2synd-grafted films were prepared to 
study the interplay between the signals 
provided by the two peptides. The cells were 
allowed to adhere for 4 h in serum free 
medium (SFM) to eliminate any effect of 
serum on early adhesion. The spreading area 
and morphology (circularity) were then 
evaluated. Actin and nuclei staining of C2C12 
cells (Fig. 1B) revealed the presence of 
adherent cells on RGD, L2synd and 
RGD/L2synd films but of very few cells on 
PGA-maleimide-functionalized ones. In 
addition, these cells were poorly spread. 
Quantitative measurement of the cell area 
revealed that the area was 1,5 to 2 times higher 
on films presenting RGD peptide alone or a 
mix of RGD/L2synd as compared to those 
grafted with L2synd only (Fig. 1C). However, 
the aspect ratio was 1,5 times lower for films 
containing only RGD peptide as compared to 
films containing L2synd peptide or a mix of 
RGD/L2synd (Fig. 1D). This results indicated 
that the presence of RGD promotes cell 
spreading, while the presence of L2synd 
renders the cells more elongated. 
As only few cells adhered on PGA-maleimide 
films, these control films were discarded from 
the subsequent experiments.  
 
3.3. Specificity of cell interaction with L2synd 
and engaged receptors 
We further wanted to verify if cell interaction 
with L2synd peptide was specific, i.e. if the 
cells specifically recognized the peptide 
sequence and bound to it. For this, we 
performed two competition assays (Fig. 1E 
and F).  
In the first assay (Fig. 1E), we pre-incubated 
the cells with L2synd peptide in solution 
(sL2synd) before depositing the cells on 
L2synd-grafted films, still in presence of 
sL2synd. The results showed that the number 
of adherent cells was about 1,5 times lower in 
presence of sL2synd, as compared to control 
without sL2synd. This indicates that the 
peptide in solution competes with the grafted 
peptide and partially prevents the cells from 
adhesion onto L2synd-grafted films.  
In the second assay (Fig. 1F) we compared cell 
adhesion on L2synd-grafted films and on the 
films grafted with a scrambled peptide: a 
peptide that has the same amino acid 
composition as L2synd, but not in the same 
order. The number of adherent cells was about 
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4 times lower on scrambled peptide as 
compared to L2synd peptide, showing that 
amino acid order was important and that the 
cells regognized quite specifically L2synd 
sequence.  
 
 
 
 
FIGURE 1. Cell adhesion, morphology and specificity of interaction on peptide-grafted films. (A) Design 
and characterization of peptide-grafted films. 1- Polyelectrolyte multilayer film is built onto a substrate by 
alternating deposits of PLL and of PGA. 2- PGA-maleimide is added on the last layer of the film. 3- 
Biochemical functionality is provided by adding peptides that covalently bind to maleimide group. 4- C2C12 
myoblasts are cultured on peptide-grafted films. (B) Actin (red) and nuclei (blue) staining of C2C12 cells to 
visualize cell adhesion and spreading after 4h of culture on RGD-, RGD/L2synd and L2synd-grafted films. 
PGA-maleimide functionalized film was used as a peptide-free control. (C) Spreading area after 4h of 
culture. (D) Aspect ratio after 4h of culture. (E) Adhesion inhibition on L2synd-grafted films by pre-
incubating the cells with L2synd peptide in solution (sL2synd); error bars correspond to SD. (F) Adhesion 
on L2synd-grafted film and on the films grafted with scrambled peptide; error bars correspond to SD. (G) 
Expression of Syndecan-1 (green) on RGD and L2synd-grafted films; actin is labeled in red. (H) Adhesion 
inhibition on L2synd-grafted film by EDTA, EGTA, HA1 (MW 4x10
5
), HA2 (MW 2x10
5
) and heparin; 
conditions that are statistically different from the control are indicated by an asterix. * p < 0.05 
 
Since L2synd peptide was shown to interact 
with SDC-1 
32
, we looked at the SDC-1 
expression and localization on L2synd-grafted 
films and compared it to RGD-grafted films. 
SDC-1 labeling was detected in cell 
extremities on L2synd films close to actin 
bundles (Fig. 1G), but not on RGD films, 
indicating that SDC-1 is involved in C2C12 
myoblast interaction with L2synd peptide, but 
not with RGD peptide.  
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Previous studies have demonstrated 
cooperation between syndecan and integrin 
receptors in cell adhesion control, although 
precise mechanisms of their crosstalk remain 
unclear 
58
. In laminin-α1 chain, LG4 module 
was shown to promote cell attachment through 
syndecans and cell spreading through integrin 
α2β1 
59
. In addition, syndecan- and integrin-
binding peptides from LG4 module were 
shown to synergistically accelerate cell 
adhesion 
60
. To determine if integrins were 
involved in myoblast adhesion to L2synd-
grafted films, we evaluated the effect of EDTA 
and EGTA on cell adhesion (Fig. 1H). 
Glycosaminoglycans (hyaluronic acid of two 
different MW and heparin) were used as 
competitors with SDC-1 polysaccaride side 
chains to confirm their involvement in cell 
adhesion to L2synd peptide. Interestingly, all 
five treatments including EDTA and EGTA 
decreased the number of adherent cells, 
although heparin had at least 2-time stronger 
effect than other treatments. These data 
showed that integrins may also be involved in 
cell adhesion to L2synd-grafted films, 
suggesting the existence of crosstalk between 
SDC-1 and integrin receptors in myoblasts. 
The major integrin beta chains in C2C12 
myoblasts are β1-integrin, which is 
constitutively expressed in skeletal muscle 
61
 
and β3 integrin, which was found to be crucial 
for myogenic differentiation of C2C12 
myoblasts 
62
. In order to investigate their 
possible role in cell adhesion to L2synd-
grafted films, we performed β1 or β3 integrin 
(or both) knockdown using siRNA approach. 
RGD-grafted films were used as control: we 
have recently reported that β3 integrins were 
involved in C2C12 myoblast adhesion to RGD 
peptide-functionalized surface 
52
. In addidion, 
we studied the mixed RGD/L2synd films to 
evaluate the possible synergy of the signals. 
The transfected cells cells were stained for 
actin after 4 h of adhesion and their area and 
morphology were quantified (Fig. 2). As 
described previously 
52
, only β3 blocking but 
not of β1 lead to a decrease in cell spreading on 
RGD (Fig. 2B-a). Double tranfection of β1 and 
β3 siRNA gave similar results. The same 
decrease of cell spreading was observed on 
mixed RGD/L2synd films (Fig. 2B-b). 
However, neither β1 nor β3 blocking had effect 
on cell spreading on L2synd-grafted films 
(Fig. 2B-c). Analysis of cell morphology 
showed that on RGD films only β1 blocking 
slightly affected aspect ratio. Interestingly, on 
L2synd-grafted films β1 and β1/β3 blocking 
significantly modified cell shape from 
elongated to very round (Fig. 2A), resulting in 
2-fold decrease in the aspect ratio (Fig. 2B-f). 
The same phenomenon was observed on 
RGD/L2synd films (Fig. 2B-e). These findings 
reveal that neither β1 nor β3 integrins are 
involved in cell spreading on L2synd films, 
but β1 is responsible for maintaining elongated 
cell shape on L2synd films. In case of mixed 
RGD/L2synd films both β1 and β3 are 
involved, with β3 responsible for cell spreading 
and β1 for elongated cell shape.  
3.4. Three-dimensional morphology and 
cytoskeleton organization 
To clarify the effects of C2C12 myoblast 
interactions via syndecan versus integrin 
receptors, we analysed cell adhesion on RGD 
and L2synd films in more details. The 3D 
reconstruction of the cells seeded on RGD or 
L2synd films revealed a significant difference 
in cell shape (Fig. 3A). The cells on RGD 
appeared as homogeneously flat with flattened 
nucleus, while on L2synd films the cells 
appeared as polarized with flattened 
lamellipodium on the leading edge and bulgy 
nucleus.  
Cross-sections in Z done by confocal 
microscopy (Fig. 3B) were used for the 
quantification of cell height in nuclear area. 
The cells on RGD films were ~8 µm high 
against ~10 µm on L2synd films (Fig. 3C).
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FIGURE 2. Effect of blocking β1 and/or β3 integrins on cell spreading on RGD, RGD/L2synd and L2synd-
grafted films. The β1 and/or β3 integrins were blocked using siR$A. (A) Actin labeling and (B) quantification 
of the cell area and aspect ratio after 4 h of adhesion. * p < 0.05 compared to control (scrambled siR$A). 
 
Cell periphery was also differentially 
organized. SEM images (Fig. 3D) show actin 
stress fiber extremities on the cell periphery on 
RGD films and large flat lamellipodia 
containing actin bundles that orthogonally 
encounter the leading edge on L2synd films. 
Actin visualization by fluorescent microscopy 
(Fig. 3E) confirmed the presence of large 
stress fibers crossing the cell and ending in 
filopodia all around cell periphery on RGD 
films. On L2synd films, a polarized 
morphology with lamellipodial leading edge, 
trailing edge and parallel stress fibers between 
them was observed. The difference in polarity 
and actin cytoskeleton was associated to 
different organization of focal adhesions (Fig. 
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 3F). Focal adhesions were visualized by 
labeling phosphorylated focal adhesion kinase 
(pFAK), an important component of mature 
FA. Robust focal adhesions or even fibrillar 
adhesions (small dashes at the cell periphery) 
were formed on RGD films, while only focal
complexes (small dots) were visible at the 
leading edge of lamellipodium on L2synd 
films.  
Thus, our data revealed completely different 
cell adhesion modes on RGD versus L2synd 
films. On RGD films, cells were well
and flattened, attached to the surface by robust 
adhesions at the extremities of thick actin 
stress fibers. On L2synd films, cells presented 
FIGURE 3. Three-dimensional morphology and c
and L2synd-functionalized films after 4h of adhesion
sections in Z done using confocal microscopy; 
stained. (C) Quantification of cell height, * p < 0.05. (D) Scanning electron microscopy (SEM) images, top 
view. Actin stress fibers (upper image) and actin bundles (lower image) are indicated by white arrows. (E) 
Staining of actin cytoskeleton (red) and nuclei (blu
(pFAK Y397, green), actin (red) and nuclei (blue).
 
-spread 
polarized morphology with large and flat 
lamellipodium at the leading edge, smaller 
adhesion complexes, thinner actin stress fibers 
organized in parallel between the leading and 
trailing edge and bulgy nucleus.
Cooperation between actin cytoskeleton and 
microtubules (MT) is known to be crucial for 
cell polarization and lamellipodia formation 
we thus looked at the organization of MT. The 
cells on RGD films mostly exhibited radial 
MT converging to the centrosome, while on 
L2synd films they seemed differentially 
organized and oriented in different senses (Fig. 
4A). 
 
ytoskeleton organization in the cells seeded on RGD 
. (A) 3D reconstruction of the cells and 
beta-tubulin (green), actin (red) and nuclei (blue) were 
e). (F) Staining of phosphorylated f
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To quantitatively analyse microtubular 
organization, we measured the angles between 
the vector parallel to the MT and the vector 
from the centrosome to the microtubule’s 
closest segment (Fig. 4B) 
64
. On RGD films 
63% of MT were oriented at less than 30° and 
15% at more than 60°, against 33% and 30% 
on L2synd films, respectively. Globally, on 
L2synd films, the distribution of the angles 
was rather homogenous, without 
predomination of particular orientation. Our 
results suggest that centrosomal microtubules 
predominate on RGD films, while on L2synd 
films they seem to polymerize much more 
from other non-centrosomal sites.  
3.5. Cell migration and directionality 
Cell polarity and movement are determined by 
cooperation between the actin and MT 
cytoskeletons 
63
. The role of non-centrosomal 
MT in cell architecture and function remains 
not fully understood. Recently, non-
centrosomal MT were shown to regulate actin 
cytoskeleton organization 
64
. Earlier, the 
balance between MT minus-end capture and 
release from the centrosome was shown to be 
critical for efficient cell migration 
65
.  
 
FIGURE 4. Orientation of microtubules and migration on peptide-grafted films (A) Fluorescent labeling 
of beta-tubulin (green), ninein (red, indicated by white arrows) and nuclei (blue). (B) Scheme of quantitative 
measurement of the microtubule organization. Angle θ is defined as the angle between the vector parallel to 
the microtubule and the vector from the centrosome to the microtubule’s closest segment. (C) Quantification 
of microtubule orientation: the histogram represents a percentage of microtubules with various angles to the 
centrosome. Data were collected from 5 cells, error bars correspond to SD.  (D) Migration was measured 
for 10h after 4h of adhesion. Migration paths for approximately 20 cells. (E)  Quantification of cell 
directionality (defined as displacement / total path length of the cell). * p < 0.05 
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To investigate if difference in cell polarity and 
MT orientation was associated to differences 
in cell migration, we followed cell migration 
for 10h on RGD, L2synd and RGD/L2synd-
grafted films (Fig. 4D) and quantified both cell 
velocity and directionality.  While there was 
no significant difference in cell migration 
speed (Fig. S2), the directionality was higher 
on L2synd films as compared to RGD films 
(Fig. 4E). Mixed RGD/L2synd films presented 
intermediate directionality values. Thus, cell 
polarity and cytoskeletal organization on 
L2synd films was associated to an increased 
directionality. 
 
 
FIGURE 5. Effect of Rac1 and Cdc42 inhibitors on cell morphology on RGD, RGD/L2synd and L2synd-
grafted films.  (A) Fluorescent labeling of beta-tubulin (green), actin (red) and nuclei (blue) after 4h of 
adhesion in absence or in presence of Rac1 inhibitor ($SC23766) or Cdc42 inhibitor (ML141). (B) 
Quantification of cell area and aspect ratio. * p < 0.05 compared to control (DMSO is a control for ML141). 
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3.6. Rac1 and Cdc42 are involved in cell 
polarization on L2synd films 
Rho GTPases Rac1 and Cdc42 are implicated 
in the formation of focal complexes, cell 
polarization and directed cell movement 
66; 67
.  
To investigate if cell polarization on L2synd-
grafted films was related to Rac1 and Cdc42 
signaling, we analysed cell spreading and 
morphology after 4h of adhesion in absence or 
in presence of Rac1 inhibitor (NSC23766) or 
Cdc42 inhibitor (Fig. 5). Cell spreading or 
circularity on RGD films were not affected by 
any of the inhibitors (Fig. 5B-a and -d). 
However, on L2synd (Fig. 5B-c and -f) and 
RGD/L2synd films (Fig. 5B-b and -e), both 
inhibitors significantly affected cell shape: the 
aspect ratio decreased while the cell area 
remained the same. Such cell response to Rac1 
and Cdc42 inhibition on L2synd-containing 
films “mimicks” the effect of beta1 blocking 
(Fig. 2B-e and -f), suggesting that these are the 
elements of the same pathway.  
3.7. Cell proliferation and differentiation 
C2C12 myoblasts are a well-known model for 
the in vitro study of myogenic differentiation 
due to their ability to reproduce processes that 
take place during in vivo differentiation of 
skeletal muscle progenitors 
68
. Syndecan-1 
expression was found downregulated during 
myoblast differentiation 
33
, and its 
overexpression inhibited the differentiation 
34; 
35
 and promoted proliferation 
36
, we thus tested 
the effect of L2synd-presenting substrate on 
C2C12 myoblast proliferation and 
differentiation. 
Cell proliferation in GM was evaluated on 
RGD, RGD/L2synd and L2synd films using 
EdU incorporation test (Fig. 6A and B). At 
24h, there was no difference in the percentage 
of proliferating cells. At 48h, proliferation 
decreased on RGD-grafted films and remained 
at the same level on L2synd and RGD/L2synd 
films. At 72h, proliferation decreased on all 
the films but was about 3 times higher on 
L2synd films.  
Control of cell proliferation by contact 
inhibition takes place when the cells reach 
confluence. To ensure that the difference in 
cell proliferation between L2synd and two 
other films is not due to different cell density, 
we labeled actin cytoskeleton and N-cadherin 
after 72h in GM (Fig. 6C). The images show 
that the cells form confluent layers on all three 
film types. However, cell-cell contact 
organization is different. On RGD, the 
contacts are visible between all the cells, the 
cells form a monolayer. However, on L2synd 
films, no cell-cell contacts are visible, the 
monolayer is disorganized. On RGD/L2synd 
films, the organization is intermediate. These 
data indicate that L2synd peptide has an effect 
not only on the morphology of individual, but 
also on the organization of confluent layers. 
During myogenic differentiation, a highly 
ordered process of temporally separable events 
that begins with the expression of myogenic 
transcription factors and is followed by cell 
cycle arrest takes place 
2
. In order to verify if 
the cells were able to undego myogenic 
differentiation on L2synd films, we quantified 
the expression of the transcription factor 
myogenin at early times of the differentiation 
process (Day 0 to 2) (Fig. 7A). The results 
show that, while myogenin expression 
progressively increased from Day 0 to 2 on 
RGD films, it remained 2 times lower on 
L2synd and RGD/L2synd films. Down-
regulation of proliferation is needed for 
myogenesis to occur 
2
, thus we also quantified 
cell proliferation on the different types of films 
after addition of the DM (Day 1) by EdU 
incorporation assay (Fig. 7B). Proliferation at 
Day 1 was lower on RGD films compared to 
L2synd and RGD/L2synd films and about 2 
times lower than after 24h in GM (Fig. 6B), 
indicating that the cells exit the cell cycle. On 
L2synd and RGD/L2synd films the 
proliferation at Day 1 remained at the same 
level as after 24h in GM, suggesting the 
absence of cell cycle exit.  
 FIGURE 6. Cell proliferation on RGD, RGD/L2synd and L2synd
nuclei (yellow) associated to a fluorescent labeling of total nuclei (blue).
cells after 24h, 48h and 72h of culture in GM
nuclei (blue) after 72h of culture in GM.
 
As we previously showed 
52
, C2C12 myoblasts 
differentiated on RGD-grafted films with 
formation of myotubes after 5 days (F
Some cell sheet detachment was observed on 
RGD/L2synd films, but the cell were also able 
to form myotubes. However, on L2synd films, 
the cell sheet completely detached after 2 days 
in DM. These data confirm previously 
described positive effect of the RGD peptide 
on myogenic differentiation and show that 
L2synd-grafted films are inappropriate for 
myogenic differentiation, but rather support 
cell proliferation. Cells on stiff films bypass 
the cell cycle exit induced by growth factor 
deprivation. Cell detachment observed on stiff 
films may thus be due to enhanced 
proliferation (Fig. 7B) leading to excessive 
cell confluence, and/or to enhanced cell 
-grafted films.  (A) 
 (B) Percentage of BrdU
, * p < 0.05. (C) Staining of $-cadherin (green), actin (red) and 
 
ig. 7C). 
migration, together with disorganization of the 
cellular monolayer and absence of N
cell-cell contacts (Fig. 6C).
Discussion 
It is becoming increasingly clear that 
biochemical properties of the substrate play an 
important role not only in cell adhesion, but in 
many other processes such as proliferation and 
differentiation 
1; 69
. However, in most st
the substrates are coated by full
proteins (fibronectin, laminin), their fragments 
(gelatin) or protein mixtures (Matrigel). 
Despite the efficacity of this approach for 
some applications, such as enhancing cell 
adhesion of primary cells o
proliferation, it doesn’t allow exploring the 
effect of each type of signal on cellular 
processes.  
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FIGURE 7. Myogenic differentiation on RGD, RGD/L2synd and L2synd
GM to reach the confluence, the medium was changed to DM (ie Day 0).
percentage of myogenin expressing cells at 72h, Day 1 and 2 of differentiation. Error bars correspond to SD, 
* p < 0.05. (B)  Percentage of EdU
microscopy observations of C2C12 cell differentiation for 5 days. Cell detachment was observed on L2synd
grafted film after 2 days in DM. 
 
 
For instance, laminins contain many domains 
interacting with numerous integrin and non
integrin cell receptors  
15; 16; 17
. To control cell 
processes in vitro, the contribution of each 
adhesive ligand has to be clarified. 
In the previous study we describe
functionalized “soft” film, compared to stiffer 
films with or without RGD peptide 
RGD-grafted films were shown to recruit 
beta3 integrins and were favorable for 
myogenesis. In the present work we targeted a 
-grafted films. 
 (A)
-positive cells after 1 day in DM, * p < 0.05. (C) 
-
 
d RGD-
52
. Soft 
non-integrin laminin receptor SDC
role in cellular processes of skeletal muscle 
remains unclear, and compared SDC
mediated response to one induced by RGD 
peptide. We especially focused on the 
sequence of events involved in C2C12 cell 
differentiation including early adhesion, 
migration, proliferation, differentiation and 
fusion of myoblast into myotubes. 
The study of laminin interaction with SDC
and its role in myogenesis is rather challenging 
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due to the difficulty of the specific targeting of 
SDC-1 by laminin. On the one hand, cell 
culture on total laminin-coated substrates does 
not allow specific SDC-1 targeting, as LN 
possesses many active domains interacting 
with different receptors. Likewise, SDC-1 
overexpression in the cells does not exclude 
the possibility of signaling via other receptors. 
On the other hand, when coating the surfaces 
with anti-SDC-1 antibody 
37
, interaction site 
targeted by the antibody (side chains or core 
protein) may be different from the one that 
ineracts with laminin, and activate different 
signaling pathways. Here, we used a novel 
model surface that allows study of SDC-1 
mediated adhesion to laminin in more specific 
way.  
Cell adhesion assays showed that RGD peptide 
induced better cell spreading, while L2synd 
peptide was responsible for elongated 
morphology. Interestingly, the cells seeded on 
mixed RGD/L2synd film presented both of 
these features: they were as spread as the cells 
on RGD films and as elongated as on L2synd 
films. Thus, the peptides can act 
simultaneously and induce a combination of 
the effects that each of them induces alone. 
Several studies provide evidences that laminin 
induces elongated/bipolar/polarized cell shape. 
Ocalan et al showed that culture of MM14 
myoblasts on laminin-coated substrate resulted 
in bipolar cell shape 
18
. Thus, our data suggest 
that polarized cell shape that was previously 
observed on laminin-coated substrates can be 
due to cell interaction via SDC-1.  
In the previous study, Hoffman and al. showed 
that adhesion of human submandibular gland 
(HSG) cells to L2synd peptide was not 
affected by anti- β1-integrin antibodies 
32
. In 
this study, we observed the effects of EDTA 
and EGTA on the number of adherent cells, 
suggesting that a divalent cation-depending 
adhesion was involved, as well as the effect of 
β1 blocking siRNA on cell morphology on 
L2synd-grafted films. Such difference may be 
explained by the use of different cell types 
and/or different peptide presentation mode 
(coating vs grafting). In addition, Hoffman and 
al. studied only number of adherent cells, but 
did not look at cell morphology. Our data 
suggest a crosstalk between SDC-1 and β1 
integrin on L2synd-grafted substrate. 
Synergistic control of cell adhesion by 
integrins and syndecans have already been 
described 
58
, although the mechanisms and 
precise roles of this interplay remain unclear. 
Syndecan-1 was shown to support integrin 
α2β1-mediated adhesion to collagen in 
Chinese hamster ovary (CHO) cells, 
suggesting a previously unknown link between 
integrin-α2β1 and SDC-1 
70
. Hozumi et al. 
showed that syndecan-1/4 and integrin-α2β1 
binding peptides derived from laminin-α1 
synergistically accelerated cell adhesion 
60
. 
Our data suggest that this link remains in 
SDC-1-mediated adhesion of C2C12 
myoblasts to laminin-α2 derived sequence. 
This interaction between integrin-β1 and 
syndecans may be a common feature of 
different cell types on different substrates.  
We also revealed that, on L2synd films, the 
cells presented a polarized phenotype with 
lamellipodia at the leading edge and increased 
directional migration compared to cells on 
RGD films. These data are in agreement with 
the effects of syndecan-1 ligation on 
lamellipodial spreading and the formation of 
fascin and actin bundles observed on COS-7 
and C2C12 cells 
71
. Functional roles of 
syndecan-1 V region in laminin-dependent 
C2C12 cell adhesion and polarized cell 
migration has also been reported 
37
. In our 
study, such cell organization and migration 
mode was induced by SDC-1 interaction with 
a precise sequence of laminin-α2. We show 
that this relatively short 12 amino acid 
sequence is sufficient to promote cell 
polarization with formation of leading and 
trailing edges, lamellipodial spreading and 
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directional migration, such as observed in 
previous studies in response to either SDC-1 
ligation or coating by total laminin 
37; 71
. 
Interestingly, cell polarization and directional 
migration are usually induced by 
environmental cues such as growth factor or 
chemokine gradients 
72; 73
. Here, polarization is 
induced by an adhesive ligand presented from 
the basal side, and the cells adapt directional 
migration mode even in absence of classic 
directionality-inducing factors.  
Microtubule growth and organization are 
linked to the formation of lamellipodia and 
cell polarization 
63
. Kinases Rac1 and Cdc42 
that are known to promote cell polarization 
and directional migration were shown to be 
associated to microtubules through a 
downstream protein linker at the leading edge 
74; 75
. In our study, polarized cell morphology 
on L2synd films correlated with the presence 
of non-centrosomal microtubules and was 
linked to Rac1 and Cdc42 activity. The role 
and functions of non-centrosomal 
microtubules are not fully understood, and 
their formation process seems to be dependent 
on cell type 
76
.We suggest that non-
centrosomal microtubules may be involved in 
lamellipodia formation and play a role in 
maintaining cell polarity through Rac1 and 
Cdc42 pathway. 
Interestingly, cell response to Rac1 and Cdc42 
inhibition on L2synd-containing films 
“mimicked” the effect of beta1 blocking, 
suggesting that these are the elements of the 
same pathway and that β1 integrin – syndecan-
1 crosstalk results in Rac1 and Cdc42 
signaling. Such cooperation of integrins and 
syndecans to regulate Rac1 has been 
mentioned in several studies 
58
. Understanding 
of this cooperation is very important: both 
modifications of SDC-1 expression and altered 
Rac1 activity are observed in many cancer 
types, leading to increased cell proliferation, 
loss of polarity and increased motility 
66
. 
Figure 8A represents our model of L2synd 
effect on cytoskeleton organization and cell 
polarity. The cells interact with L2synd-
grafted film through SDC-1 that cooperates 
with β1-integrin to activate Rac1 and Cdc42 
pathway. Rac1 and Cdc42 contribute to 
formation of polarized phenotype (microtubule 
organization and lamellipodia formation), 
resulting in increased directionality.  
Figure 8B represents the state of art 
concerning regulation of myoblast 
proliferation and differentiation by SDC-1, 
integrins and Rac1/Cdc42 pathway (black 
arrows) and contribution of our study to the 
understanding of this regulation (red arrows). 
Several studies have demonstrated that 
laminin-coated substrates were favorable for 
myoblast proliferation 
18
. Meriane et al. have 
reported that Rac1 and Cdc42 impaired cell 
cycle exit of L6 myoblasts, inhibited 
myogenin expression and myogenic 
differentiation 
77; 78
. On the other hand, SDC-1 
overexpression also promoted cell 
proliferation 
36
 and inhibited the differentiation 
34; 35
. In addition, β3-integrin was found to be 
crucial for myogenic differentiation 
62
, while 
β1-integrin, which is constitutively expressed 
in skeletal muscle, has been shown to be 
dispensable to myogenesis 
61
. We 
demonstrated that the cells on L2synd films 
exhibited increased proliferation and absence 
of cell cycle exit in DM, decreased myogenin 
expression and absence of myotube formation.  
Thus, our results make a reconstruction of the 
events by linking together the previously 
observed separate effects of laminin, integrin 
β1 and syndecan-1 receptors and Rac1/ CdC42 
pathways on myoblast proliferation and 
differentiation.  
Conclusion and perspectives 
Here, we used a novel model surface for the 
study of SDC-1 mediated adhesion to laminin 
and its role on skeletal myoblast cellular 
processes. We especially focused on the 
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sequence of events involved in C2C12 cell 
differentiation including early adhesion, 
migration, proliferation, differentiation and 
fusion of myoblast into myotubes. This work 
makes a connection between myoblast 
interaction with laminins via SDC-1 and 
signaling through Rac1 and CDC42 pathways 
that induce changes in cell architecture, 
enhanced proliferation and inhibition of 
myogenic differentiation. We also reveal SDC-
1 cooperation with beta-1 integrins in 
maintaining cell polarity and directional 
migration.  
This study demonstrates that by combining 
materials science/chemistry and cell biology 
approaches it is possible to target specific cell 
surface receptors and study their roles without 
changing their normal expression level by 
transfection or knock-down. It is also possible 
to combine two or more ligands targeting 
different receptors, in order to investigate their 
combined or synergistic effects. Moreover, 
biochemical functionality can be further 
combined to stiffness modulation (PEM films 
cross-linking), which is now recognized to 
play a crucial role in many cellular processes, 
or surface micropatterning. Thus, by using 
bottom-up approach, multifunctional 
substrates with perfect control over cell 
processes can be created.  Such substrates are 
needed for fundamental studies, but also for 
creating scaffolds for tissue engineering and 
for stem cell expansion. 
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FIGURE 8. Proposed model of L2synd peptide on C2C12 myoblast cytoskeletal organization, proliferation 
and differentiation. (A) L2synd-grafted films promote lamellipodia formation, increased cell polarity, 
presence of non-centrosomal microtubules and directional migration. This interaction involves cooperation 
between Syndecan-1 and beta-1 integrins and passes through Rho GTPases Rac1 and Cdc42 pathways. (B) 
Regulation of myoblast proliferation and differentiation by SDC-1, integrins and Rac1/Cdc42 pathway and 
contribution of our study to the understanding of this regulation (red arrows). 
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Quartz Crystal Microbalance with dissi
Film buildup was followed by 
Sweden) using a previously published procedure 
mg/mL in the HEPES-NaCl buffer were successively injected in the cell. They were let to adsorb 
for 8 min and rinsed for 6 min with the HEPES
allowed to equilibrate in MilliQ water, and the MilliQ water
was injected overnight. The unbound peptide was rinced with MilliQ water.
When a mass ∆m is adsorbed at the crystal and the measurements are conducted in air, the resulting 
decrease ∆f typically obeys the Sauerbrey equation:
where C is the mass sensitivity constant (17.7 ng/cm
FIGURE S1. Exponential growth of the film and peptide binding followed by QCM
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IV.C. PEM FILMS FOR α-DYSTROGLYCAN TARGETING IN SKELETAL 
MYOBLASTS 
Recently, two αDG binding sequences in the laminin-α2 chain LG4-5 module were identified, 
one binding heparin and αDG, and other specifically binding αDG (Suzuki et al. 2010). The 
peptides specifically inhibited end bud formation of submandibular glands in culture (Suzuki et al. 
2010). In this work, we used a 12-amino acid laminin-α2 chain derived peptide (named L2dystro) 
that was shown to specifically bind αDG (Suzuki et al. 2010). The peptide was grafted to PEM 
films using maleimide chemistry to create αDG-targeting surface. The L2dystro-functionalized 
films were used as substrates for C2C12 culture to study the effects of this peptide on cell adhesion, 
proliferation and differentiation. 
 
IV.C.1. Results 
IV.C.1.a) Cell adhesion on L2dystro-functionalized films 
To evaluate the effect of L2dystro peptide on C2C12 myoblast adhesion, cells were cultured 
on L2dystro-grafted films. RGD-grafted films were used as a positive control for myoblast adhesion 
(Chapter III). In addition, mixed RGD/L2dystro-grafted films were prepared to study the interplay 
between the signals provided by the two peptides. The cells were allowed to adhere for 4 h in SFM 
to eliminate any effect of serum on early adhesion. Actin and nuclei staining of C2C12 cells 
revealed the presence of adherent cells on RGD, L2dystro and RGD/L2dystro (Fig. IV-7A).  
 
Figure IV-7. C2C12 cell adhesion after 4h on RGD- and L2dystro-grafted films. (A) Fluorescent labeling 
of actin (red) and nuclei (blue). (B) Quantification of the cell area. (C)  Quantification of the circularity. (D) 
Quantification of the aspect ratio. * p < 0.05 
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Next, the spreading area and morphology (circularity and aspect ratio) of the cells on RGD 
and on L2dystro-grafted films were compared. Quantitative measurement of the cell area revealed 
that the area was 1.5 to 2 times higher on films presenting RGD peptide as compared to those 
grafted with L2dystro (Fig. IV-7B). However, there was no difference of either circularity or aspect 
ratio (Fig. IV-7C and D). 
 
IV.C.1.b) Inhibition of adhesion by addition of soluble peptide 
To test if the cells bound to the peptide sequence on the films surface, we performed a 
competition assay (Fig. I-8). We pre-incubated the cells with L2dystro peptide in solution 
(sL2dystro) before depositing the cells on L2dystro-grafted films, still in presence of sL2dystro. 
The results showed that the cell spreading area was about 2 times smaller in presence of sL2dystro 
(Fig. IV-8A), as compared to control without sL2dystro. This indicates that the peptide in solution 
competes with the grafted peptide and partially prevents the cells from spreading. However, there 
was no difference in the number of adherent cells (Fig. IV-8B), suggesting that receptor blocking by 
the soluble peptide was not complete and still allowed cell interaction of the film. 
 
Figure IV-8. C2C12 cell adhesion inhibition on L2dystro-grafted films by pre-incubating the cells with 
L2dystro peptide in solution (sL2dystro). (A) Cell spreading after 1h of adhesion. (B) Cell number. 
 
IV.C.2.c) Migration 
To investigate if L2dystro peptide had effect on cell migration, we followed the migration for 
10h on RGD, L2dystro and RGD/L2synd-grafted films (Fig. IV-9A) and quantified both cell 
velocity and directionality (Fig. IV-9B and C). Cell migration speed was higher on L2dystro films 
as compared to RGD films (Fig. IV-9B). Mixed RGD/L2dystro films presented intermediate 
velocity values. However, there was no significant difference in the directionality (Fig. IV-9B). 
Thus, cell culture on L2dystro films was associated to an increased cell migration speed without 
affecting the directionality. 
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Figure IV-9. Migration on RGD, L2dystro and RGD/L2dystro-grafted films. Migration was measured for 
10h after 4h of adhesion. (A) Migration paths for approximately 15 cells. (B) Quantification of cell velocity. 
(C) Quantification of cell directionality (defined as displacement / total path length of the cell). * p < 0.05 
 
IV.C.2.d) Differentiation 
As we previously showed, C2C12 myoblasts differentiated on RGD-grafted films with 
formation of myotubes after 5 days. Some cell sheet detachment was observed on RGD/L2dystro 
films, but the cells were also able to form myotubes. However, on L2dystro films, the cell sheet 
completely detached after 2 days in DM, showing that only L2dystro-grafted films were 
inappropriate for myogenic differentiation (Fig. IV-10A and B) and required the presence of 
additional adhesion ligands. These results are in agreement with previous findings showing that β3 
integrin is crucial for myogenic differentiation of C2C12 myoblasts (Liu et al. 2011). For this 
reason, RGD or another adhesive peptide needs to be added. Indeed, when L2dystro was mixed 
with RGD peptide, formation of myotubes could be observed. To avoid partial cell detachment from 
such RGD/L2dystro mixed surfaces, an appropriate ratio of the peptides has to be determined. 
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Figure IV-10. Myogenic differentiation on RGD, L2dystro and RGD/L2dystro-grafted films. After culture 
in GM to reach the confluence, the medium was changed to DM (ie Day 0). (A) Phase contrast microscopy 
observations of C2C12 cell differentiation for 5 days. Cell detachment was observed on L2dystro-grafted 
films after 2 days in DM. (B) Myosin heavy chain (green) and nuclei (blue) labeling.  
 
IV.C.2. Conclusions and perspectives 
In this study, we engineered L2dystro peptide-presenting PEM films. These films were able to 
promote adhesion, spreading and migration of C2C12 myoblasts, but were inappropriate for 
myogenic differentiation, indicating that the differentiation process requires the presence of 
additional adhesion ligands. 
As dystroglycan interaction with laminin-α2 chain is crucial for maintaining the function of 
skeletal muscle, L2dystro-grafted films may become a tool for studying the cellular mechanisms 
and roles of αDG/laminin-α2 interaction. Different types of dystrophic myotubes may be cultured 
on L2dystro-grafted films to evaluate the possibility of L2dystro utilization as a therapeutic agent in 
myopathies. Also, such substrate may be used to follow the restoration of laminin/dystrophin-
glycoprotein complex interaction in hybrid myotubes (i.e. myotubes obtained by fusion of normal 
myoblasts with dystrophic myotubes). This may have important considerations in the design of 
strategies for both myoblast transplantation and gene therapy of muscular dystrophy.  
Besides its role in skeletal muscle, dystroglycan plays diverse roles in Schwann cells. 
However, the molecular mechanisms are just beginning to be revealed (Masaki et al. 2003; Masaki 
and Matsumura 2010). Understanding of these mechanisms is promising for the development of 
effective treatments for human peripheral neuropathies. 
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Besides differentiation into myotubes, C2C12 myoblasts can also undergo osteogenic 
differentiation when treated with BMP-2 growth factor. PEM films with incorporated rhBMP-2 
were already shown to orient C2C12 myoblasts towards osteogenic pathway. 
In this chapter, our aim was to guide skeletal muscle progenitors towards an osteogenic 
pathway using BMP-2 derived mimetic peptide. We grafted this peptide to PEM films and 
evaluated its capacity to induce the osteogenic differentiation of C2C12 myoblasts.  
 
V.A. INTRODUCTION 
Saito et al. identified the most effective osteogenic peptide derived from BMP-2 amino acid 
sequence, corresponding to residues 73–92 of the knuckle epitope of BMP-2 (Saito et al. 2003). 
Osteoinductive activity of this peptide was observed both in vitro and in vivo (for the review, see 
(Jabbari 2013)). The sequences used in different studies, their presentation mode and observed 
effects are shown in Table V-1.  
In vitro, the peptide was used in solution (Saito et al. 2003; Kloesch et al. 2007; He et al. 
2008a), coated onto cell culture substrate (Saito et al. 2003) or conjugated to synthetic (He et al. 
2008a; Zouani et al. 2010; Moore et al. 2011; Zouani et al. 2013) or natural (Saito et al. 2003; Saito 
et al. 2005; Kloesch et al. 2007) polymers. The peptide induced expression of osteogenic 
transcription factors and ALP activity, as well as significantly inhibited the binding of rhBMP-2 to 
both BMP receptors type IA and type II (Saito et al. 2003). The synergistic effect of the BMP-2 
peptide with RGD peptide was also studied. The results demonstrated that RGD and BMP peptides, 
when presented simultaneously, acted synergistically to enhance osteogenic differentiation peptide 
(He et al. 2008a; Zouani et al. 2010; Moore et al. 2011). Recently, the interplay of substrate 
stiffness and presentation of BMP-2 peptide was studied (Zouani et al. 2013). BMP-2 peptide 
showed osteogenic capacity when presented by stiffer substrates. These experiments were 
conducted using mesenchymal cell lines (Saito et al. 2003; He et al. 2008a; Moore et al. 2011) or 
MC3T3-E1 pre-osteoblasts (Zouani et al. 2010). However, when C2C12 myoblasts were used for 
the evaluation of BMP-2 peptide effect in solution or loaded into Collagraft blocks, no osteogenic 
effect was observed (Kloesch et al. 2007).  
In vivo, 73–92 peptide-conjugated alginate gels promoted ectopic calcification in rat calf 
muscle and repair of rat tibial bone defects (Saito et al. 2003; Saito et al. 2005).  
 Table V-1. Sequences of BMP-2 derived peptides used in different studies, their
observed effects. The Table is not exhaustive and presents the most important studies on BMP
peptides. 
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In this work, we used BMP-2 derived peptide (pBMP-2) (Saito et al. 2003) to evaluate the 
capacity of pBMP-2-presenting PEM films of controlled stiffness to induce the osteogenic 
differentiation of C2C12 myoblasts.  
 
V.B. RESULTS 
V.B.1. Cell adhesion and proliferation on BMP-2 peptide-grafted films 
BMP-2 derived peptide was grafted to PGA using maleimide chemistry (Chapter II - 
Materials and methods) to obtain PGA-pBMP-2. The final product was analysed by NMR and had 
substitution degree of 5.5% (Annexe IV). 
PGA-BMP-2 was further used to functionalize PLL/PGA films, cross-linked or not. The 
respective films were called NCL and NCL-pBMP-2 for soft films without and with final layer of 
PGA-pBMP-2, and CL and CL-pBMP-2 for stiffer films without or with PGA-pBMP-2. NCL films 
were described in our previous studies as non-adhesive and were used as a negative control. 
Conversely, CL films were favorable for cell adhesion and proliferation and were used as a positive 
control. 
C2C12 myoblasts were deposited on the films in SFM. After 1h of adhesion, the medium was 
replaced by GM and the cells were allowed to adhere for 3 more hours, then fixed and stained for 
actin and nuclei (Fig. V-1). At 4h after seeding, the cells were spread on all the films types, except 
for NCL which is a negative control for cell adhesion. However, more round cells were observed on 
NCL-pBMP-2 films compared to both cross-linked films. 
 
Figure V-1. Adhesion at 4h of C2C12 myoblasts on different types of PLL/PGA films. The cells were 
seeded on soft or cross-linked films, with or without PGA grafted with BMP-2 peptide (pBMP-2) deposited 
on the final layer, and cultured in SFM for 1h, then in GM for 3h. 
NCL-pBMP-2
CL CL-pBMP-2
NCL
152 
 
Then the cells were cultured for three days to evaluate their capacity to proliferate on different 
types of films. The cells proliferated on all the film types, although the cell layer was less confluent 
on NCL-pBMP-2 film compared to both cross-linked films (Fig. V-2). These results show that 
C2C12 myoblasts were able to recognize pBMP-2 for adhesion and to proliferate on pBMP-2-
functionnalized films.  
 
 
Figure V-2. Proliferation of C2C12 myoblasts on different types of PLL/PGA films. The cells were seeded 
on soft or cross-linked films, with or without PGA grafted with BMP-2 peptide (pBMP-2) deposited on the 
final layer, and cultured in GM for 3 days. 
 
 
V.B.2. Evaluation of osteoinductive capacity of BMP-2 peptide-grafted films 
We next evaluated the capacity of pBMP-2 grafted surfaces, soft or stiff, to induce ALP 
expression by C2C12 myoblasts. NCL films, which did not promote any cell adhesion, were 
discarded from the study. CL films were used as control for stiff films since substrate stiffness is 
known to affect cell differentiation. Cells seeded on plastic, with or without soluble rhBMP-2 at a 
concentration known to induce ALP activity, were used as positive and negative controls, 
respectively. The results showed no effect of pBMP-2-presenting films on ALP activity, which was 
close to zero and corresponded to the values of negative control (Fig. V-3).  
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Figure V-3. Effect of BMP-2 
peptide presented by PLL/PGA 
films on induction of ALP in 
C2C12 cells. ALP activity was 
measured after 72 h in GM on 
different types of substrates. 
Positive control corresponds to GM 
supplemented with 500 ng/mL of 
rhBMP-2. 
 
 
 
In several previous studies, the RGD peptide was shown to synergistically enhance the effect 
of pBMP-2 (He et al. 2008a; Zouani et al. 2010; Moore et al. 2011). We co-deposited PGA-RGD 
and PGA-pBMP-2 (mixed at 1:1 v/v) on the last layer to investigate if combined presentation of an 
adhesive RGD peptide and pBMP-2 could induce ALP activity. However, no difference compared 
to a negative control could be observed (Fig. V-4). 
 
Figure V-4. Effect of RGD and 
BMP-2 peptide simultaneous 
presentation on induction of 
ALP in C2C12 cells. ALP 
activity was measured after 72 h 
of culture  in GM on different 
types of substrates. Positive 
control corresponds to GM  
supplemented with 500 ng/mL of 
rhBMP-2. 
 
 
V.B.3. Evaluation of osteoinductive capacity of BMP-2 peptide in solution 
We hypothesized that absence of ALP activity in response to pBMP-2 may be due to its 
presentation mode, because the chemical grafting can influence peptide’s bioactivity.  
The efficacity of BMP-2 peptide delivered in solution to induce ALP activity was already 
demonstrated using rat bone marrow stromal cells (He et al. 2008a). The Az-mPEG-BMP-2 peptide 
concentration used in this experiment was 200 ng/mL. However, in another study, much higher 
concentrations were used (Saito et al. 2003). Expression of osteocalcin was observed in response to 
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addition of 100 µg of peptide per well in 96-well plate, which corresponds to a peptide 
concentration of 1 mg/mL (supposing that 100 µL of medium are used for culture in 96 well-plate). 
This is a very high concentration that corresponds to rhBMP-2 concentration of approximately 6.5 
mg/mL, when considering the same number of knuckle epitopes contained (rhBMP-2: 2 epitopes, 
MW 26 kDa; BMP-2 peptide: 1 epitope, MW about 2 kDa. Thus, the mass ratio for rhBMP-2 and 
BMP-2 peptide for 1 epitope is 6.5:1). However, rhBMP-2 concentration used in this study (Saito et 
al. 2003) as a control was only 50 ng/mL. The concentration used for C2C12 myoblasts to induce 
ALP expression is 500 ng/mL. 
For this reason, we chose a lower peptide concentration of 500 ng/mL that is closer to the 
concentration used by He et al. (He et al. 2008a) and corresponds to approximately 3 µg/mL of 
rhBMP-2. The peptide was delivered in solution to the cells cultured on the substrates of different 
stiffnesses that presented or not RGD adhesive peptide. We compared the effect of rhBMP-2 in 
solution on these films as well.  
The NCL-RGD, CL or CL-RGD films alone did not induce any ALP activity (Fig. V-5) 
indicating that RGD and/or stiffness had no ALP-inductive capacities. When rhBMP-2 was added 
to the cells cultured on the same films, ALP activity was induced and was comparable to the control 
(plastic + rhBMP-2). Interestingly, ALP activity on NCL-RGD films was about 2 times higher 
compared to cross-linked films or positive plastic control. However, still no ALP activity could be 
observed in response to pBMP-2, here delivered in solution.  
 
Figure V-5. Effect of BMP-2 peptide in solution on induction of ALP in C2C12 cells cultured on 
RGD-presenting films. ALP activity was measured after 72 h of culture on different types of substrates in 
GM supplemented with 500 ng/mL of BMP-2 peptide (pBMP-2) or 500 ng/mL of rhBMP-2.  
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To exclude the possibility that the peptide concentration was too low, we tested much higher 
concentrations, but still no effect could be observed (Fig. V-6). 
 
Figure V-6. Effect of different 
concentrations of BMP-2 
peptide in solution on induction 
of ALP in C2C12 cells. ALP 
activity was measured after 72 h of 
culture on plastic in GM  
supplemented with different 
concentrations of BMP-2 peptide 
(pBMP-2) or 500 ng/mL of rhBMP-
2.  
 
 
In addition to ALP test, we performed a highly sensitive test using C2C12 A5 myoblast cell 
line. In response to the activation of Smad pathway, these cells express a reporter gene luciferase. 
Additionally, we tested a peptide sequence derived from original protein sequence, in which CC and 
M are not replaced by SS and T. 
• pBMP-2(1): KIPKA SSVPT ELSAI STLYL (Saito et al. 2003)  
• pBMP-2(2) : KIPKA CCVPT ELSAI SMLYL (GenBank: AAB05665, AAF21646.1)  
In positive control (in presence of rhBMP-2), luciferase activity normalized to DNA content 
was about 12-fold higher than in absence of rhBMP-2 (Fig. V-7). However, no activation of Smad 
pathway could be detected in response to any of the peptides. 
 
Figure V-7: Effect of different 
concentrations of BMP-2 peptide in 
solution on activation of Smad 
pathway in C2C12 cells. Luciferase 
activity normalized to D$A content was 
measured after 24h of culture in 
presence of BMP-2 peptides (pBMP-2) 
or 500 ng/mL of rhBMP-2.  
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 We also tested if the peptide could induce ALP activity in other cell type than C2C12 
myoblasts. We thus evaluated if pBMP
osteoblastic cell line. In presence of rhBMP
to negative control, but no effect of pBMP
 
 
V.C. DISCUSSION 
In this work, we evaluated the capacity of BMP
differentiation of C2C12 myoblasts. Presented by the films surface, BMP
adhesion and supported cell proliferation over 3 days. However, BMP
with RGD peptide, was not sufficient to induce ALP expression of C2C12 myoblasts. Also, no 
effect on either ALP expression or on Smad pathway activation could be observed when the peptide 
was presented in solution at different c
To better understand the reasons of such results, we carefully analysed the articles published 
so far in the literature and paid particular attention to the BMP
models and culture conditions used in differe
summarized in Table V-1, several observations can be done. 
Peptide sequence 
The first remark concerns the sequence of the BMP peptide. Amino acids containing thiol or 
thioether groups (cystein, methionin) from the original BMP
SMLYL) are being replaced by thiol
Zouani et al. 2013) or both thiol and thioether
2003; He et al. 2008a; Moore et al. 2011)
-2 could contribute to ALP expression by MC3T3 
-2, ALP activity was more than 2
-2 on was observed at any concentration (Fig. V
 
Figure V-8. Effect of different 
concentrations of BMP
solution on induction of ALP in 
MC3T3 cells. 
measured after 7 days of culture on 
plastic in osteogenic medium 
supplemented with different 
concentrations of BMP
rhBMP-2.  
 
-2 derived peptide to induce the osteogenic 
-2 peptide promoted cell 
-2 peptide, presented alone or 
oncentrations.  
-2 peptide presentation mode, cell 
nt studies. From these different articles, which are are 
 
-2 sequence (KIPKA 
-free (KIPKA SSVPT ELSAI SMLYL) 
-free (KIPKA SSVPT ELSAI S
 amino acids  in order to exclude possible reactivity 
156 
-fold higher compared 
-8). 
-2 peptide in 
ALP activity was 
-2 peptide or 
CCVPT ELSAI 
(Zouani et al. 2010; 
TLYL) (Saito et al. 
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(formation of disulfide bonds). However, such modifications may affect the secondary structure of 
the peptide and its functionality. 
Effect of the peptide in solution 
Another remark concerns the effect of peptide in solution (Saito et al. 2003; He et al. 2008a). 
In one case (Saito et al. 2003) it was used at very high concentration, providing about 10
6
 times 
more knucle epitopes than rhBMP-2 used in this study as a control. At such concentration, some 
peptide probably sediment onto the surface and adsorb, thus affecting cell adhesion. In another 
study (He et al. 2008a), the cells were cultured with Az-mPEG-BMP peptide, and an increased in 
ALP activity increase was observed after 2 weeks of culture in osteogenic medium. This is a rather 
long period and one may question to true effect of the peptide. In addition, the medium used was 
osteoinductive and promotes the differentiation in itself, and the peptides had a mini-PEG + azide 
modification , which may also play a role.  
Presentation of BMP-2 by the surface 
In our study, we observed that cell adhrere on BMP-2 peptide grafted soft PLL/PGA films. 
Without cross-linking or addition of an adhesive ligand, such films are non-adhesive, thus, cell 
adhesion can be only due to the presence of BMP-2 peptide. Of note, cell spreading on rhBMP-2-
loaded soft (PLL/HA) films has already been observed (Crouzier et al. 2011a). Neither BMP-2-free 
films nor BMP-2 delivery in solution could induce such effect, indicating that the presentation 
mode is important. However, while matrix-bound rhBMP-2 showed a drastic osteoinductive  effect 
on C2C12 myoblasts, the grafted pBMP-2 did not (Fig. V-1).  
In other studies, osteoinductive activity of surface-bound pBMP-2 was observed on peptide-
coated substrate (Saito et al. 2003) or on synthetic matrix grafted with pBMP-2 (He et al. 2008a). 
However, in the latter study, RGD peptide grafted alone increased the expression of osteogenic 
markers at the same level as pBMP-2 (He et al. 2008a). Interestingly, when pBMP-2 and RGD were 
co-grafted together, they acted synergistically to enhance osteogenic differentiation (He et al. 
2008a; Moore et al. 2011). RGD and pBMP-2 co-grafting was also used by Zouani et al., and 
induced expression of osteogenic markers (Zouani et al. 2010). However, in this study, the effect of 
pBMP-2 grafted alone is not shown as control (Zouani et al. 2010).  
Based on these results, we hypothesize that BMP-2 peptide may contribute to cell 
differentiation via its adhesive effect, and that this effect may be significantly improved by the 
presence of the RGD adhesive peptide. Both peptides may act together to enhance cell adhesion and 
thus make the substrates more favorable for differentiation. Indeed, the effect of cell adhesion and 
spreading on osteogenic differentiation was already demonstrated: cell shape regulated commitment 
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of human mesenchymal stem cells (hMSCs) to adipocytes or osteoblasts (McBeath et al. 2004; 
Anderson et al. 2011). hMSCs allowed to adhere, flatten, and spread underwent osteogenesis, while 
unspread, round cells became adipocytes. (McBeath et al. 2004). RGD-functionalized peptide 
amphiphiles synergistically enhanced osteogenic differentiation in combination with osteogenic 
medium (Anderson et al. 2011). In addition, the cell fate of MSCs is sensible to ligand density: on 
patterns of large RGD nanospacing, osteogenesis was predominant (Wang et al. 2013). It was also 
shown that collagen sponges with bound RGD peptide and loaded with a subfunctional dose of 
BMP-2 could promote the formation of ectopic bone, while no bone formation was observed with 
BMP-2 only (Visser et al. 2013). Interestingly, we also observed higher ALP activity in presence of 
rhBMP-2, when the cells were grown on NCL-RGD films (Fig.V-5).  
This may also explain why, when we tested pBMP-2 in solution on MC3T3 cells, we could 
not observe any increase of ALP activity due to peptide treatment, while in another study that used 
the same cells, expression of osteogenic markers and increase in matrix thickness were observed 
(Zouani et al. 2010). These results were obtained for MC3T3 cells cultured on RGD and BMP-2 
peptide grafted surfaces (Zouani et al. 2010), where both peptides could be contributing to strong 
cell adhesion and creating favorable conditions for osteogenic gene expression and matrix 
synthesis. Similarly, improved bone repair in response to alginate gels grafted with BMP-2 peptide 
(Saito et al. 2005) may be explained by better adhesive properties of peptide-grafted gels.  
Besides RGD adhesive peptide, other characteristics of the material are also known to 
influence osteogenic differentiation, among them degree of sulfation (Hempel et al. 2012), 
carboxyle groups (Moore et al. 2011) and substrate stiffness (Zouani et al. 2013). Thus, it is rather 
difficult to fully decouple the proper osteogenic effect of BMP-2 peptide from the materials 
chemical and mechanical properties.  
Role of the cell type 
The last remark concerns the cellular models used in different studies. In the majority of the 
studies, the cells used were systematically those with a high potential for osteogenic differentiation, 
such as human MSC or murine C3H10T1/2, or pre-committed such as MC3T3-E1 preosteoblasts. 
We noted that C2C12 myoblasts, which are widely acknowleged as being BMP-2 responding cells 
(Katagiri, 1994), were used only once, and pBMP-2 had no osteogenic effect on these cells, neither 
in vitro nor in vivo (Kloesch et al. 2007) (Table V-1). 
According to the lineage-priming model, stem cells in an undifferentiated state have a basal 
level of expression of different TF. During differentiation into a cell type, the expression of TF 
associated to this cell type increases, while the expression of other TF decreases. For instance, in 
bone marrow MSC, the master transactivator proteins PPARG (adipogenesis), RUNX2 
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(osteogenesis), and SOX9 (chondrogenesis) are coexpressed before differentiation induction 
(Delorme et al. 2009). Thus, mesenchymal cells have a basal level of expression of osteoblast-
specific genes even in absence of BMP-2. The osteogenic differentiation media for these cells does 
not necessarily include BMP-2 and is usually based on the addition of dexamethasone, ascorbic acid 
and β-glycerophosphate. Such conditions induce an increase in Runx2 expression in both 
C3H10T1/2 and MC3T3-E1 cells (Tsai et al. 2012). MC3T3-E1 cells express high levels of 
osteoblast-specific markers and mineralize after growth in ascorbic acid (AA)-containing medium 
for several days (Wang et al. 1999). C3H10T1/2 cells have a basal level of osteocalcin expression 
(Zhao et al. 2009). In addition, C3H10T1/2 cells in osteogenic medium synthesize BMP-2 and 
induce Runx2 expression by autocrine signaling (Phimphilai et al. 2006). 
Conversely, C2C12 are committed to a myogenic lineage and express myogenic markers such 
as MyoD. Unlike mesenchymal and osteoblastic cells, C2C12 cells that start to express osteogenic 
markers only in response to BMP-2, which makes them a valuable model for the investigation of 
signaling via BMP-2 receptors (Heining et al. 2011). However, we could not observe induction of 
osteogenesis in C2C12 by pBMP-2, neither in solution nor in substrate-conjugated form, indicating 
that pBMP-2 is probably insufficient to induce BMP-2 receptor-mediated signaling. In our point of 
view, this raises an important question concerning “BMP-2 mimetic” properties of pBMP-2. 
 
Based on these data, we suggest that expression of osteogenic markers in mesenchymal and 
osteoblastic cells may be induced by synergistic effects between adhesive properties of used 
materials, osteogenic medium and autocrine signaling, but cannot be fully attributed to the effect of 
the BMP-2 peptide (Fig.V-9). This could explain why C2C12 cells, which do not express 
osteogenic markers in absence of proper BMP-2 stimulation, could adhere and proliferate on BMP-
2 peptide grafted surface, but did not express osteogenic markers. 
We conclude that, although pBMP-2 seems to have favorable effect on osteogenic 
differentiation, the ability of the BMP-2 peptide to mimic BMP-2 protein osteoinductive function 
by acting via BMP-2 receptors should be confirmed in further studies.  
 
160 
 
 
Figure V-9. Model of osteogenesis induction by pBMP-2-presenting substrates. The increase in expression 
of osteogenic markers in mesenchymal and osteoblastic cells may be induced by synergistic effects between 
biochemical and mechanical properties of used materials, osteogenic medium, and autocrine signaling. 
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CHAPTER VI – Three-dimensional myoblast 
tissues fabricated by cell-accumulation method 
 
  
 Althought PEM films are mostly perceived as 2D substrates, LbL deposition method can be 
also used for the construction of 3D tissue models. In this chapter, we used LbL deposition method 
to construct 3D skeletal muscle tissue models. This work has been conducted in collaboration with 
Pr Mitsuru Akashi and Dr Michiya Matsusaki from Osaka University.
 
VI.A. ARTICLE SUMMARY
Muscle tissue is characterized by a complex three
muscle fibers surrounded by an extracellular matrix. One of the current challenges in muscle tissue 
engineering is to develop techniques for  constru
Different methods are currently being used, among them hydrogel scaffolds and cell sheet
based techniques; all of the methods present certain advantages, but also drawbacks.
cell sheet-based tissue engineering has 
cell sheets.  
Recently, a new technology allowing fast and relatively simple construction of thick 3D 
tissues using LbL deposition method 
technique”, consists in coating the cells with (FN/G)
substrate to form multilayered structures 
fabrication of approximately 8L of 3
of incubation (Nishiguchi et al. 2011)
In this work, we used cell-
tissue models. The multilayered tissues were constructed in the inserts with porous bottom to 
provide two-sided medium supply to thick multilayers 
 
Figure VI-1. Construction of C2C12 multilayered tissues by cell
illustration of C2C12 multilayered tissue construction by cell
(F$/G)4F$ nanofilms and seeded into 24
supply. 
 
As expected, the thickness increased with increasing cel
layers was 1 layer (1L) for 10
5 
seeded cells, 5L for 5 x 10
 
 
-dimensional (3D) organization of aligned 
ction of 3D muscle tissues. 
limitations due to complicated manipulation of the fragile 
has been developed. The method, called “cell
4FN films and putting them together onto a 
(Nishiguchi et al. 2011). The method allowed successful 
D tissues made of human dermal fibroblasts
. 
accumulation method for rapid construction of 3D skeletal muscle 
(Fig. VI-1).  
-accumulation method. 
-accumulation technique. Cell are coated by 
-well inserts with porous bottom allowing two
l number. The estimated number of 
5 
cells and 10L for 10
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 For instance, 
-accumulation 
 after only one day 
 
Schematic 
-sided medium 
6
 cells. Seeding more 
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cells (2 x 10
6
) did not lead to the formation of a homogeneous cell multilayer and induced the 
formation of aggregates. This phenomenon seems to be related to nutrient supply and may be 
overcome by creating a vascular network within the constructs. 
Actin stress fiber formation and microtubular network were detected in 1L, 5L and 10L 
constructs, indicating that the cells were able to bind to the extracellular adhesion ligands and 
reorganize their cytoskeleton within FN/G matrix. Fibronectin labeling revealed the fibrillar 
network surrounding the cells: these fibers may include FN secreted by the cells, as the total FN 
was labeled.  
The number of proliferating cells was evaluated after 24h of culture. It decreased with 
increasing number of layers. In all the constructs, proliferating cells were detectable mostly in the 
lower part of the multilayer.  
Next, we compared differentiation capacity of the constructs made of FN/G-coated or non-
coated cells. Expression of nuclear myogenin was detected after 1 day of differentiation in 1L and 
5L constructs made of both coated and non-coated cells, but only cytoplasmic myogenin was found 
in 10L constructs. After 2 more days of differentiation, presence of myotubes and troponin T expression 
were detected in 1L and 5L constructs made of both coated and non-coated cells. However, 
differentiated 10L constructs could not be analyzed because of their partial detachment from the 
periphery and aggregation in the center. We hypothesize that such behavior is due to higher 
contractile forces in more populated 10L tissues.   
Analysis of myotube width and length revealed the advantage of FN/G coating for the 
formation of 3D skeletal muscle models, as the myotubes were thicker and wider in FN/G-coated 
constructs compared to non-coated ones. In addition, 5L coated constructs better preserved their 
thickness over time.  
Such muscle constructs fabricated by cell-accumulation method can become a useful model 
system to study myogenic differentiation in 3D. Because in vivo muscle environment can vary in 
matrix composition depending on muscle type, location and individual variability, cell coating can 
be additionally adjusted to better mimic specific muscle ECM.  
Our approach makes it possible to rapidly form 3D muscle tissues and is promising for the in 
vitro construction of physiologically relevant skeletal muscle tissue models. 
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Abstract 
One of the current challenges in muscle tissue 
engineering is to develop techniques for 
construction of three-dimensional (3D) muscle 
tissues. Muscle tissue is characterized by a 
complex 3D organization of aligned muscle 
fibers surrounded by an extracellular matrix 
(ECM). In the present work, we used a “cell-
accumulation method” to fabricate 3D 
multilayered muscle constructs. The method 
consists in coating myoblasts cells with 
fibronectin-gelatin (FN/G) nanofilms 
mimicking the ECM before seeding them onto 
a substrate where the cells self-organize. We 
performed the buildup of up to 10 layers (~40 
µm thick) myoblast constructs and analyzed 
their structure. We demonstrated that the 
thickness of the constructs depends on the 
number of seeded cells. We also induced 
myogenic differentiation and followed the 
expression of the myogenic markers myogenin 
and troponin T in the constructs made of either 
FN/G-coated or non-coated cells. The 3D 
tissues expressed myogenin after 1 day of 
culture in differentiation medium and formed 
multinucleated myotubes after 3 days. Our 
approach makes it possible to rapidly build 3D 
muscle tissues and is promising for the in vitro 
construction of skeletal muscle tissue models. 
1. Introduction 
Skeletal muscle tissue engineering holds 
promise for the replacement of muscle after an 
injury or a trauma and for the treatment of 
muscle diseases. In vitro engineered muscle 
tissue models may also find use for drug 
screening or for the examination of the 
functional effects of patient-specific 
mutations.  
The process of muscle formation requires that 
muscle precursor cells (myoblasts) proliferate, 
differentiate and fuse together to form 
multinucleated myotubes. The development of 
skeletal muscle is known to strongly depend 
on the interaction of muscle cells with their 
surrounding extracellular matrix (ECM). 
Mature skeletal muscle has a complex three-
dimensional (3D) organization of aligned 
muscle fibers surrounded by ECM. Skeletal 
muscle ECM consists of the basal lamina that 
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surrounds individual myofibers and of 
interstitial connective tissue 
1; 2; 3
. Skeletal 
muscle basal lamina contains type IV collagen, 
laminin and heparin sulfate proteoglycans. The 
interstitial connective tissue consists mostly of 
collagens type I, III and V. Fibronectin is 
detected in both of these compartments 
4
. 
One of the current challenges in muscle tissue 
engineering engineering is to construct 3D 
well-organized muscle tissues. Another 
important challenge consists in vascularizing 
such engineered tissues, since blood supply is 
necessary to bring nutritive elements and 
oxygen to the cells in thick constructs 
5
. The 
most commonly used method for 3D muscle 
tissue construction consists in myoblast 
association to polymeric scaffolds. 
Some scaffolds made of synthetic materials 
have been developed 
6; 7; 8
. Levenberg et al. 
have used a polymer scaffold composed of 
50% poly- (L-lactic acid) (PLLA) and 50% 
poly(lactic-glycolic) acid (PLGA) to construct 
a prevascularized skeletal muscle 3D 
constructs by co-culturing myoblasts, 
endothelial cells and fibroblasts 
8
. This 
scaffold was also used to evaluate the effect of 
the stiffness on myoblasts. The results 
indicated that compliant scaffolds were 
insufficient to withstand cell forces, while 
excessively firm scaffolds could not lead to 
parallel oriented myotube organization 
9
.  
However, natural matrices such as collagen 
gels 
10
, matrigel 
11; 12
 or fibrin gels 
13
 present 
advantages compared to synthetic scaffolds, 
because they possess cell adhesion ligands that 
can interact with integrins and thus naturally 
allow cell anchorage.  In addition, some of the 
scaffolds, e. g. fibrin gels, have the capacity to 
bind specifically many growth factors 
14
.  
 Another widely used method to create 3D 
muscle constructs is cell sheet-based tissue 
engineering. A thermoresponsive polymer 
poly(N-isopropylacrylamide) (PIPAAm), 
grafted on a cell culture substrate, allows 
confluent cells to be detached as a single cell 
sheet and to create scaffold-free 3D tissues by 
layering multiple cell sheets 
15; 16
. Sasagawa et 
al. developed prevascularized 3D tissues using 
human umbilical vein endothelial cells 
(HUVECs) sandwiched between two myoblast 
sheets 
17
. Recently, myoblast sheets with well-
aligned orientation were fabricated to create 
3D oriented myoblast and myotube constructs 
18
. However, this method has limitations due to 
complicated manipulation of the fragile cell 
sheets  
A new technology allowing fast and relatively 
simple construction of thick 3D tissues have 
recently been developed. The method called 
“cell-accumulation technique” consists in 
coating the cells with (FN/G)4FN films and 
putting them together onto a substrate to form 
multilayered structures 
19
. Nanometer-sized 
fibronectin-gelatin (FN/G) films prepared by 
layer-by-layer (LbL) assembly 
20
 provide the 
cells with an “artificial ECM” and allow the 
self-organization of the cells into 3D 
constructs. As measured by Quartz Crystal 
Microbalance with Dissipation Monitoring 
(QCM-D) on a phospolipid bilayer, the 
thickness of such films is less than 10 nm 
21
.The method allowed successful fabrication 
of approximately 8L of 3D tissues made of 
human dermal fibroblasts after only one day of 
incubation 
19
. Furthemore, vascularized tissues 
were obtained by a sandwich culture of 
endothelial cells between fibroblasts 
assembled by cell-accumulation technique 
19
. 
In this work we report rapid construction of 
3D skeletal muscle tissue models using cell-
accumulation method. By assembling FN/G-
coated C2C12 myoblasts, we were able to 
build up to 40 µm thick 3D constructs that 
expressed myogenin after 1 day of culture in 
differentiation medium and formed 
multinucleated myotubes after 3 days. Our 
approach makes it possible to rapidly form 3D 
muscle tissues and is promising for the in vitro 
construction of physiologically relevant 
skeletal muscle tissue models. 
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2. Materials and Methods  
2.1. Cell culture 
C2C12 cells (from ATCC, used at passages 5-
15) cultured in growth medium (GM) 
composed of Dulbecco’s modified Eagle’s 
medium (DMEM)/F12 medium (1:1; Gibco, 
Invitrogen, Cergy-Pontoise, France) 
supplemented with 10% fetal bovine serum 
(PAA Laboratories, Les Mureaux, France) 
containing 10 U/mL of penicillin G and 10 
µg/mL of streptomycin (Gibco, Invitrogen, 
Cergy-Pontoise, France). Cells were 
subcultured prior to reaching 60–70% 
confluence (approximately every 2 days). Cell 
were differentiated in a differentiation medium 
(DM) composed of DMEM/F12 (1:1) 
supplemented with 2% horse serum (PAA 
Laboratories, Les Mureaux, France) and 
antibiotics.  
2.2. Fabrication of multilayered structures 
The cells were detached from culture dishes 
using trypsin 0,25% EDTA 0,02% and washed 
twice with the GM. After resuspending the 
cells in Tris-HCl buffer (Tris-HCl 50 mM pH 
7,4), the cells were subsequently incubated for 
1 min using a Microtube Rotater with 0,04 
mg/mL fibronectin (FN, Sigma–Aldrich, St. 
Louis, USA) or gelatin (G, Wako Pure 
Chemical Industries, Osaka, Japan) solutions 
in Tris-HCl buffer, then centrifuged at 200 g 
for 1 min, and the supernatant was gently 
removed by pipetting. After each FN or G 
deposition step the cells were rinsed in Tris-
HCl buffer for 1 min using a Microtube 
Rotater, followed by centrifugation. When 
(FN/G)4FN nanofilms were formed, the cells 
were resuspended in GM and 300 µl of cell 
suspension containing desired cell number 
(10
5
, 5 x 10
5
 or 10
6
 cells) were deposited into 
24-well inserts with a semipermeable 
membrane (Corning 3470, 0,4 µm pore size) 
coated with FN and placed into 24-well plates. 
For inserts coating, 100 µl of 0,04 mg/mL FN 
solution was deposited into the inserts and 
incubated at 37°C for 30 min, then rinsed once 
with Tris-HCl buffer. One milliliter of GM 
were added in 24-well plate, respectively, 
outside the inserts. The cells were incubated 
for 2 hours at 37°C, then another 1 mL of GM 
was added to 24-well plate to connect the 
media between the inside and the outside of 
the insert (Fig.1A).  
2.3. Histological analysis 
The tissues were rinsed with phosphate 
buffered saline (PBS) solution, then incubated 
in 10% formaldehyde solution at room 
temperature for 30 min. The samples were 
then maintained in PBS solution before being 
mounted in paraffin-embedded blocks. These 
paraffin-embedded blocks containing layered 
tissues were cut into 3–4 µm thick sections. 
The specimens were then stained with 
hematoxylin and eosin (H&E).  
2.4. Immunofluorescence analysis 
Cells were first rinsed in phosphate-buffered 
saline (PBS) and fixed in 4% formaldehyde for 
30 min at room temperature before being 
permeabilized in 0.5% Triton X-100 for 5 min. 
After rinsing with PBS the samples were 
incubated for 1 h in 1% bovine serum albumin 
(BSA) in TRIS-buffered saline (TBS, 50 mM 
TRIS, 150 mM NaCl, 0.1% NaN3, pH 7.4). 
Actin was labeled with phalloidin-TRITC 
(1:800, Sigma) for 30 min. Cell nuclei were 
stained with Hoechst 33342 (Invitrogen) at 5 
µg/ml for 10 min. After incubation with the 
primary antibodies diluted in 1% BSA in TBS 
for 1h at RT the cells were washed three times 
with TBS and incubated for 2h at RT with the 
secondary antibodies. Primary antibodies: 
rabbit anti-myogenin antibody (1:50) (Tebu-
Bio), mouse anti-troponin T (1:50) (Sigma), 
mouse anti-tubulin (1:200) (Sigma) and rabbit 
anti-fibronectin (1:100, Sigma). Secondary 
antibodies: goat anti-mouse Alexa-Fluor 488- 
and Alexa-Fluor 568-conjugated antibodies 
and goat anti-rabbit Alexa-Fluor 568- and 
Alexa-Fluor 647-conjugated antibodies 
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(Invitrogen) were used at 1:1000. Confocal 
laser scanning microscopy (CLSM) 
observations were performed using a Zeiss 
LSM 700 confocal microscope.  
2.5. Cell proliferation and differentiation 
Cell proliferation was quantified by a EdU (5-
ethynyl-2'-deoxyuridine) assay (Click-iT EdU 
Imaging Kit, Invitrogen). Briefly, the cells 
were incubated with EdU diluted at 1/1000 in 
cell culture medium for 1h. The detection was 
carried out following the manufacturer 
instructions. At the end, nuclei were counter-
stained with Hoechst 33432 (Invitrogen). The 
images of EdU and Hoechst-labeled nuclei 
were taken using a Zeiss LSM 700 confocal 
microscope  
2.6. Statistics 
Images were analyzed with ImageJ software (v 
1.44p,NIH, Bethesda). Data are reported as 
means ± standard deviation. For thickness 
quantification, 20 measurements for each 
sample were collected. For quantification of 
myotube width, 20 myotubes (3 measurements 
per myotube) were analyzed. For myotube 
length, 50 myotubes were analyzed. The 
differentiation was characterized by the fusion 
index, which is a ratio of the nuclei contained 
in myotubes reported to the total number of 
nuclei 
22
. Statistical comparisons were 
performed using SigmaPlot Version 11.0 
software and based on either Student’s t-test or 
on analysis of variance (ANOVA) followed by 
an appropriate pairwise comparison. 
Statistically different values (p < 0.05 was 
considered significant) are reported on the 
figures. 
3. Results and discussion 
3.1. Build-up of myoblast multilayered 
structures  
The multilayered tissues were constructed by 
cell-accumulation technique using the inserts 
with porous bottom to provide two-sided 
medium supply to thick multilayers (Fig. 1A). 
Construction of the tissues was followed by 
phase contrast microscopy. On the image from 
the top many round cells are visible after 2h of 
seeding, indicating that the tissues were not 
formed yet (Fig. 1B), especially on the 
samples with more cells seeded per insert (5 x 
10
5
 or 10
6
 cells). After 24h, no more round 
cells can be detected, showing that the cells 
spread and form homogeneous multilayers. To 
clarify the relationship between the number of 
seeded cells and the number of layers 
obtained, we evaluated the morphology of the 
constructs by histological analysis (Fig. 1C). 
As expected, the thickness increased with 
increasing cell number. These data are in 
agreement with the previous study 
19
. The 
estimated number of layers was 1 layer (1L) 
for 10
5 
seeded cells, 5L for 5 x 10
5 
cells and 
10L for 10
6
 cells. We also performed 3D 
reconstruction of the constructs stained for 
actin and nuclei using confocal microscopy 
(Fig. 1D). All three constructs presented 
homogeneous surface and their thickness 
increased with the number of seeded cells, 
consistently with the results from histological 
analysis. Because histological analysis caused 
partial detachment of 10L tissues (probably 
during the cutting step), we quantified the 
thickness from intact cross-sections obtained 
by confocal microscopy. The thickness of 1L, 
5L and 10L tissues after 24h of culture in GM 
were approximately 12 µm, 22 µm and 37 µm, 
respectively (Fig. 1E). Interestingly, the 
maximum thickness (37 µm for 10L) was 
about the same as described in the previous 
study 
19
. Seeding more cells (2 x 10
6
) did not 
lead to the formation of a homogeneous cell 
multilayer and induced the formation of 
aggregates (Fig. S1). These inhomogeneous 
samples were discarded from the further study. 
This phenomenon seems to be related to 
nutrient supply and may be overcome by 
creating a vascular network within the 
constructs. 
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Figure 1. Construction of C2C12 multilayered tissues by cell-accumulation method. (A) Schematic 
illustration of C2C12 multilayered tissue construction by cell-accumulation technique. Cell are coated by 
(F$/G)4F$ nanofilms and seeded into 24-well inserts with porous bottom allowing two-sided medium 
supply. (B) Phase contrast microscopy observations from the top of 1L, 5L and 10L C2C12 cell constructs 
after 2h and 24 h of culture in GM. (C) Histological analysis of C2C12 multilayered tissues: phase contrast 
microscopy observations of hematoxylin-eosin stained cross-sections in Z of 1L, 5L and 10L C2C12 cell 
constructs after 24 h of culture in GM. (D) 3D reconstruction of 320 x 320 µm fragments of multilayered 
tissues and cross-sections in Z done using confocal microscopy. Actin (red) and nuclei (blue) are stained. (E) 
Quantification of the 1L, 5L and 10L thickness. Error bars correspond to SD, * : p < 0.05. 
 
3.2. Cytoskeleton organization and 
proliferation 
The cells are mechano-sensors that actively 
sense their environment. Cell binding to ECM 
promotes cytoskeleton reorganization and 
influences cell proliferation through cell 
surface receptors, especially integrins 
23; 24
. To 
analyze cell organization within the FN/G 
matrix, we visualized actin cytoskeleton, 
microtubules, nuclei and total FN after 24 h of 
culture (Fig. 2A). Actin stress fiber formation 
and microtubular network were detected in 1L, 
5L and 10L constructs, indicating that the cells 
were able to bind to the extracellular adhesion 
ligands and reorganize their cytoskeleton 
within FN/G matrix. Fibronectin labeling 
revealed the fibrillar network surrounding the 
cells, as previously described 
25
. These fibers 
may include FN secreted by the cells, as the 
total FN was labeled. Interestingly, the cells in 
10L constructs had more elongated nuclei, as 
compared to 1L and 5L constructs. Actin stress 
fibers were thinner and, like FN fibers, 
oriented in parallel. This may be due to the 
particularities of cell organization in thick 3D 
constructs compared to flatter constructs. It 
was reported in comparative 2D vs 3D cell 
adhesion studies that the cells exhibited more 
elongated shape with less stress fibers on the 
arrays of large flexible micropillars, as 
compared to the cells spread on flat surfaces 
26; 
27
.  
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Figure 2. Cytoskeleton and matrix labelling of C2C12 multilayered tissues. (A) Confocal images of actin 
(red), beta-tubulin (green), fibronectin (magenta) and nuclei (blue) staining of 1L, 5L and 10L C2C12 cell 
constructs after 24 h of culture in GM. (B) Cell proliferation: staining of EdU (red) associated to a 
fluorescent labeling of total nuclei (blue). Upper images: view from the top; lower images: and cross-
sections in Z.  
Cell proliferation in GM was evaluated after 
24h in GM using EdU incorporation test (Fig. 
2B). The number of proliferating cells 
decreased with increasing number of layers. In 
all the constructs, proliferating cells were 
detectable mostly in the lower part of the 
multilayer. This can be explained by the 
stiffness of the membrane, because 
proliferation is generally low in soft matrix 
and high in stiff matrix 
28; 29
. Proliferation of 
C2C12 myoblasts is also increased on stiff 
substrates as compared to soft ones 
30; 31; 32
. 
Thus, in the 10L thickest construct where only 
a small fraction of total myoblasts are in 
contact with the membrane, the cells undergo 
faster withdrawal from the cell cycle.  
3.3. Myogenic differentiation of myoblast 
multilayered structures  
C2C12 myoblasts are a well-known model for 
the in vitro study of myogenic differentiation 
due to their ability to reproduce processes that 
take place during in vivo differentiation of 
skeletal muscle progenitors 
33; 34
. For the 
construction of functional 3D skeletal muscle 
tissue models in vitro, the formation of 
myotubes is a crucial step. 
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Figure 3. Comparison of C2C12 multilayered tissues prepared by cell-accumulation method from F7/G-
coated and non-coated cells at early time of differentiation. (A) Phase contrast microscopy observations 
from the top of 1L, 5L and 10L C2C12 cell constructs after 48 h of culture (24h in GM then 24h in DM). (B) 
Cross-sections in Z with thickness indicated done using confocal microscopy. Actin (red) and nuclei (blue) 
are stained. (C) Quantification of the thickness. Error bars correspond to SD, * : p < 0.05. (D) Myogenin 
(green) and nuclei (blue) labelling of  C2C12 cell constructs after 24h in GM and 24h in DM.  
 
We studied the ability of the cells to 
undergo myogenic differentiation in 
multilayered constructs made of FN/G-coated 
cells, but also compared them to the constructs 
made of non-coated cells. When observed 
from the top at Day 1 of differentiation (24h in 
GM then 24h in DM), no difference in cell 
deposition between coated and non-coated 
constructs could be detected (Fig. 3A). 
However, the analysis of cross-sections 
revealed the difference of the thicknesses, 
although the same cell number was seeded in 
the beginning (Fig. 3B and C). Thickness was 
higher for 1L, 5L and 10L constructs made of 
FN/G-coated cells, compared to non-coated 
ones. The difference increased with increasing 
number of layers, reaching about 10 µm for 
10L constructs. These results demonstrate the 
advantage of “artificial ECM” provided by 
FN/G coating for maintaining 3D structure.  
Next, we quantified the expression of the 
transcription factor myogenin at early time of 
the differentiation process (Day 1). Myogenin 
is a marker for entry of myoblasts into the 
differentiation pathway 
33
. Nuclear myogenin 
expression was detected in 1L and 5L 
constructs made of both coated and non-coated 
cells, but only cytoplasmic myogenin was 
found in 10L constructs (Fig. 3D). Thus, 
although thickness of the constructs made of 
FN/G-coated cells was higher, we could not 
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detect any advantage for differentiation 
potential at early stage of myogenesis.  
We allowed the constructs to differentiate for 2 
more days, until formation of multinucleated 
myotubes could be observed, and performed the 
staining for troponin T, which is a part of 
troponin-tropomyosin complex involved in 
muscle contraction. Presence of myotubes and 
troponin T expression were detected in 1L and 
5L constructs made of both coated and non-
coated cells (Fig. 4A). The myotubes were 
mostly located in the upper part of the 
constructs. Unfortunately, differentiated 10L 
constructs could not be analyzed because of 
their partial detachment from the periphery 
and aggregation in the center. We hypothesize 
that such behavior is due to higher contractile 
forces in more populated 10L tissues.   
We further analyzed the thickness of the 
constructs, fusion index, as well as myotube 
width and length, to evaluate the functional 
properties of the resulting tissues. There was 
no difference of tissue thickness for 1L 
constructs made of coated or non-coated cells, 
but 5L constructs made of FN/G-coated cells 
were 5 µm thicker than those made of non-
coated cells (Fig. 4B). The fusion index, which 
is a ratio of the nuclei contained in myotubes 
reported to the total number of nuclei, was of 
9% for 1L coated and 5L non-coated 
constructs and of 17% for 1L non-coated and 
5L coated constructs (Fig. 4C). Myotubes were 
slightly larger in non-coated constructs for 1L 
(11,4 µm for coated and 13,6 µm for uncoated) 
and about 2 times larger in FN/G-coated 
constructs for 5L (8,9 µm for uncoated and 
14,4 µm for coated) (Fig. 4D). Myotubes 
length in 5L FN/G-coated constructs was also 
higher than for 5L non-coated constructs (Fig. 
4E). Thus, we reveal the advantage of FN/G 
coating for the formation of 3D skeletal 
muscle models in vitro. Interestingly, there 
was more fusion for non-coated 1L and FN/G-
coated 5L constructs, demonstrating 
complexity of cell response to environmental 
cues (substrate chemistry, mechanical and 
biochemical properties) in 2D vs 3D systems. 
In 2D, myoblasts were shown to preferentially 
differentiate on either stiffer substrates 
30; 32
 or 
on softer substrates functionalized with 
adhesion ligands 
31
. The particularities of 
myoblast differentiation in 3D are not fully 
understood. Recently, myoblast interaction 
with 3D fibrin-based matrix was studied 
13
. 
Differentiation kinetics were faster in 3D 
system, but the pattern of myogenin 
expression, an early differentiation marker, did 
not differ between 2D and 3D. These data are 
consistent with our observations. 
Muscle constructs fabricated by cell-
accumulation method can become a useful 
model system to study myogenic 
differentiation in 3D. The thickness of the 
coating (~10 nm) 
21
 is close to the thickness of 
muscle basement membrane (~18 nm) 
35
. 
Because in vivo muscle environment can vary 
in matrix composition depending on muscle 
type, location and individual variability, cell 
coating can be additionally adjusted to better 
mimic specific muscle ECM. 
Conclusion 
Here, we performed the buildup of up to 10L 
(~40µm) 3D myoblast multilayered constructs 
using murine cell line. We analyzed their 
structure and expression of myogenic markers. 
The thickness of the constructs could be 
successfully controlled by varying the number 
of seeded cells. We also induced myogenic 
differentiation and followed the expression of 
myogenic markers myogenin and troponin T in 
the constructs made of either FN/G-coated or 
non-coated cells. The 3D tissues expressed 
myogenin after 1 day of culture in 
differentiation medium and formed 
multinucleated myotubes after 3 days.  
Our approach makes it possible to rapidly 
build 3D muscle tissues and is promising for 
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the in vitro construction of physiologically 
relevant human skeletal muscle tissue models. 
3D muscle constructs with controlled cell 
organization may help to answer fundamental 
questions of muscle development by 
mimicking skeletal muscle in vivo 
environment. Secondly, multilayered muscle 
tissues may be used as an artificial tissue 
model for drug response and toxicity assays in 
pharmaceutics. Moreover, pathological muscle 
tissue models may be created using this 
approach to help investigation and treatment of 
muscle diseases. Finally, development of 3D 
muscle constructs would be one more step 
towards in vitro engineering of skeletal muscle 
for the replacement of muscle due to an injury 
following a surgery, due to a trauma or 
paralysis.  
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Figure 4. Myogenic differentiation of C2C12 multilayered tissues prepared by cell-accumulation method 
from F7/G-coated and non-coated cells. (A) Confocal images of troponin T (green), actin (red) and nuclei 
(blue) staining of 1L and 5L C2C12 cell constructs after 3 days of differentiation. Upper images: view from 
the top; lower images: and cross-sections in Z. (B) Quantification of fusion index. (C) Quantification of 
thickness of the constructs. (D) Quantification of myotube width. (E) Quantification of myotube length. Error 
bars correspond to SD, * : p < 0.05. 
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Figure S1. Construction of 20L tissues by cell-accumulation method. (A) Phase contrast microscopy 
observations from the top after 24 h of culture in GM. (B) Histological analysis: phase contrast microscopy 
observations of hematoxylin-eosin stained cross-sections in Z after 24 h of culture in GM. 
 
 
 
 
  
20L
100 µm
20L
A B
50 µm
176 
 
 
 
 
 
 
 
 
 
 
CHAPTER VII – Conclusions and directions for 
future research 
 
  
177 
 
VII.A. CONCLUSIONS AND PERSPECTIVES OF THE THESIS WORK 
In this work, we used layer-by-layer assemblies for two goals. The first consisted in the 
development of multifunctional biomimetic thin films for the control of skeletal muscle cell fate on 
2D substrates. We used layer-by-layer films made of polypeptides, which can be stiffened by 
chemical cross-linking and can be specifically functionalized by grafting of biomimetic peptides 
onto their surface. We showed that such films with tunable mechanical and biochemical properties 
can be used as a model substrate to study the specific effects of each type of stimuli, or their 
synergy, on cell adhesion and cell fate. In the second, we used LbL assemblies for the construction 
of 3D skeletal muscle microtissues by “cell-accumulation technique”. The method consists in 
coating the cells with nano-films made of fibronectin and gelatin using layer-by-layer assembly 
method and putting them together onto a substrate to form multilayered structures. 
 
Interplay of mechanical and biochemical properties 
In the first part, four different types of PEM films, with or without cross-linking and with or 
without the RGD-peptide, allowed investigation of the effect of mechanical and biochemical signals 
and their combinations on important events of myogenesis. Mechanical and biochemical properties 
could be either combined or presented separately. Decoupling of material’s mechanical and 
biochemical properties revealed that these stimuli differentially influence cellular processes. Soft 
films with RGD peptide appeared as the most appropriate for myogenic differentiation of C2C12 
myoblasts, while stiff films induced enhanced migration and proliferation and inhibited myogenic 
differentiation. Our model allowed highlighting how important events in myogenesis such as 
adhesion, migration proliferation, myogenin expression and fusion are regulated by substrate 
elasticity and presence of an adhesive ligand. These results suggest that thin films with tunable 
mechanical and biochemical properties may be a useful tool for biophysical studies of muscle 
progenitors on controlled 2D microenvironments as well as for their expansion and differentiation 
in vitro.  
In addition, we combined the peptide-grafted films with substrate microtopography, showing 
that these films can coat microstructured materials. Such approach is promising for the development 
or multifunctional materials that recapitulate physical, biochemical but also microtopography cues.  
Peptide-grafted films for specific targeting of cell surface receptors 
Besides well-studied peptides such as RGD peptide, which interact with a wide range of 
integrin receptors, specific targeting of other types of receptors is important for both understanding 
of their roles and for the control of the cell fate via these receptors.  
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In the second part of the work, we selected from the literature specific peptide sequences 
derived from laminin-α2 chain. One is targeting syndecan-1 cell surface receptors and the other 
dystroglycan. Both proteins are important for skeletal muscle functions. We performed PEM films 
functionalization with the peptides (or their combinations with RGD peptide) and focused on the 
sequence of events involved in C2C12 cell differentiation including early adhesion, migration, 
proliferation, differentiation and fusion of myoblast into myotubes. 
The results showed that cell stimulation by peptide-grafted films induced changes in cell 
morphology, cytoskeletal organization, migration and affected cell proliferation and myogenic 
differentiation. We demonstrated that PEM films may serve a tool to investigate cell signaling via 
non-integrin cell surface receptors. By combining materials science/chemistry and cell biology 
approaches, it is possible to target specific cell surface receptors. This represents a new 
experimental approach as compared to the more “traditional” biological techniques, which consist 
in changing the normal expression level of a protein to study its function (either by overexpression 
or knock-down). In addition, it is possible to combine two or more ligands targeting different 
receptors in order to investigate their combined or synergistic effects.  
PEM films grafted with GF-derived peptides 
Besides adhesion ligands, PEM films can also serve for the presentation of GF-derived 
peptides. A BMP-2 osteogenic peptide has been identified and its osteoinductive activity was 
demonstrated by several studies. 
In the third part of the work, we evaluated the capacity of BMP-2 derived peptide to induce 
the osteogenic differentiation of C2C12 myoblasts. Presented by the film surface, BMP-2 peptide 
promoted cell adhesion and supported cell proliferation over 3 days. However, BMP-2 peptide, 
presented alone or with RGD peptide, was not sufficient to induce ALP expression of C2C12 
myoblasts. Also, no effect on either ALP expression or on Smad pathway activation was observed 
when the peptide was presented in solution at different concentrations.  
We analysed the presentation modes, cellular models and the effects of the peptide in different 
studies. We hypothesize that expression of osteogenic markers in mesenchymal and osteoblastic 
cells may be induced by synergistic effects between adhesive properties of used materials, 
osteogenic medium and autocrine signaling, but may not be fully attributed to the effect of the 
BMP-2 peptide. The ability of the BMP-2 peptide to mimic BMP-2 protein osteoinductive function 
by acting via BMP-2 receptors should be confirmed in further studies.  
3D muscle tissues 
In the last part, we performed the buildup of 3D thick constructs using cells coated with LbL 
protein films “cell-accumulation method”, and analyzed their structure and expression of myogenic 
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markers. The thickness of the constructs could be successfully controlled by varying the number of 
seeded cells. We also induced myogenic differentiation and followed the expression of myogenic 
markers myogenin and troponin T. 
Such muscle constructs fabricated by cell-accumulation method can become a useful model 
system to study myogenic differentiation in 3D. Because in vivo muscle environment can vary in 
matrix composition depending on muscle type, location and individual variability, cell coating can 
be additionally adjusted to better mimic specific muscle ECM.  
Our approach made it possible to rapidly build 3D muscle tissues and is promising for the in 
vitro construction of physiologically relevant skeletal muscle tissue models. Such multilayered 
muscle tissues may be used as an artificial tissue model for drug response and toxicity assays in 
pharmaceutics. Finally, development of 3D muscle constructs is promising for in vitro engineering 
of skeletal muscle for the replacement of muscle due to an injury following a surgery, due to a 
trauma or paralysis.  
 
VII.B. DIRECTIONS FOR THE FUTURE RESEARCH 
Development of the materials with controlled properties is important for the field of 
implantable materials, drug delivery and tissue engineering. PEM films appear as a new type of 
biomaterial with controlled physical and chemical/biochemical properties and able to trigger a 
specific cellular response. This can be used for the controlled presentation of bioactive molecules to 
cells and for unraveling the subtle interplay between cell adhesion receptors, growth factor 
receptors and mechano-transduction pathways.  
Design of specific receptor-targeting biomaterials  
Targeting a particular cell surface receptor is important to activate specific signaling 
pathways. We demonstrated that PEM films can be functionalized with different bioactive peptides 
or their combinations. Besides the sequences used in this study, other sequences can be selected 
from the literature to target another cell receptors. By carefully choosing peptide sequences, the 
films may be used for stem cell maintenance in undifferentiated state, for cell amplification or to 
induced cell differentiation. For instance, maintaining these cells in a stem state is an important 
challenge in muscle tissue engineering; films grafted with a peptide sequence targeting syndecan-4, 
which is a marker of muscle satellite cells, may be explored for satellite cell culture. Such 
sequences derived from laminin-α1 chain are already available (Suzuki et al. 2003a).  
The peptide-functionalized films may be used for the studies of pathological cell models. For 
instance, dystroglycan interaction with laminin-α2 chain is crucial for maintaining of the 
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sarcolemma integrity and of the function of skeletal muscle. L2dystro-grafted films may be 
explored for culture of dystrophic myotubes or for the evaluation of the possibility of L2dystro 
utilization as a therapeutic agent in myopathies. 
Finally, this novel approach can be applied to a variety of cell types. Besides its role in 
skeletal muscle, dystroglycan is also associated with myelinogenesis in peripheral nerves (Masaki et 
al. 2003). Films functionalized with L2dystro peptide may be thus used for the investigation of 
molecular mechanisms and may be promising for the development of effective treatments for 
human peripheral neuropathies. 
Combination with physical properties 
Substrates allowing independent adjustment of physical and biochemical properties of 
different parameters are needed in order to investigate the respective roles of each parameter as well 
as their synergistic effects.  
The peptide presentation by PEM films can be combined with a range of film’s stiffnesses, as 
both factors, biochemical and physical, induce cellular response and can act independently or in 
synergy. In this work, we used (PLL/PGA) films of crosslinked at two different degrees, leading to 
soft and stiff films. The control of (PLL/PGA) film cross-linking degree is challenging as these 
films are very thin (nanometer schale thickness) and have a low hydration. Other types of PEM 
films allowing a better control of the stiffness, such as (PLL/HA) films, may be used to study the 
effects of peptide presentation on the substrates of different stiffnesses.  
Towards multifunctional substrates  
Besides chemical and physical properties, material’s topographical cues are important for cell 
morphology and for collective cell organization. This is particularly important for skeletal muscle, 
which is a highly aligned tissue. In this work, we used peptide-grafted films for coating of 
microstructured PDMS, and aligned the myotubes. This approach can also be used for other 
topographies and other cell types. Creation of RGD peptide gradient using microfluidics technology 
has already been demonstrated (Almodovar et al. 2013). Creation of double gradients of two 
different peptides may be useful to explore the effects of the different peptide/peptide ratios. 
Creation of peptide micropatterns may be achieved by microprinting technology. This may allow 
investigation of the synergistic effects of cell geometry and biochemical cues.  
Such approach is promising for the development of multifunctional materials that combine 
physical, biochemical and topographic cues. 
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Development of osteogenic PEM films 
Although pBMP-2 seems to have favorable effect on osteogenic differentiation, the ability of 
the BMP-2 peptide to mimic BMP-2 protein osteoinductive function by acting via BMP-2 receptors 
remains unclear. Cellular models and experimental conditions have to be carefully controlled to 
avoid the side effects that may come from the substrate’s adhesive properties, osteogenic media or 
even cell potential to undergo osteogenesis. In this context, C2C12 cells appear to be an appropriate 
model, as these cells do not express myogenic markers in absence of BMP-2 receptor stimulation.  
Besides BMP-2 derived peptide, other osteogenic peptides are being developed, among them 
BMP-9 derived peptide (Marquis et al. 2008; Bergeron et al. 2009). These sequences can also be 
employed for PEM film functionalization.  
Osteogenic PEM films present an important potential for medical applications in orthopedics. 
The bioactive films may be coated onto a wide range of materials used as prosthesis and implants, 
and improve materials integration and bone regeneration. 
Development of 3D organized muscle tissue models 
One of the current challenges in muscle tissue engineering is to construct 3D well-organized 
muscle tissues; another important challenge consists in vascularizing such engineered tissues, since 
blood supply is necessary to bring nutritive elements and oxygen to the cells in thick constructs. 
We showed that cell-accumulation technique (Nishiguchi et al. 2011) could be used for the 
construction of thick 3D structures from skeletal myoblasts and their subsequent differentiation. 
The same group demonstrated vascularization of such tissues, based on multilayer co-culture 
system with human umbilical vein endothelial cells (HUVEC) (Nishiguchi et al. 2011). This 
method may be applied for the development of vascularized 3D muscle tissues. The alignment of 
the myofibers may be induced by culturing the 3D constructs on micropatterned substrates or by 
adding pre-aligned layers, a described recently (Takahashi et al. 2013).  
Such approach makes it possible to form 3D tissues reproducing in vivo muscle organization 
and make advances in construction of physiologically relevant human skeletal muscle tissue 
models. Moreover, pathological muscle tissue models may be created using this approach to help 
investigation and treatment of muscle diseases. 
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Abstract  
Cells respond to a variety of stimuli, including 
biochemical, topographical and mechanical 
signals originating from their micro-
environment. Cell responses to the mechanical 
properties of their substrates have since about 
14 years been increasingly studied. To this 
end, several types of materials based on 
synthetic and natural polymers have been 
developed. Presentation of biochemical 
ligands to the cells is also important to provide 
additional functionalities or more selectivity in 
the details of cell/material interaction. In this 
review article, we will emphasize the 
development of synthetic and natural 
polymeric materials with well-characterized 
and tunable mechanical properties. We will 
also highlight how biochemical signals can be 
presented to the cells by combining them with 
these biomaterials. Such developments in 
materials science are not only important for 
fundamental biophysical studies on 
cell/material interactions but also for the 
design of a new generation of advanced and 
highly functional biomaterials.  
1. Introduction 
Our body contains several types of tissues 
(skin, bone, cartilage…) whose mechanical 
and biochemical properties depend on their 
composition. Tissues are composed of cells 
embedded within an extracellular matrix 
(ECM) made of proteins, polysaccharides, and 
other bioactive molecules such as growth 
factors. The field of tissue engineering, which 
consists in recreating new tissues by means of 
a combination of engineering, cell biology and 
materials, was pioneered about 18 years ago 
by Langer and colleagues from MIT 
1
. A goal 
of biomaterials scientists is to design 
biocompatible scaffolds in which cells can 
adhere, proliferate, differentiate and synthesize 
their own matrix to regenerate tissue. 
Molecules promoting cell adhesion have 
already been included in the design of 
biomaterials, as it is known that many cells 
need to adhere for their survival 
2
.  
More recently, other parameters like 
mechanical properties of biomaterials 
3; 4
 and 
delivery of growth factors 
5
 have also been 
taken into account. On the other hand, 
biophysicists have long been studying the 
process of cell adhesion 
6; 7
 and the cell’s 
mechanical properties. More recently, cell 
aggregates and tissues have been studied 
8
. To 
this end, several characterization techniques 
have been adapted to soft biological materials, 
including micromanipulation, microrheology 
9
 
and nano-indentations.  
How the cells exert forces on to a substrate 
and how these forces are transmitted at the 
molecular level inside the cells are key 
questions, which have been and are still being 
investigated. Such questions are tackled by a 
wide range of investigators, from a cell 
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biology point of view to a mechanical point of 
view 
7; 10
.  
This has also led to the development of new 
materials that would, ideally, make possible 
independent variation in mechanical and 
biochemical properties. If surface properties of 
the materials are taken into consideration, they 
are viewed as 2D materials and cells will 
interact with them from their basal side. In the 
case of hydrogel materials, their bulk 
(volumic) properties are important, as the cells 
embedded in the hydrogel are fully surrounded 
by it. 
We are now entering a new era where the 3
rd
 
dimension is more and more taken into 
account. In this context, measurements of 
forces in 3D are starting to be measured. 
However, it is important to underline that both 
2D and 3D studies of cell/material interactions 
are required, as these studies will provide 
complementary information.  
Although the two scientific communities of 
biomaterials scientists and biophysicists have 
different goals and different experimental 
approaches, they nevertheless share a common 
interest in designing materials with well-
defined mechanical and biochemical 
properties. For biomaterials scientists, these 
may serve as new scaffolds to control cell fate 
and tissue regeneration. For biophysicists, they 
may be used as toolbox to decorticate and 
understand the specific effects of different 
environmental signals on the cell. Until 
recently, cell biologists commonly used glass 
substrates or tissue culture polystyrene 
substrates to investigate cell behavior. 
Commercial products of model basement 
membrane-like ECM such as Matrigel are also 
used and have become popular in cancer cell 
biology. Matrigel is composed of mainly 
laminin-111, collagen IV, heparan sulfate 
proteoglycan, entactin/nidogen, and various 
growth factors (fibroblast growth factor, 
transforming growth factor beta, epidermal 
growth factor, etc.) but is poorly defined. Even 
though it contains natural biomolecules, it 
cannot be used to identify the role of specific 
parameters on cell behavior and to modulate 
them in a controlled manner.  
In this review, we will be writing from a 
materials point of view. First, we will give an 
overview of the different types of materials, 
including synthetic and natural ones, which 
have been developed for their tunable 
physical/mechanical and biochemical 
properties (Table 1). 
We will focus on the advances made in the 
design of 2D and 3D polymeric materials with 
well-defined mechanical and biochemical 
properties (Figure 1). We will discuss the 
range of mechanical properties, depending on 
type and composition of the material.  
We will also present different ways of 
providing them a biochemical functionality. 
Two main strategies of functionalization are 
usually employed: covalent coupling or 
physical adsorption of the bioactive molecules 
(entire proteins, fragments or peptides). The 
coupling strategy is often required for 
synthetic materials, which do not have any 
natural interaction with biomolecules. 
Conversely, natural materials that exhibit low 
and high affinity interactions with ECM 
proteins and growth factors, can be favorably 
exploited to present these stimuli.  
The third important aspect concerns spatio-
temporal properties of the materials, especially 
spatial control of stiffness or of ligand 
presentation. For more information on these 
aspects, the reader is referred to very 
interesting recent reviews, which adopt either 
a “cell point of view” 
11
 or a “biomaterials 
point of view” 
12
.  
Finally, the paper will end with some 
concluding remarks and a short outlook.  
2. 2D and 3D materials used for 
mechano-sensitivity studies  
Polymeric materials have been developed both 
by biophysicists and biomaterial scientists. 
Controlling and modulating their biochemical 
and mechanical properties is one of the current 
challenges, ideally aimed to achieve 
simultaneous and independent control of each 
of these properties. First, we should mention 
that polymeric materials have mechanical 
properties that are somewhat difficult to 
compare, due to the various methods used to 
measure them. Each of these methods, 
including dynamic shear rheology, dynamic 
compression for hydrogels and nano-
indentations for films, is well-suited to a given 
type of material. 
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TABLE 1. Summary of the main properties of natural and synthetic materials, from 2D to 3D materials, 
which are used in mechano-sensitivity studies. This includes their physical/mechanical and biochemical 
properties. Their main disadvantages and advantages are also given.  
 
The Young’s modulus (E0) is most often 
measured by traction tests or nano-
indentations. The elastic and viscous moduli 
(G’,G”) of soft materials are rather measured 
by oscillatory shear rheology. However, a 
close look at all values measured for various 
materials indicates that E0 or G’ lie in the 
range of a few Pa to hundred MPa, depending 
on the material (Figure 2A). Indeed, this is in 
the physiological range of cell and tissue 
stiffnesses (Figure 2B). It has to be noted that, 
very often, the strategies employed for 
modulating mechanical properties also involve 
changes in the nature or density of the 
chemical bonds within the materials. 
Unfortunately, it is simply impossible to fully 
decouple both. The main strategies for creating 
ionic or/and covalent crosslinks in polymeric 
materials are summarized in Figure 3. 
Incorporation of nano-objects has also been 
shown to stiffen a polymeric material. 
However, this method has never been applied 
in the context of the 2D or 3D materials used 
for cell mechano-sensitivity studies. Here, we 
will distinguish between synthetic materials 
and natural materials, which are made of 
naturally occurring biomolecules. The main 
physical/mechanical and biochemical 
properties, advantages and drawbacks of these 
two types of materials are summarized in 
Table 1. 
2.1 Synthetic polymeric materials  
Synthetic polymers can be tuned in terms of 
composition, rate of degradation, mechanical 
and chemical properties. There are four major 
types of polymers that are used in mechano-
sensitivity studies (Figure 2 and Table 1). 
Three of them are mostly employed as 2D 
culture substrates, e.g polyacrylamide (PA), 
polydimethylsiloxane (PDMS) and 
polyelectrolyte multilayer films made of 
synthetic polyelectrolytes, whereas the fourth, 
poly(ethylene glycol) (PEG), is used as a 3D 
hydrogel with cells embedded in it. We will 
present below the design strategies for each of 
these. 
PROPERTIES NATURAL                            SYNTHETIC
2D
3D
PEM-films
Fibrin
Collagen
Hyaluronan
Alginate
PA gels
PDMS
PEG
Physical/mechanical
properties
- Viscoelasticity
- Physical architecture
- Porosity (nm to µm scale)
- Degradability (proteases)
- Pure elasticity
- No physical architecture
- Small porosity
- Non biodegradabile (unless
grafted with MMP peptides)
Biochemical
properties
- Non specific interactions
(electrostatic, H-bonds)
- Specific (natural ligands)
- Inertness
- Need grafting with ligands
Main disadvantage - Difficulty to decouple
mechanics and chemistry
- High swellability (for PEG)
- Stability over time
Main advantage -Biomimetism
(natural presence in tissues)
-Versatility of the control
IPN
Composites
201 
 
 
 
FIGURE 1. Scheme presenting the possibilities of control of the cell microenvironment using engineered 
materials : mechanical properties with typical variation in elastic moduli from few Pa to tens of MPa; 
biochemical properties obtained by adsorbing or grafting entire proteins, protein fragments as well as 
peptides; spatio-temporal properties, e.g. hydrolytically degradable materials or controlled presentation of 
ligands by nano and micropatterning. 
 
2.1.1 Polyacrylamide hydrogels 
PA gels, initially used by biologists for protein 
electrophoresis, have been used for about 14 
years for mechano-sensitivity studies 
3
. Their 
stiffness can be adjusted by varying the molar 
fraction of the bis-acrylamide cross-linker. 
Cross-linking can be induced by chemicals 
such as ammonium persulfate to trigger a free 
radical-dependent polymerization of double 
bonds (vinyl groups) in the otherwise stable 
acrylamide and bis-acrylamide monomers. 
Alternately, cross-linking can be photo-
induced (Irgacure is commonly used), leading 
to E0 in the range of 10 to 100 kPa. PA 
hydrogels are relatively simple in their 
mechanics, and have been extensively 
characterized by other traditional techniques, 
including bulk tensile loading, 
microindentation, and rheology 
3; 13
. Classic 
theory of rubber elasticity would predict that 
the elastic modulus of a polymer gel scales 
linearly with cross-linker concentration, which 
is fairly well validated by experimental 
measurements 
14
. For this reason, PA gels are 
very popular and have been extensively used 
to investigate the mechanical effects on cell 
morphology, adhesion, migration and 
differentiation in 2D cell cultures. 
4; 15; 16
 
The chemical inertness of polyacrylamide is 
one of its greatest advantages and 
disadvantages. PA doesn’t promote any 
specific cell adhesion when used as a culture 
substrate, and ligands have to be grafted to 
control adhesive interactions, which is a clear 
advantage when demonstrating the mechanical 
contribution of a given receptor or adhesive 
protein. Unfortunately, the degree of inertness 
is also a limitation, as the chemical nature of 
the PA does not allow easy covalent 
attachment. 
ECM proteins (e.g. FN, COL, LAM)
Growth factor (e.g. VEGF, PDGF, EGF, BMP-2U)
Entire protein
Fragments
Peptides Adhesion peptides (derived from ECM proteins)
BMP-2 derived peptides
e.g. FN domains
Size Adsorption
Grafting
Increased stiffness
S
P
A
T
IO
-T
E
M
P
O
R
A
L
B
IO
C
H
E
M
IC
A
L
M
E
C
H
A
N
IC
A
L
Temporal distribution (e. g. induced by cells, hydrolyzable)
Patterning of adhesive ligands (2D or 3D ) at nano or micro-scales
Natural Synthetic
MPakPaPa
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FIGURE 2. (A) Range of stiffnesses of the different synthetic and natural materials that are currently 
employed for mechanosensitivity studies, which are presented in this review. These include both synthetic 
and natural 2D and 3D materials. (B) Range of stiffnesses found in selected human tissues (from $emir and 
West, Annals of Biomed. Eng.($emir and West, Ann. Biomed. Eng., 2010)).  
 
There are additional possibilities offered by 
PA gels. First, in case of photo-polymerized 
gels, gradients in mechanical properties can be 
created by illuminating the gel using 
photomasks 
17
.  
Second, as cells cannot be entrapped in 3D in 
PA gels due to the toxicity of acrylamide, a 
simple approach that involves sandwiching 
cells between two polyacrylamide hydrogels 
has been proposed 
18; 19
. This method does not 
fully embed the cells in the environment but it 
does engage at least part of the dorsal cell 
receptors, thus mimicking the native 3D 
environment. Furthermore, it makes it possible 
to manipulate compliance and measure 
traction forces. Indeed, microparticles of well-
defined sizes can be inserted into PA gels, 
allowing cell traction forces to be measured, 
provided that the Young’s modulus and the 
deformation regime of the gels are known 
20
. 
For this reason, PA gels are by far the most 
commonly used substrate for quantification of 
traction forces 
21
.  
2.1.2 PDMS  
PDMS has arisen from the development of soft 
lithography. As PDMS is elastically 
deformable, non toxic and exhibits excellent 
optical properties, it has become a material of 
choice to stretch cells in controlled conditions. 
PDMS is always used as a 2D culture substrate 
(i.e with cells grown at its surface): this 
material it too dense for the cells to migrate 
through in 3D. In addition, it is a non-
degradable material and cannot be remodeled 
by cells. To prepare PDMS, a “base” and a 
“curing agent”, which contains monomers and 
is also named “cross-linker”, are typically 
mixed in a 10:1 w:w ratio. Thus, to prepare 
substrates with different elastic moduli, the 
silicone elastomer base and the cross-linker 
can be mixed at various ratios, forming gels 
from 50 kPa to 1.7 MPa 
22; 23; 24
. However, 
PDMS exhibits uncontrolled protein 
adsorption and can sometimes cause non-
specific cell adhesion, depending on its surface 
properties and cell type. Thus, PDMS surface 
needs to be chemically modified by various 
cell adhesion molecules to induce more 
reproducible adhesion 
22; 23
. Various strategies 
have been developed for this purpose (see 
paragraph 3.1).  
B
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FIGURE 3. Overview of the main strategies used to modulate mechanical properties of synthetic and 
natural materials. The methods are essentially based on chemical cross-linking, as physical cross-linking is 
so far barely employed for biomaterials. We have classified cross-linking by divalent cations at the border 
between chemical and physical cross-linking, as addition of cations changes the film chemistry but, at the 
same time, induces a physical gelation (no need for covalent crosslinks).  
 
 
2.1.3 Polyelectrolyte multilayer films 
made of synthetic polymers 
Polyelectrolyte multilayer films are a new kind 
of self-assembled material that emerged 
almost 20 years ago 
25
 and has versatile 
properties depending on the assembly 
conditions and post-assembly treatments. The 
thickness of these films can be adjusted in the 
range of few nm to several µm by varying the 
deposition conditions (pH, ionic strength and 
concentration of the polyelectrolytes) and the 
polyelectrolyte pairs. Using pH-dependent 
assembly of poly(acrylic 
acid)/poly(allylamine) (PAA/PAH), Van Vliet 
et coll. evidenced that such films can exhibit 
elastic moduli E from 200 kPa to 142 MPa 
(measured by nano-indentation), which is as 
much as one thousand-fold more compliant 
than tissue-culture polystyrene. 
26
. Extremely 
stiff films with a high degree of ionic cross-
links are obtained at neutral pH whereas soft 
films are obtained when films are built in 
acidic pH. 
27; 28
. 
A different strategy was proposed by Senger et 
coll.
29
, who prepared a composite film made of 
a first (PLL/HA)24 stratum capped by a second 
(PSS/PAH)n stratum (n varying between 0 and 
12). As the (PSS/PAH) films were much 
stiffer, the progressive deposition of these 
layers rendered the composite film stiffer, 
from roughly 50 to 500 kPa. An apparent 
elastic modulus was estimated from elasticity 
measurements by modeling the different strata. 
These films were recently used to investigate 
whether substrate elasticity has an effect on 
nuclear processes such as replication and 
transcription 
30
.  
2.1.4 PEG-based 
To date, there are very few synthetic materials 
with controlled mechanical properties that can 
be used for 3D cell studies, because of their 
high density, low porosity and lack of 
biodegradability. PEG-based hydrogels with 
well-controlled molecular properties have been 
developed for this purpose. These synthetic 
hydrogels are biologically inert and, as such, 
Type of cross-linking Properties
CHEMICAL
PHYSICAL
Amide bond (EDC/sulfoNHS)
COO- and NH3
+     →
Irreversible
UV Photo-induced
Ex: HA-Methacrylate
Ex: PEG-Diacrylate
Irreversible
Possible variation in 
spacer arm 
Thiol groups; disulfide bond
S-H  +   H-S  → S-S
Reversible
Enzyme mediated
Transglutaminase: amine and glutamine  
Irreversible
Divalent cations
Ca2+ , Sr2+, or Ba2+ (Ex: alginate)
Gel formation, 
reversible by 
chelating agents
Incorporation of nano-objects
Nanoparticles
Nanotubes
Irreversible
10 nm
10 nm
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they often require the insertion of adhesion 
peptides during polymerization 
31
. Typically, 
the hydrogels are formed by Michael-type 
addition of PEG-diacrylate (PEG-DA) and of 
thiol-containing peptides on to multiarm PEG-
Vinyl sulfone (VS). These gels are very 
sensitive to their preparation conditions 
including pH, stoichiometry, precursor 
concentration, chain length and number of 
arms of the macromers 
31
. PEG gels are known 
to swell greatly when introduced in solution, 
with the equilibrium swelling ratio ranging 
from 10 to 70 and elastic moduli from 0 to 
6 kPa as determined by small strain oscillatory 
shear measurements 
31
.These parameters were 
found to be connected by a power law, with 
more swelling for softer gels. Of note, these 
gels have a very low viscous component G” 
and very low porosity (of around 25 nm) as 
compared to physical hydrogels such as fibrin 
or collagen 
32
. This low porosity renders them 
resistant to cell migration, as incorporated 
cells essentially have an isotropic continuum 
without sensible physical architecture. 
Subsequent developments of these gels have 
included the grafting of protease-sensitive 
peptides (sensitivity to matrix metallo-
proteases) with bifunctional groups to be 
grafted at both of their extremities 
33
. Thus, 
these materials are locally degraded in 
response to cell-surface proteases, allowing 
cells to create paths for 3D migration (Figure 
4).  
 
 
 
 
FIGURE 4. Representative images of human neonatal foreskin fibroblasts (HFFs) cultured within 
the four materials: two biopolymers, namely collagen I (COL, at 2 mg/mL) and fibrin (FIB, at 2 
mg/mL) and PEG hydrogels that possess matrix metalloprotease sequence (MMP-sensitive PEG 
hydrogels, M-PEG) or plasmin-sensitive PEG hydrogels (P-PEG). Upper row : brightfield images; 
Lower row : confocal images obtained after staining for F-actin (rhodamine-phalloidin, green) and 
nuclei (DAPI, red). Scale bars, 100 µm (upper row) and 30 µm (lower row). Of note, the MMP 
sensitive cross-linker allows HFFs to spread and attain cell shapes in synthetic M-PEG gels (M-
PEG) very similarly to HFFs in biopolymers (FIB, COL) (images of the bottom row). In contrast, 
HFFs are not able to form a spindle-shaped morphology in plasmin-sensitive PEG hydrogels (P-
PEG) as seen by the increased compactness and a decrease in projected cell area. (From Hubbell 
and coll., Biophys J, 2005, copyright Cell Press 2005). 
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2.2. 2atural materials  
Natural biopolymers have the advantage of 
being components of native ECM matrices, i.e. 
they provide compositional uniqueness such as 
stimulating a specific cellular response and 
serve both as mechanical as well as 
biochemical signals. Natural materials are also 
particularly interesting due to their unique 
structural properties (Table 1). Their nano and 
microstructure are similar to that of native 
tissues in terms of functional groups, backbone 
(presence of neutral and charged groups, 
chirality) and structural organization (coils, 
fibers…). Conversely, natural materials have 
also some drawbacks. They are more fragile, 
polydisperse, and not always pure. Moreover, 
their mechanical properties are often difficult 
to measure mechanically or rheologically as 
they can exhibit non linear behaviors. In 
addition, their natural bioactivity makes it 
fastidious to fully decouple the effect of 
mechanics from chemistry. The main 
biopolymers used to study the effect of 
substrate stiffness on cell behavior are 
collagen, alginate, fibrin, and agarose (Figure 
2 and Table 1). 2D PEM coatings made by 
self-assembly of polypeptides and 
polysaccharides are emerging as a new class of 
materials with well-defined properties. The 
methods employed to cross-link natural 
materials are similar to those employed for 
synthetic materials. They are summarized in 
Figure 3.   
2.2.1 Collagen  
Type I collagen is a major protein component 
of fibrous connective tissues, which provides 
mechanical support and frameworks for the 
other tissues in the body. Collagen is a natural 
ligand for several integrin receptors. Collagen 
gels exhibiting different mechanical properties 
can be prepared by varying the pH during 
hydrogel formation 
34
 or by varying its 
concentration 
35
. Thus, porosity as well as 
density of ligands, which are changed 
simultaneously, are coupled to the material’s 
mechanical properties. Elastic modulus G’ of 
such gels can vary between 5 and 1000 Pa as 
measured by oscillation rheometry. Collagen 
gels can be prepared as 2D culture surfaces or 
3D matrices 
35
. They exhibit a rather organized 
physical architecture characterized by the 
presence of fibers.  
Grinnel et al. recently investigated the effect 
of 2D and 3D collagen matrices on cell 
adhesion and migration. They quantified the 
effects of matrix stiffness and porosity on 
collagen translocation, fibroblast cell 
spreading and cell migration for collagen gels 
with average pore diameter varying from 1.1 
to 2.2 µm. Drying collagen fibrils appears to 
have an impact on cell spreading and 
proliferation. Plant et al. 
36
 showed that thin 
films of collagen fibrils can be dehydrated, and 
when seeded on these dehydrated fibrils, 
smooth muscle cells spread and proliferate 
extensively. Indeed, the dehydrated collagen 
gels were found to be mechanically stiffer than 
their hydrated counterparts. Tanishita et al. 
found that in vitro formation of microvessel 
networks by endothelial cells was also affected 
by the mechanical properties of collagen gels 
34
. 
Microbial transglutaminase, an enzyme that 
catalyzes the formation of a covalent bond 
between a free amine group (e.g., protein- or 
peptide-bound lysine) and the gamma-
carboxamid group of protein- or peptide-
bound glutamine, can also be employed to 
covalently crosslink collagen I 
37
. This resulted 
in a 6-fold increase in G” (1.3 kPa versus 210 
Pa). In terms of cell behavior, these authors 
showed a significant reduction in the level of 
cell-mediated contraction of scaffolds with 
increased concentrations of enzymes.  
2.2.2 Alginate  
Alginate is a linear polysaccharide of (1-4)-
linked β-mannuronic acid and α-guluronic acid 
monomers, which forms a gel in the presence 
of certain divalent cations (calcium, strontium, 
or barium) (Figure 3) 
38
. The block structure of 
alginate dictates the structure of ionic cross-
links, and covalent cross-links can also be 
formed 
39; 40; 41
. Due to their biocompatibility, 
alginate gels have long been used for 
biomedical purposes, particularly in the 
manufacture of surgical dressings for exuding 
wounds. More recently, they were employed 
as scaffolds for the immunoprotection of 
transplanted cells. Elastic modulus and 
toughness can be modulated from 2 to 70 kPa 
by controlling the parameters for gel cross-
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linking. However, alginate needs to be 
chemically modified to interact specifically 
with mammalian cells, which is usually 
achieved by grafting RGD (arginine-glycine-
aspartic acid)-containing cell adhesion ligands 
42
. In this context, alginate gels were used to 
investigate the substrate mechanics effect on 
chondrocyte adhesion 
43
. Very recently, the 
same group demonstrated that the commitment 
of mesenchymal stem cell populations changes 
in response to the rigidity of 3D alginate gels, 
with osteogenesis occurring predominantly at 
11-30 kPa 
44
. Matrix stiffness was found to 
regulate integrin binding as well as 
reorganization of adhesion ligands at the 
nanoscale. Both were traction-dependent and 
correlated with osteogenic commitment of 
mesenchymal stem cell populations. 
2.2.3 Hyaluronan and other 
biopolymers  
Hyaluronan (HA) is a non-sulfated 
glycosaminoglycan (GAG) that is present in 
different types of tissues and fluids, including 
synovial fluid, cartilage, tendon and skin. It 
plays a role in tissue viscoelasticity and 
hydration, due to its ability to interact with 
water molecules and to establish multiple 
hydrogen bonds. 
45
. Hyaluronan is also present 
in the pericellular coat (also called glycocalyx) 
of different cell types, chondrocytes being a 
prominent example with a thick coat of ∼5 µm 
46
. Despite their biocompatibility, native HA 
gels have poor mechanical properties. 
Although HA can be cross-linked using 1-
ethyl-3-(3-dimethylamino-propyl) carbo-
diimide (EDC) 
47
 before serving as a soft 
substrate for cell biology experiments, such 
hydrogel preparations lack long-term stability 
and have very low elasticity (3 to 250 Pa). To 
increase its mechanical properties, the 
Prestwich group has proposed a method that 
consists in grafting thiol groups to HA (HA–
SH) 
48
 to form disulfide (S-S) bonds in the 
presence of an oxidizing agent. Adding PEG-
DA to the mixture can provide additional 
cross-links. AFM nano-indentations have been 
performed on S-S crosslinked HA gels, and 
moduli were found in the range of 1 to 100 
kPa 
14
. One of the drawbacks of such gels is 
the dissociation of the S-S bond over several 
days. Another is that PEG-DA addition leads 
to the formation of hydrolytically degradable 
esters, which may balance the stiffening effect 
of the cross-links. Engler et al. recently 
compared the growth of pre-cardiac cells on 
HA and PA gels of similar stiffness 
49
. They 
showed that pre-cardiac cells grown on 
collagen-coated HA hydrogels exhibit a 3-fold 
increase in mature cardiac specific markers 
and form up to 60% more maturing muscle 
fibers than they do when grown on compliant 
PA hydrogels over 2 weeks. 
Other biomolecules are being developed to 
investigate the effects of substrate mechanics. 
Bellamkonda et al. used agarose gels at 
different concentrations (ranging from 0.75 to 
2 % wt/vol) to investigate the rate of neurite 
extension 
50
, which was found to be inversely 
correlated to the mechanical stiffness of the 
gels. Soichet et coll. have developed cross-
linkable forms of chitosan by grafting 
methacrylate groups 
51
. These hydrogels have 
been used for the regeneration of neuronal 
tissue.  
2.2.4 Polyelectrolyte multilayer films 
made of biopolymers as 2D coatings 
As mentioned above, polyelectrolyte 
multilayer films are a new type of self-
assembled coating that has found applications 
for cell studies in the past 10 years 
52
. PEM 
films made of polysaccharides and 
polypeptides have been engineered and studied 
53; 54
. Their mechanical properties can be 
modulated by several methods. A now popular 
method is to covalently cross-link carboxylic 
with amine groups in the films to form 
covalent amide bonds. This was first applied to 
poly(L-lysine)/hyaluronan (PLL/HA) films 
55
 
for a fixed cross-linker concentration and 
subsequently to the same films on a large 
range of cross-linker concentration 
56
. The 
apparent Young’s modulus of the films, as 
probed by AFM-nano-indentations, could thus 
be modulated over a range of a few kPa to 
∼500 kPa. More recently, this strategy has 
been applied to several other types of 
multilayer films to obtain mechanical 
properties that depend on the type of 
polyelectrolyte pairs, deposition conditions 
and cross-linker concentrations 
57
. Recent 
developments include the investigation of the 
effect of film cross-linking on hepatocyte 
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adhesion 
58
, on the differentiation of myoblast 
cells into myotubes 
59
 and of selective cross-
linking on the outer region of the films. This 
results in a rigid outer “skin” to promote cell 
attachment, while leaving the film’s interior 
unaffected 
60
.  
Another strategy relies on the use of a natural 
cross-linking agent such as genipin 
61
. The 
viscoelastic properties of chitosan/hyaluronan 
(CHI/HA) and chitosan/alginate (CHI/ALG) 
multilayer films without cross-linking or after 
cross-linking with genipin have been 
investigated using quartz crystal microbalance 
with dissipation monitoring (QCM-D). 
(CHI/HA) cross-linked films proved to be 
highly non-adhesive for pre-osteoblasts and 
fibroblastic skin cells. Conversely, cross-
linking (CHI/ALG) films dramatically 
improved pre-osteoblast and rat fibroblastic 
skin cell adhesion, especially for high bi-layer 
numbers and using high concentrations of 
cross-linker. Finally, photo-crosslinking can be 
employed to modulate the Young’s modulus of 
(PLL/HA) films that contain a photosensitive 
derivative of HA (HA-vinyl benzyl) grafted at 
various percentages 
62
.  
2.3. Mixtures of synthetic/natural  
As both synthetic and natural biomaterials 
have advantages and drawbacks, efforts have 
also been made to develop composite 
biomaterials made of mixtures of synthetic and 
natural materials. In this respect, Putnam and 
coll. developed PEG-conjugated fibrinogen 
gels 
63
, by coupling PEG-DA to full-length 
fibrinogen. These gels can be additionally 
cross-linked by exogenous cross-linkable 
PEG-DA (typical range from 0 to 2 wt%) and 
make possible the simultaneous manipulation 
of mechanical properties and adhesion ligand 
density presented to cells. Their bulk 
compressive moduli ranged from 450 to 5.2 
kPa. 
63
. However, their mechanical properties 
decreased over a seven-day immersion period 
in phosphate buffered saline, and it was 
probably due to the combined effects of 
hydrolysis and proteolysis. Adding soluble 
factors such as ascorbic acid to the gels was 
found to stimulate matrix remodeling by 
modulating smooth muscle cells phenotype 
(induction of contractility), which led to an 
increase in elastic modulus 
64
.  
Semi-interpenetrating hydrogels (IPNs) are an 
emerging class of hydrogels, which make it 
possible to combine the advantages of each 
component. For instance, photo-cross-linkable 
hyaluronic acid (HA) and semi-
interpenetrating collagen components were 
found to exhibit superior mechanical 
properties 
65
. The inclusion of the semi-
interpenetrating collagen chains provided a 
synergistic mechanical improvement over 
unmodified HA hydrogels. These semi-IPNs 
supported fibroblast adhesion and proliferation 
and were shown to be suitable for cell 
encapsulation at high levels of cell viability. 
They were also employed to fabricate cell-
laden microstructures and microchannels. 
Another example is that of fibroin/collagen 
hybrid hydrogels 
66
, which were prepared by 
cross-linking a fibroin/collagen solution using 
the water soluble EDC. G’ of these gels varied 
between 3 and 10 kPa. Some mobility of 
fibroin molecules inside the gels was noticed. 
These composite gels allowed vascular smooth 
muscle cells to grow.  
3. Biochemical functionalization  
A common approach in the field of 
biomaterials is to start from a “blank slate” 
67
, 
i.e. a substrate or material preventing protein 
adsorption and cell adhesion, and to add a 
biochemical functionality to the material in a 
controlled fashion. As mentioned above, cell 
attachment on many synthetic polymers is very 
poor, due to their inertness and lack of specific 
adhesive motifs. Such a low background 
attachment has been observed for PA, PDMS 
and PEG hydrogels. In the case of natural 
materials, although cells may possess specific 
receptors recognizing the material, their 
naturally high hydration, softness and the 
possible lack of accessibility for functional 
groups often render them poorly adhesive. 
Such low cell attachment has been observed 
for hydrated polysaccharides such as HA and 
ALG.  
Researchers have thus designed strategies for 
giving additional biochemical functionality to 
different types of synthetic and natural 
materials. We will distinguish here between 
three types of biochemical functionality 
(Figure 1): i) full length ECM proteins, ii) 
fragments and peptides derived from these 
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proteins and iii) growth factors (GF). Among 
the important biomolecules are ECM proteins 
like fibronectin, collagen and laminin as well 
as GAGs. These GAGs are negatively charged 
polysaccharides that can interact with proteins 
by non covalent and covalent interactions 
68
. In 
this latter case, they form what is called a 
proteoglycan. In addition, growth factors are 
an important class of signaling molecules 
playing a key role in cellular processes 
including growth, proliferation, differentiation, 
adhesion and migration 
69
.  
Biochemical functionality can be provided 
either by grafting or by physically adsorbing 
the bioactive molecule. Notably, presentation 
of a biochemical signal from a biomaterial or a 
substrate in a “matrix-bound” manner is 
important for mimicking physiological 
conditions, as many bioactive molecules are 
bound to the ECM matrix in vivo 
70
. Indeed, in 
the ECM, glycosaminoglycans are found 
immobilized by ionic or covalent cross-links. 
We will present below the different strategies 
(grafting versus physical adsorption), how they 
are achieved and what types of biomolecules 
have been grafted or adsorbed to date. 
3.1. Biochemical functionalization by 
grafting 
The advantage of grafting is that it provides 
good control of surface composition, a stable 
link and limits release of the functional group 
into the culture medium. Covalent grafting of 
short bioactive peptides or protein fragments is 
more frequently performed than that of full 
length ECM proteins, which is more difficult 
to handle. A key issue is to preserve the 
bioactivity of the grafted molecules, especially 
entire proteins, because their activity depends 
on their 3D conformation. Moreover, using 
harsh solvents and/or high temperatures often 
leads to the denaturation of biologically active 
molecules. Thus, selecting the appropriate 
conjugation strategy and using spacer arms are 
essential to retain the bioactivity of grafted 
molecules and provide them with sufficient 
flexibility and accessibility by the cell 
receptors. 
3.1.1 Major grafting strategies 
Grafting of proteins/peptides can be performed 
in solution on hydrogel components prior to 
formation of the 2D or 3D biomaterial or 
directly at the surface of a biomaterial. This 
latter strategy can only be performed on 2D 
biomaterials. As mentioned earlier, a key 
requirement is to preserve the bioactivity of 
the biomolecules.  
3.1.1.1 Targeting amino and 
carboxylic groups  
Proteins can be coupled to polymers via their 
amino-groups. To this end, sulfo-SANPAH 
(sulfosuccinimidyl-6-[40-azido-20-
nitrophenylamino]hexanoate) can be 
employed. It is a hetero-bifunctional cross-
linker containing a photosensitive phenyl azide 
group on one end and an amine-reactive N-
hydroxysuccinimide on the other end. Proteins 
can thus react via their amine group with 
sulfo-SANPAH, which can itself react with the 
gel 
71
 upon exposure to UV light. However, 
the limited solubility, stability and shelf-life of 
sulfo-SANPAH have urged researchers to look 
for alternative grafting strategies. 
Alternatively, the water soluble carbodiimide 
coupling chemistry can be employed to create 
a covalent amide bond, which is formed 
between activated carboxylic groups and 
ammonium groups 
72
. This is, in principle, 
straightforward coupling chemistry, but 
several side reactions are known to complicate 
the subject. These are especially present when 
the polymer contains a large amount of water, 
as in the case of HA 
73
. Therefore, sulfo-N-
hydroxysulfosuccinimide ester is often 
employed to catalyze the reaction. This 
strategy has been applied to alginate gels, 
which contain carboxylic groups 
42
 to 
covalently attach a G4RGDSP oligopeptide so 
as to promote cell-matrix interactions 
74
. It has 
also been used to graft different proteins or 
fragments (extracted human fibronectin, 
collagen I or collagen IV; recombinant 
fragments of fibronectin and vitronectin) on to 
polyelectrolylte multilayer films containing 
hyaluronan 
75
.  
3.1.1.2 Targeting cysteine residues 
Thiol groups of proteins or peptides are 
another target for coupling reactions. 
Maleimides linked to PEG are often used as 
flexible linker molecules to attach whole 
proteins, protein fragments or peptides to 
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surfaces. The double bond of maleimide 
readily reacts with the thiol group found on 
cysteine to form a stable carbon-sulfur bond. 
Attaching the other end of the polyethylene 
chain to a bead or solid support, or to a 
polyelectrolyte 
76
 allows to separate the protein 
from other molecules in solution, provided that 
molecules do not also possess thiol groups.  
Acrylate groups are often used in Michael 
addition, which is a conjugate reaction based 
on the nucleophilic addition of a carbanion or 
another nucleophile to an alpha, beta 
unsaturated carbonyl compound. This is one of 
the most useful methods for the mild 
formation of C-C bonds and thus for 
covalently cross-linking acrylated polymers, 
usually by light activation. Acrylates are also 
known to react with thiols of cysteines (on 
peptides or proteins) under defined 
experimental conditions. This reaction, which 
belongs to the thiol-ene family of reactions, 
involves the addition of an S-H bond across a 
double or triple bond by either a free radical or 
ionic mechanism. Thus, acrylates are often 
employed to graft either peptides or full-length 
proteins. For example, RGD sequences have 
been incorporated into PEG hydrogel networks 
through the acrylation of the peptide sequence 
at the N-terminus, followed by 
copolymerization of the acrylated peptides 
with PEG-DA via photocross-linking in 
aqueous solution 
77; 78; 79
. On similar PEG 
hydrogels, bis-cysteine peptides that contain 
an additional acrylate group and that are 
MMP-sensitive (e.g., Ac-GCRD-
GPQGYIWGQ-DRCG) or plasmin sensitive 
(e.g., Ac-GC-YKYNRD-CG) have been 
prepared 
32
. Burdick et al. 
80
 used an acrylate 
derivative of HA to graft two peptide 
components: one to support cell adhesion and 
the other for proteolytic degradability. Full-
length fibrinogen was also coupled to PEG-
DA at room temperature but in the presence of 
a strong denaturating agent (urea) 
81
. 
The potentiality of acrylate to serve for cross-
linking polymeric chains but also for peptide 
coupling has recently been shown for acrylated 
HA hydrogels. These were subjected to two 
step experimental protocol: the first step was 
designed to couple peptides to the acrylate 
groups and the second to initiate free radical 
polymerization of the remaining acrylate 
groups by exposure to UV light 
80
. The 
resulting UV-HA hydrogels were expected to 
prevent remodeling due to the incorporation of 
non-degradable covalent cross-links from 
kinetic chain formation and thus to confine 
encapsulated cells to a rounded morphology. 
3.1.2 Grafting of different types of 
molecules 
As mentioned above, we will distinguish here 
the three types of molecules - full length ECM 
proteins, protein fragments or shorter peptides 
(typically from 4 to 20 amino acids) and GF– 
that can be grafted. Grafting sequences has 
great advantages over grafting full length 
molecules. In entire proteins (ECM proteins or 
GF), many different active sequences there can 
be recognized by cell surface receptors. Using 
a bioactive fragment makes it possible to 
enhance the specificity of the interaction and 
to target one particular partner to better control 
cellular processes. The problem is that such 
short sequences are usually less bioactive than 
entire molecules because of the loss of  active 
site spatial architecture owing the protein’s 
specific conformation 
82
.  
3.1.2.1 Peptides 
The most common grafted peptides are derived 
from ECM proteins, mainly fibronectin 
83
, 
collagen 
84
, laminin 
85; 86
 and vitronectin 
87
 
(Table 2). More recently, peptides that exhibit 
protease sensitive sequences have been grafted 
to the biomaterials to add biodegradability in 
response to cellular activity 
88
.  
The tripeptide sequence RGD is very popular, 
as it is present in many ECM proteins, 
including fibronectin, vitronectin, fibrinogen, 
von Willebrand factor, thrombospondin, 
laminin, osteopontin, bone sialo protein, and 
some collagen isoforms 
82
. It binds to a wide 
range of integrin receptors in a non selective 
manner, i.e. not specific to a given integrin 
receptor. The literature about the various 
forms of RGD peptides is rich and the reader 
is referred to more specialized reviews 
89
. To 
achieve better selectivity and/or target only 
one type of integrin receptor, several strategies 
have been investigated: i) synthesis of cyclic 
peptides 
90
, or peptide multimerization to 
enhance avidity with particular cell adhesion 
receptors 
91
, ii) using a more selective peptide 
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sequence that is not based on RGD but 
contains other key sequences or iii) associating 
two different bioactive peptides derived from 
the same ECM protein 
92
 or from different 
ones 
93
 (Table 2). Thus, collagen-mimetic 
peptides 
94; 95
, laminin-derived peptides 
85; 86; 96
 
and fibronectin-derived peptides or fragments 
83; 92
 are increasingly used for their higher 
selectivity.  
Garcia et al. 
97
 engineered polymer brushes of 
oligo(ethylene glycol) methacrylate on PDMS, 
which resisted biofouling and prevented cell 
adhesion. These polymer brushes were 
functionalized to display bioadhesive peptides, 
which were either tethered uniformly or 
constrained to micropatterned domains using 
standard peptide chemistry approaches. Benoit 
and Anseth 
92
 showed that associating an 
RDG-containing peptide to another 
fibronectin-derived epitope like PHSRN not 
only made it possible to enhance the 
bioactivity of the functionalized surface 
compared to RGD only, but also to specifically 
target a particular integrin receptor 51. 
Each domain independently contributed little 
to binding, but when combined, they 
synergistically bound to 51 to provide 
stable adhesions 
92; 98
. 
We are now progressively entering a new era, 
where peptides with higher specificity, high 
biological activity as well as targeting other 
receptors than integrins are being designed 
(Table 2). Indeed, it is now acknowledged that 
besides integrin receptors, other families of 
receptors including syndecans
99
 and growth 
factor receptors play key roles in early cellular 
events. Recent developments also include 
grafting the peptide sequence of growth 
factors, mostly bone morphogenetic protein 2 
(BMP-2) derived peptides 
100; 101
. 
 
 
TABLE 2. Peptide sequences used for targeting adhesion receptors of four main ECM proteins (collagen, 
fibronectin, laminin and vitronectin) as well as for providing degradability (matrix-metalloprotease 
sequence). The targeted receptor (or receptor family) as well as cell type used in the study are indicated. 
ECM protein
PEPTIDE SEQUENCE TARGETED RECEPTOR CELL  TYPE REFERENCE
GFOGER lntegrin α2β1
Primary bone marrow stromal 
cells
 Reyes et al., Biomaterials  2007 
[94]
CGPKGDRGDAGPKGA
Integrins α1β1 , α2β1 Primary human osteoblasts
Picart et al.  Adv. Funct. Mater . 
2005 [76]
DGEA lntegrin α2β1 MIN6 b-cells Weber Biomaterials 2007 [95]
Osteoblasts
Petrie et al., Biomaterials  2008 
[83]
hESC, hMSC
Doran et al., Biomaterials  2010 
[75]
RGD-PHSRN Inegrin α5β1 Osteoblasts
Benoit and Anseth, Biomaterials 
2005 [90]
RKRLQVQLSIRT (α1 chain 
LAM-1, LG4 module)
Syndecans
ATLQLQEGRLHFXFDLGKGR, 
X: Nle (α1 chain, LG4 module)
lntegrin α2β1
PPFLMLLKGSTRFC (LG3 of 
the lam-5  α3 chain)
Integrins α6β4, α3β1
Oral keratinocyte cell line, TERT-
2 OKF-6
Werner et al., Biomaterials  2009 
[96]
IKLLI (LAM α1 chain) lntegrin α3β1
IKVAV (LAM α1 chain)
110 kDa laminin receptor 
protein
YIGSR (LAM β1 chain)
67 kDa laminin receptor 
protein
VITRONECTIN rhVN, N-terminal Somatomedin 
B and RGD domain
Plasminogen activator inhibitor-
1 (PAI-1), integrin receptors
hESC
 Doran et al., Biomaterials  2010 
[75]
MC3T3-E1 preostoblasts
Zouani et al., Biomaterials  2010 
[100]
Human foreskin fibroblasts 
Lutolf et al., Nature Biotech . 2003 
[84]
G4RGDSP Integrins
Cyclic RGD: G4CRGDSPC
Integrin receptors, higher 
specifity for αVβ3
MMP-sensitive peptide: Ac-
GCRD-GPQGIWGQ-DRCG-
NH2
Matrix metalloproteinases 
(MMP)
Human foreskin fibroblasts
Lutolf et al. Nature Biotech  2003 
[84]
 Hsiong et al. Tissue Eng . 2009 
[92]
Hozumi et al, Biomaterials  2009 
[83]
LAMININ 
(LAM)
COLLAGEN 
(Type I)
FIBRONECTIN 
(FN)
RGDSPC
Multiple ECM 
proteins 
Primary human bone marrow 
stromal cells, MC3T3-E1 
preosteoblasts, mouse bone 
marrow stromal D1 cell line
Human dermal fibroblasts, neural 
PC12
MIN6 b-cells
rhFN fragment FNIII7-10  (with 
RGD and PHSRN)
Interin α5β1
Integrins
 Weber, Biomaterials  2007 [95]
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3.1.2.2 Grafting ECM proteins to 
synthetic surfaces  
Synthetic polymers such as PA and PDMS are 
often biofunctionalized by grafting proteins. 
For PA gels, three major methods, which are 
reviewed in 
71
, are commonly used. The first 
relies on carbodiimide coupling of proteins to 
poly(acrylic acid), which has to be inserted 
into the PA gel during gel formation. Another 
method uses molecules that have bi-
functionality, one end of the molecules 
mediating the incorporation into 
polyacrylamide whereas the other end is 
reactive toward primary amines. Here again, 
we find acrylate and N-hydroxysuccinimide in 
the form of acrylic acid N-hydroxysuccinimide 
ester (NHS-acrylate), which is incorporated 
into a one-step polymerization reaction 
102
 
during the acrylamide polymerization reaction.  
Recent developments include the fabrication 
of a synthetic interfacial hydrogel culture 
system, termed variable moduli 
Interpenetrating Polymer Networks (vmIPNs) 
103
. The principle is to build at the first step a 
polyacrylamide gel by varying the 
concentration of acrylamide and bisacrylamide 
monomers to synthesize PA gels from 10 Pa to 
10 kPa and of low swelling ratio (∼2). Then, 
the IPN is created by polymerizing a second 
layer of amino-PEG (4 nm thick) within the 
top few nanometers of the first acrylamide 
layer for subsequent grafting of adhesion 
peptides. Such materials were then used to 
investigate the adhesion, proliferation and 
differentiation of adult neural stem-cells. 
Under mixed differentiation conditions with 
serum, softer gels were found to favor 
neurons, whereas harder gels promoted glial 
cultures.  
PDMS, if untreated, exhibits high 
hydrophobicity and extremely low cell 
attachment 
23
. Different methods have thus 
been developed to biochemically modify the 
surface of PDMS for cell adhesion. Recently, 
Hinz et al. systematically compared the 
immobilization of cell-adhesive molecules to 
PDMS using electrostatic (simple protein 
adsorption and layer-by-layer deposition) and 
covalent surface coating procedures 
104
. They 
developed a functionalization protocol that is 
based on: (1) PDMS oxidation by oxygen 
plasma treatment, (2) binding of 3-
aminopropyltriethoxysilane (APTES) to the 
oxidized surface and (3) covalent cross-linking 
of ECM proteins to the silane using 
glutaraldehyde. They found that the covalent 
linkage of adhesive molecules was superior to 
non-covalent methods in providing a coating 
that resisted to major deformations and that 
fully transmitted this stretch to cultured cells.  
3.1.2.3 Grafting growth factors 
There are only a few examples of covalent 
immobilization of entire growth factors on 
materials whose mechanical properties can 
also be modulated. One of the most studied 
“tethered” growth factor is epidermal growth 
factor (EGF) 
105
. EGF plays an important 
physiological role in the maintenance of oro-
esophageal and gastric tissue integrity. It was 
initially tethered to poly(methyl methacrylate)-
graft-poly-(ethylene oxide) (PMMA-g-PEO) 
amphiphilic comb copolymers by activation 
with 4-nitrophenyl chloroformate (NPC) to 
target the N-terminal amine of murine EGF 
105; 
106
. In the latest work by this group 
106
, a 
biotinylated recombinant protein containing 
the 53 amino acid human EGF domain was 
linked to a biotonylated peptide hydrogel by 
neutravidin. This EGF-containing recombinant 
protein also contained a protease-resistant 20 
amino acid hydrophilic spacer arm to provide 
optimal bioactivity. Another strategy consists 
in synthesizing photoreactive EGF via the 
reaction of primary amine groups in the 
growth factor with the N-hydroxysuccinimide 
functionality of Sulfo-SANPAH 
107
. In a 
subsequent step, EGF is covalently tethered to 
polystyrene by means of UV irradiation.  
Nerve growth factor (NGF) has been grafted to 
2-hydroxyethy methacrylate (HEMA) gels 
using ethylene dimethacrylate as crosslinker, 
ammonium persulfate as initiatior and 
tetramethy ethylenediamine (TEMED) as 
accelerator 
108
. By modifying these p(HEMA)-
NGF gels with pAA, neuronal PC12 cells 
adhered and responded to the immobilized 
NGF by extending neuritis in a manner similar 
to that which is observed with soluble NGF. 
PC12 cell neurites were even observed to be 
thicker when cultured on immobilized NGF 
than when cultured in the presence of soluble 
NGF. Very recently, vascular endothelial 
growth factor (VEGF) has been coupled to a 
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PEG-hydrogel through photo-polymerization 
via laser scanning lithography 
109
. Endothelial 
cell cultures in these gels underwent 
accelerated tubulogenesis forming 
endothelium tubes that possess lumens only in 
the presence of tethered VEGF. 
3.2. Biochemical functionalization by 
physical adsorption 
The complex environment surrounding the 
cells in vivo is composed of ECM components 
(fibrillar proteins, proteoglycans, adhesion 
molecules) and soluble biomacromolecules 
such as cytokines, growth factors and other 
signaling molecules. Many of these 
biomolecules interact by non convalent 
interactions, including electrostatic, Van der 
Waals, hydrogen bonds and hydrophobic 
interactions, but also by ligand/receptor 
interactions. In vivo, these biomolecules are 
often presented by the ECM proteins or 
glycosaminoglycans in a “matrix-bound” 
manner. Thus, biomaterial scientists are also 
trying to associate different components of the 
in vivo cellular microenvironment to reproduce 
it in a simple way and to create biologically 
active materials. Three principal types of 
molecules or their fragments can be 
physisorbed on 2D biomaterials or entrapped 
in 3D biomaterials: ECM polysaccharides 
(glycosaminoglycans), ECM proteins 
(fibronectin, collagen, laminins) and growth 
factors (including EGF, VEGF, BMP-2 and 
fibroblast growth factor FGF2). In this part, 
we focus on non covalent interactions between 
proteins and polymers.  
3.2.1 Adsorption of ECM proteins and 
of glycosaminoglycans 
Due to the natural interactions between ECM 
proteins and natural polyelectrolytes, ECM 
proteins are often simply adsorbed on PEM 
films. Several parameters, including the 
amount of adsorbed protein (often in the range 
of several ng/cm
2
), the strength of the 
interaction (affinity) as well as protein 
conformation will depend on the physical and 
chemical parameters of the multilayer film: 
type of functional groups (sulfate, carboxylic, 
ammonium…), pH and ionic strength used 
during film builduip, and type of ending layer. 
Fibronectin (FN) is often used as an adhesive 
protein, due to its interaction with different 
types of integrin receptors. Wittmer et al. 
110
, 
investigated the LbL formation of films 
composed of PLL and dextran sulfate (DS), 
the adsorption of FN on to these films, and the 
subsequent spreading behavior of human 
umbilical vein endothelial cells. Overall, the 
FN-coated PLL monolayer and the FN-coated 
PLL-terminated multilayer were the best 
performing films in promoting cell spreading. 
They concluded that the presence of FN is an 
important factor (more than film charge or 
layer number) in controlling the interaction 
between cells and multilayer films. Semenov 
et al. 
111
 also adsorbed or chemically coupled 
FN on to (PLL/HA) cross-linked films and 
demonstrated that film cross-linking strongly 
influenced FN surface distribution, leading to 
denser presentation of adhesion sites for cells.  
Chen et al. 
28
 modified synthetic (PAH/PAA) 
PEM films with type I collagen and the 
proteoglycan decorin . They showed that this 
did not alter substrate stiffness, but enhanced 
the retention of spheroids on surfaces and 
stabilized hepatic functions (such as albumin 
and urea secretion). Very interestingly, decorin 
was found to exhibit unique compliance-
mediated effects on hepatic functions, down-
regulating the hepatocyte phenotype when 
presented on highly compliant substrata, while 
up-regulating hepatocyte functions when 
presented on increasingly stiffer substrata. 
Collagen adsorption was also found to be 
important for the attachment and function of 
adult rat hepatocytes on cross-linked 
(PLL/ALG) and (PLL/PGA) multilayer films 
58
. Collagen 
112
 and fibronectin can even be 
used as building blocks for layer-by-layer film 
buildup.  
Besides ECM proteins, GAGs are more and 
more often used as main component of new 
biomimetic coatings and nanoparticles, which 
were reviewed recently 
54; 113
. They are often 
simply adsorbed and interact by non specific 
and/or specific interactions with other 
positively charged biomolecules 
68
.  
3.2.2 Adsorption of growth factors on 
thin films or matrices. 
Due to their utmost importance in signaling 
processes, GF are now often inserted into 2D 
and 3D biomaterials to achieve a specific 
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function: to regulate cell proliferation for 
FGF2 
114
, or promote the formation of new 
vessels for VEGF 
109
, induce bone 
regeneration for BMP-2 or chondrogenesis for 
TGF-1. There are several high affinity 
partners of growth factors among biological 
materials. Fibrin, a non globular fibrous 
protein, is involved in a large number of 
biological processes (blood clotting by 
polymerization of fibrin, signal transduction, 
platelet activation) and is a very interesting 
candidate for growth factor immobilization. 
Thus, natural interactions of fibrin with FGF, 
BMP-2 and EGF have been used to present 
these growth factors in their immobilized form 
115; 116; 117
 (Figure 5). Desorption experiments 
using radiolabeled proteins demonstrated that 
the patterns were retained in vitro with less 
than a 30% loss of growth factor over 9 days 
116
, which confirms the high affinity of growth 
factors for fibrin. 
The 12th-14th type three repeats of fibronectin 
(FN III12-14) also appear to be a natural 
affinity fragment for several GFs 
118
. In a 
recent study, Hubbell and coll. 
118
 showed by 
surface plasmon resonance that this FN 
fragment binds to GFs from different families, 
including most of the GFs from the platelet-
derived growth factor (PDGF, VEGF and FGF 
families and some GFs from the TGF-β and 
neurotrophin families). Affinities were high in 
the nanomolar range, without inhibiting GF 
activity. These authors subsequently employed 
a fibrin-bound variant of FN III12-14 as 3D 
biomaterials and showed that it was highly 
effective as a GF delivery system. For 
instance, in matrices functionalized with FN 
III12-14, PDGF-BB-induced sprouting of 
human smooth muscle cell spheroids was 
greatly enhanced.  
Other natural high affinity binding domains 
are those derived from heparin. Recently, 
Chow et al. 
119
 created a self-assembled 
bioactive hierarchical membrane 
functionalized with a heparin-binding peptide 
amphiphile (HBPA). HBPA contains a 
consensus sequence to bind and display 
heparin loops on the surface of nanofibers in 
order to localize and activate potent 
angiogenic growth factors through their 
respective heparin-binding domains. Both 
VEGF and FGF2 are known to have heparin-
binding domains along with potent angiogenic 
activity. Release of these factors was 
effectively lower in the presence of heparin in 
the membrane.  
 
 
FIGURE 5. Bioprinting of BMP-2 growth factor, which is here fluorescently labeled, on a fibrin film. Left 
image: BMP-2 was printed at various surface concentrations by varying the number of overprints, leading to 
increased fluorescence on the surface. The four images correspond to, respectively: 2, 8, 14 and 20 
overprints. Right images: corresponding expression of the bone marker alkaline phosphatase (in blue), 
which is expressed during differentiation of muscle derived stem cells in bone. (From Campbell and coll., 
Stem cells, 2007, copyright AlphaMed press) 
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Polyelectrolyte multilayer films can also be 
employed to sequester growth factors and 
present them to cells in a “matrix-bound” 
manner. VEGF could be adsorbed on to 
(PAH/PSS)4 films and was shown to exhibit a 
specific bioactivity toward endothelial cells 
120
. (PLL/HA) crosslinked films or (PLL/HA-
heparin) films can be used as a reservoir for 
BMP-2 delivery and controlled differentiation 
of myoblasts to osteoblasts 
121; 122
. Very 
interestingly, these films are made of natural 
components, are biodegradable, and their 
mechanical properties can also be modulated. 
 
4. Concluding remarks and outlook 
Different types of synthetic and natural 
materials in various forms (thin films or gels) 
have been and are currently being developed 
to reproduce in vitro the in vivo cell 
microenvironment. Here, we have particularly 
focused on materials mechanical and 
biochemical properties. Biochemical 
functionalization has up to now mostly 
focused on improving cell adhesion by 
presenting cell adhesive ligands. However, 
many ligands are not highly specific and do 
not target a particular receptor type. Recent 
developments have begun to focus : i) on 
targeting a given type of integrin or non-
integrin receptors (such as syndecans) and ii) 
to present not only adhesive signals but also 
signals triggered by growth factors (FGF, 
BMP, VEGF…), which affect cell 
proliferation and cell differentiation. There is 
no doubt that this direction will be further 
developed and studied in order to understand 
how different signals can act in synergy. The 
control over mechanical and biochemical 
properties will enable and foster further studies 
aimed at understanding possible synergies 
between these signals. Cross-talks between the 
different signaling pathways may be unveiled 
in a near future.  
Natural materials that have some adhesive 
sites intrinsically and that can bind growth 
factors with a high affinity will be particularly 
interesting candidates as compared to their 
synthetic counterparts. Indeed, if multiple 
functionalities have to be added to synthetic 
materials, the strategy of coupling may 
become even more tedious and time-
consuming. Ease of implementation is an 
important criterion for biomaterials scientists, 
as well as for biophysicists and cell biologists. 
Such experimental constraints should be kept 
in mind when designing materials, as only 
simple, easy-to-handle and easy-to-
characterize materials would be used by cell 
biologists. 
Creating anisotropic properties to mimic the 
natural environment is also a current challenge 
123
. Gradients in both mechanical properties 
and growth factors will thus be developed and 
used to understand how cells respond to these 
cues, from adhesion and proliferation to 
differentiation. We have seen that UV light is 
already widely used for the synthesis of 
biomaterials.  Light-initiated cross-linking 
steps and gradients will probably be a valuable 
tool for basic cell-material interaction studies 
or advanced tissue engineering applications. It 
is also predicted that new methodological 
developments emerging from soft lithography 
and microfluidics will be combined to further 
develop these 2D and 3D biomaterials 
124
. 
Importantly, these technologies can be applied 
to a wide range of polymeric biomaterials 
currently in use. This will make it possible to 
incorporate spatial control which is crucial for 
developing complex microenvironments 
125
. 
Ultimately, control over biochemical and 
mechanical properties in a spatially-controlled 
manner will be achieved to investigate the 
respective role of each parameter as well as to 
produce innovative biomaterials 
126
.  
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Abstract 
Controlling the bulk and surface properties of 
materials is a real challenge for bioengineers 
working in the fields of biomaterials, tissue 
engineering and biophysics. The layer-by-
layer (LbL) deposition method, introduced 20 
years ago, consists in the alternate adsorption 
of polyelectrolytes that self-organize on the 
material’s surface, leading to the formation of 
polyelectrolyte multilayer (PEM) films.
1; 2
 Due 
to its simplicity and versatility, the procedure 
has led to considerable developments of 
biological applications within the past 5 years. 
In this review, we focus our attention on the 
design of PEM films as surface coatings for 
applications in the field of biomaterials, tissue 
engineering and for fundamental biophysical 
studies. This will include a survey of the 
chemical and physical properties that have 
emerged as being key points in relation to 
biological processes. The numerous 
possibilities for adjusting the chemical, 
physical and mechanical properties of PEM 
films have fostered studies on the influence of 
these parameters on cellular behaviors. 
Importantly, PEM have emerged as a powerful 
tool for immobilization of biomolecules with 
preserved bioactivity. 
1. Introduction 
Controlling the bulk and surface properties of 
materials is a real challenge for bioengineers 
working in the fields of biomaterials, tissue 
engineering and biophysics.  
In the field of implantable biomaterials, the 
bulk properties of materials are known to be 
important for the overall properties, especially 
for mechanical strength, but their surface 
properties have long been recognized as being 
of utmost importance. 
3
 The surface of the 
material is an interface between the material 
and the host tissue and is able to trigger a wide 
variety of processes, from the initial 
inflammatory reaction to ultimate tissue 
remodeling. Considerable efforts are thus 
currently devoted towards functionalization of 
the surfaces of biomaterials used in biomedical 
applications (typically metals, polymers, 
ceramics) in order to render them bioactive, 
i.e. able to trigger a specific cell response.
4
 
Polymeric coatings appear especially 
interesting due to the diversity of the chemical 
and physical properties they offer. For 
instance, polymeric coatings have recently 
been employed for the coating of stents. 
5
 
Natural biopolymers appear promising as 
biomimetic coatings, due to their natural 
similarity to human tissues. Lots of efforts are 
thus dedicated to engineering new forms of 
biomimetic surfaces. Tissue engineering has 
grown as a field in its own: its aim is to use a 
combination of cells, engineering and 
materials, and, together with suitable 
biochemical and physico-chemical factors, 
improve the biological functions of damaged 
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tissues (bone, cartilage, blood vessels, skin…) 
or replace them.
6
 Here, a scaffold in 
combination with cells and appropriate 
biochemical signals are needed to trigger a 
specific cell response and lead to formation of 
a new tissue. Synthetic polymeric materials 
can be employed as scaffolds when 
mechanical strength is needed and hydrogels 
can be used for soft tissues.
7
 Thus, surface 
modification of the scaffold may provide it 
with new functionalities. 
Lastly, for more fundamental studies on 
cellular processes, biophysicists have already 
developed several tools to control the 
important properties of surfaces: spatial 
presentation of extracellular matrix proteins 
has been designed using microtechnologies to 
constrain cells in specific areas,
8
,biochemical 
adhesive ligands have been grafted to surfaces 
in controlled amounts,
9
 and more recently, the 
mechanical properties of the substrate have 
also been recognized as playing a key role in 
cell adhesion 
10
 but also in cell fate.
11
 
Developments are now dedicated to the 
combined presentation of several stimuli and 
to the presentation of new types of 
biochemical ligands playing a role in cell fate, 
such as growth factors.
12
 This would also help 
to investigate possible synergies between 
intracellular signaling pathways. Also, the 
presentation of biochemical stimuli is 
traditionally performed for cells grown on stiff 
substrates such as tissue culture polystyrene or 
glass. Now, the aim is to present them from 
softer, more physiological substrates.  
Several techniques have thus been developed 
to design thin films at the molecular level, 
including Langmuir-Blodgett (LB) and self-
assembled monolayers (SAMs). As already 
indicated by Kotov in his review,
13
 both 
present a certain number of limitations and 
disadvantages. For biological applications, 
there was thus a need for easier and more 
versatile deposition methods. The layer-by-
layer (LbL) deposition method, introduced by 
Moehwald, Decher and Lvov 20 years ago, 
consists in the alternate adsorption of 
polyelectrolytes that self-organize on the 
material’s surface, leading to the formation of 
polyelectrolyte multilayer (PEM) films.
1; 2
  
The procedure is simple and versatile, as it is 
possible to control the processing parameters 
to modulate film growth and internal structure. 
Thus, the nature of the polyelectrolytes, the 
nature and number of the functional groups, 
pH and ionic strength during assembly 
14
 and 
the substrate used to build the films can be 
carefully chosen.
15
 PEM film fabrication can 
be performed under mild conditions in an 
aqueous environment, which is a great 
advantage when using biopolymers and 
bioactive molecules. Film growth can be more 
or less rapid and films can be either stratified 
or can exhibit some interdiffusion, which 
makes it possible to use them either as barriers 
16
 or as compartments for the loading of 
bioactive molecules.
17
  
Importantly, as will be shown below, PEM 
films appear highly suitable for 
immobilization of biomolecules with 
preserved bioactivity. They have emerged as a 
new type of coating, besides the more 
traditionally employed self-assembled 
monolayers and Langmuir-Blodgett films. 
18
 In 
fact, the most problematic are probably the 
limited amounts of biological molecules 
incorporated into Langmuir-Blodgett films due 
to their limited stability. For self-assembled 
monolayers, these are monolayers and there is 
a need for the presence of thiols on the 
substrate (e.g for only noble metals or silane) 
in order to deposit them. For PEM films, no 
expensive equipment is required. In addition, 
surfaces of various chemistry and shape have 
already been coated with PEM films.
19
 As will 
be shown below, one of the great advantages 
of the PEM technology is also its ability to 
preserve the bioactivity of biological 
molecules and the possibility to deliver large 
amounts of biomolecules.  
For all these reasons, there have been 
considerable developments in the past 5 years 
in the field of PEM for biomedical 
applications. Several reviews that include the 
biological field have been published recently. 
They concern either the internal structure of 
the films 
15; 20; 21; 22
 or the applications of PEM 
films at the nanoscale.
23
 These applications 
can be for controlled erosion using 
biodegradable polymers, 
24
 protein inspired 
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nanofilms, 
25
 biosensors and biomimetics 
13
 
and drug delivery.
26; 27
 
In this review, we focus our attention on the 
design of PEM films as surface coatings for 
applications in the field of biomaterials, tissue 
engineering and for fundamental biophysical 
studies. This will include a survey of the 
chemical and physical properties that have 
emerged as being key points in relation to 
biological processes. The numerous 
possibilities for adjusting the chemical, 
physical and mechanical properties of PEM 
films have fostered studies on the influence of 
these parameters on cellular behaviors.  
We will include the different possibilities for 
controlling cell behavior by means of film 
composition, presentation of bioactive 
molecules, and modulation of mechanical 
properties. We will focus here on processes 
that require cell adhesion and will not review 
the potentiality offered by PEM films in cell 
transfection 
28
 or as anti-microbial coatings.
29
 
Also, due to limited space, we will not review 
other interesting aspects of controlling cellular 
processes through spatial organization of cell 
adhesion. Spatio-temporal control offers other 
possibilities 
19
 that may open up new 
applications for PEM films that will be 
presented below.  
Through selected examples from the recent 
literature, we will show that PEM films have 
truly emerged as a promising tool for the 
confinement of bioactive molecules, while 
preserving their bioactivity and delivering 
them locally. Very interestingly, these can be 
achieved via specific non covalent 
interactions. By combining the different types 
of properties of PEM films, it is thus possible 
to control the early steps in cell adhesion but 
also longer time scale processes such as cell 
differentiation and tissue formation. Last but 
not least, the controlled presentation of 
bioactive molecules to cells by means of the 
engineered PEM films offers a new tool for 
biophysicists who are interested in unraveling 
the subtle interplay between cell adhesion 
receptors, growth factor receptors and 
mechano-transduction pathways.  
 
2. Role of film composition 
2.1. Films made of synthetic polymers 
2.1.1. Case of (PSS/PAH) films 
Synthetic polyelectrolytes such as poly(styrene 
sulfonate) (PSS, a strong polyelectrolyte), 
poly(acrylic acid) (PAA) or poly(allylamine 
hydrochloride) (PAH) have been widely used 
in cell/film studies. The main advantage of 
using synthetic polymers is the possibility of 
adjusting certain parameters, including ionic 
strength and assembly pH, to a considerable 
degree. Furthermore, they are easy to modify 
chemically. In this case, initial cell adhesion is 
mostly mediated through electrostatic 
interaction (i.e. non specific) and, more 
indirectly, via serum proteins adsorbed on to 
the films. 
The most frequently studied synthetic PEM is, 
by far, linearly growing and dense (PSS/PAH) 
film. Its thickness can be precisely varied from 
a few nanometers to a few tens of nanometers 
30
. Cell types such as endothelial cells, 
31
 
fibroblasts, 
32; 33; 34
 osteoblastic cells,
35
 and 
hepatocytes 
36
 have been cultured on these 
films. As a general rule, adhesion and 
proliferation on these films are very good. This 
may be attributed partly to the presence of 
sulfonate groups. (PSS/PAH) can be coated on 
the inner side of cryoperserved arteries 
37
 
(Figure 1). This improved the mechanical 
properties of the cryopreserved vessel. It also 
made possible the adhesion and spreading of 
endothelial cells so that the internal structure 
of the vessel resembles that of fresh arteries. 
By looking at the expression of specific 
endothelial markers, namely PECAM-1 and 
von-Willebrand-factor (vWF), the authors 
proved that the phenotype of the endothelial 
cells was preserved. In a subsequent study of 
the same group, PEM-treated arteries (rabbit 
carotids) as grafts bypassed native (untreated) 
rabbit carotids.
38
 The in vivo evaluation of 
cryoperserved human umbilical arteries treated 
with (PSS/PAH) multilayers demonstrated a 
high graft patency after 3 months of 
implantation. Such modified arteries could 
constitute a useful option for small vascular 
replacement. 
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FIGURE 1. Scanning electron microscopy images of untreated and PEM-treated explanted arteries A) 
were occluded and with pervasive thrombus (A2) after 1 week of implantation When the artery was treated 
with a (PSS/PAH) film (C), the internal surface of the treated arteries (C2) showed no adherent cells and 
platelets. After 12 weeks, the treated internal artery surfaces (E2 and F2) showed a similar morphology to 
the native carotid internal surface (images not shown). Original magnification 400 (A and C) and 1,000 (A2 
and C2) (adapted from Journal of the American College of Cardiology Vol. 52, $o. 19, 2008 © 2008, ref 
33.), copyright Elsevier 2008). 
 
In another study, the same group investigated 
the differentiation potential of endothelial 
progenitor cells (EPCs), which are currently 
seen as very promising cells in tissue 
engineering for the design of autologous 
vascular grafts. Very interestingly, a rapid 
differentiation of endothelial progenitor cells 
(EPCs) into confluent mature endothelial cells 
was observed on (PSS/PAH) multilayers, 
which was higher than on conventional 
surfaces.
39
 Indeed, the time needed to obtain 
these mature cells was reduced from two 
months to two weeks. Very recently, human 
mesenchymal stem cells (MSCs) were also 
found to differentiate into endothelial-like 
cells after only two weeks of culture on the 
(PSS/PAH) films, as shown by the expression 
of PECAM-1 and vWF. Thus, (PSS/PAH) 
films appears to have potential for vascular 
tissue engineering.  
Recently, also using human MSCs, Guillaume-
Gentil et al. showed that (PSS/PAH) films on 
conductive indium tin oxide (ITO) electrodes 
can be used as a platform for growing viable 
cell sheets.
40
 In this study, films made of nine 
layer pairs ending with PSS and of ∼20 nm in 
thickness were used. The resulting stem cell 
sheets retained their phenotypical profile and 
mesodermal differentiation potency. The 
authors showed that both electrochemically-
induced local pH lowering and a global 
decrease in the environmental pH resulted in a 
rapid detachment of intact stem cell sheets. 
Furthermore, they evidenced that the 
recovered stem cells sheets recovered 
maintained their capacity to differentiate 
toward the adipogenic and osteogenic lineages.  
2.1.2. Other PEM films made of 
synthetic polyelectrolytes 
Another type of popular PEM assembly is the 
(PAA/PAH) system, which was initially 
developed by Rubner’s group.
41
 The thickness 
of these films can be varied by changing the 
pH of the assembly.
14
 Interestingly, the 
topography of such films can be modified by 
post-treatment in acidic solution to render 
them either nanoporous or sub-microporous.
41
 
Rajagopalan et al. 
42
 investigated the potential 
of such films for wound healing in the cornea 
using corneal epithelial cells as cellular 
models, as the epithelium presents a physical 
barrier to external agents. During wound 
healing, corneal epithelial cells undergo 
proliferation and migrate to the wound site. In 
their study, they created pore diameters in the 
100–600 nm range by post-treatment of 
(PAH/PAA) films in solutions of pH ranging 
from 1.9–2.5 range. Porous surfaces that 
exhibited either 100 nm or 600 nm pore 
diameters supported corneal cell adhesion, but 
the nanoscale porosity significantly enhanced 
corneal epithelial cellular response. Corneal 
epithelial cell proliferation and migration 
speeds were significantly higher on 
nanoporous topographies. The actin 
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cytoskeletal organization was well defined and 
vinculin focal adhesions were found in cells 
presented with a nanoscale environment. 
These trends prevailed for fibronectin(FN)-
coated surfaces as well suggesting that for 
human corneal epithelial cells, the physical 
environment plays a defining role in guiding 
cell behavior. Of note, FN is a cell-surface 
protein, which is a very important component 
of the ECM as it mediates cellular adhesive 
interactions. 
2.2. Films made of natural polymers 
Tissues are composed of cells embedded 
within an extracellular matrix (ECM) made of 
proteins, polysaccharides, and other bioactive 
molecules such as growth factors. ECM 
provides the cells with mechanical and 
biochemical signals.  
ECM proteins, polysaccharides or their 
fragments can be used in PEM construction to 
promote cell adhesion and proliferation. Entire 
films can be made of ECM components; ECM 
molecules or their fragments can be adsorbed 
on the film’s surface or covalently linked, 
respectively. A step closer to recreating the 
original matrix in which cells develop in vivo 
is to use ECM components as building blocks 
for the films.  
Natural biopolymers, such as collagen (COL), 
43; 44
 gelatin,
45; 46
 hyaluronan (HA) 
47; 48
, 
chondroitine sulfate (CS) 
49
 
50
 or heparin 
(HEP) 
51; 52
 can be used as building blocks for 
PEM films. This type of PEM film provides 
compositional uniqueness such as stimulating 
a specific cellular response and serves both as 
mechanical and biochemical signals. 
Type I collagen is a major protein component 
of fibrous connective tissues, which provides 
mechanical support and frameworks for the 
other tissues in the body. Collagen is a natural 
ligand for several cell receptors in the integrin 
family. Gelatin is a partially hydrolyzed and 
denaturated form of collagen.  
HA, CS and HEP belong to the family of 
glycosaminoglycans, which is made of 
disaccharide repeating units containing a 
derivative of an amino sugar, either 
glucosamine or galactosamine. They contain a 
negatively charged carboxylate and/or sulfate 
groups. HA and CS are responsible for the 
unique hydration and mechanical properties of 
synovial fluid, cartilage and tendons. HA and 
CS are highly hydrated polymers surrounded 
by respectively ∼20 and ∼30 water molecules 
per disaccharide unit in interaction through 
hydrogen bonds 
53
. Importantly, these 
polysaccharides are part of the pericellular 
coat (also called glycocalyx). This coat, which 
can be up to several µm in thickness,
54
 plays a 
major role in the interactions between a cell 
and its environment by mediating cellular 
adhesion and the diffusion of 
biomacromolecules such as growth factors.
55
 
HEP has several possibilities for sulfate 
groups. Some forms act as anticoagulants by 
binding specifically to antithrombin, which 
accelerates the sequestration of thrombin. This 
is why HEP is often used as an anti-coagulant.  
In an early study, gelatin was associated with 
polyethyleneimine (PEI) and deposited on a 
synthetic degradable poly(DL-lactide) 
substrate.
56
 Chondrocytes were found to attach 
and proliferate, and their viability was good on 
these PEM-modified scaffolds.  
Gelatin was also associated with chitosan 
(CHI), a polysaccharide that is not present in 
the human body but can be found in crustacean 
shells, and deposited on to titanium films.
46
 
Here, the authors showed that the proliferation 
and viability of osteoblast cells on the PEM-
modified titanium substrates were better than 
on control surfaces after one and 7 days of 
culture in vitro.  
COL has been associated with HA to build 
(COL/HA) films.
44
 Interestingly, the fibrillar 
structure of collagen was preserved as 
observed by AFM imaging of the films. The 
authors showed that chondrosarcoma cells 
spread well and synthesized the extracellular 
matrix components solely on the collagen 
ending films, whereas no cellular matrix was 
found for those ending with HA. 
The introduction of HEP into PEM films is 
often applied to coatings of blood-contacting 
biomaterials. In fact, endothelialization and 
antithrombogenicity are two key issues in stent 
implantation. Heparin was initially introduced 
with PEI.
57
 Recently, (COL/HEP) films have 
been employed as titanium coatings to study 
endothelial progenitor cell (EPC) attachment 
and proliferation.
58
 In vitro, the (COL/HEP) 
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greatly increased EPC attachment and 
proliferation as only 3 days were required to 
form a confluent layer. Furthermore, platelet 
adhesion was found to be reduced on such 
coatings.  
As CS is an important component of cartilage 
and bone tissues, the adhesion of bone cells to 
(CS/HEP) coatings was recently 
investigated.
59
 When CS was used as a film 
component, the films displayed a low Young’s 
modulus and cell adhesion was poor. 
However, the cells responded differently when 
CS was adsorbed on to a stiffer polypeptide 
PEM basis. Similar films made of (COL/HEP) 
and (COL/CS) were recently built on 
poly(dimethylsiloxane) (PDMS) substrates,
60
 
with COL retaining its fibrillar structure. 
Whereas (COL/CS) films were stable in 
culture medium, (COL/HEP) were not. 
Primary bovine chondrocyctes were found to 
adhere better on PEM films than on tissue 
culture polystyrene. Interestingly, these 
authors showed that 1 integrin antibodies 
prevented cell spreading, suggesting that cell 
adhesion and spreading were specifically 
mediated by interactions with the collagen 
fibrils.  
One advantage of these natural components is 
their ability to specifically interact with living 
cells, their bioavailability and their possible 
biodegradability, as specific enzymes are 
present in tissue and biological fluids.  
2.3 Role of the final layer: surface charge 
and hydrophobicity 
As PEM films are 2D materials, not only their 
entire composition, but also their surface 
composition is important. Surface charge can 
affect protein adsorption (depending on the pI 
of the protein) and ultimately cell adhesion. 
The typical functional groups of the 
polyelectrolytes are carboxylic acid, sulfate, 
sulfonate as negatively charged groups and 
amine as positively charged groups. In the case 
of synthetic polyelectrolytes, PAA-ending 
films (carboxylic group) were found to be 
resistant to the adsorption of BSA, fibrinogen 
or even to lysozyme, which is oppositely 
charged to PAA.
61
 This was explained by the 
low charge density of PAA but also by its 
strong hydration, which creates an exclusion 
volume above the PAA layer. Usually, 
proteins adsorb preferentially on to films of 
opposite charge.
61; 62; 63
 For instance, PAH-
terminated films lead to a very high adsorption 
of proteins from the serum 
64
. On PSS-ending 
films, certain serum proteins present in the cell 
culture medium, such as BSA, adsorb weakly 
65
 and may be implicated in the cell response 
to PSS-ending films.  
However, it now seems to be accepted that 
protein adsorption alone cannot account for the 
significant differences in cell adhesion.  
Depending on the cell type, cell may prefer 
positively or negatively charged film-ending 
layers. For instance, hepatocytes grown on the 
films made from synthetic polymers 
poly(dimethyldiallylammonium chloride) 
(PDDA) as polycation and PSS
66
 adhered only 
to the films terminated with a PSS layer, and 
not to PDDA-ending films. However, other 
cells lines, such as fibroblasts, were less 
sensitive and adhered on both the PDDA and 
PSS-ending films.  
In a different field of application, the 
differentiation potential of myoblast into 
myotubes was assessed recently.
67
 The authors 
first investigated the growth of myoblasts on 
PSS or PAH-ending films with PSS of 
different molecular weighs. They found better 
viability and growth on PSS-ending films but 
observed that there was no difference for PSS 
of different molecular weights. They also 
followed differentiation into myotubes over 7 
days and observed it was more effective on 
PSS-ending films, as assessed by the higher 
fusion index. The molecular weight of the PSS 
had no influence.  
Hydrophilicity/Hydrophobicity are also known 
to influence protein interactions with the 
surface and cell adhesion as well. Synthetic 
polymers were employed by Salloum et al. for 
investigating the combined effects of 
increasing surface charge and hydrophobicity 
68
 on vascular smooth muscle cell (SMC) 
adhesion. On the most hydrophobic surfaces, 
the A7R75 SMCs spread and were not very 
motile. Conversely, on the most hydrophilic 
surfaces, these cells adhered poorly and 
displayed characteristics of being highly 
motile.  
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It was shown that surface wettability, surface 
charge and lateral structures could be 
controlled by changing the pH value of the 
HEP solution to acidic, neutral or alkaline 
values during multilayer assembly of PEI and 
HEP multilayer films, resulting in modulation 
of fibroblast adhesion.
69
 All terminal layers 
were cytophobic, unless pre-adsorption of 
serum or of FN was achieved. The effect of the 
serum was more prominent on PEI final layers, 
probably due to their positive surface charge, 
whereas the effect of FN was more 
pronounced on HEP terminated multilayers, 
possibly due to its ability to bind FN 
specifically. The PEM films that were initially 
non adhesive were also found to inhibit 
fibroblast growth. On the contrary, those 
favoring cell adhesion also induced higher cell 
growth and metabolic activity.  
To conclude, surface charge and 
hydrophobicity of PEM films can have a 
significant impact on cell adhesion, in a 
manner that depends on the nature of the 
functional groups and on the cell types, as 
well.  
2.4 Influence of film thickness 
Some films are known to grow linearly over a 
wide range of conditions, whereas other PEM 
films grow exponentially. This is the case for 
(PLL/PGA)
70
, (PLL/HA)
71
 and (PLL/CSA)
49
 
films built in physiological conditions (pH 7.4, 
0.15 M NaCl). Film thickness is related to the 
ability of the polyelectrolyte to take up water, 
to the charge matching of the polyelectrolyte 
pairs and to the affinity of the polyelectrolytes 
for each other 
15
. Usually, PEM films made 
from highly hydrated polysaccharides and 
polyaminoacids yield gel-like films. In such 
cases, the films are very soft and hydrated, and 
cells adhere poorly to them.
72; 73; 74
 On the 
contrary, as mentioned above (see 2.1.1.), cell 
adhesion is usually good (PSS/PAH) films 
exhibiting linear growth.  
Film thickness can also be modulated by pH 
variations during film assembly, one of the 
best characterized PEM films in this category 
being (PAH/PAA) films. Rubner’s group has 
plotted the film thickness matrix as a function 
of the pH of each polyelectrolyte solution ,
14
 
with thick films being formed when the pH of 
PAA is close to 2, while highly stitched and 
dense films are formed at neutral pH. 
(PAH/PAA) films were found to be non 
adhesive when films were built at pH 2 (thick 
films), whereas high adhesion was observed 
for films built at pH 6.5. This was attributed to 
the ability of the former films to swell. 
75; 76 
 
3. Modulation of film mechanical 
properties 
It is increasingly accepted that cell processes 
depend on the reciprocal and dynamic 
interactions of cells with their surrounding 
microenvironment, which include biochemical 
and mechanical stimuli defined by neighboring 
cells and extracellular matrices.
77
 Cells are 
mechano-sensors known to transduce a 
mechanical signal into a biochemical signal, or 
vice versa. Specific proteins are known to play 
a key role in this process and among those are 
integrins. Integrins are trans-membrane 
receptors that exhibit conformational changes 
in response to mechanical stimuli.
78
 Some 
components of the adhesive structures of the 
cells that are formed during adhesion (e.g focal 
adhesions) can also exhibit conformational 
changes and transducer forces. Many cell 
types are sensitive to the mechanical properties 
of the underlying substrate and respond by 
increasing their adherence, spreading and 
proliferation. 
In a pioneer study by Discher’s group, 
decoupling (or independent adjusting) of the 
mechanical and chemical properties has been 
achieved, using model synthetic gels such as 
polyacrylamide gels grafted with COL at 
increasing densities.
79
 The same group showed 
that altering polyacrylamide gel stiffness made 
possible MSC differentiation into neurons on 
soft PA gels, bone cells on stiff gels that 
mimicked collagenous bone,
11
 and myoblasts 
for gels of intermediate stiffness. Other types 
of synthetic and natural polymeric materials 
with controlled mechanical properties have 
been developed, such as poly(ethylene 
glycol),
80; 81
 PDMS, alginate 
82
 or 
hyaluronan.
83
  
Although a full decoupling of mechanical and 
chemical properties is the ideal goal, this is in 
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fact very difficult to achieve. There are several 
reasons for this: first, many of the cross-
linking strategies are based on a chemical 
modification of the material. Second, 
biochemical ligands are added by grafting it or 
by adsorbing it. Grafting involves a chemical 
modification at the surface of the material and 
adsorption, which relies on non covalent 
interactions, is a natural process that depends 
on the physico-chemical properties of both the 
material and the protein.   
PEM films are materials whose mechanical 
properties can be controlled in several ways, 
thus allowing cell studies on the films of 
different stiffnesses.  
Different strategies employed for modulating 
the mechanical properties of PEM films have 
already been reviewed recently: adding “stiff” 
layers,
84
 modulating pH during assembly 
85
, 
chemical cross-linking by means of 
glutaraldehyde 
86
 or by means of a 
carbodiimide,
72
 photo-crosslinking using 
photosensitive derivatives of the 
polyelectrolytes,
87; 88
 or incorporating 
nanoobjects into the film.
89
 (Figure 2) 
 
            A 
 
  
FIGURE 2. (A) Overview of the main strategies used to modulate mechanical properties of polyelectrolyte 
multilayer films. The methods are essentially based on ionic cross-linking, chemical cross-linking and 
physical cross-linking. (B) Range of stiffnesses of the natural and synthetic polyelectrolyte multilayer films.  
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As mentioned by Sukhishvili et al. 
27
, cross-
linking is often applied to convert PEM films 
into “surface hydrogels”. Often, soft and 
hydrated films do not exhibit stratification but 
what is required here is rather a change in their 
“bulk” properties. The film is seen as a 
“surface adsorbed hydrogel” whose 
confinement provides it with very interesting 
properties for local changes in biochemical 
and mechanical properties. Of note, this 
modulation in mechanical properties over one 
or two orders of magnitude in Young’s 
modulus can only be achieved if the film’s 
stiffness in uncrosslinked conditions is 
sufficiently low. 
3.1. Adding “stiff” layers  
For instance, (PSS/PAH) films are already so 
stiff (Young’s modulus of up to 100 MPa) that 
nobody has tried to stiffen them even more. 
Instead, they can be employed as a rigid 
barrier to stiffen (PLL/HA) films.
84; 90
 Thus, 
by adding several layer pairs of (PSS/PAH) on 
to the (PLL/HA) basis, Vautier et al. 
90
 have 
shown that the adhesion of kidney epithelial 
cells progressively increased when the films 
become stiffer. In a very elegant manner, they 
have studied the influence of substrate 
elasticity on replication and transcription, 
using such PEM films as model substrates. 
The sequential relationship between Rac1 (a 
very important protein involved in cytoskeletal 
changes), vinculin adhesion assembly, and 
replication becomes efficient at above 200 kPa 
because activation of Rac1 leads to vinculin 
assembly, actin fiber formation and, 
subsequently, to the initiation of replication. 
Above 50 kPa, transcription was correlated 
with the engagement of a specific integrin 
(v-integrin) together with histone H3 
hyperacetylation and chromatin 
decondensation, allowing little cell spreading. 
In contrast, soft substrates (below 50 kPa) 
promoted morphological changes 
characteristic of apoptosis, including cell 
rounding, nucleus condensation, loss of focal 
adhesions and exposure of phosphatidylserine 
at the outer cell surface. 
3.2. Modulating pH during assembly 
As shown by Van Vliet et al., the stiffness of 
(PAH/PAA) films assembled at different pH 
can be varied from 200 kPa to 142 MPa and 
can affect cell function.
85
 They showed that 
the adhesion and proliferation of human 
microvascular endothelial cells strongly 
increased as the PEM became stiffer.
85
 In a 
recent work, the same group adjusted 
independently the mechanical and chemical 
properties of films by modifying the film’s 
surface with COL I or a mixture of COL 
I/decorin and studying primary hepatocyte 
adhesion and functions. These cells are widely 
considered to be ideal for constructing liver 
tissue models but are known to rapidly (within 
a few hours or days) lose their viability and 
phenotype functions upon isolation from the 
native in vivo microenvironment of the liver. 
They found that, on unmodified (PAH/PAA) 
surfaces, hepatocyte attachment increased with 
PEM rigidity,
91
 but this trend was canceled 
when the PEM substrata was modified with 
COL I or with COL I pre-mixed with the small 
proteoglycan decorin. They also demonstrated 
that hepatic albumin secretion (a marker for 
liver-specific protein synthesis) over two 
weeks decreased with increasing substrata 
stiffness, correlating that hepatocytes formed 
stable, spheroid aggregates preferentially on 
protein-modified compliant surfaces, whereas 
cells detached from stiffer substrata after only 
a few days of culture. Such detachment was 
presumably due to the dominance of cell–cell 
over cell–substrata interactions.
91
  
3.3. Chemical cross-linking  
Chemical cross-linking by means of 
carbodiimide chemistry has been applied to 
various PEM films and quantified by means of 
infrared spectroscopy and AFM nano-
indentations 
92
. Amine and carboxylic groups 
are converted into covalent amide bonds 
72
 in 
the presence of 1-Ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC). 
Chondrosarcomas and chondroytes,
93
 
osteoblasts,
74
 have been found to adhere more 
when the (PLL/HA) or (PLL/PGA) film 
74
 
stiffness is increased. For SMCs,
94
 and skeletal 
muscle cells,
95
 
19
 an increase in cell spreading 
on (PLL/HA) cross-linked films as well as on 
(PAH/PGA) cross-linked films was observed.  
Recently, the behavior of two different types 
of stem cell was investigated on (PLL/HA) 
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cross-linked films: MSCs and embryonic stem 
cells (ESCs). MSCs represent a particularly 
interesting cell type for research and therapy 
because of their ability to differentiate into 
mesodermal lineage cells such as adipocytes, 
osteocytes, chondrocytes, cardiac muscle, or 
endothelial cells.
96
  Zisch et al. observed that 
native (PLL/HA) (e.g. uncrosslinked) showed 
poor adhesion for MSCs despite a high surface 
density of preadsorbed FN.
97
 However, MSC 
adhesion and proliferation was very good on 
cross-linked (PLL/HA) films. Covalent 
attachment of FN was necessary to maintain 
the MSC over weeks for their differentiation. 
Furthermore, the MSC were capable of 
differentiating into osteocytes and 
chondrocytes upon culture with induction 
factors. 
The behavior of ESCs on (PLL/HA) films has 
also been investigated. ESCs are derived from 
the inner cell mass (ICM) of the blastocyst at 
an early stage of embryonic development 
following the segregation of the embryo into 
the ICM and the trophectoderm.
98
 Blin et al. 
showed that ESC adhesion and proliferation 
increased on stiffer films. ESCs were also 
shown to keep their pluripotency when grown 
on native nanofilms, which prevented their 
adhesion. Their phenotype was more 
reminiscent of the ICM stage of 
embryogenesis. Furthermore, cells grown on 
native (PLL/HA) films exhibited a better 
potential for differentiation than cells grown 
on cross-linked films. These latter cells 
reached the epiblast stage, which had a more 
limited repertoire of differentiation.  
The chemistry of the native film played an 
important role in the maintenance of ESC 
pluripotency. In fact, the native films, but not 
cross-linked ones, released a small amount of 
PLL, which was sufficient to induce the 
expression of ICM genes for ESC cells.  
This very small release may be related to the 
mechanical properties of the native (PLL/HA) 
film. Indeed, reflection interference contrast 
microscopy and confocal laser scanning 
microscopy experiments have evidenced that 
native (PLL/HA) film is rather a viscoelastic 
liquid whose equilibrium elastic modulus is 
zero.
99
 This was not observed for EDC-
crosslinked films.   
3.4. Photo-crosslinking  
Photo-crosslinking is another way of 
modifying a film’s mechanical properties after 
film buildup, provided that one of the 
polyelectrolytes has a photo-sensitive group.
87
 
Pozos-Vasquez et al. also reported on the 
preparation of polyelectrolyte films based on 
PLL and HA derivatives modified by 
photoreactive vinylbenzyl (VB) groups.
88
 The 
VB-modified HA incorporated into the films 
was cross-linked on UV irradiation and the 
force measurements taken by atomic force 
microscopy proved that the rigidity of the 
cross-linked films increased up to four times. 
Adhesion of myoblast cells increased on the 
stiffest films.  
These research papers, studying different cell 
types on different PEM films, highlight on the 
one hand the strong dependence of cell 
processes on both the mechanical and 
chemical properties of the substrata, and, on 
the other, the difficulties for decoupling these 
two distinct properties. Thus, care is needed 
when concluding from the respective roles of 
these factors, that they are often correlated.  
3.5. Incorporating nanoparticles 
Incorporating nanoobjects into an organic 
matrix is another way of stiffening it, and has 
already been widely applied to PEM films 
100; 
101
. Different types of nanoobject have been 
introduced as film components, including 
carbon nanotubes 
102
 
100
 and montmorillonite, 
103
 Evaluating the mechanical properties of 
these composite films displayed up to 2 orders 
of magnitude more on Young’s modulus when 
compared with the pure polyelectrolyte.
104
 The 
mechanical properties also depend on the non 
aggregated or aggregated state of the 
nanoparticles 
105
. Such composite assemblies 
with interesting mechanical and electrical 
properties appear particularly interesting for 
the coating of neuroprosthetic devices .
106
 In a 
first study, Kotov et al. showed that thin PEM 
membranes containing single-walled carbon 
nanotubes (SWNT) supported extensive 
neurite outgrowth.
100
 Later on, the same group 
demonstrated that mouse embryonic neural 
stem cells (NSCs) could be successfully 
differentiated into neurons, astrocytes and 
oligodendrocytes with clear formation of 
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neuritis on the PEI/SWNT multilayer films.
89
 
NSCs behaved similarly to those cultured on 
the standard and widely used poly(L-ornithine) 
substratum in terms of cell viability, 
development of neural processes, and 
appearance and progression of neural markers.  
More recently, synthetic PEI was replaced by 
the protein laminin, which is an important 
component of the extracellular matrix of the 
brain, to “humanize” the carbon 
nanocomposite film 
107
. The authors found that 
the adhesion of NSCs up to 7 days in culture 
depended on the outermost layer and on the 
post-treatment (heating at 300°C for a very 
short time) (Figure 3). The (SWNT/laminin) 
nanocomposites did not support cell adhesion, 
unless they were stiffened by heating. The 
substrate that was most conducive to cell 
adhesion and attachment was the PEM film 
that contained SWNT as the topmost layer and 
that was heat treated. Extensive formation of 
functional neural networks was observed as 
indicated by the presence of synaptic 
connections. Importantly, 98% of the cells 
were found to remain viable. Immuno-staining 
of specific neuronal markers MAP-2 (for 
neurons), glial fibrillary acidic protein, GFAP 
(for astrocytes), and nestin (for NSCs) were 
performed after 7 days of culture. 
Interestingly, it was found that differentiated 
neurons and glial cells were present in large 
amounts due to spontaneous differentiation 
caused by the physical properties of the 
SWNT/laminin composites. Furthermore, 
calcium imaging of the NSCs revealed 
generation of action potentials upon the 
application of a lateral current through the 
SWNT substrate. All together, these results 
appear very promising as they indicate that the 
protein-SWNT composite can serve as the 
material foundation of neural electrodes with a 
chemical structure better adapted to long-term 
integration with the neural tissue. 
 
 
FIGURE 3. Micrograph assessing neural stem cell adhesion and differentiation 72 h after initial seeding 
on (a) laminin-coated glass slides and on 10 bilayers SW$T/laminin thin films that were (b) used as is or (c) 
heated at 300 °C for 10 min. (d) Distance of outgrowth from neurospheres after 24 h (yellow), 48 h (red), 72 
h (blue), and 120 h (green) on laminin-coated slides and heat-treated SW$T/laminin film on slide. (e) Live-
dead viability assay on seeded cells where live cells are stained green and dead cells are red. Scale bars are 
200 µm (reproduced with permission from ref Kotov et al, $anoletters 2009, copyright ACS 2009).00 
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3.6. Modeling the cell response  
There are still only a few models of cell 
interactions with PEM films. In a recent model 
of cell adhesive behavior on thin 
polyelectrolyte multilayers, Chan et al. 
108
 
implemented a finite element analysis to help 
elucidate the trends observed in cell spreading, 
e.g. decreased cell spreading when the number 
of layer pairs in the film was increased (for 
very thin films of less than 100 nm in 
thickness). The authors correlated the focal 
adhesion area to the amount of work done by 
the cell during active mechanosensing. The 
film was modeled as a linear elastic material. 
An “effective stiffness” was defined to account 
not only for its mechanical properties but also 
for its thickness and for the number of focal 
adhesions recruited. Their results suggest that 
the energy consumed by the cells during active 
probing with a constant adhesion force 
regulates cell morphology and adhesion 
behavior. 
Further modeling of cell/film interactions may 
help to better understand the role of various 
parameters in cell response. 
4. Biochemical functionalization  
Biochemical functionalization can be achieved 
in order to activate a specific cellular signal. 
Presentation of a biochemical signal by the 
PEM films allows this signal to be spatially 
controlled at the cell adhesion site. The 
biochemical signal can also be potentially 
sustained for a long time period. Different 
strategies may be employed (Figure 4). 
4.1. Modification by ECM molecules 
4.1.1. Adsorption of entire ECM 
proteins on PEM films 
To improve cell adhesion on PEM films, 
adsorption of ECM proteins (Figure 4A) on to 
multilayers is a useful tool, usually achieved 
using COL or FN as adhesive proteins. These 
proteins are widely used by biomaterial 
scientists,
109; 110
, biophysicists 
79
 and biologists 
111
 as they are important ECM proteins and 
probably the best characterized. The aim is to 
provide specific attachment to the cells via 
integrin receptors. 
Wittmer et al. 
36
 investigated the effect of 
various parameters on the attachment and 
function of three different types of hepatic cell, 
human hepatocellular carcinoma (HepG2) 
cells, rat hepatocytes and human fetal 
hepatoblasts. To this end, they chose different 
types of PEM film, such as (PAH/PSS), 
(PLL/PGA) or (PLL/ALG) films and 
systematically studied the influence of 
composition, terminal layer, and rigidity 
(using EDC cross-linked films, see 3.3). They 
also investigated the influence of a terminal 
layer of COL I or COL IV, a prominent extra-
cellular matrix protein within the human liver 
parenchyma. In a first step, they studied cell 
attachment and growth over a 7-day period 
and in a second step, they quantified albumin 
secretion of the confluent systems. 
Importantly, all the PEM systems produced 
albumin, indicating the presence of functional 
hepatoblasts and/or hepatocytes. The cross-
linked (PLL/PGA)n-PLL films promoted the 
greatest level of function at 8 days. From the 
large set of conditions they studied, they 
conclude that film composition, terminal layer, 
and rigidity are key variables in promoting 
attachment and function of hepatic cells, while 
film charge and biofunctionality were 
somewhat less important. 
Using (PAH/PAA) films as a matrix for 
hepatocyte attachment, Van Vliet et al. 
showed that adsorption of COL on the softest 
films (PEM built at pH 2) led to enhanced 
hepatocyte attachment, which was statistically 
similar to the stiffer, unmodified and protein-
modified substrata.
91
 
The effect of FN adsorption on to PEM films 
has also been investigated in some specific 
cases. For instance, Olenych et al. 
76
 found 
that FN bound best to PAH-terminated and 
Nafion-terminated PEMUs, but poorly to PEM 
films terminated with a copolymer of PAA. 
A7r5 smooth muscle cells were found to 
adhere and spread well on the Nafion-
terminated PEMU surfaces. In contrast, cells 
spread less and migrated more on both FN-
coated and uncoated PAH-terminated PEM 
surfaces. Interestingly, these results indicate 
that A7r5 cell adhesion, spreading, and 
motility on PEMUs can be independent of FN 
binding to the surfaces. 
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FIGURE 4. Scheme representing different possibilities of incorporing bioactive molecules inside or on top 
of PEM films. (A) Adsorption of the bioactive molecule can be achieved after film buildup or at a certain 
step during build up. In case of diffusion, the bioactive molecule can be loaded in the “bulk” of the film; (B) 
Very small molecules such as bioactive peptides can be grafted to one of the polyelectrolytes; (C) if one of 
the components is hydrolysable, then the bioactive molecule can be delivered in solution.   
 
Using (PLL/dextran sulfate) PEM films, 
Wittmer et al. 
112
 also showed, by means of 
quantitative measurements of FN adsorption, 
that FN adsorption on PLL-terminated films 
exceeded that on dextran sulfate-terminated 
films by 40%, correlating with the positive 
charge and lower degree of hydration of PLL 
terminated films. They followed the 
attachment of endothelial cells (human 
umbilical vein endothelial cells) and found that 
PLL-ending films exhibited a greater extent of 
cell spreading than dextran sulfate-ending 
films. Furthermore, adsorption of FN led to an 
increase in cell spreading. For these PEM 
films, they concluded that the presence of FN 
was an important factor, more than film charge 
or layer number, in controlling the interaction 
between multilayer films and living cells.  
Based on all these studies, it appears that it is 
not possible to draw a unique conclusion. In 
some cases, film composition and mechanical 
properties can be more important than the 
biochemical signal provided by the adsorbed 
ECM molecules. However, in the case of 
poorly adhesive films (especially soft PEM 
films), the biochemical signal may compensate 
and lead to engagement of integrin cell 
receptors, leading to increased cell attachment 
and spreading. 
It should be noted that solely quantifying the 
adsorbed amount of protein is not predictive 
enough of the conformation of the protein on 
the PEM films. Indeed, conformational 
changes that occur upon protein adsorption are 
difficult to assess with quantitative methods 
due to the low amount of adsorbed amounts. 
Garcia et al. 
113
 showed that FN 
conformational changes can be detected by 
different antibodies recognizing specific 
protein motifs. Antibody binding also depends 
on the state of the molecule (stretched versus 
relaxed).
114
 Such FN conformational changes 
can control switching between proliferation 
and differentiation. Last by not least, other 
proteins present in a much lower amount in the 
serum may act in synergy with the pre-
adsorbed proteins.  
Recently, gold nanoparticles (AuNPs) were 
used as a tool for depositing cell adhesion 
proteins, fibronectin and ephrinB3, on top of 
PEM films.
115
 The authors studied cancer cell 
adhesion and found that it was affected by 
nanoparticle density, an optimum being 
observed for an intermediate nanoparticle 
density. Drastic changes in cell adhesion were 
observed, with the formation of protractions 
(lamellipodia and filopodia). Of note, the 
influence of the nanotopology here was also 
higher than the influence of the coating of the 
Au NP. Interestingly, the authors also studied 
Adsorption of biomolecules
diffusion inside no diffusion embedding
A
RGDRGDRGDRGDRGD
Grafted peptidesB Hydrolysable polyelectrolyteC
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ephrin signaling by quantifying the expression 
of paxillin. They found that it was more 
effective when ephrin B3 was presented from 
the Au NP than when it was directly attached 
to the polymer film.  
4.1.2. Grafting ECM-derived peptides 
Selectivity, i.e. specificity in adhesion, can be 
achieved by grafting peptides (Figure 4B) that 
are known to interact with specific cell 
adhesion receptors, typically integrins. In this 
case, only short sequences of ECM proteins 
are considered. The most prominent example 
is that of the RGD sequence, RGD being a 
central integrin-binding region in FN and 
COL, which has already been grafted to 
polymers using various strategies.
9
 Using 
PEM, two different strategies have been 
developed. The first consists in grafting the 
peptide to one of the polyelectrolytes and then 
adsorbing the modified polyelectrolyte as a 
regular layer. The synthetic step is thus 
performed aside from the film buildup. PEM 
films with poor adhesion are excellent 
candidates for such functionalization, which 
was applied using PAH-RGD and PGA-RGD 
for cell attachment.
74; 116
 PGA-RGD added as 
the outermost layer was shown to have a 
beneﬁcial inﬂuence on osteoblast adhesion and 
proliferation.
74
 Recently, in an elegant work by 
Werner et al.,
117
 it was shown that a laminin5-
derived peptide grafted to PGA could induce 
specific cell adhesive structures in epithelial 
cells called hemidesmosomes and specifically 
activate β4 integrins. PAH-RGD was also 
found to increase adhesion on (PAH/PAA) 
films.
118
 The osteoblasts exhibited a better 
differentiated phenotype on the pH 2.0 films 
than the pH 6.5 films with respect to calcium 
deposition. However, incorporation of another 
peptide (LHRRVKI) known to be a heparin 
binding domain did not support cell adhesion, 
growth or matrix mineral deposition. 
The second strategy consists in directly 
coupling the RGD peptide on to the film using 
the carbodiimide EDC as coupling agent.
119
 
This was achieved on (HA/CHI) films 
deposited on titanium. Osteoblast cells adhered 
and proliferated much better in the presence of 
the grafted peptide.  
Importantly, however, the question has been 
raised as to whether these chemical 
modifications in the polyelectrolytes may alter 
other physical chemical properties such as 
protein adsorption or mechanical properties, in 
turn influencing cell adhesion and 
proliferation. These points were investigated 
by Thompson et al. 
120
 and Schneider et al. 
121
 
who measured the mechanical properties of the 
films with or without modified 
polyelectrolytes.  
4.2. PEM films modified with growth 
factors and hormones 
Another way to render the films bioactive and 
induce specific cell responses is to use 
bioactive molecules like growth factors and 
hormones that control cell proliferation and 
differentiation.  
4.2.1. Grafting of hormones 
A short peptide hormone, α-MSH (alpha-
melanocyte-stimulating hormone), with anti-
inflammatory properties, has been successfully 
integrated into multilayer films. Initially 
coupled with PLL, α-MSH was effective 
toward melanoma cells that were induced to 
produce melanocortin.
122
 Then, coupled with 
PGA and introduced into (PLL/PGA) films, it 
was efficient in annihilating the effect of a 
bacterial endotoxin that stimulated an 
inflammatory response in human monocytic 
cells.
123
 The morphology of the monocytes 
was also affected by α-MSH as the cells 
formed many “fiber like” protrusions not 
visible on standard (PLL/PGA) films. 
4.2.2. Presenting matrix-bound 
growth factors 
It should be noted that grafting proteins is 
more difficult to control than grafting peptides, 
as the protein should not be denaturated during 
the reaction. In addition, as the precise active 
site in a protein is not always known, or 
requires a special 3D conformation, the 
presence of the full length protein (and not of a 
peptide sequence) can be required to achieve 
bioactivity.  
Up to now, two major strategies have been 
employed to provide films with a specific 
bioactivity using larger molecules such as 
growth factors (Figure 4A): i) adsorption of 
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the bioactive molecule as a regular layer. The 
deposition step has to be carefully chosen 
depending on the physico-chemical properties 
of the protein (isolectric point, solubility 
depending on solution pH and ionic strength). 
ii) adsorption and possibly post-loading the 
bioactive molecule in the as-prepared films. 
Depending on the film’s internal structure 
(thickness, porosity, internal groups and 
charges), the bioactive molecule may simply 
adsorb at the film’s surface or diffuse in it. Of 
note, if the PEM film is made of biodegradable 
polymers, then the bioactive molecule will be 
delivered in solution (Figure 4C). If it is not 
biodegradable, the bioactive molecule may 
partially diffuse out of the PEM film and is 
delivered to the basal surface of the cell.  
Growth factors, i.e. proteins that can control 
growth and maturation of tissues, cell 
proliferation, division and differentiation are 
especially interesting in this respect. 
The first strategy was applied for basic 
Fibroblast growth factor (bFGF or FGF-2), a 
factor that is involved in cell proliferation and 
differentiation of a wide variety of cells and 
tissues. This factor was also deposited with CS 
by Shen et al. 
124
, who built (FGF-2/CS) films. 
These authors showed that approximately 30% 
of the incorporated FGF-2 was released within 
8 days. In vitro cell culture found that the 
fibroblasts showed star-like morphology with 
plenty of pseudopods on the FGF-2 
incorporated collagen film after 1 day of 
culture, and the collagen films assembled with 
FGF-2 have better bioactivity than that of the 
virgin one and the FGF-2 control.  
The second strategy of adsorption on top of 
PEM films was also applied to FGF-2 by 
Tezcaner et al.
49
 Using (PLL/CSA) films with 
adsorbed FGF-2, these authors showed that 
FGF-2 increased the number of photoreceptor 
cells attached and maintained the 
differentiation of rod and cone cells.  
(CHI/HEP) film construction was recently 
achieved in the presence and absence of 
adsorbed FN and FGF-2.
125
 The functional 
response of bone marrow-derived ovine MSCs 
to these PEM coatings deposited on TCPS and 
titanium was investigated. These authors found 
that FGF-2 adsorbed to heparin-terminated 
PEMs with adsorbed FN induced greater cell 
density and a higher proliferation rate of 
MSCs than any of the other conditions tested, 
including delivery of the FGF-2 in solution, at 
an optimally mitogenic dose. This effect was 
observed for PEM-coated TCPS. However, 
surprisingly, the same effects were not 
observed when the FGF-2 was delivered from 
PEM adsorbed on titanium and the response of 
ovine MSCs to adsorbed FGF-2 was not as 
strong as the response to FGF-2 delivered in 
solution. This requires further investigation.  
More recently, the loading and release of FGF-
2 from synthetic hydrolytically degradable 
multilayer thin films of various architectures 
were explored by Hammond’s group.
126
 Three 
parameters were studied: number of layers, 
counterpolyanion (heparin or chondrotin 
sulfate), and type of degradable polycation. 
The incorporated amounts were found in the 
range 7-45 ng/cm
2
 of FGF-2 and the release 
time varied between 24 h and approximately 
five days. The effective bioactivity of the 
released FGF-2 was proved in vitro as it 
promoted the proliferation of MC3T3-E1 
preosteoblast cells. Interestingly, FGF-2 
released from LbL films demonstrated 
increased ability of up to 8 times the negative 
control values to enhance proliferation 
compared to the free FGF-2 (about 2 times). 
Importantly, none of the other film 
components (including CS and HEP) showed 
any proliferative effect on the preosteoblasts.  
FGF-2 adsorption via heparin-based PEM was 
also recently applied to decellularized porcine 
aortic heart valve leaflets 
127
, which are used in 
the replacement of diseased aortic valves. 
FGF-2 was found to be released slowly from 
the valve and was sustained over 4 days while 
its biological activity was preserved, as proved 
by increased fibroblast viability.  
As the immobilized growth factors can 
maximally retain their bioactivity, the LBL 
assembly would be a potential approach for 
constructing a bioactive substrate for 
biomedical applications.  
Additional bioactivity can be provided for 
(PSS/PAH) films by adsorbing growth factor 
on to them or by adding them before the last 
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deposited layer. Here again, the charge of the 
polyelectrolyte can influence cell adhesion, 
metabolic activity and adsorbed growth factor 
as well. The first proof of effective bioactivity 
of two nerve growth factors was provided by 
Vodouhe et al.
128
 First, the authors showed 
that better neuron viability was observed on 
(PSS/PAH) and (PLL/PGA) films in 
comparison to a simple monolayer. Second, 
they embedded two nerve growth factors, 
brain-derived neurotrophic factor (BDNF) and 
semaphoring 3A (Sema3A) into (PSS/PAH) 
films before depositing a final PSS layer. The 
adsorbed protein amounts were 95 ng/cm
2
 for 
BDNF and 25 ng/cm
2
 for Sema3A. They 
evidenced that the embedded proteins 
remained functional and available, even under 
two layers of polyelectrolytes. Both proteins 
modified the growth of the neurons either by 
increasing it (BDNF) or by reducing neurite 
length (Sema3A). Such PEM films would 
allow the direct presentation of growth factors 
in the injury environment for promoting repair 
of neuronal tissue. 
Vautier et al.
129
 modified the surface of porous 
titanium implants with polyelectrolyte 
multilayer (PEM) films functionalized with 
vascular endothelial growth factor (VEGF). Of 
the two PEM systems investigated, poly(L-
lysine)/poly(L-glutamic acid) (PLL/PGA) and 
(PAH/PSS), they selected a (PAH/PSS) film 
made of four layer pairs ending with PSS for 
both its high efficiency to adsorb VEGF and 
its biocompatibility toward endothelial cells. 
Furthermore, they showed that it stimulated 
the proliferation of endothelial cells. 
They demonstrated that VEGF adsorbed on 
(PAH/PSS)4 maintains its bioactivity in vitro 
by measuring the phosphorylation of the 
endothelial VEGF receptor VEGFR2 and the 
specific activation of the mitogen-activated 
protein kinases (MAPK) ERK ½ pathway. 
This effect was correlated with specific 
activation of intracellular signaling pathways 
induced by successive phosphorylation of the 
endothelial VEGF receptor VEGFR2 and 
mitogen-activated protein kinases (MAPK) 
ERK1/2.  
Cells capable of differentiating and, in 
particular, stem cells that are multi- or 
pluripotent cells, are currently the subject of 
several studies thanks to their potential 
applications in tissue repair in situ and tissue 
engineering. Here again growth factors are of 
special interest.  
Dierich et al.
130
 were the first to show the use 
of PEM films for the differentiation of 
embryonic bodies (EBs) into cartilage and 
bone. A poly(L-lysine succinylated)/PGA film, 
into which BMP-2 (bone morphogenetic 2) 
and TGFβ1 (transforming growth factor 1) had 
been embedded was chosen for this purpose. 
They found that both BMP-2 and TGFβ1 
needed to be present simultaneously in the 
film to trigger proteoglycan production and 
drive the EBs to cartilage and bone formation. 
The same authors subsequently investigated 
the effect of a growth factor, BMP-4, and its 
antagonist, Noggin, embedded in a PLL/PGA 
film on tooth development. 
131
 They showed 
that these films can induce or inhibit cell death 
in tooth development and that the biological 
effects of the active molecules are conserved. 
The functionalized PEMs could thus act as 
efficient delivery tools for activating cells. 
This approach shows promise as it could be 
used to finely reproduce architectures with cell 
inclusions as well as to provide tissue 
organization.  
BMP-2 is another member of the BMP family 
that is particularly interesting for accelerating 
bone healing.
132
 BMP-2 has been inserted into 
a film as a regular layer, but the successive 
washing steps do not allow a high amount of 
BMP-2 to be retained (less than 100 ng per 
substrate) 
133
. When it is combined with 
hydrolytically degradable polycations (-
aminoesters), several µg can be loaded and 10 
µg of BMP-2 are released over a period of two 
weeks in vitro.
134
 Of note, there was no initial 
burst (less than 1% is released in the first 3 h) 
as compared with commercial collagen 
matrices which can release up to 60% of BMP-
2. BMP-2 released from LbL films retains its 
ability to induce bone differentiation in 
MC3T3 pre-osteoblasts, as measured by 
induction of alkaline phosphatase and stains 
for calcium. In vivo, BMP-2 film coated 
polymeric scaffolds and implanted 
intramuscularly in rats were shown to induce 
bone formation.   
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The adsorption strategy was also applied to 
BMP-2, which was shown to diffuse in cross-
linked (PLL/HA) films.
17
 Indeed, (PLL/HA) 
films are a reservoir for BMP-2, as very high 
loaded amounts can be obtained (up to 7 
µg/cm
2
) and only a small fraction was released 
initially. The amount of BMP-2 trapped could 
be adjusted by varying both the number of 
layers in the film and the initial BMP-2 
concentration in solution. The effective proof 
of bioactivity was obtained on myoblast cells: 
cells differentiated into myotubes on cross-
linked (PLL/HA) films without BMP-2 in the 
films, but they differentiated into osteoblasts 
in a dose-dependent manner when cultured on 
the BMP-2 loaded films. The expression of 
alkaline phosphatase, a marker for osteoblastic 
activity, was dependent on the amount of 
BMP-2 loaded into the films.
17
  
If a mixture of heparin and hyaluronan is used 
as a polyanion in the film buildup, heparin is 
found to be preferentially incorporated. In this 
case, thinner and denser films are obtained, on 
to which only a small amount of BMP-2 can 
be adsorbed. Interestingly, the ALP production 
by myoblast cells was found to be solely 
correlated to the amount of BMP-2 adsorbed 
or trapped in the film, independently of the 
film’s internal chemistry.
135
 Furthermore, the 
bioactivity of BMP-2 loaded in cross-linked 
(PLL/HA) films deposited on TCP/HAP 
granules, biomaterials used in orthopedic 
surgery as a bone substitute, was recently 
confirmed by in vivo studies in rats.
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Induction of bone around the PEM-film coated 
implant (i.e osteo-induction) was proved to be 
due to the sole presence of BMP-2, the film 
itself being inert. In addition, the PEM film did 
not induce an inflammatory response in the 
surrounding tissues. 
4.3 Other types of specific interactions 
A receptor that is especially important for the 
healing of the endothelium is CD34. In the 
cardiovascular field, stent implantation is a 
common procedure, which may subsequently 
lead to in-stent restenosis (i.e obstruction of 
the vessel) or even stent thrombosis. It is 
therefore important to stimulate healing of the 
endothelium in appropriate conditions. Ji et al. 
developed a strategy to mimic the natural 
endothelium healing mechanism that consists 
in stimulating neighboring endothelial cell 
(EC) migration or capturing the circulating 
endothelial cells directly from the blood 
circulation.
86
 To this end, they immobilized an 
anti-CD34 antibody on heparin/collagen 
multilayers. They found that the PEM coating 
with or without the anti-CD34 antibody 
functionalization preserved good 
hemocompatibility, but also promoted cell 
attachment and growth notably in a non 
selective manner. However, the anti-CD34 
antibody functionalized heparin/collagen 
multilayers could specifically promote the 
attachment and growth of vascular ECs at the 
expense of smooth muscle cells.  
Specificity in the interaction may also be 
observed for other types of receptor. HA, 
which is an important polysaccharide 
component of ECM, is known to interact with 
several receptors. Among them is CD44, a cell 
surface glycoprotein involved in cell/cell 
adhesion, cell adhesion and migration. B 
lymphocyte adhesion on to (CHI/HA) films 
was recently investigated by varying the 
deposition conditions, especially ionic strength 
and pH.
137
 The authors showed that there was 
a specific interaction between the CD44 
receptor in lymphocyte cells and HA. 
Furthermore, the deposition conditions of the 
films had an influence on the interaction, low 
pH and added salt being the preferred 
conditions for higher cell binding. This 
interaction was favored in conditions that 
favor loops and tails in HA. However, they 
also noticed that CHI-terminated films 
prepared without NaCl in the deposition 
solutions presented a similar high lymphocyte 
binding efficiency, which they attributed to 
increased electrostatic contributions.   
The same group showed that that it is possible 
to attach a superparamagnetic PEM patch to 
the membrane of T- and B-lymphocytes using 
CD44-HA interactions.
138
 B-cells responded to 
an applied magnetic field, and T-cells 
continued to chemokinetically migrate on 
intercellular adhesion molecule (ICAM)-
coated surfaces following patch attachment.  
However, it should be noted that, for other 
films that contain HA, such as (PLL/HA) 
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films, no specific interaction with HA 
receptors has been evidenced.
139
 This might be 
due to the fact that the films are cross-linked, 
which may affect the presentation of HA to the 
cell receptors due to its entanglement with 
PLL chains.  
5. Toward multifunctionality  
PEM coatings may offer new tools to tissue 
engineers and biophysicists, who need well 
controlled and well characterized biomimetic 
matrices. PEM coatings offer new 
potentialities when compared to classic 
synthetic materials such as polyacrylamide 
gels 
10
 or poly(ethylene glycol) 
140
 by making 
use of both covalent and non covalent 
interactions. The potentialities for 
manufacturing multi-functional coatings that 
combine, for instance, spatial organization and 
bioactivity, or adjustable stiffness and 
chemistry, or adjustable stiffness and 
bioactivity, are apparently unlimited. Recent 
examples illustrate that we are now entering an 
area of new developments for the design of 
multifunctional films.  
5.1 Three-dimensional microenviron-
ments containing bioactive films 
PEM films can be considered as 2D matrices, 
even if they can be several tens of micrometer 
thick, in the sense that they cannot provide a 
sufficiently porous 3D scaffold for the cells to 
grow in. However, PEM films can be 
deposited on porous materials and provide 
additional properties for the biomaterial 
surface.  
In a recent study describing further efforts to 
provide stem cells with a biomimetic niche 
environment, Nichols et al. 
141
 built an elegant 
scaffold with an inverted colloidal crystal 
topography reminiscent of bone marrow 
architecture, which was further coated with 
albumin/PDDA films. Bone marrow stromal 
cells were first allowed to attach to the 
scaffold. Subsequently, CD34+ hematopoietic 
stem cells were seeded in the scaffold to create 
a three dimensional co-culture. The authors 
demonstrated that the scaffold supports 
CD34+ cell expansion and B lymphocyte 
differentiation with production of antigen 
specific IgG antibodies. Recently, the same 
group achieved a further step toward 
mimicking the cell microenvironment of the 
bone marrow and thymus by presenting a 
Notch ligand (Delta-like 1, DL-1) at the 
surface of the PEM film.
142
 For this purpose, 
they used mononuclear cells derived from 
human umbilical cord that were positive for 
the surface marker CD34 (CD34+). After 28 
days of growth on the PEM-coated colloidal 
scaffolds, the cells were found to be CD4+ and 
CD8-, an observation that was specifically due 
to the presence of the DL-1 Notch ligand. 
Without the DL-1 coating, the cells were 
shown to express a CD34 for 2 weeks, which 
indicated that the PEM-coated scaffold 
stimulated ex vivo hematopoietic stem cell 
expansion without notch signaling. In addition, 
the cells progressively developed their own 
ECM.  
3D microwells are increasingly used for cell 
culture arrays.
143
 Recently, Lynn et al. 
developed an approach to the fabrication and 
selective functionalization of amine-reactive 
polymer multilayers on the surface of 3D-
polyurethane-based microwells
144
. These 
authors prepared film-coated arrays that could 
be chemically functionalized postfabrication 
by treatment with different amine-
functionalized macromolecules or small 
molecule primary amines. They showed that 
spatial control over glucamine 
functionalization yielded 3D substrates that 
could be used to confine cell attachment and 
growth to microwells for periods up to 28 
days. A dual functionalization could also be 
achieved by sequential treatment with two 
different fluorescently labeled cationic 
polymers: functionalization of the surface of 
the wells with one polymer and the regions 
between the wells with a second. This 
approach to dual functionalization opens 
perspectives for the long-term culture and 
maintenance of cell types, e.g stem cells. 
5.2 Bioactivity of two different growth 
factors 
The group of Prof Hammond recently showed 
that is it possible to release at precise doses 
two types of potent growth factors, osteogenic 
BMP-2 (to induce bone regeneration) and 
angiogenic VEGF165 (to induce neo-
vascularization) in different ratios in a 
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degradable [poly(b-amino ester)/polyanion/ 
growth factor/polyanion] LbL tetralayer repeat 
architecture. 
145
 The amount of biologically 
active molecules loaded was precisely 
controlled by varying the number of 
tetralayers. Very interestingly, both growth 
factors were shown to retain their bioactivity 
in vitro: BMP-2 initiated differentiation of pre-
osteoblastic cells and VEGF induced 
proliferation of endothelial cells. The authors 
also showed that the mineral density of the 
ectopic bone formed was about 33% higher in 
the case of the dual release (Figure 5) as 
compared to BMP-2 alone, which they 
attributed to an increased local vascular 
network. . 
 
FIGURE 5. Two dimensional microCT scans (2D) and matched three dimensional reconstructions (3D) 
of excised PCL-bTCP half disc scaffolds, which were implanted in the intramuscular region of rats. 
Implants were coated with (i) no growth factor, (ii) 6 µg of single growth factor rhBMP-2 and (iii) 6 µg of 
single growth factor rhBMP-2 followed by 4 µg of rhVEGF165. The amount of growth factor loaded was 
determined by fabricating triplicate companion copies along with the implanted scaffolds, releasing the 
growth factors in vitro and performing ELISA detection assays. (Top row) Control scaffolds without growth 
factors produce no detectable bone over the duration of the study. Low levels of backscatter is caused by the 
polymer. (Middle row) In single growth factor rhBMP-2 films lacking rhVEGF165, bone formation is 
restricted to the periphery of the scaffold at 4 weeks (images not shown) and 9 weeks. (Bottom row) As a 
result of increased vascularity, scaffolds releasing rhVEGF165 demonstrate a smooth, continuous profile in 
the ectopically formed bone which matures from 4 weeks to 9 weeks to fill the entire scaffold. In all the 
images, the bone formed takes the shape of the scaffold and grows inward when VEGF is present. Images 
are an isosurface rendering at 0.25 surface quality factor at a level threshold of 640, as defined by the 
proprietary Microview_ software from GE Healthcare. (reproduced with permission from McDonnald et al, 
Biomaterials 2011, copyright Elsevier 2011) 
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5.3. Mechanical stimulation and delivery 
of bioactive molecules 
PEM film properties may also be combined 
with mechanical stimulation or with 
electrochemical stimulation. In an elegant 
study, Lavalle et al. showed that (PLL/HA) 
films coated with PDMS substrates can be 
stretched and release an enzyme that is loaded 
in the bulk of the film and capped with a 
synthetic PEM barrier. 
146
 The biocatalytic 
activity of the film could be switched on/off 
reversibly by mechanical stretching, which 
exposed enzymes through the capping barrier, 
similarly to mechanisms involved in proteins 
during mechanotransduction. This opens new 
possibilities for triggering the release of 
bioactive molecules from the film “bulk”.  
Interestingly, a recent study by Schaaf et al. 
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showed that the adhesive state of fibroblasts 
can be changed from cytophobic to cytophilic 
simply by stretching a film with a cell 
repellent phosphatidylcholine–PAA layer as 
the final layer. In the afore-mentioned 
examples, the substrate supporting the PEM 
film is stretched in a controlled fashion. 
The ability to construct stable ECM-based 
films on PDMS 
148; 149
 has particular relevance 
in mechanobiology, microfluidics and other 
applications. A combination of PEM with 
microfluidics appears to be highly promising. 
It was recently shown that PEM films can be 
deposited in a microfluidic device and that a 
pH gradient could be generated during 
multilayer formation.
150
 The authors showed 
that cells started to migrate from the films built 
at pH 5 to those built at pH 9. Developments 
of PEM films in combination with 
electrochemistry also appear promising as 
biomolecules can be released from the films 
151; 152
 as well as whole cell sheets.
153
 
Mechanical stimulus can also be provided by 
varying the film’s stiffness. As mentioned 
previously, cells can respond actively to the 
rigidity of a substrate by exerting forces on it, 
which allows them to adhere and spread more 
or less, depending on the rigidity of the 
underlying matrix. Recently, using (PLL/HA) 
films, we have shown that it is possible to 
combine film stiffness and presentation of the 
BMP-2 growth factor by the matrix 
154
. Here, 
the PEM film offers the possibility of 
providing two independent stimuli: a 
mechanical stimulus and a biochemical 
stimulus that is known to impact cell 
differentiation.
17
 By preparing films of 
different stiffness and by loading a known 
amount of BMP-2, we revealed that BMP-2 
has a drastic effect on early cell adhesion 
(Figure 6A) as well as on cell migration 
(Figure 6B). This effect was especially 
potentiated when BMP-2 was presented from 
soft films. First, this highlights that 
biochemical stimuli can override mechanical 
stimuli in certain conditions. Second, this also 
proves that BMP-2 not only has an effect on 
cell differentiation but also possibly in the 
early stages of cell adhesion. This opens a 
route for studies on the interplay between 
growth factor presentation from the matrix 
(and associated cell signaling) and cell 
adhesion receptors involved in rigidity 
sensing.  
Other types of stimulation such as light-
triggered release of activated molecules 
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might also be used in the future to locally 
delivery bioactive molecules to cells, as they 
have shown promise in the delivery of cargo 
from microcapsules adsorbed onto the films 
156
.  
 
6. Evaluation of toxicity and in vivo 
studies  
For translation of PEM-coated surfaces or 
PEM microcapsules into medicine, both the 
efficiency and toxicity of the PEM assemblies 
must be evaluated. It is already known that 
several single polycations are potentially 
cytotoxic, depending on the dose and site of 
injection. This is valid for PEI and PLL 
157
 and 
for CHI as well.
158
 Systematic studies for each 
specific case are thus required.  
The biocompatibility of a single PEI layer was 
tested on both fibroblastic and osteoblastic 
cells. Pure titanium (Ti) and nickel–titanium 
(NiTi) alloy were coated with PEI and 
morphology, adhesion and viability were 
assessed for up to 7 days after seeding. The 
results show that the cells were less viable and 
proliferated less on PEI-coated titanium than 
240 
 
on the control, suggesting that PEI is 
potentially cytotoxic.
159
 On the other hand, 
(PSS/PAH) films deposited on human 
umbilical arteries showed good grafting 
behavior and no inflammation in a rabbit 
model after 12 weeks of implantation.
160
 
Coronary stents have also been coated with 
(CHI/HEP) films and they were tested in vitro 
and in vivo in a pig model.
161
 This PEM 
coating was found to be safe and efficient in 
promoting re-endothelialization and intimal 
healing after stent implantation in addition to 
having good hemocompatibility. Similarly, 
(PLL/PGA) films have been coated on a 
tracheal prosthesis and implanted for up to 
three months.
162
 For prostheses modified by 
PGA ending multilayer films, a more regular 
and less obstructive cell layer was observed on 
the endoluminal side compared to those 
modified by PLL ending films. An anti-
inflammatory peptide grafted to PGA was 
found to be bioactive in vivo. No inflammation 
was observed in the case of BMP-2 delivered 
intramuscularly.
134; 136
  
 
FIGURE 6. Sustained effect of matrix-bound BMP-2 on cell morphology and on cell migration. Cell 
morphology is observed 16 hours after plating the cells. Actin and nucleus staining of C2C12 cells revealed 
a well spread morphology on the glass control substrate as well as on stiff (PLL/HA) films in the presence or 
in the absence of BMP-2, independently of the presentation mode of BMP-2 (“soluble” versus “matrix-
bound”). Conversely, for soft (PLL/HA) films, sBMP-2 did not induce any noticeable effect on cell spreading 
but bBMP-2 induced a striking increase in cell spreading (images not shown). (A) The cell surface area is 
plotted for the different conditions. This shows the drastic increase in cell spreading in response to bBMP-2 
on soft films is sustained after initial adhesion. (B) Migration velocity (µm/hour) of C2C12 cells cultured on 
different substrates: standard tissue culture polystyrene (TCPS) and either stiff or soft films. Matrix-bound 
BMP-2 greatly increases cell velocity on stiff films and even more on soft films with bBMP-2. The soluble 
form of BMP-2 had no significant effect compared to the condition where no BMP-2 is added, except on 
TCPS. ** p<0.005 (reproduced with permission from Crouzier et al, Adv Materials 2011, copyright Wiley 
2011) 
A
B
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De Geest et al. recently carried out an 
interesting study using a terrestrial slug, 
namely Arion lusitanicus as a nonvertebrate 
model organism to investigate mucosal 
irritation.
163
 This slug has recently been used 
to test several pharmaceutical, as well as 
health care components in vivo 
164
 as an 
alternative to tests in mice, rabbits or non-
human animals. They investigated the mucosal 
irritation potency of several classes of 
biopolymers, synthetic polyelectrolytes and 
the reactive polyelectrolytes of oppositely 
charged polyelectrolytes, their complexes as 
well as hollow multilayer capsules, which they 
intend to use in vaccines.
165
 They found that 
single polyelectrolyte components induced 
tissue irritation. But, very interestingly, this 
response was dramatically reduced upon 
complexation with an oppositely charged 
polyelectrolyte, regardless of whether the 
polyelectrolytes were randomly complexed in 
water or assembled in a controlled fashion in 
multilayer capsules.  
The chemical modification of polycations is 
also possible for decreasing their potential 
toxicity. By using PLL modified with PEG 
groups (PLL-g-PEG) and by assembling them 
with alginate, Chaikof et al. recently showed 
that individual pancreatic islets can be coated 
with (PLL-g-PEG/ALG) multilayer films 
166
. 
These authors also demonstrated that 
additional biological specificity can be 
provided for the islets by depositing specific 
groups (such as biotin or azide functionalized-
PEG). Very interestingly, they also showed 
that the functional capacity of islets to release 
insulin in a glucose-responsive manner was 
not adversely influenced by the PEM film. 
Indeed, the islets engineered with PEMs 
secreted statistically similar amounts of insulin 
at both basal and high glucose concentrations 
compared to untreated controls. Furthermore, 
by implanting these islets in vivo into mice 
through the portal vein and into the liver 
microvasculature, they proved that the survival 
and function of these PEM-coated cells.  
All together, these studies show that it is 
possible to design PEM films with bioactive 
properties in vivo, which can be fully 
integrated in vivo without any noticeable 
toxicity. Here again, each engineered PEM 
system will have to be studied in the 
framework of a specific application.  
8. Concluding remarks 
In the last 5 years, there have been 
considerable developments in synthetic and 
natural PEM assemblies for the coating of 
biomaterial surfaces and tissue engineering. 
An important aspect is the dynamic nature of 
mono or multi-cellular systems (interactions 
between cells or cell/matrix) that occur over 
several hours, days, and weeks. Based on this 
survey, it appears that better defined 
applications and multi-functionalization using 
several strategies simultaneously have recently 
emerged. The various strategies that are used 
to non-covalently localize bioactive adhesion 
molecules and growth factors appear highly 
promising for future in vivo studies on tissue 
regeneration as well as for more fundamental 
mechanistic studies. PEMs may serve as new 
biomimetic matrices with controlled physical 
properties and controlled presentation of 
biochemical moieties, for investigating 
cell/material or cell/cell interactions. It is now 
acknowledged that the means of presentation 
of a bioactive molecule is a key point in its 
bioactivity and that matrix-bound presentation 
is much more physiologic than delivering 
growth factors in solution.
167
 As we have seen 
here that many growth factors retain their 
bioactivities inside or on top of PEM films, we 
foresee that PEMs will help answer important 
biological questions such as: How do matrix-
bound molecules interact with cell receptors 
and transduce biochemical signals, as 
compared to soluble molecules added in the 
culture medium? It will also be interesting to 
unravel the structure of the bioactive 
molecules inside PEM films and to understand 
the molecular mechanisms at the basis of their 
preserved bioactivity. General rules may 
emerge. This will require the use of new 
biochemical and biophysical analytical tools. 
PEMs will undoubtedly find a place alongside 
other well established materials such as 
polyacrylamide or polyethylene glycol 
hydrogels, which require covalent grafting for 
the coupling of chemical ligands.  
The potentialities for manufacturing multi-
functional PEM coatings are apparently 
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unlimited. The design and pertinence of such 
architectures will rely on a strong 
multidisciplinary approach and will require 
collaboration between engineers, physical 
chemists, organic chemists, biochemists, and 
cell and stem cell biologists. In the burgeoning 
field of stem cells, PEM films also appear to 
offer a tool to maintain stemness or to guide 
cell differentiation. Besides being a 2D 
coating, their application in 3D mimetic 
architectures will be an original means of 
controlling supra-cellular organization. Thus, 
the reciprocal interactions between active cells 
and active PEM surfaces offer tremendous 
potentialities that will be explored in the 
future.   
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LIST OF ABBREVIATIO2S 
ALG : alginate 
AuNP : gold nanoparticles  
BDNF : brain derived neurotrophic factor 
BMP : bone morphogenetic proteins 
CHI : chitosan 
CS : chondroitin sulfate  and CSA for chondroitin 
sulfate A 
CLSM : confocal laser scanning microscopy 
COL : collagen 
EDC : 1-Ethyl-3-(3-dimethylaminopropyl) 
carbodiimide 
EPC : endothelial progenitor cell 
ESC : embryonic stem cells 
FGF-2 (or bFGF) : basic fibroblast growth factor  
FN : fibronectin 
ICM : inner cellular mass 
HA : hyaluronan 
HEP : heparin 
LbL : layer-by-layer  
MAPK : mitogen-activated protein kinases  
MSC : mesenchymal stem cells 
α-MSH : alpha-melanocyte-stimulating hormone 
NGF : nerve growth factor 
PA  : polyacrylamide 
PDMS : poly(dimethylsiloxane) 
PEI : poly(ethylene)imine 
PLL : poly(L-lysine) 
PAH : poly(allylamine) hydrochloride 
PEM : polyelectrolyte multilayer 
PSS : poly(styrene) sulfonate 
SMC :  smooth muscle cells 
SWNT : single-walled carbon nanotube  
TCPS : tissue culture polystyrene 
VB : vinylbenzyl 
VEGF : vascular endothelial growth factor 
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Annexe III – Grafting protocols 
 
Synthesis of PGA-maleimide 
Materials: 
• PGA (Poly-(L-glutamic acid)), Sigma 54886, lot 017K5108 
• EDC (N-ethyl-N(3-dimethylaminopropylcarbodiimide), Sigma E7750, lot BCBB9878V 
• S-NHS (N-hydroxysulfosuccinimide), Sigma 56485, lot BCBB6771 
• HEPES, Sigma  
• Maleimide : 1) N-(2-aminoethyl maleimide trifluoracetate), Sigma 56951, lot 1442171V; 2) 
2-maleimidoethylamine, Aochem (China) E3333, lot 20121129  
• Spectra/Por dyalisis membrane, MWCO 6-8,000 , Spectrum Laboratories 
Grafting procedure (for ~100 mg of the final product): 
• Prepare “HEPES 6.5” buffer: HEPES 10 mM pH 6.5 (store at 4°C) 
• Dissolve 100 mg of PGA in 2 mL HEPES 6.5 buffer, transfer to a small round-bottom flask 
(~10-20 mL of total volume) under magnetic stirring (= reaction mixture) 
• Dissolve 5 mg of S-NHS in 1 mL HEPES 6.5 buffer and add to the reaction mixture  
• Dissolve 33 mg of EDC in 1 mL HEPES 6.5 buffer and add to the reaction mixture  
• Place under nitrogen atmosphere 
• Dissolve 40 mg (Sigma) or 23 mg (Aochem) of maleimide in 1 mL HEPES 6.5 buffer and 
add to the reaction mixture under stirring and nitrogen atmosphere (use syringe to inject) 
• Incubate for 24h at RT 
Purification (dialysis): 
• Wash the membrane in Na2HCO3 (~1 spoon of powder for 1L of water) at 80°C for 20 
minutes, rinse with water 
• Add the product and dialyse against water 
Freeze-drying: 
• Transfer the product to a round-bottom flask for freeze-drying, freeze with liquid nitrogen 
and insert into the freeze-dryer 
• Store the dry product at -20°C 
$MR analysis:  
• Dissolve ~3-4 mg of the product in 500-600 µL of D2O 
• Analyse by 1H NMR at 298K 
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Grafting of RGD peptide 
Materials: 
• PGA-maleimide DS 16% 
• HEPES, Sigma  
• RGD peptide: CGPKGDRGDAGPKGA, Genecust 
• MPA (3-mercaptopropionic acid), Sigma 145801 
• Spectra/Por dyalisis membrane, MWCO 6-8,000 , Spectrum Laboratories 
Grafting  procedure (for about 10 mg of the final product): 
• Prepare the “HEPES 7.4” buffer: HEPES 10 mM pH 7,4 (store at 4°C) 
• Dissolve 10 mg of PGA-maleimide in 1,5 mL of HEPES 7.4 buffer 
• Dissolve 10 mg of RGD peptide in1,5 mL of HEPES 7.4 buffer 
• Mix and incubate under magnetic stirring at RT for 24h 
• Add 2 µl of MPA (under the hood!) and incubate under magnetic stirring at RT for 24h 
• Purify by dialysis, freeze-dry, analyse by 1H NMR at 298K, store at -20°C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 Annexe IV 
 
 
 
PGA, 353 K 
 
 
 
 
PGA-maleimide, 353 K 
 
  
- NMR spectra 
H2O 
H2O 
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 RGD, 298 K 
Cys-Gly-Pro-Lys-Gly-Asp-Arg-Gly
 
 
PGA-maleimide-RGD, 298 K 
 
 
  
H2O 
H2O 
-Asp-Ala-Gly-Pro-Lys-Gly-Ala 
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 pBMP-2, 298 K 
Cys-Gly-Lys-Ile-Pro-Lys-Ala-Ser
 
 
PGA-maleimide-pBMP-2, 298 K
 
  
H2O 
H2O 
-Ser-Val-Pro-Thr-Glu-Leu-Ser-Ala-Ile-Ser-Thr
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-Leu-Tyr-Leu 
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Abstract 
Tissue engineering approach consists in combining cells, engineering and biomaterials to 
improve the biological functions of damaged tissues or to replace them. Production of “artificial 
tissues” is still challenging and requires collaboration of scientists from different domains like cell 
biology, chemistry, materials and polymer science. 
Skeletal muscle tissue engineering holds promise for the replacement of muscle due to an 
injury and for the treatment of muscle diseases, such as muscle dystrophies or paralysis, but is also 
required for pharmaceutical assays. To this end, materials with tunable mechanical and biochemical 
properties for myoblast expansion and differentiation in vitro, as well as for the studies of 
myogenesis on controlled 2D microenvironments or in 3D scaffolds, are crucially needed.  
In this work, we used layer-by-layer (LbL) assemblies for two goals. The first consisted in the 
development of multifunctional biomimetic thin films for the control of skeletal muscle cell fate on 
2D substrates. We used LbL films made of polypeptides, which can be stiffened by chemical cross-
linking and can be specifically functionalized by grafting of biomimetic peptides onto their surface. 
In addition, we combined the peptide-grafted films with substrate microtopography. Such approach 
is promising for the development or multifunctional materials that combine the different stimuli 
present in in vivo ECM, among them physical and biochemical cues, but also microtopography.  
In the second part, we use LbL assemblies for the construction of 3D skeletal muscle 
microtissues. This allows to rapidly build 3D muscle tissues and is promising for the in vitro 
construction of physiologically relevant skeletal muscle tissue models.  
 
 
Résumé 
L’ingénierie tissulaire consiste à assembler de façon intelligente des cellules et des matériaux 
biocompatibles dans le but de créer des tissus artificiels. Pour la construction de tissus en 
laboratoire, il est indispensable d’élaborer des matériaux qui miment cet environnement. Dans ce 
cadre, la collaboration entre les scientifiques de différents domaines (matériaux, chimie, biologie, 
biochimie) s’avère nécessaire. 
L’ingénierie du muscle squelettique est prometteuse pour remplacer le tissu musculaire 
endommagé et pour le traitement des maladies du muscle, mais aussi pour les essais 
pharmaceutiques. Dans ce but, les matériaux avec les propriétés mécaniques et chimiques 
contrôlées sont requis -- pour l’amplification et la différenciation in vitro de cellules souches 
musculaires, mais aussi pour l’étude de la myogenèse sur des microenvironnements contrôlés 2D et 
dans les matrices 3D.  
Dans ce travail, nous avons utilisé la technique d’assemblage couche par couche (LbL, layer-
by-layer) pour deux buts. Le premier a été de développer de nouveaux films biomimétiques 
possédant des propriétés biochimiques et mécaniques parfaitement contrôlées, pour étudier les 
interrelations entre ces deux paramètres sur les processus cellulaires. En plus, nous avons associé 
ces films biomimetiques aux substrats avec la topographie contrôlée, afin de guider la formation du 
tissu. 
Dans un second temps, nous avons utilisé la technique LbL pour organiser les cellules en 
structures 3D. Nous avons ainsi crée des microtissus d’épaisseur contrôlée, qui pourraient être 
utilisés en tant que modèles de tissus artificiels pour les applications thérapeutiques ou pour les 
évaluations de médicament en industrie pharmaceutique.  
 
